
<html lang="en"     class="pb-page"  data-request-id="e12ae055-aca0-4f29-8ad9-bf5f9c45d7de"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-2;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b01876;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity" /></meta><meta name="dc.Creator" content="Maciej  Dawidowski" /></meta><meta name="dc.Creator" content="Vishal C.  Kalel" /></meta><meta name="dc.Creator" content="Valeria  Napolitano" /></meta><meta name="dc.Creator" content="Roberto  Fino" /></meta><meta name="dc.Creator" content="Kenji  Schorpp" /></meta><meta name="dc.Creator" content="Leonidas  Emmanouilidis" /></meta><meta name="dc.Creator" content="Dominik  Lenhart" /></meta><meta name="dc.Creator" content="Michael  Ostertag" /></meta><meta name="dc.Creator" content="Marcel  Kaiser" /></meta><meta name="dc.Creator" content="Marta  Kolonko" /></meta><meta name="dc.Creator" content="Bettina  Tippler" /></meta><meta name="dc.Creator" content="Wolfgang  Schliebs" /></meta><meta name="dc.Creator" content="Grzegorz  Dubin" /></meta><meta name="dc.Creator" content="Pascal  Mäser" /></meta><meta name="dc.Creator" content="Igor V.  Tetko" /></meta><meta name="dc.Creator" content="Kamyar  Hadian" /></meta><meta name="dc.Creator" content="Oliver  Plettenburg" /></meta><meta name="dc.Creator" content="Ralf  Erdmann" /></meta><meta name="dc.Creator" content="Michael  Sattler" /></meta><meta name="dc.Creator" content="Grzegorz M.  Popowicz" /></meta><meta name="dc.Description" content="Trypanosoma protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against Trypanosoma is limited, and the existing therapies are ..." /></meta><meta name="Description" content="Trypanosoma protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against Trypanosoma is limited, and the existing therapies are ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 20, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01876" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01876" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01876" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01876" /></link>
        
    
    

<title>Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01876" /></meta><meta property="og:title" content="Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0024.jpeg" /></meta><meta property="og:description" content="Trypanosoma protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against Trypanosoma is limited, and the existing therapies are partially ineffective and cause serious adverse effects. Formation of the PEX14–PEX5 complex is essential for protein import into the parasites’ glycosomes. This transport is critical for parasite metabolism and failure leads to mislocalization of glycosomal enzymes, with fatal consequences for the parasite. Hence, inhibiting the PEX14–PEX5 protein–protein interaction (PPI) is an attractive way to affect multiple metabolic pathways. Herein, we have used structure-guided computational screening and optimization to develop the first line of compounds that inhibit PEX14–PEX5 PPI. The optimization was driven by several X-ray structures, NMR binding data, and molecular dynamics simulations. Importantly, the developed compounds show significant cellular activity against Trypanosoma, including the human pathogen Trypanosoma brucei gambiense and Trypanosoma cruzi parasites." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01876"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01876">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01876&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01876&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01876&amp;href=/doi/10.1021/acs.jmedchem.9b01876" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 847-879</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01815" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02072" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship in Pyrazolo[4,3-<i>c</i>]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maciej Dawidowski</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maciej Dawidowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div><div class="loa-info-affiliations-info">Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8fe2eeece6eae5a1ebeef8e6ebe0f8fce4e6cff8fae2a1eaebfaa1ffe3"><span class="__cf_email__" data-cfemail="2f424e4c464a45014b4e58464b40585c44466f585a42014a4b5a015f43">[email protected]</span></a> (M.D.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maciej++Dawidowski">Maciej Dawidowski</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7262-5718" title="Orcid link">http://orcid.org/0000-0002-7262-5718</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vishal C. Kalel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vishal C. Kalel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vishal+C.++Kalel">Vishal C. Kalel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valeria Napolitano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valeria Napolitano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, Krakow 30-387, Poland</div><div class="loa-info-affiliations-info">Małopolska Center of Biotechnology, Jagiellonian University in Kraków, Gronostajowa 7, Kraków 30-387, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Napolitano">Valeria Napolitano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roberto Fino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roberto Fino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Fino">Roberto Fino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenji Schorpp</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenji Schorpp</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Assay Development and Screening Platform, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Schorpp">Kenji Schorpp</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leonidas Emmanouilidis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leonidas Emmanouilidis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leonidas++Emmanouilidis">Leonidas Emmanouilidis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dominik Lenhart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dominik Lenhart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology,  Institute of Medicinal Chemistry, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dominik++Lenhart">Dominik Lenhart</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Ostertag</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Ostertag</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Ostertag">Michael Ostertag</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marcel Kaiser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marcel Kaiser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland</div><div class="loa-info-affiliations-info">University of Basel, 4001 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marcel++Kaiser">Marcel Kaiser</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marta Kolonko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marta Kolonko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Department of Biochemistry, Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Kolonko">Marta Kolonko</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bettina Tippler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bettina Tippler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bettina++Tippler">Bettina Tippler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wolfgang Schliebs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wolfgang Schliebs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wolfgang++Schliebs">Wolfgang Schliebs</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grzegorz Dubin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grzegorz Dubin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Małopolska Center of Biotechnology, Jagiellonian University in Kraków, Gronostajowa 7, Kraków 30-387, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grzegorz++Dubin">Grzegorz Dubin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pascal Mäser</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pascal Mäser</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland</div><div class="loa-info-affiliations-info">University of Basel, 4001 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++M%C3%A4ser">Pascal Mäser</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3122-1941" title="Orcid link">http://orcid.org/0000-0003-3122-1941</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Igor V. Tetko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Igor V. Tetko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Igor+V.++Tetko">Igor V. Tetko</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kamyar Hadian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kamyar Hadian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Assay Development and Screening Platform, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kamyar++Hadian">Kamyar Hadian</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8727-2575" title="Orcid link">http://orcid.org/0000-0001-8727-2575</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Oliver Plettenburg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oliver Plettenburg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Medicinal Chemistry, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Institute of Organic Chemistry, Leibniz Universität Hannover, Schneiderberg 1b, Hannover 30167, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Plettenburg">Oliver Plettenburg</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9671-278X" title="Orcid link">http://orcid.org/0000-0001-9671-278X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ralf Erdmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ralf Erdmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Erdmann">Ralf Erdmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Sattler</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Sattler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#deadbfaaaab2bbac9eb6bbb2b3b6b1b2aaa4f3b3abbbb0bdb6bbb0f0babb"><span class="__cf_email__" data-cfemail="3e4d5f4a4a525b4c7e565b52535651524a4413534b5b505d565b50105a5b">[email protected]</span></a> (M.S.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Sattler">Michael Sattler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1594-0527" title="Orcid link">http://orcid.org/0000-0002-1594-0527</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Grzegorz M. Popowicz</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grzegorz M. Popowicz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</div><div class="loa-info-affiliations-info">Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie, Technische Universität München, Lichtenbergstrasse 4, 85747 Garching, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#0c6b7e76696b637e76227c637c637b656f764c64696061646360787621617969626f646962226869"><span class="__cf_email__" data-cfemail="ec8b9e96898b839e96c29c839c839b858f96ac848980818483809896c1819989828f848982c28889">[email protected]</span></a> (G.M.P.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grzegorz+M.++Popowicz">Grzegorz M. Popowicz</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01876&amp;href=/doi/10.1021%2Facs.jmedchem.9b01876" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 847–879</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 20, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 November 2019</li><li><span class="item_label"><b>Published</b> online</span>20 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01876" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01876</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc text">with CC-BY-NC-ND<a href="/page/policy/authorchoice_ccbyncnd_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01876"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2244</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01876" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maciej&quot;,&quot;last_name&quot;:&quot;Dawidowski&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;C. Kalel&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Napolitano&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Fino&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Schorpp&quot;},{&quot;first_name&quot;:&quot;Leonidas&quot;,&quot;last_name&quot;:&quot;Emmanouilidis&quot;},{&quot;first_name&quot;:&quot;Dominik&quot;,&quot;last_name&quot;:&quot;Lenhart&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Ostertag&quot;},{&quot;first_name&quot;:&quot;Marcel&quot;,&quot;last_name&quot;:&quot;Kaiser&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Kolonko&quot;},{&quot;first_name&quot;:&quot;Bettina&quot;,&quot;last_name&quot;:&quot;Tippler&quot;},{&quot;first_name&quot;:&quot;Wolfgang&quot;,&quot;last_name&quot;:&quot;Schliebs&quot;},{&quot;first_name&quot;:&quot;Grzegorz&quot;,&quot;last_name&quot;:&quot;Dubin&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Mäser&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;V. Tetko&quot;},{&quot;first_name&quot;:&quot;Kamyar&quot;,&quot;last_name&quot;:&quot;Hadian&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Plettenburg&quot;},{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Erdmann&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Sattler&quot;},{&quot;first_name&quot;:&quot;Grzegorz&quot;,&quot;last_name&quot;:&quot;M. Popowicz&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;847-879&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01876&quot;},&quot;abstract&quot;:&quot;Trypanosoma protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against Trypanosoma is limited, and the existing therapies are partially ineffective and cause serious adverse effects. Formation of the PEX14–PEX5 complex is essential for protein import into the parasites’ glycosomes. This transport is critical for parasite metabolism and failure leads to mislocalization of glycosomal enzymes, with fatal consequences for the parasite. Hence, inhibiting the PEX14–PEX5 protein–protein interaction (PPI) is an attractive way to affect multiple metabolic pathways. Herein, we have used structure-guided computational screening and optimization to develop the first line of compounds that inhibit PEX14–PEX5 PPI. The optimization was driven by several X-ray structures, NMR binding data, and molecular dynamics simulations. Importantly, the developed compounds show significant cellular activity against Trypanosoma, including the human pathogen Trypanosom&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01876&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01876" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01876&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01876" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01876&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01876" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01876&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01876&amp;href=/doi/10.1021/acs.jmedchem.9b01876" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01876" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01876" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01876%26sid%3Dliteratum%253Aachs%26pmid%3D31860309%26genre%3Darticle%26aulast%3DDawidowski%26date%3D2020%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bin%2BPyrazolo%255B4%252C3-c%255Dpyridines%252C%2BFirst%2BInhibitors%2Bof%2BPEX14%25E2%2580%2593PEX5%2BProtein%25E2%2580%2593Protein%2BInteraction%2Bwith%2BTrypanocidal%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D2%26spage%3D847%26epage%3D879%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/jmcmar.2020.63.issue-2/20200123/jmcmar.2020.63.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText"><i>Trypanosoma</i> protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against <i>Trypanosoma</i> is limited, and the existing therapies are partially ineffective and cause serious adverse effects. Formation of the PEX14–PEX5 complex is essential for protein import into the parasites’ glycosomes. This transport is critical for parasite metabolism and failure leads to mislocalization of glycosomal enzymes, with fatal consequences for the parasite. Hence, inhibiting the PEX14–PEX5 protein–protein interaction (PPI) is an attractive way to affect multiple metabolic pathways. Herein, we have used structure-guided computational screening and optimization to develop the first line of compounds that inhibit PEX14–PEX5 PPI. The optimization was driven by several X-ray structures, NMR binding data, and molecular dynamics simulations. Importantly, the developed compounds show significant cellular activity against <i>Trypanosoma</i>, including the human pathogen <i>Trypanosoma brucei gambiense</i> and <i>Trypanosoma cruzi</i> parasites.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human African trypanosomiasis (HAT, sleeping sickness) and Chagas disease (American trypanosomiasis) are among the most devastating and deadliest parasitic diseases. They occur predominantly in sub-Saharian Africa and Latin America, respectively, but Chagas disease has spread globally because of international human migration. Both qualify as neglected tropical diseases threatening millions of people in poor communities.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> The impact of <i>Trypanosoma</i> protists on livestock is also threatening the well-being of multiple communities.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">HAT is caused by two protozoans: <i>Trypanosoma brucei gambiense</i> and <i>Trypanosoma brucei rhodesiense</i> (accounting for 98 and 2% of HAT cases, respectively), transmitted by the bite of an infected tsetse fly. The disease consists of two phases: the haemolymphatic stage (stage I) with trypanosomes being present in the blood and lymphatic system and the meningoencephalitic stage (stage II), when parasites have spread to the central nervous system. Without appropriate diagnosis and treatment, the disease can be fatal.<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3,6)</a> No effective vaccine has so far been developed because the parasites employ several immune evasion strategies such as antigenic variation. Therefore, chemotherapy is the only therapeutic option currently available (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Suramin and pentamidine are used in stage I of HAT, while melarsoprol, eflornithine, and nifurtimox–eflornithine combination therapy (NECT) are used in stage II of the disease. Unfortunately, these drugs have severe side effects and require continuous parenteral administration, which is not optimal, given that the patients live in rural African areas with very limited health resources.<a onclick="showRef(event, 'ref6 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref9">(6,9)</a> There is a better treatment option because recently a first all-oral drug fexinidazole completed clinical trials in humans and was approved for HAT treatment.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> The efficacy of this monotherapy is comparable to intravenous NECT and the possibility of oral administration makes it easier to use in rural African realities. Nevertheless, cross-resistance with nifurtimox is likely to develop because of the same mechanism of action and no convenient polytherapy is available to overcome this issue.<a onclick="showRef(event, 'ref12 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref15 ref16">(12,14−16)</a> Another drug candidate, the benzoxaborole derivative SCYX-7158 (acoziborole) is currently in the advanced phase of clinical trials.<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12,17)</a> In spite of these promising developments, the Drugs for Neglected Diseases initiative (DNDi) still requires new candidates for stage-2 HAT treatment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of drugs used for the treatment of <i>Trypanosoma</i>-related diseases and clinical candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The situation is more dramatic for Chagas disease, caused by <i>Trypanosoma cruzi</i>. The parasite is spread by triatomine bugs (“kissing bugs”), by blood transfusions, congenitally, and even orally, by contaminated food.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It is considered to be the parasitic disease with the greatest socioeconomic impact in Latin America and one of the leading causes of myocarditis. There are two stages of the disease. In the acute phase, the symptoms vary between the individuals and in most cases they decline spontaneously after 1–2 months. In the chronic phase, the patients may develop potentially fatal cardiac and digestive pathologies. Currently, there are two drugs for Chagas disease, benznidazole and nifurtimox (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, both have serious side effects and are ineffective in the chronic phase of the disease.<a onclick="showRef(event, 'ref4 ref19'); return false;" href="javascript:void(0);" class="ref ref4 ref19">(4,19)</a></div><div class="NLM_p">Undeniably, there is an urgent need for novel drugs against <i>Trypanosoma</i> infections, especially for Chagas disease, with high clinical efficiency, favorable pharmacological profiles, and ease of use. In an ideal setting, the pipeline would comprise several new agents that are suitable for combination therapy, which, in turn, would allow for better efficacy and minimal risk of resistance development.<a onclick="showRef(event, 'ref2 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref16">(2,16)</a> This can be achieved inter alia by finding promising targets and pathways essential for parasite survival. In the past, various molecular targets have been proposed and successfully validated.<a onclick="showRef(event, 'ref16 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref20 ref21">(16,20,21)</a> It is intriguing that although the trypanosomatids share similarities in genetic sequence and biochemical pathways,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> so far most drug discovery campaigns aimed either at <i>T. brucei</i> or <i>T. cruzi</i>, with fewer seeking for new, broad-spectrum agents which would affect both species.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a></div><div class="NLM_p">Glycosomes are peroxisome-related organelles unique to kinetoplastids, including <i>Trypanosoma</i> spp. These organelles contain the enzymes required for glycolysis and for other intermediary metabolic pathways.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Hence, glycosomes are essential for parasite survival and they have long been considered attractive targets for development of new drugs against trypanosomatids.<a onclick="showRef(event, 'ref20 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref20 ref29 ref30">(20,29,30)</a></div><div class="NLM_p">As glycosomes lack DNA, glycosomal matrix proteins encoded in the nuclear genome have to be post-translationally transported from the cytosol to the organelle. Cargo proteins are imported by a cascade of interactions of specialized transport proteins, called peroxins (PEX#). The PEX14–PEX5 protein–protein interaction (PPI) plays a key role in this process. The PEX5 import receptor is capable of binding short peroxisomal targeting sequences (PTS) of the cargo. Next, the PEX5–cargo complex binds PEX14, which is localized at the glycosomal membrane and is required for cargo translocation into the matrix of the organelle.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Many of the glycosomal enzymes have been proposed and validated as potential drug targets.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, the glycosomal transport system should be a more attractive drug target because it provides the opportunity to interfere with the function of many critical metabolic processes at once. Furthermore, mislocalization to the cytosol provides the glycosomal kinases access to the cytosolic ATP pool. Enzymes such as <i>T. brucei</i> hexokinase function at such a high rate that they deplete ATP faster than it can be replenished by substrate-level phosphorylation, which will be fatal to the trypanosomes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">A series of RNAi studies has previously shown the importance of PEX14 function for glucose metabolism in <i>Trypanosoma</i>.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> Recently, we reported a proof-of-concept study for targeting the PEX14–PEX5 PPI in <i>T. brucei</i> and <i>T. cruzi</i> parasites by small molecules.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Using a structure-based drug discovery approach we developed a subset of prototypic pyrazolo[4,3-<i>c</i>]pyridine derivatives—the first inhibitors of this PPI and the first compounds that disrupt glycosomal import of matrix proteins and kill <i>T. brucei</i> and <i>T. cruzi</i> in vitro in nanomolar concentrations. Here, we present the details on the medicinal chemistry program that led to this group of active molecules along with the in-depth structure–activity relationship (SAR) study.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structural Basis for PEX14–PEX5 PPI Targeting</h3><div class="NLM_p">During the initial phase of the project, the structural basis for the PEX14–PEX5 PPI interaction was known (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> The N-terminal part of PEX5 contains several diaromatic WXXX(F/Y) motifs that address the respective hydrophobic Trp and Phe/Tyr pockets on the surface of the N-terminal helical domain (NTD) of PEX14. These two relatively shallow cavities are separated by two π-stacked phenyl rings of PEX14 (Phe17 and Phe34, the explanation of residue numbering among different species is given in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf" class="ext-link">Table S1</a>) that protrude to the solvent. In addition to the hydrophobic and aromatic binding of Trp and Phe/Tyr of WXXX(F/Y) motifs in PEX5 with their respective hotspots on the PEX14 surface, the positively charged Lys38 and Arg22 side chains of PEX14 plausibly facilitate the protein–protein complex formation by cation−π interactions. Other hydrophilic residues that might be of an importance for TbPEX14 ligand design are Asn13, Glu16, and Asp20. These three residues are different in <i>T. cruzi</i> and human sequences, and thus they might account for the ligands’ cross-species selectivity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural basis for PEX14–PEX5 PPI interface targeting. Left: Solution NMR structure of the HsPEX14 NTD in complex with the di-aromatic WXXXF pentapeptide motif of PEX5 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84">2W84</a><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a>). PEX14 is shown in light blue, whereas PEX5 is shown in magenta. Two hydrophobic cavities on the PEX14 surface accommodating Trp103 and Phe107 residues of PEX5 WXXXF are separated by two π-stacked phenylalanine side chains (Phe17 and Phe34). Right: Superposition of the solution NMR structures of HsPEX14 (light blue, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84">2W84</a>) and TbPEX14 (gold, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMC">5MMC</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>) NTDs. The polar residues (represented as sticks) surrounding the binding pocket are significantly different in both species. Bottom: Sequence alignment of HsPEX14, TbPEX14, and TcPEX14.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The PEX14–PEX5 protein–protein interface poses several challenges for medicinal chemistry that are typical for the PPI target class.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> First, it is hydrophobic in nature, with only few water exposed polar amino acid side chains in the spatial vicinity. Furthermore, the interface is relatively flat, with only two shallow cavities in the highly solvent-exposed surface. The Phe hotspot appeared as particularly difficult to address, being a “shelf”<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> rather than a classical PPI pocket.</div><div class="NLM_p">We created a pharmacophore model that mimicked the native binding of the PEX5 WXXX(F/Y) motif to TbPEX14. Two pharmacophoric elements were set as hydrophobic, aromatic rings addressing the respective Trp and Phe pockets. Further, we anticipated that the presence of “protruding” Phe17 and Phe34 side-chains can be an exploitable feature for ligand design and we defined the third pharmacophore as another connecting aromatic ring that would allow for additional π-stacking. The in silico screening cascade using a TbPEX14 homology model prepared from the NMR structure of HsPEX14 NTD (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84">2W84</a>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> identified several compounds with convincing docking poses. We tested these hits for binding to <sup>15</sup>N-labelled TbPEX14 NTD using the <sup>1</sup>H–<sup>15</sup>N HSQC NMR chemical shift perturbations (CSP) assay. A pyrazolo[4,3-<i>c</i>]pyridine derivative <b>1</b> was the most potent hit, with a <i>K</i><sub>D</sub> of 163 μM in the NMR CSP analysis and was resynthesized. The compound disrupted the interaction of the PEX5-derived peptide (ALSEN<b>W</b>AQE<b>F</b>LA) with both TbPEX14 and TcPEX14, having an EC<sub>50</sub> of 265 and 539 μM, respectively, in the AlphaScreen<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> assays (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Furthermore, <b>1</b> was characterized by a proper drug-likeness profile and was chemically tractable, rendering this compound an attractive starting point for medicinal chemistry optimization.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure, properties, and proposed derivatization sites of the pyrazolo[4,3-<i>c</i>]pyridine in silico hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial Optimization of <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0016.gif" alt="" id="GRAPHIC-d7e836-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated as a Hill curve fit to 12 point titration. SD represents fitting error. nd = not determined.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean (<i>n</i> = 4). Values in parentheses are 95% confidence intervals.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index is calculated as HepG2 EC<sub>50</sub> [μM]/<i>T. brucei</i> EC<sub>50</sub> [μM].</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">N-2 regioisomer of <b>1</b>.</p></div></div><div></div></div><div class="NLM_p">The docking results suggested that the phenyl residue of <b>1</b> addressed the Trp pocket on the TbPEX14 surface, while the indole moiety filled the Phe hotspot (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, top). Such placement of aromatic residues is in fact a mirror image of the native binding mode of PEX5 WXXX(F/Y) fragments to PEX14. However, we have previously shown that the Trp pocket of PEX14 can effectively accommodate the Phe residue of the F/YXXXF motif in its PPI with another peroxin, PEX19.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Another hallmark of the docking-derived binding pose of <b>1</b> to PEX14 is that the pyrazolo[4,3-<i>c</i>]pyridine central scaffold of the hit compound lays over the Phe17 and Phe34 residues, forming the favorable π–π interactions. We have also identified lower-scored poses, in which the projection of the aromatic phenyl and indole residues of <b>1</b> in TbPEX14 cavities was reversed, that is, directly mimicking the native placement of the aromatic rings in the PEX14–PEX5 PPI (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, bottom). Although this inverted binding pose seemed less plausible because of the number of possible unfavorable interactions with the hydrophilic residues present in the vicinity of the hotspots, it could not be completely disregarded because the overall shape of the PEX14–PEX5 PPI interface is highly symmetrical.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking poses of <b>1</b> to the TbPEX14–PEX5 PPI interface. Top: Phenyl residue of <b>1</b> occupies the Trp pocket while the indole is positioned in the Phe pocket on the PEX14 surface. Bottom: The “reversed” binding mode of <b>1</b> to the TbPEX14–PEX5 PPI interface. Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Initial Optimization Trials</h3><div class="NLM_p">For optimization purposes we divided the initial hit <b>1</b> into four regions: (1) the pyrazole N substituent, (2) the residue addressing the Trp pocket, (3) the residue addressing the Phe pocket, and (4) the central scaffold (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><div class="NLM_p">According to the preferred docking pose of <b>1</b>, the methyl group on pyrazole N-1 atom points to the solvent-exposed region of the interface, suggesting that substituents of different sizes should be tolerable at this position. Despite the proximity of Asn13 (Ser13 in TcPEX14 and Thr13 in HsPEX14) and Glu16 (Gln16 in TcPEX14 and Lys16 in HsPEX14), we expected that modifications addressing this region of the interface may affect the ligand’s physicochemical properties (e.g., solubility) rather than significantly influence the affinity to the target. We have found that the binding to PEX14 depends on the position of the substituent in the pyrazole ring. Contrary to the active hit <b>1</b>, the N-2 regioisomer <b>2</b> showed modest inhibitory activity in the AlphaScreen assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and did not bind TbPEX14 in a <sup>1</sup>H–<sup>15</sup>N HSQC NMR experiment. This was inconsistent with the anticipated binding mode of <b>1</b> to TbPEX14 because the distance to the proximal Asn13 and Glu16 should allow the methyl group to be tolerated at the N-2 position of the pyrazole. Compound <b>3</b> lacking substituents at the N-1 atom of the pyrazole had a slightly decreased ability to disrupt PEX5 interaction with both <i>T. brucei</i> and <i>T. cruzi</i> PEX14, and it was inactive against the human protein. Likewise, the hydroxyethyl derivative <b>4</b> showed no superior activity compared to <b>1</b>. Carboxylate derivatives <b>5–7</b> proved inactive. In conclusion, the initial SAR of the solvent-exposed region could not be fully rationalized on the basis of molecular docking. We have chosen the hydroxyethyl residue in this position because of the superior solubility of the compounds and sought further structural modifications that would yield more potent compounds suitable for cocrystallization trials with TbPEX14.</div><div class="NLM_p">Because the binding of the PEX5 WXXX(F/Y) motifs to PEX14 is hydrophobic and aromatic in nature, we assumed that optimizing the residues addressing the Trp and Phe hotspots would likely improve ligand affinity. Structural data show that the Trp pocket is quite shallow (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). As a result, the orientation of the indole ring in the native PEX14–PEX5 PPI is vertical with respect to the surface of the interface, and the imidazole component of the fused system slightly points out from the hotspot cavity, being surrounded by Lys38 and Asn13 (Ser13 in TcPEX14 and Thr13 in HsPEX14). On the other hand, this pocket has an elongated shape and the docking pose of <b>1</b> suggested that there is space that could be filled by a residue larger than the unsubstituted phenyl. Hence, we first modified the substitution pattern on the phenyl ring (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We synthesized derivatives <b>8–12</b> having various small lipophilic substituents in meta- and para-position, none of which showed superior activity or species selectivity, when compared to <b>1</b>. In contrast to the flat SAR of the substituted phenyls, derivatives <b>13</b> and <b>14</b> bearing naphthalene moieties, were more effective in disrupting the TbPEX14–PEX5 PPI, with AlphaScreen-derived EC<sub>50</sub> values five and eightfold lower than the respective parent compounds <b>1</b> and <b>4</b>. We have also observed the increased ability of these derivatives to interrupt the Tc and HsPEX14–PEX5 complex formation.</div><div class="NLM_p last">As already mentioned, the Phe hotspot on the PE14–PEX5 PPI interface appeared more difficult to target than the Trp pocket because this cavity is shallow and more exposed to solvent. The docking pose of <b>1</b> in TbPEX14 showed that this region of the interface is well filled by the indole moiety of the inhibitor. In fact, replacement of the bicyclic aromatic system of <b>1</b> with smaller phenyls yielded only very weak compounds <b>15–18</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Interestingly, inhibitor <b>19</b> bearing a bulky naphthalene was inactive, while its 4-methoxy derivative <b>20</b> proved 10-fold more potent in disrupting the TbPEX14–PEX5 PPI than <b>4</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Secondary Optimization—Phe Pocket</h3><div class="NLM_p">The above SAR was in large parts difficult to rationalize without additional structural data. Fortunately, at this stage of the project we were able to obtain a high-resolution X-ray structure of TbPEX14 bound to <b>13</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L87">5L87</a>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) that guided further optimization. Overall, the crystallographic data were consistent with the binding mode of <b>1</b> to TbPEX14 as predicted by docking. According to the TbPEX14-<b>13</b> complex structure, the double aromatic naphthalene system effectively filled the Trp hotspot. However, unlike the vertically oriented Trp side chain in the native PEX5 WXXX(F/Y)–PEX14 PPI, the orientation of the naphthyl group in the Trp pocket is horizontal. A very important feature of the X-ray structure that could not have been predicted on the basis of docking is the presence of one structural water that mediated binding of <b>13</b> to the TbPEX14 Asn13 side chain. This has a pronounced influence on the ligand binding mode. Most of all, the ligand is shifted toward Asn13 and Glu16 residues with respect to its orientation speculated on the basis of docking. As a consequence, the indole residue of <b>13</b> is shifted out toward the upper rim of the Phe pocket rather than being deeply inserted into this cavity as we postulated previously. Thus, the filling of the hotspot by the indole can be considered shallow and suboptimal. On the other hand, the aromatic residue of <b>13</b> is closer to the Arg22 side chain of PEX14, which, in turn, can stabilize the ligand–protein complex by forming cation−π interactions. The presence of the abovementioned thermodynamically stable water molecule may also explain the loss of affinity of <b>2</b>, in which the methyl group attached to the N-2 pyrazole nitrogen atom interferes with the solvation shell of the protein–ligand complex.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of TbPEX14 in complex with <b>13</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L87">5L87</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Left: surface representation of TbPEX14 (gold). A highly conserved water molecule is represented as a sphere. Right: cartoon representation of TbPEX14; relevant residues are shown as sticks. A water-mediated hydrogen bond between the PEX14 N13 side chain and the amide nitrogen of <b>13</b> is presented (gray dashed line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Driven by the obtained high-resolution structural information we decided to systematically exploit the SAR of the Phe hotspot, while keeping the Trp pocket occupied by the naphthyl (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The overall optimization strategy was thus focused on preserving the orientation of the aromatic portion of the substituents addressing the Phe hotspot close to its rim, while simultaneously extending the ligand deeper toward its bottom. First, we synthesized compounds <b>21–24</b> bearing various small substituents in the N-1 position of the indole system, of which only the methyl and ethyl derivatives <b>21</b> and <b>22</b>, respectively, showed potency comparable to <b>14</b> in the AlphaScreen assay. On the other hand, compounds <b>23</b> and <b>24</b>, with larger, more polar pendant residues, were slightly less active in disrupting the PEX14–PEX5 PPI. As seen in the TbPEX14-<b>13</b> complex structure, the Phe pocket of the interface is filled tightly by the indole residue of the ligand. Hence, there is no possibility of rotation along the N–CH<sub>2</sub> bond that links the indole residue to the central scaffold, which would be required to accommodate large indole N-1 substituents. Furthermore, as observed in the TbPEX14-<b>13</b> complex structure, the ligand binds to the interface in its low-energy conformation. Hence, a considerable entropic penalty would have to be paid for the N-1 substituted ligand adaptation to the hotspot.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Secondary Optimization of the Residue Addressing the Phe Pocket</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0018.gif" alt="" id="GRAPHIC-d7e1132-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0019.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated as a Hill curve fit to 12 point titration. SD represents fitting error. nd = not determined.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean (<i>n</i> = 4). Values in parentheses are 95% confidence intervals.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index is calculated as HepG2 EC<sub>50</sub> [μM]/<i>T. brucei</i> EC<sub>50</sub> [μM].</p></div></div><div></div></div><div class="NLM_p">While indole N-1 substituents are in a steric conflict with the amino acid side chain forming the Phe pocket and there is no possibility to compensate this by the adjustment of ligand’s orientation, the analysis of the TbPEX14-<b>13</b> complex structure showed that there is enough space in the hotspot to accommodate substituents in the C-7 position. Therefore, in the next optimization round we synthesized compounds <b>25–27</b> having small residues attached to this carbon atom (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Gratifyingly, these proved superior to <b>14</b> in disrupting the TbPEX14–PEX5 complex formation, each being 2 times more potent than the parent compound in the AlphaScreen assay. As of Tc and HsPEX14–PEX5 PPI inhibition, the results varied. Compound <b>25</b> had a comparable activity to the parent <b>14</b>, while its N-1 methyl derivative <b>26</b> was 2 times more active. On the other hand, <b>27</b> bearing a methyl ester function on C-7 of indole was twofold less potent in inhibiting the <i>T. cruzi</i> protein. We have also synthesized <b>28</b>, in which indole was attached to the central scaffold through a C-2 carbon atom, allowing for a deeper insertion of the aromatic residue into the pocket (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). As a result, <b>28</b> was more active than its C-3 regioisomer <b>14</b> and roughly equipotent to the isomeric methoxy indole derivative <b>26</b>.</div><div class="NLM_p">The different activities of the undecorated indole derivative <b>14</b> and <b>26</b> resulting from the unequally deep occupation of the Phe pocket recalled the observations made previously for naphthalenes <b>19</b> and <b>20</b> during the initial optimization trials. With the aim to improve binding of the ligands and to further investigate SAR in the Phe pocket, we solved the crystal structure of the methoxynaphthalene derivative <b>20</b> in complex with TbPEX14 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L8A">5L8A</a>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Overall, the binding mode of <b>20</b> to the TbPEX14–PEX5 PPI interface closely resembled the one observed for <b>13</b> in the TbPEX14-<b>13</b> complex. Thus, the phenyl ring of the inhibitor was buried in the Trp pocket, while the naphthalene system filled the upper part of the Phe hotspot, with the methoxy residue reaching the bottom part of the cavity. Importantly, the orientation of the pyrazolo[4,3-<i>c</i>]pyridine central scaffold in <b>13</b> and <b>20</b> was identical, which was a clear indication that a more potent PEX14–PEX5 PPI inhibitor can be obtained by merging those two ligands. Indeed, the hybrid molecule <b>29</b> showed a superior activity in the AlphaScreen TbPEX14–PEX5 PPI inhibition assay, when compared to both parent compounds (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The methoxy group present at the C-4 atom of the naphthalene in <b>29</b> was crucial for the high-affinity interaction with TbPEX14 because derivatives <b>30</b> and <b>31</b> lacking this residue proved significantly less active. Next, we synthesized <b>32</b>, in which one of the fused benzenes of the naphthalene system was saturated. The compound was 3 times less potent than the parent <b>29</b>, most likely because of its inability to form cation−π and π–π interactions with the Arg22 and Phe17 residues, respectively. Next, we investigated compounds <b>33–35</b> having small substituents other than methoxy at C-4 carbon of the naphthalene. Switching to a larger methylthiol group in <b>33</b> resulted in a 3 times stronger inhibition of the TcPEX14–PEX5 complex formation when compared to <b>29</b>. Sulfoxide <b>34</b>, an expected metabolite of <b>33</b>, was significantly less potent. The dimethylamino derivative <b>35</b> was as active as the parent compound <b>29</b> in inhibiting the TbPEX14–PEX5 PPI and significantly more potent against Tc and HsPEX14.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Top: Crystal structure of TbPEX14 in complex with <b>20</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L8A">5L8A</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Bottom: overlay of the binding poses of <b>13</b> (purple) and <b>20</b> (green). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, we synthesized a series of phenyl derivatives <b>36–45</b> having small lipophilic substituents in para- or (and) meta-positions (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). By this, we wanted to verify whether a single aromatic system can outcompete, or at least be as active as, the bulkier and highly lipophilic indoles and naphthalenes. By changing the substitution patterns on the phenyl, we have observed that a gain of potency can be achieved by expanding the ligand toward the bottom of the pocket, similar to what had been observed for the bicyclic aromatic systems in <b>14</b> and <b>21–35</b>. Several phenyl derivatives were equipotent to <b>14</b> in disrupting the TbPEX14–PEX5 complex formation; however, none of them could outcompete the more potent <b>25–28</b> or the C-4-substituted naphthalenes <b>29</b> and <b>33–35</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Secondary Optimization—around Trp Pocket</h3><div class="NLM_p">To further expand the SAR information in PEX14–PEX5 PPI targeting we turned our attention to the region of the interface near the entrance to the Trp hotspot. The crystallographic structures of TbPEX14 in complex with <b>13</b> and <b>20</b> show that the amide moiety that projects the aromatic residue of the ligand into the Trp pocket is in a low-energy conformation that is coplanar with the pyrazole ring. Hence, we posed the question whether an entropic gain from freezing this favorable conformation can be achieved and we synthesized <b>46</b> and <b>47</b>, tricyclic derivatives of <b>29</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Both compounds were less potent than the parent inhibitor in the AlphaScreen assay. As previously mentioned, the TbPEX14–<b>13</b> complex structure shows an important interaction of the amide NH proton with Asn13 of the protein, mediated through a water molecule. Hence, it is possible that the gain in entropy in <b>46</b> and <b>47</b> from freezing the molecules in their low-energy conformations cannot compensate the loss in the binding affinity caused by the inability of forming the mentioned important connection through water. Intriguingly, this structural change proved deleterious for the ability of the inhibitors to bind Tc and HsPEX14 but did not abolish its interaction with the <i>T. brucei</i> protein. As a result, <b>46</b> and <b>47</b> are highly selective in inhibiting the latter PPI. To further explore the importance of the amide linkage in this region of the ligand, we synthesized <b>48</b>, a derivative of <b>29</b> in which carbonyl oxygen was removed (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The obtained inhibitor projecting the naphthalene into the Trp pocket through an alkylamino linker was significantly weaker in inhibiting the PEX14–PEX5 PPI than the parent molecule. We attributed this to the repulsive interactions with Lys38, weaker hydrogen bond-accepting properties of the amine, and to the increased conformational freedom of the linker when compared to the amide. With the aim to explore the possible polar interactions with Asn13 and Lys38 surrounding the entrance to the Trp pocket, we synthesized sulfonamide <b>49</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The compound failed to inhibit the TbPEX14–PEX5 PPI, likely because of the inability of the relatively narrow Trp pocket to accommodate the sulfonamide moiety.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Secondary Optimization around the Trp Pocket</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0020.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated as a Hill curve fit to 12 point titration. SD represents fitting error. nd = not determined.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean (<i>n</i> = 4). Values in parentheses are 95% confidence intervals.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index is calculated as HepG2 EC<sub>50</sub> [μM]/<i>T. brucei</i> EC<sub>50</sub> [μM].</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Secondary Optimization—Amines in N-1 Pyrazolo Substituent</h3><div class="NLM_p">Our initial optimization trials showed that the substitution pattern at N-1 of pyrazole does not significantly alter binding of the ligands to the PEX14–PEX5 PPI interface. However, a closer inspection of the TbPEX14-<b>20</b> complex structure revealed that the pendant hydroxyalkyl chain can adopt a conformation in which the hydroxyl lies in a spatial proximity of the carboxylic amino acid residues, Glu16, Asp20, in the solvent-exposed region. Therefore, we posed a question if a switch to an amine can lead to a further improvement in the binding affinity originating from additional electrostatic contacts. Indeed, a simple −OH to–NH<sub>2</sub> transition resulted in primary amine <b>50</b> which was sixfold more active in disrupting the TbPEX14–PEX5 PPI and fivefold more potent against TcPEX14, respectively, than the parent <b>29</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Encouraged by this result, we pursued a series of derivatives <b>51–61</b> with various alkylamine residues at the N-1 pyrazolo position. Secondary and tertiary amines were tolerated. An important observation was that binding to PEX14 correlates positively with the basicity of the substituents (e.g., <b>50</b> vs <b>58</b>, <b>54</b> vs <b>57</b>, <b>55</b> vs <b>56</b>, and <b>59</b> vs <b>60</b>) rather than with their hydrogen bond donor or acceptor capabilities (e.g., <b>50</b> vs <b>58</b>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Secondary Optimization of the Pyrrole N-Substituent: Amines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0021.gif" alt="" id="GRAPHIC-d7e1519-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0022.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated as a Hill curve fit to 12 point titration. SD represents fitting error. nd = not determined.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean (<i>n</i> = 4). Values in parentheses are 95% confidence intervals.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index is calculated as HepG2 EC<sub>50</sub> [μM]/<i>T. brucei</i> EC<sub>50</sub> [μM].</p></div></div><div></div></div><div class="NLM_p">We solved high-resolution crystal structures of <b>50</b> and <b>61</b> in the complex with the TbPEX14 N-terminal domain (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V">5N8V</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, respectively). The TbPEX14-<b>50</b> complex structure provides a snapshot of the pendant amino group interacting with Glu16 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). However, this interaction is not seen in the TbPEX14-<b>61</b> complex structure (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), which reflects the flexibility of the hydroxyalkyl chain. As X-ray crystallography may not always precisely reveal the flexible ligand–protein interactions because of the crystal symmetry-related contacts, we analyzed the binding of the amino groups in <b>50</b> and <b>61</b> and hydroxyl of <b>29</b> with the carboxylic residues of Glu16 and Asp20 of TbPEX14 by performing molecular dynamics (MD) simulations (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> and S2—see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf" class="ext-link">Supporting Information</a>). The computations clearly show the high occurrence of interactions of the amino groups with both residues. In contrast, the MD simulation did not show significant interaction of the pendant hydroxyethyl group of derivative <b>29</b>. Here, the occurrence of the interaction during the MD run is much lower.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High resolution crystal structure of N-terminal domain of TbPEX14 in complex with compound <b>50</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V">5N8V</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. High resolution crystal structure of N-terminal domain of TbPEX14 in the complex with compound <b>61</b> (1.2 Å, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a>). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ligand interaction diagrams of the final MDs simulations snapshots. The MDs were performed for TbPEX14-<b>29</b> (A), TbPEX14-<b>50</b> (B), and TbPEX14-<b>61</b> (C) complexes. Blue lines represent H-bonding interactions, red cation−π, and green π–π interactions. Introduction of alkylamine residues at N-1 pyrazolo position leads to formation of direct and water-mediated interaction patterns significantly improving compound affinity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The negatively charged Glu16 residue is present in the TbPEX14 amino acid sequence, but not in TcPEX14 (Gln16) or HsPEX14 (Lys16). Furthermore, in the HsPEX14 sequence Asp20 is replaced by the neutral Asn20. In this context, it is intriguing that the ligands bearing positive charge (i.e., amines <b>50–55</b>, <b>59</b>, and <b>61</b>) show enhanced inhibitory activity in the latter two PPIs. On the other hand, it has been shown that the binding affinity and thermodynamics in solvent-exposed protein cavities, such as those present on the PEX14 surface, is not only affected by the direct interactions of ligand atoms with protein residues, but can also depend significantly on the alterations of the water envelope around the ligand–protein complex.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Indeed, both TbPEX14-<b>50</b> and TbPEX14-<b>61</b> complex X-ray structures document the involvement of the flexible alkylamines in the water network around the ligand. Similar engagement can be expected in Tc and HsPEX14, which might explain the enhancement in inhibitory activity of the ligands against the PPIs of those proteins with PEX5.</div><div class="NLM_p last">Overall, the sum of the effects described above provided a significant improvement of the activity of the ligands against all three tested PEX14 proteins. This enhancement was most pronounced in the case of TbPEX14–PEX5 PPI, which resulted in the higher selectivity of compounds toward this PPI.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Secondary Optimization—Central Scaffold</h3><div class="NLM_p">Finally, we decided to obtain some SAR information of the central bicyclic scaffold. Quaternization of the tertiary amine in <b>29</b> resulted in a permanently charged derivative <b>62</b>, which did not show superior binding to PEX14 (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Decreasing the size of the aliphatic ring of <b>29</b> by one methylene unit produced the pyrrolo[3,4-<i>c</i>]pyrazole <b>63</b>, which was twofold more active than the parent compound in inhibiting the TbPEX14–PEX5 PPI, and threefold more potent against TcPEX14 and HsPEX14. The amino derivative of alcohol <b>63</b>, compound <b>64</b>, showed the expected enhancement in PEX14 binding, with respect to its six-membered ring homologue <b>50</b>. Finally, the amino alcohol <b>65</b> was the most potent PEX14 binder, representing a first inhibitor of TbPEX14–PEX5 PPI with submicromolar EC<sub>50</sub> value in the AlphaScreen assay.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Secondary Optimization—Central Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0023.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were calculated as a Hill curve fit to 12 point titration. SD represents fitting error. nd = not determined.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean (<i>n</i> = 4). Values in parentheses are 95% confidence intervals.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index is calculated as HepG2 EC<sub>50</sub> [μM]/<i>T. brucei</i> EC<sub>50</sub> [μM].</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Activity of the PEX14–PEX5 PPI Inhibitors</h3><div class="NLM_p">The synthesized compounds were evaluated for their trypanocidal effect against the <i>T. brucei brucei</i> bloodstream form (Lister 427, MITat 1.2) in the resazurin-based cell survival assay. <i>T. b. brucei</i> is the causative agent of animal trypanosomiasis and was used as a model organism for the primary screening of trypanocidal activities of the inhibitors. The obtained EC<sub>50</sub> values are presented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Besides several outliers, the trypanocidal activity of the tested derivatives correlates well with the results of the AlphaScreen-based TbPEX14–PEX5 PPI inhibition assay. We have also observed a remarkable enhancement of the antiparasitic activity in compounds bearing an aminoalkyl chain attached to the N-1 position of the pyrazole, resulting in submicromolar EC<sub>50</sub> values in the resazurin-based assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We attribute this to the greater inhibitory potency of these compounds against the TbPEX14–PEX5 PPI. Compounds <b>50–52</b> were most active from the series, having EC<sub>50</sub> values below 100 nM (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">Additionally, the investigated PEX14–PEX5 PPI inhibitors were assayed for their cytotoxicity in the human-derived HepG2 cell line (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In general, the cytotoxicity of some of the compounds followed their inhibitory activity against HsPEX14–PEX5 PPI. This was most pronounced for many of the indole derivatives (e.g., <b>2–8</b>, <b>14</b>, and <b>21–28</b>). On the other hand, some other active HsPEX14 ligands did not follow this trend (e.g., naphthalenes <b>20</b>, <b>29</b>, and <b>35</b>). Overall, the selectivity index for trypanocidal activity against <i>T. b. brucei</i> improved along with increased efficacy of compounds in disrupting PEX14–PEX5 PPI. This was most pronounced in the alkylamine derivatives (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), many of which displayed favorable selectivity profiles (e.g., <b>50</b>, <b>51</b>, <b>53</b>, <b>54</b>, <b>61</b>, <b>64</b>, and <b>65</b>).</div><div class="NLM_p">The PEX14–PEX5 PPI inhibitors showing high trypanocidal efficacy against <i>T. b. brucei</i> were further evaluated activity against <i>T. b. rhodesiense</i> STIB900, a human pathogen derived from an African (United Republic of Tanzania) patient (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). In general, the results followed the SAR pattern observed in the primary <i>T. b. brucei</i> screening. The <i>T. b. rhodesiense</i> STIB900 strain was even more susceptible to the PEX14–PEX5 PPI inhibitors, which resulted in more preferable selectivity indices. The high activity of the compounds against the human pathogen may have practical implications and merit further development of the PEX14–PEX5 PPI inhibitors as potential treatments against HAT.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Trypanocidal Activity of Compounds Against <i>T. b. rhodesiense</i> STIB900 and <i>T. Cruzi</i></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center" char="±"><i>T. b. rhodesiense</i> IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>T. cruzi</i> IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">L6 IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SI<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.67</td><td class="colsep0 rowsep0" align="char" char="±">9.16 ± 0.87</td><td class="colsep0 rowsep0" align="char" char="±">16.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">6.00 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">16.8 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">34.5 ± 3.9</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">6.38 ± 0.40</td><td class="colsep0 rowsep0" align="char" char="±">21.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">43.2 ± 3.2</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="±">2.14 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">5.22 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">5.93 ± 0.16</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char="±">4.42 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">3.83 ± 1.94</td><td class="colsep0 rowsep0" align="char" char="±">12.7 ± 2.6</td><td class="colsep0 rowsep0" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char="±">5.54 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">4.35 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">17.6 ± 0.70</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.004</td><td class="colsep0 rowsep0" align="char" char="±">0.320 ± 0.074</td><td class="colsep0 rowsep0" align="char" char="±">1.80 ± 0.06</td><td class="colsep0 rowsep0" align="left">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="char" char="±">0.009 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">3.16 ± 1.36</td><td class="colsep0 rowsep0" align="char" char="±">1.66 ± 0.01</td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char="±">1.98 ± 0.57</td><td class="colsep0 rowsep0" align="char" char="±">7.22 ± 1.30</td><td class="colsep0 rowsep0" align="char" char="±">5.84 ± 0.70</td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char="±">0.029 ± 0.001</td><td class="colsep0 rowsep0" align="char" char="±">2.20 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">1.82 ± 0.10</td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="char" char="±">1.89 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.32</td><td class="colsep0 rowsep0" align="char" char="±">9.19 ± 0.42</td><td class="colsep0 rowsep0" align="left">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="char" char="±">0.075 ± 0.008</td><td class="colsep0 rowsep0" align="char" char="±">0.627 ± 0.290</td><td class="colsep0 rowsep0" align="char" char="±">1.96 ± 0.04</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="char" char="±">0.179 ± 0.048</td><td class="colsep0 rowsep0" align="char" char="±">2.28 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">1.96 ± 0.10</td><td class="colsep0 rowsep0" align="left"><1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values are shown as mean ± deviation from the mean (<i>n</i> = 2).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index is calculated as L6 EC<sub>50</sub> [μM]/<i>T. cruzi</i> EC<sub>50</sub> [μM].</p></div></div></div><div class="NLM_p last">Unlike <i>T. brucei</i>, <i>T. cruzi</i> parasites do not use glycolysis as the main energy source for the cell. However, they still use glycosomes to compartmentalize other essential metabolic processes. Hence, we wanted to check whether impairing the function of the organelle by PEX14–PEX5 PPI inhibition is also lethal to <i>T. cruzi</i>. When assayed for their trypanocidal activity against the amastigote forms of the <i>T. cruzi</i> Tulahuen strain C2C4 grown in rat L-6 myoblasts (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), the tested PEX14–PEX5 PPI inhibitors demonstrated varied efficiency. The IC<sub>50</sub> values were higher than those obtained for <i>T. brucei</i> and thus the selectivity indices determined with uninfected L-6 cells were narrower. The aminoalkyl derivatives <b>50</b>, <b>61</b>, and <b>64</b> displayed highest potency, showing submicromolar trypanocidal activities and fair therapeutic indices. A general observation was that the correlation between the ability to break the PEX14–PEX5 PPI and trypanocidal efficacy is less clear in <i>T. cruzi</i> than in <i>T. brucei</i>. Presumably, this reflects the characteristics of the assay, in which the <i>T. cruzi</i> parasites are located within myoblasts and therefore the compounds have to pass multiple cellular membranes and environments to reach the target.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p">The synthetic pathway used to access the in silico hit <b>1</b> and its C-2 regioisomer <b>2</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The key pyrazolo[4,3-<i>c</i>]pyridine <b>66</b> was obtained by adopting a literature method<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> to a one-pot process, without isolating the intermediate mixed-Claisen condensation product. The subsequent N-methylation of the pyrazole ring of <b>66</b> resulted in two chromatographically separable regioisomers <b>67</b> and <b>68</b>, in a 60:40 proportion. The 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD)-catalyzed aminolysis<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> of the respective esters <b>67</b> and <b>68</b>, followed by Boc-deprotection and reductive amination steps, gave the corresponding regioisomeric compounds <b>1</b> and <b>2</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to the in Silico Hit <b>1</b> and Its C-2 Regioisomer <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LHMDS, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (b) hydrazine hydrate, THF, EtOH, AcOH, reflux; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, then MeI, DMF, rt; (d) benzylamine, TBD, THF, 60 °C; (e) 4 M HCl, 1,4-dioxane, rt; (f) TEA, THF, rt, then AcOH, indole-3-carboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt.</p></p></figure><div class="NLM_p">Highlighted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> are the synthetic routes employed for initial optimization trials. Compound <b>66</b> was used as a common intermediate to synthesize the derivatives having various substituents in the N-1 position of the pyrazolo[4,3-<i>c</i>]pyridine system. Aminolysis of <b>66</b> resulted in <b>70</b>, which was subjected to Boc-deprotection and reductive amination steps to give the N-1 unsubstituted derivative <b>3</b>. Conversion of <b>70</b> to <b>71</b> and <b>72</b> by N-alkylation and N-acylation reactions, respectively, followed by the deprotection/reductive amination sequence, resulted in corresponding derivatives <b>6</b> and <b>7</b>. Ester <b>6</b> was saponified to give the carboxylate <b>5</b>. Attempts to obtain the hydroxyethyl derivatives <b>73</b> and <b>74</b> by the direct N-alkylation of <b>66</b> with 2-bromoethanol resulted in low conversions and afforded complex mixtures that were difficult to purify. Hence, we turned to a more practical route employing one pot mixed-Claisen condensation and pyrazole formation that gave the mixture of regioisomers <b>73</b> and <b>74</b> in a 75:25 proportion. These regioisomers were readily separable by recrystallization and chromatography. Deprotection and reductive amination of intermediate <b>73</b> afforded compound <b>75</b> that served as a starting material for subsequent aminolyses, leading to derivatives <b>4</b> and <b>8–12</b> bearing various phenyl substituents. Finally, reaction of ester <b>73</b> with benzylamine gave intermediate <b>76</b> that was used in the subsequent Boc-deprotection and reductive amination steps that led to derivatives <b>15–19</b> with different aromatic substituents addressing the Phe pocket of PEX14.</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes Employed for the Initial Optimization Trials (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzylamine, TBD, THF, 60 °C; (b) 4 M HCl, 1,4-dioxane, rt; (c) TEA, THF, rt, then AcOH, indole-3-carboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt; (d) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, then ethyl 2-bromoacetate, DMF, rt (for <b>71</b>) or ethyl chloroformate, DIPEA, 0 °C to rt (for <b>72</b>); (e) KOH, EtOH/H<sub>2</sub>O, rt, then NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, rt; (f) LHMDS, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (g) 2-hydrazinoethanol, THF, EtOH, AcOH, reflux; (h) amine, TBD, THF, 60 °C; (i) TEA, THF, rt, then AcOH, aldehyde, NaBH(OAc)<sub>3</sub>, THF, rt.</p></p></figure><div class="NLM_p">The synthetic route used for the secondary optimization trials of the residue addressing the Phe pocket is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Briefly, ester <b>73</b> was converted to amide <b>77</b> by the previously described method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Intermediate <b>77</b> was then Boc-deprotected and the resulting amine salt <b>78</b> was used to generate the desired derivatives <b>14</b>, <b>21–28</b>, and <b>30–45</b> either by reductive aminations or by the ZnCl<sub>2</sub>-mediated Mannich reaction.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes Employed for the Optimization of the Residue Addressing the Phe Pocket (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 M HCl, 1,4-dioxane, rt; (b) TEA, THF, rt, then AcOH, aldehyde, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>14</b>, <b>21–26</b>, <b>28</b>, and <b>30–45</b>) or 7-methoxycarbonyl-1<i>H</i>-indole, HCHO<sub>aq</sub>, ZnCl<sub>2</sub>, EtOH, rt (for <b>27</b>).</p></p></figure><div class="NLM_p">The synthesis of compounds <b>46–49</b>, having modifications within the region projecting aromatic residues to the Trp pocket of PEX14, is depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Intermediate <b>80</b> was obtained from compound <b>74</b> by an aminolysis/Boc-deprotection/reductive amination sequence. The hydroxyl group of <b>80</b> was then converted to mesylate and the subsequent treatment with a strong base induced the ring closure leading to compound <b>46</b>. To obtain the sterically constrained derivative <b>47</b>, intermediate <b>66</b> was first converted to compound <b>82</b> in a manner similar to synthesis of compound <b>80</b> from <b>74</b>. The amide <b>82</b> was then reduced with LiAlH<sub>4</sub> and the resulting amine <b>83</b> was treated with 1,1′-carbonyldiimidazole (CDI) to afford tricyclic compound <b>47</b>. Derivatives <b>48</b> and <b>49</b> were accessed by reductive amination or acylation, respectively, of the common intermediate amine <b>86</b> obtained from compound <b>73</b> by a sequence comprising aminolysis/Boc-deprotection/reductive amination/LiAlH<sub>4</sub> reduction.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Routes Employed for the Optimization around the Trp Pocket (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-naphthalenemethylamine, TBD, THF, 60 °C; (b) 4 M HCl, 1,4-dioxane, rt; (c) TEA, THF, rt, then AcOH, 4-methoxy-1-naphthaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt; (d) MsCl, DIPEA, DMAP, DCM, 0 °C to rt; (e) <sup><i>t</i></sup>BuOK, THF, 0 °C to rt; (f) LiAlH<sub>4</sub>, THF, rt, then reflux; (g) CDI, DCM, rt; (h) NH<sub>3aq</sub>, EtOH, reflux; (i) TEA, THF, rt, then AcOH, 1-naphthalenecarboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>48</b>), or 1-naphthalenesulfonyl chloride, TEA, DMAP, DCM, 0 °C to rt (for <b>49</b>).</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> shows the synthesis of pyrazolo[4,3-<i>c</i>]pyridine derivatives bearing various alkylamino substituents on the N-1 atom. Compounds <b>51</b>, <b>55–57</b>, and <b>59</b> were obtained from the tosylate <b>87</b> by the N-alkylation reactions of the appropriate aliphatic amines or heterocyclic bases. Glycinate ester <b>59</b> was saponified to give the corresponding carboxylic acid <b>60</b>. Compounds <b>52</b>, <b>54</b>, and <b>58</b> were obtained by reductive amination or acetylation of the primary amine <b>50</b>. The azetidine derivative <b>53</b> was synthesized from compound <b>82</b> by alkylation of the pyrazole nitrogen atom with <i>tert</i>-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate, followed by removal of the Boc protecting group.</div><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes Employed for the Secondary Optimization of the Pyrazole N-Substituent (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeNH<sub>2</sub>, DCM/EtOH, reflux (for <b>51</b>), imidazole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>55</b>), pyrazole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>56</b>), morpholine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>57</b>), methyl glycinate hydrochloride, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux (for <b>59</b>); (b) NaOH, MeOH/H<sub>2</sub>O, rt; (c) acetone, AcOH, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>52</b>), HCHO<sub>aq</sub>, AcOH, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>54</b>) or Ac<sub>2</sub>O (neat), 80 °C (for <b>58</b>); (d) <i>tert</i>-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C; (e) 4 M HCl, 1,4-dioxane, rt, then K<sub>2</sub>CO<sub>3</sub>, rt.</p></p></figure><div class="NLM_p">Synthetic routes to compounds with modifications within the central heterobicyclic core are shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. The quaternary ammonium salt <b>62</b> was obtained by treatment of <b>29</b> with excess of MeI. To synthesize derivatives with pyrazolo[4,3-<i>c</i>]pyrrole heterocycle as the central scaffold we attempted to apply the one-pot procedure used for construction of the homologous (2-hydroxyethyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridines <b>73</b> and <b>74</b>. This resulted in formation of mixtures containing cyclized regioisomeric products and open-chain hydrazones, as judged by liquid chromatography–mass spectrometry analyses. An additional step comprising prolonged refluxing in acetic acid was required to drive the cyclocondensation process to completion. Acetylation of the hydroxyl group in products <b>89</b> and <b>90</b> as well as partial lactonization of the N-2 regioisomer <b>89</b> to compound <b>90</b> was observed at the same time. Acetyl removal with K<sub>2</sub>CO<sub>3</sub> in intermediate <b>89</b> afforded the free alcohol <b>92</b> that gave the final compounds <b>63</b>, <b>64</b>, and <b>65</b> in similar synthetic sequences to those used previously for synthesis of derivatives <b>29</b>, <b>50</b>, and <b>61</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Routes Employed for the Optimization of the Central Scaffold (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, CHCl<sub>3</sub>, rt; (b) LDA, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (c) 2-hydroxyethylhydrazine, THF, EtOH, AcOH, reflux; (d) AcOH, reflux; (e) K<sub>2</sub>CO<sub>3</sub>, EtOH, 60 °C; (f) 1-naphthalenemetylamine, TBD, THF, 60 °C; (g) 1,4-cyclohexadiene, 10% Pd/C, MeOH, reflux; (h) HCl, Et<sub>2</sub>O, DCM, 0 °C to rt; (i) 4-methoxy-1-naphthaldehyde, NaBH(OAc)<sub>3</sub>, AcOH, THF, rt; (j) TsCl, TEA, DMAP, DCM, 0 °C to rt; (k) NaN<sub>3</sub>, DMF, 70 °C; (l) PPh<sub>3</sub>, THF, rt, then H<sub>2</sub>O, THF, 50 °C; (m) 2-amino-2-methyl-1-propanol, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glycosomal enzymes have long been considered attractive molecular targets for combating parasitic diseases, such as HAT and Chagas disease. Targeting the PEX14–PEX5 PPI leads to mislocalization of multiple glycosomal enzymes, which has a dual effect: the absence of the enzymes in the lumen of the glycosome compromises glycosome biogenesis and function, while the presence of the glycosomal kinases in the cytosol dissipates ATP levels. To verify that this is indeed a useful target for molecular intervention, we have used a structure-based drug design approach to develop the first small-molecule agents that inhibit the PEX14–PEX5 PPI. We have performed a systematic optimization of different sites in the initial in silico pyrazolo[4,3-<i>c</i>]pyridine hit <b>1</b> and found compounds that disrupt PEX14–PEX5 PPI, kill <i>T. brucei</i> and <i>T. cruzi</i> parasites in submicromolar concentrations, and display fair therapeutic windows between trypanocidal activity and cytotoxicity for the mammalian cells. Hence, the pyrazolo[4,3-<i>c</i>]pyridine series of compounds represent an attractive lead series for treatment of HAT and Chagas disease and can also serve as tools for studying biochemical processes related to glycosomes and peroxisomes.</div><div class="NLM_p last">There have been successful medicinal chemistry campaigns that developed new PPI inhibitors as preclinical and clinical candidates. Still, this target class is considered difficult to be targeted by classical small molecules and successful drug development may require involvement of an alternative chemical matter that goes far beyond the established criteria of drug-likeness.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A good example of such compound is Venetoclax, a Bcl-2-Bak/Bax PPI inhibitor that displays violations of the classical drug-likeness principles (e.g., large MW, high log <i>D</i>, and poor aqueous solubility) but has quite recently been approved for treatment of chronic lymphocytic leukemia.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The presented PEX14–PEX5 PPI inhibitors display suboptimal pharmacochemical properties<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> because the binding of the ligands to PEX14 hotspots is mostly lipophilicity-driven. However, we also show that polar interactions with charged amino-acids in the spatial proximity of the PPI hotspots can be addressed and illustrate this by providing detailed structure activity data. Importantly, our results indicate that addressing specific water-mediated interactions is very important for design of compounds that bind the highly solvent-exposed PEX14 surface, and may be useful to improve the overall physicochemical profile of the obtained inhibitors, which is another subject of our ongoing efforts.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all reagents were obtained from commercial sources and used without further purification. Technical grade solvents for chromatography and aqueous workup were distilled prior to use. Dry DCM, DMF, and THF were purchased from Acros. Manual flash column chromatography (FC) was performed using Merck silica gel 60 (particle size: 0.040–0.063 mm). Automated preparative chromatography was performed on a Grace Reveleris Prep purification system using linear gradient elution and Buchi Reveleris Silica 40 μm cartridges for normal phase (SiO<sub>2</sub>) and Buchi Reveleris C-18 40 μm cartridges for reverse-phase (RP-C18) separations. Analytical thin layer chromatography (TLC) was performed on Merck silica coated plates (silica gel 60 F 254). Compounds were detected by ultraviolet (UV) irradiation at 254 or 366 nm. The final compounds were ≥95% pure, as determined by high-performance liquid chromatography–mass spectrometry analyses performed on a Dionex UltiMate 3000 HPLC system coupled with a Thermo Finnigan LCQ ultrafleet mass spectrometer, using the following methods: (A) Waters X-Bridge C18 (4.6 × 30 mm, 3.5 μm) column; gradient: 5–95% of acetonitrile +0.1% formic acid v/v in water +0.1% formic acid v/v over 5 min period; flow rate: 1.1 mL/min; UV detection at 214 and 280 nm; (B) Thermo Scientific Accucore aQ (2.1 × 50 mm, 2.6 μm) column; gradient: 5–95% of acetonitrile +0.1% formic acid v/v in water +0.1% formic acid v/v over 5 min period; flow rate: 0.9 mL/min; UV detection at 214 and 280 nm. High-resolution mass spectrometry (HRMS) measurements were performed on a Thermo Finnigan LTQ FT apparatus using an electrospray ionization (ESI) detector. NMR spectra were recorded on a Bruker AV250, Bruker AVHD300, Bruker AV360, Bruker AVHD400 or Bruker AV500C (equipped with a QNP CryoProbe) spectrometer. NMR peaks are reported as follows: chemical shift (δ) in parts per million (ppm) relative to residual nondeuterated solvent as an internal standard (CHCl<sub>3</sub>: δH = 7.26, δC = 77.2; DMSO: δH = 2.50, δC = 39.5 ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet and bs = broad signal), coupling constant (in Hz) and integration. Compounds <b>1</b>, <b>13</b>, <b>20</b>, <b>29</b>, <b>50</b>, <b>61</b>, <b>77</b>, and <b>87</b> were synthesized as described previously.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-benzyl-2-methyl-4,5,6,7-tetrahydro-2<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>2</b>)</h4><div class="NLM_p last">Intermediate <b>69</b> (100 mg, 0.27 mmol 1.0 equiv) was dissolved in a 4 M solution of HCl in 1,4-dioxane (0.5 mL). The mixture was stirred for 4 h at rt and concentrated in vacuo. The crude solid material was suspended in dry THF (1 mL) and TEA (27 mg, 0.27 mmol, 1.0 equiv) was added. The mixture was stirred for 0.5 h followed by addition of indole-3-carboxaldehyde (39 mg, 0.27 mmol, 1.0 equiv), AcOH (16 mg, 0.27 mmol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (86 mg, 0.40 mmol, 1.5 equiv). After stirring for 12 h, the mixture was quenched with saturated aqueous solution of NaHCO<sub>3</sub> (2 mL) and extracted with EtOAc (2 × 2 mL). The combined organic extracts were washed with water (1 mL), brine (1 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (EtOAc/MeOH/TEA 99:1 to 94:5:1) to yield 65 mg (60%) of the title compound <b>2</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.30 (br s, 1H), 7.69 (d, <i>J</i> = 7.9 Hz, 1H), 7.37 (d, <i>J</i> = 8.2 Hz, 1H), 7.34–7.30 (m, 3H), 7.22 (ddd, <i>J</i> = 7.1, 3.1, 1.8 Hz, 2H), 7.13–7.07 (m, 2H), 5.79 (t, <i>J</i> = 5.2 Hz, 1H), 4.53 (d, <i>J</i> = 5.7 Hz, 2H), 4.10 (s, 3H), 3.93 (s, 2H), 3.65 (s, 2H), 2.88 (t, <i>J</i> = 5.8 Hz, 2H), 2.79 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 160.2, 145.8, 137.7, 136.2, 130.9, 128.8, 127.8, 127.7, 127.6, 123.7, 122.2, 119.7, 119.2, 115.0, 112.3, 111.2, 52.4, 50.1, 49.5, 43.5, 39.1, 23.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>26</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 400.21319; found, 400.21345.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-benzyl-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>70</b> (200 mg, 0.56 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (1 mL), TEA (56 mg, 0.56 mmol, 1.0 equiv), indole-3-carboxaldehyde (81 mg, 0.56 mmol, 1.0 equiv), AcOH (34 mg, 0.56 mmol, 1.0 equiv) and NaBH(OAc)<sub>3</sub> (119 mg, 0.84 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (hexane/EtOAc 1:1 to 0:1, then AcOEt/TEA 99:1) gave 2.15 g (89%) of the title compound <b>3</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.86 (br s, 1H), 10.94 (br s, 1H), 8.52 (t, <i>J</i> = 6.5 Hz, 1H), 7.63 (d, <i>J</i> = 7.9 Hz, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.35–7.24 (m, 5H), 7.24–7.16 (m, 1H), 7.06 (t, <i>J</i> = 7.5 Hz, 1H), 6.95 (t, <i>J</i> = 7.5 Hz, 1H), 4.35 (d, <i>J</i> = 6.5 Hz, 2H), 3.83 (s, 2H), 3.35 (s, 1H), 2.72 (t, <i>J</i> = 5.6 Hz, 2H), 2.66 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.0 (br s), 141.5 (br s), 140.5 (br s), 139.0 (br s), 136.9, 128.6, 127.9, 127.7, 127.0, 124.9, 121.4, 119.6, 118.8, 115.9 (br s), 111.8, 111.8, 53.1, 49.7, 49.6, 42.1, 22.0 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O [M + H]<sup>+</sup>, 386.19809; found, 386.19743.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-benzyl-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>4</b>)</h4><div class="NLM_p last">Compound <b>4</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.40 mmol, 1.0 equiv), benzylamine (51 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 90 mg (64%) of the title compound <b>4</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.95 (s, 1H), 8.44 (t, <i>J</i> = 6.0 Hz, 1H), 7.63 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.1 Hz, 1H), 7.33–7.24 (m, 5H), 7.24–7.18 (m, 1H), 7.07 (t, <i>J</i> = 7.4 Hz, 1H), 6.97 (t, <i>J</i> = 7.4 Hz, 1H), 4.91 (t, <i>J</i> = 5.5 Hz, 1H), 4.36 (d, <i>J</i> = 6.3 Hz, 2H), 4.05 (t, <i>J</i> = 5.3 Hz, 2H), 3.84 (br s, 2H), 3.72 (d, <i>J</i> = 4.8 Hz, 2H), 3.58 (br s, 2H), 2.73 (br s, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.6, 140.50, 140.47, 139.9, 136.3, 128.6, 127.9, 127.8, 127.0, 125.0, 121.4, 119.6, 118.8, 116.5, 111.8, 60.6, 53.0, 52.0, 49.6, 49.5, 42.1, 22.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 430.22375; found, 430.22358.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(5-((1<i>H</i>-Indol-3-yl)methyl)-3-(benzylcarbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)acetic Acid (<b>5</b>)</h4><div class="NLM_p last">Compound <b>6</b> (100 mg, 0.21 mmol, 1.0 equiv) was dissolved in EtOH (4 mL), followed by addition of aqueous solution of KOH (59 mg, 1.05 mmol, 5.0 equiv in 0.5 mL of water). The solution was stirred for 0.5 h at rt and saturated aqueous solution of NH<sub>4</sub>Cl (0.5 mL) was added. The mixture was concentrated in vacuo and the residue was refluxed with water (3 mL). The resulting solid was filtered and dried in vacuo to give 63 mg (67%) of the title compound <b>5</b> as a white solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.16 (br s, 1H), 8.54 (t, <i>J</i> = 6.4 Hz, 1H), 7.69 (d, <i>J</i> = 7.9 Hz, 1H), 7.39 (d, <i>J</i> = 8.2 Hz, 2H), 7.33–7.15 (m, 5H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 7.01 (t, <i>J</i> = 7.4 Hz, 1H), 4.75 (s, 2H), 4.33 (d, <i>J</i> = 6.4 Hz, 2H), 4.17 (s, 2H), 3.85 (s, 2H), 3.03 (s, 2H), 2.73 (t, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.9, 162.3, 140.4, 140.3, 139.1 (br s), 136.7, 128.6, 128.0, 127.7, 127.0, 126.6 (br s), 121.7, 119.3, 114.7 (br s), 112.0, 108.4 (br s), 52.5 (br s), 51.6 (br s), 48.8 (br s), 48.4 (br s), 42.2, 20.9 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>26</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 444.20302; found, 444.20284.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Ethyl 2-(5-((1<i>H</i>-Indol-3-yl)methyl)-3-(benzylcarbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)acetate (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>71</b> (701 mg, 1.59 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (5 mL), TEA (161 mg, 1.59 mmol, 1.0 equiv), indole-3-carboxaldehyde (231 mg, 1.59 mmol, 1.0 equiv), AcOH (95 mg, 1.59 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (506 mg, 2.39 mmol, 1.5 equiv), and dry THF (10 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 94:5:1) gave 533 mg (71%) of the title compound <b>6</b> as a pale yellow solid. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 8.48 (br s, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.40–7.29 (m, 5H), 7.22–7.16 (m, 1H), 7.16–7.08 (m, 4H), 4.73 (s, 2H), 4.59 (d, <i>J</i> = 6.0 Hz, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 3.98 (s, 2H), 3.96 (s, 2H), 2.86 (t, <i>J</i> = 5.7 Hz, 2H), 2.61 (t, <i>J</i> = 5.6 Hz, 2H), 1.27 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 167.2, 162.4, 141.4, 140.0, 138.4, 136.4, 128.6, 127.9, 127.9, 127.3, 123.9, 121.9, 119.5, 119.4, 118.1, 112.6, 111.1, 62.0, 52.4, 50.8, 49.6, 48.5, 42.9, 22.1, 14.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 472.23432; found, 472.23447.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Ethyl 5-((1<i>H</i>-Indol-3-yl)methyl)-3-(benzylcarbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-1-carboxylate (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>72</b> (545 mg, 1.27 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (5 mL), TEA (128 mg, 1.27 mmol, 1.0 equiv), indole-3-carboxaldehyde (184 mg, 1.27 mmol, 1.0 equiv), AcOH (76 mg, 1.27 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (404 mg, 1.91 mmol, 1.5 equiv), and dry THF (10 mL). Purification by FC (EtOAc/MeOH 99:1 to 95:5) gave 510 mg (88%) of the title compound <b>7</b> as a white solid. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>): δ 8.41 (br s, 1H), 7.81–7.66 (m, 1H), 7.42–7.27 (m, 7H), 7.24–7.07 (m, 3H), 4.57 (d, <i>J</i> = 6.1 Hz, 2H), 4.47 (q, <i>J</i> = 7.1 Hz, 2H), 4.05–3.86 (m, 4H), 3.02 (t, <i>J</i> = 5.8 Hz, 2H), 2.85 (t, <i>J</i> = 5.7 Hz, 2H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>): δ 161.5, 149.6, 145.2, 143.0, 137.9, 136.3, 128.7, 127.9, 127.8, 127.5, 124.1, 122.0, 120.4, 119.6, 119.4, 111.8, 111.1, 64.7, 52.2, 49.0, 48.6, 43.0, 25.5, 14.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 458.21867; found, 458.21897.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-(4-chlorobenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.33 mmol, 1.0 equiv), 4-chlorobenzylamine (57 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 63 mg (41%) of the title compound <b>8</b> as a white solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.92 (s, 1H), 8.50 (t, <i>J</i> = 6.3 Hz, 1H), 7.62 (d, <i>J</i> = 7.9 Hz, 1H), 7.39–7.30 (m, 3H), 7.30–7.22 (m, 3H), 7.06 (t, <i>J</i> = 7.5 Hz, 1H), 6.95 (t, <i>J</i> = 7.5 Hz, 1H), 4.90 (br s, 1H), 4.32 (d, <i>J</i> = 6.3 Hz, 2H), 4.04 (t, <i>J</i> = 5.4 Hz, 2H), 3.81 (s, 2H), 3.72 (t, <i>J</i> = 5.1 Hz, 2H), 3.55 (s, 2H), 2.71 (br s, 4H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.2, 139.9, 139.5, 139.1, 136.4, 131.1, 129.1 (2× C), 128.1 (2× C), 127.4, 124.4, 120.9, 119.1, 118.3, 116.2, 111.3 (2× C), 60.1, 52.5, 51.5, 49.2, 49.1, 41.0, 21.8. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 464.18478; found, 464.18476.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-(4-fluorobenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.33 mmol, 1.0 equiv), 4-fluorobenzylamine (50 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 60 mg (41%) of the title compound <b>9</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 10.91 (s, 1H), 8.45 (t, <i>J</i> = 6.2 Hz, 1H), 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.35 (d, <i>J</i> = 7.7 Hz, 1H), 7.30 (t, <i>J</i> = 7.1 Hz, 2H), 7.25 (s, 1H), 7.10 (t, <i>J</i> = 8.8 Hz, 2H), 7.05 (t, <i>J</i> = 8.0 Hz, 1H), 6.95 (t, <i>J</i> = 7.5 Hz, 1H), 4.89 (br s, 1H), 4.32 (d, <i>J</i> = 5.6 Hz, 2H), 4.04 (t, <i>J</i> = 5.0 Hz, 2H), 3.82 (s, 2H), 3.71 (d, <i>J</i> = 4.7 Hz, 2H), 3.71 (d, <i>J</i> = 4.7 Hz, 2H), 3.55 (s, 2H), 2.71 (br s, 4H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.1, 161.0 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 240.0 Hz), 139.0, 139.5, 136.4, 136.2 (d, J<sub>CF</sub> = 3.0 Hz), 129.3, 129.2, 127.4, 124.4, 120.9, 119.1, 118.3, 116.2, 114.9, 114.7, 111.3 (2× C), 60.1, 52.5, 51.5, 49.2, 49.1, 41.0, 21.8. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 448.21433; found, 448.21425.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-(3-chlorobenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.33 mmol, 1.0 equiv), 3-chlorobenzylamine (57 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 92 mg (60%) of the title compound <b>10</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.91 (s, 1H), 8.53 (t, <i>J</i> = 6.4 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.37–7.19 (m, 6H), 7.06 (t, <i>J</i> = 7.5 Hz, 1H), 6.95 (t, <i>J</i> = 7.5 Hz, 1H), 4.89 (br s, 1H), 4.34 (d, <i>J</i> = 6.4 Hz, 2H), 4.05 (t, <i>J</i> = 5.5 Hz, 2H), 3.82 (s, 2H), 3.72 (br s, 2H), 3.55 (s, 2H), 2.71 (br s, 4H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.2, 142.7, 139.8, 139.6, 136.4, 132.8, 130.1, 127.1, 126.5, 126.0, 124.4, 120.9, 119.1, 118.3, 116.2, 111.3 (2× C), 60.1, 52.5, 51.5, 49.2, 49.1, 41.2, 21.8. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>27</sub>ClN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 464.18478; found, 464.18481.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-(3-methylbenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.33 mmol, 1.0 equiv), 3-methylbenzylamine (48 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 76 mg (52%) of the title compound <b>11</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.92 (s, 1H), 8.36 (t, <i>J</i> = 6.2 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.25 (s, 1H), 7.17 (t, <i>J</i> = 7.5 Hz, 1H), 7.10–6.99 (m, 4H), 6.95 (t, <i>J</i> = 7.1 Hz, 1H), 4.88 (t, <i>J</i> = 5.5 Hz, 1H), 4.31 (d, <i>J</i> = 6.3 Hz, 2H), 4.04 (t, <i>J</i> = 5.5 Hz, 2H), 3.83 (br s, 2H), 3.71 (q, <i>J</i> = 5.5 Hz, 2H), 3.50 (br s, 2H), 2.71 (br s, 4H), 2.26 (s, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 141.0, 139.7, 138.5, 136.4, 128.7, 128.7, 128.3, 128.0, 125.0, 124.4, 122.1, 119.7, 119.4, 117.4, 111.9, 111.4 (2× C), 61.4, 52.5, 51.2, 49.8, 48.9, 43.0, 22.4, 21.5. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>26</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 444.23940; found, 444.23924.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-(3-trifluoroethylbenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>75</b> (120 mg, 0.33 mmol, 1.0 equiv), 3-methylbenzylamine (70 mg, 0.40 mmol, 1.2 equiv), TBD (15 mg, 0.11 mmol, 0.3 equiv), and dry THF (1 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 68 mg (41%) of the title compound <b>12</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.91 (s, 1H), 8.61 (t, <i>J</i> = 6.3 Hz, 1H), 7.67–7.47 (m, 5H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.25 (d, 2.0 Hz, 1H), 7.06 (t, <i>J</i> = 7.3 Hz, 1H), 6.95 (t, <i>J</i> = 7.3 Hz, 1H), 4.89 (t, <i>J</i> = 9.2 Hz, 1H), 4.42 (d, <i>J</i> = 6.2 Hz, 2H), 4.05 (t, <i>J</i> = 5.4 Hz, 2H), 3.81 (s, 2H), 3.72 (d, <i>J</i> = 4.9 Hz, 2H), 3.55 (s, 2H), 2.71 (br s, 4H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.3, 141.6, 139.8, 139.6, 136.4, 131.5, 129.2, 128.9 (d, J<sub>CF</sub> = 31.6 Hz), 128.3 (q, J<sub>CF</sub> = 151 Hz), 127.4, 124.4, 123.8 (d, J<sub>CF</sub> = 3.8 Hz), 123.3 (d, J<sub>CF</sub> = 3.3 Hz), 120.9, 119.1, 118.3, 116.2, 111.3 (2× C), 60.1, 52.5, 51.5, 49.2, 49.1, 41.3, 21.8. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 498.21114; found, 498.21120.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-((1<i>H</i>-Indol-3-yl)methyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>14</b>)</h4><div class="NLM_p last">Compound <b>78</b> (120 mg, 0.31 mmol, 1.0 equiv), was suspended in dry THF (5 mL), followed by addition of TEA (31 mg, 0.31 mmol, 1.0 equiv). The mixture was stirred for 0.5 h and indole-3-carboxaldehyde (45 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (100 mg, 0.46 mmol, 1.5 equiv) were added. After stirring for 12 h, the mixture was quenched with saturated aqueous solution of NaHCO<sub>3</sub> (5 mL) and extracted with EtOAc (2 × 5 mL). The combined organic extracts were washed with water (5 mL), brine (5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) to yield 81 mg (54%) of the title compound <b>14</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.82 (br s, 1H), 8.07–8.03 (m, 1H), 7.86–7.82 (m, 1H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 7.70 (d, <i>J</i> = 7.8 Hz, 1H), 7.50–7.44 (m, 2H), 7.44 (dd, <i>J</i> = 6.9 Hz, <i>J</i> = 1.5 Hz, 1H), 7.41–7.35 (m, 1H), 7.28 (d, <i>J</i> = 7.9 Hz, 1H), 7.19 (t, <i>J</i> = 5.8 Hz, 1H), 7.16–7.07 (m, 2H), 7.03 (d, <i>J</i> = 4.6 Hz, 1H), 5.02 (d, <i>J</i> = 5.6 Hz, 2H), 3.92 (s, 2H), 3.89 (s, 2H), 3.80 (t, <i>J</i> = 4.9 Hz, 2H), 3.68 (t, <i>J</i> = 4.9 Hz, 2H), 2.75 (t, <i>J</i> = 5.9 Hz, 2H), 2.61 (t, <i>J</i> = 5.9 Hz). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.4, 140.8, 139.8, 136.4, 140.0, 133.8, 131.6, 128.8, 128.6, 128.0, 126.8, 126.7, 126.0, 125.5, 124.3, 123.6, 122.0, 119.6, 119.3, 117.5, 111.6, 111.4, 61.2, 52.4, 51.1, 49.8, 48.7, 41.0, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>29</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 480.23940; found, 480.23940.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>,5-Dibenzyl-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>15</b>)</h4><div class="NLM_p last">The crude amine hydrochloride liberated from intermediate <b>76</b> (305 mg, 0.91 mmol, 1.0 equiv) was suspended in dry THF (10 mL), followed by addition of TEA (92 mg, 0.91 mmol, 1.0 equiv). The mixture was stirred for 0.5 h and benzaldehyde (96 mg, 0.91 mmol, 1.0 equiv), AcOH (55 mg, 0.91 mmol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (288 mg, 1.36 mmol, 1.5 equiv) were added. After stirring for 12 h, the mixture was quenched with saturated aqueous solution of NaHCO<sub>3</sub> (10 mL) and extracted with EtOAc (2 × 10 mL). The combined organic extracts were washed with water (5 mL), brine (5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (EtOAc/MeOH/TEA 99:1 to 94:5:1) to yield 184 mg (52%) of the title compound <b>15</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.43–7.30 (m, 8H), 7.30–7.23 (m, 2H), 7.20 (t, <i>J</i> = 6.0, 1H), 4.56 (d, <i>J</i> = 6.1 Hz, 1H), 4.01 (t, <i>J</i> = 4.8, 1H), 3.92–3.84 (m, 4H), 3.76 (s, 2H), 3,20 (br s, 1H) 2.79–2.67 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.4, 140.8, 139.5, 138.5, 137.9, 129.2, 128.6, 128.4, 127.8, 127.4, 127.3, 117.2, 61.9, 61.2, 51.1, 49.9, 48.7, 42.8, 22.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 391.21285; found, 391.21275.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-Benzyl-5-(3-chlorobenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-c]pyridine-3-carboxamide (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was synthesized by employing the procedure described for compound <b>15</b>, using the crude amine hydrochloride liberated from intermediate <b>76</b> (105 mg, 0.31 mmol, 1.0 equiv), TEA (31 mg, 0.31 mmol, 1.0 equiv), 3-chlorobenzaldehyde (44 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (98 mg, 0.46 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 89 mg (68%) of the title compound <b>16</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.38 (br s, 1H), 7.32 (d, <i>J</i> = 4.4 Hz, 4H), 7.28–7.25 (m, 1H), 7.24 (br s, 3H), 7.11 (t, <i>J</i> = 5.8 Hz, 1H), 4.55 (d, <i>J</i> = 5.8 Hz, 2H), 4.04 (t, <i>J</i> = 5.6 Hz, 2H), 3.93 (t, <i>J</i> = 5.6 Hz, 2H), 3.83 (s, 2H), 3.70 (s, 2H), 2.72 (d, <i>J</i> = 5.0 Hz, 2H), 2.70 (d, <i>J</i> = 5.0 Hz, 2H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 141.0, 140.7, 139.6, 138.6, 134.4, 129.8, 129.0, 128.8 (2× C), 128.0 (2× C), 127.5, 127.5, 127.2, 117.4, 61.5, 61.4, 51.1, 50.0, 49.0, 43.0, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 425.17388; found, 425.17420.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-Benzyl-5-(4-chlorobenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> was synthesized by employing the procedure described for compound <b>15</b>, using the crude amine hydrochloride liberated from intermediate <b>76</b> (105 mg, 0.31 mmol, 1.0 equiv), TEA (31 mg, 0.31 mmol, 1.0 equiv), 4-chlorobenzaldehyde (44 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (98 mg, 0.46 mmol, 1.5 equiv), and dry THF (5 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 110 mg (84%) of the title compound <b>17</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.31 (d, <i>J</i> = 4.4 Hz, 4H), 7.29 (s, 4H), 7.27–7.24 (m, 1H), 7.13 (t, <i>J</i> = 6.1 Hz, 1H), 4.55 (d, <i>J</i> = 6.1 Hz, 2H), 4.02 (t, <i>J</i> = 4.9 Hz, 2H), 3.91 (t, <i>J</i> = 4.9 Hz, 2H), 3.81 (s, 2H), 3.70 (s, 2H), 3.35 (br s, 1H), 2.72 (d, <i>J</i> = 5.2 Hz, 2H), 2.69 (d, <i>J</i> = 5.2 Hz, 2H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 141.0, 139.6, 138.6, 136.7, 133.1, 130.5 (2× C), 128.8 (2× C), 128.7 (2× C), 128.0 (2× C), 127.5, 117.3, 61.4, 61.2, 51.1, 49.9, 48.9, 43.0, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 425.17388; found, 425.17406.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-Benzyl-5-(4-methoxybenzyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was synthesized by employing the procedure described for compound <b>15</b>, using the crude amine hydrochloride liberated from intermediate <b>76</b> (105 mg, 0.31 mmol, 1.0 equiv), TEA (31 mg, 0.31 mmol, 1.0 equiv), 4-methoxybenzaldehyde (42 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (98 mg, 0.46 mmol, 1.5 equiv), and dry THF (5 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 107 mg (82%) of the title compound <b>18</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.31 (d, <i>J</i> = 4.3 Hz, 4H), 7.27 (d, <i>J</i> = 6.7 Hz, 3H), 7.13 (t, <i>J</i> = 5.8 Hz, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 2H), 4.54 (d, <i>J</i> = 5.8 Hz, 2H), 4.00 (t, <i>J</i> = 4.7 Hz, 2H), 3.89 (t, <i>J</i> = 5.0 Hz, 2H), 3.81 (s, 2H), 3.79 (s, 3H), 3.68 (s, 2H), 3.09 (br s, 1H), 2.71 (d, <i>J</i> = 5.0 Hz, 2H), 2.67 (d, <i>J</i> = 5.0 Hz, 2H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 159.0, 141.0, 139.7, 138.6, 130.5 (2× C), 130.1, 128.8 (2× C), 127.9 (2× C), 127.5 (2× C), 117.5, 113.9 (2× C), 61.4, 55.4, 51.1, 49.8, 48.7, 42.9, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>24</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 421.22342; found, 421.22375.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-Benzyl-1-(2-hydroxyethyl)-5-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was synthesized by employing the procedure described for compound <b>15</b>, using the crude amine hydrochloride liberated from intermediate <b>76</b> (52 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 1-naphthaldehyde (25 mg, 0.16 mmol, 1.0 equiv), AcOH (9 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (51 mg, 0.24 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 32 mg (45%) of the title compound <b>19</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.28 (dd, <i>J</i> = 6.7 Hz, 2.7 Hz, 1H), 7.84 (dd, <i>J</i> = 6.3 Hz, 3.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.49–7.46 (m, 3H), 7.42 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 6.9 Hz, 1H), 7.32 (d, <i>J</i> = 4.4 Hz, 4H), 7.28–7.24 (m, 1H), 7.14 (t, <i>J</i> = 6.1 Hz, 1H), 4.56 (d, <i>J</i> = 6.1 Hz, 2H), 4.14 (s, 2H), 4.00 (t, <i>J</i> = 5.6 Hz, 2H), 3.96 (s, 2H), 3.90 (t, <i>J</i> = 5.6 Hz, 2H), 2.78 (t, <i>J</i> = 5.6 Hz, 2H), 2.61 (t, <i>J</i> = 5.6 Hz, 2H), 2.02 (s, 1H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 141.0, 139.9, 138.6, 134.1, 134.0, 132.8, 128.8 (2× C), 128.5, 128.3, 128.0 (2× C), 127.7, 127.5, 126.0, 125.8, 125.3, 124.8, 117.6, 61.4, 60.1, 51.0, 50.4, 48.8, 43.0, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 441.22850; found, 441.22828.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(2-Hydroxyethyl)-5-((1-methyl-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 1-methyl-1<i>H</i>-indole-3-carbaldehyde (24 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) gave 60 mg (76%) of the title compound <b>21</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.85 (dd, <i>J</i> = 7.0 Hz, 1.7 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.55–7.47 (m, 2H), 7.46 (d, <i>J</i> = 6.8 Hz, 1H), 7.40 (t, <i>J</i> = 6.8 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.23 (t, <i>J</i> = 7.6 Hz, 1H), 7.15–7.09 (m, 2H), 7.08 (s, 1H), 4.99 (d, <i>J</i> = 5.7 Hz, 2H), 3.96 (s, 2H), 3.94 (s, 2H), 3.88 (t, <i>J</i> = 5.3 Hz, 2H), 3.78–3.73 (m, 5H), 2.79 (t, <i>J</i> = 5.6 Hz, 2H), 2.61 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.3, 140.9, 139.7, 137.2, 133.9, 133.8, 131.6, 128.9, 128.8, 128.6, 128.5, 126.8, 126.7, 126.0, 125.5, 123.8, 121.7, 119.6, 119.2, 117.6, 110.7, 109.3, 61.3, 52.4, 51.0, 49.8, 48.8, 41.0, 32.3, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 494.25505; found, 494.25478.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(2-Hydroxyethyl)-5-((1-ethyl-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 1-ethyl-1<i>H</i>-indole-3-carbaldehyde (26 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) gave 25 mg (31%) of the title compound <b>22</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.07 (dd, <i>J</i> = 8.0 Hz, 1.3 Hz, 1H), 7.85 (dd, <i>J</i> = 7.2 Hz, 2.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.43 (m, 4H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.34 (d, <i>J</i> = 8.2 Hz, 1H), 7.24–7.18 (m, 2H), 7.15–7.10 (m, 2H), 4.99 (d, <i>J</i> = 5.7 Hz, 2H), 4.15 (q, <i>J</i> = 7.3 Hz, 2H), 4.04 (s, 2H), 4.02 (s, 2H), 3.90 (t, <i>J</i> = 4.4 Hz, 2H), 3.78 (t, <i>J</i> = 5.4 Hz, 3H), 2.86 (t, <i>J</i> = 5.7 Hz, 2H), 2.69 (t, <i>J</i> = 5.7 Hz, 2H), 1.46 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.2, 141.0, 139.4, 136.2, 134.0, 133.8, 131.6, 128.8, 128.7, 128.6, 127.7, 126.8, 126.7, 126.0, 125.5, 123.8, 121.7, 119.5, 116.6, 109.6, 109.3, 61.3, 53.6, 52.1, 51.4, 49.4, 48.4, 41.1, 22.0, 15.6. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 508.27070; found, 508.27076.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(2-Hydroxyethyl)-5-((1-acetyl-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 1-acetyl-1<i>H</i>-indole-3-carbaldehyde (29 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 53 mg (63%) of the title compound <b>23</b> as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.43 (t, <i>J</i> = 6.0 Hz, 1H), 8.32 (d, <i>J</i> = 8.1 Hz, 1H), 8.24–8.09 (m, 1H), 7.93 (dd, <i>J</i> = 6.4 Hz, <i>J</i> = 3.1 Hz, 1H), 7.87–7.76 (m, 2H), 7.75 (d, <i>J</i> = 7.4 Hz, 1H), 7.58–7.49 (m, 2H), 7.48–7.40 (m, 2H), 7.32 (t, <i>J</i> = 7.1 Hz, 1H), 7.24 (t, <i>J</i> = 7.0 Hz, 1H), 4.89 (t, <i>J</i> = 5.4 Hz, 1H), 4.83 (d, <i>J</i> = 6.0 Hz, 2H), 4.04 (t, <i>J</i> = 5.4 Hz, 2H), 3.83 (s, 2H), 3.71 (q, <i>J</i> = 5.4 Hz, 2H), 3.65 (s, 2H), 2.75 (br s, 4H), 2.64 (s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.3, 162.1, 140.0, 139.5, 135.4, 134.9, 133.2, 130.8, 130.2, 128.5, 127.3, 126.1, 125.7, 125.4 (2× C), 125.3, 124.7, 123.5, 123.1, 120.1, 118.7, 115.9 (2× C), 60.1, 52.0, 51.5, 49.6, 49.2, 23.9, 21.8. 1 C-atom overlaps with DMSO-<i>d</i><sub>6</sub> signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 522.24997; found, 522.24997.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(2-Hydroxyethyl)-5-((1-methanesulfonyl-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 1-methanesulfonyl-1<i>H</i>-indole-3-carbaldehyde (32 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH 99:1 to 95:5) gave 48 mg (41%) of the title compound <b>24</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.07 (dd, <i>J</i> = 7.6 Hz, 1.5 Hz, 1H), 7.90 (d, <i>J</i> = 8.2 Hz, 1H), 7.86 (dd, <i>J</i> = 7.0 Hz, 2.0 Hz, 1H), 7.79 (t, <i>J</i> = 8.4 Hz, 2H), 7.56–7.34 (m, 6H), 7.30 (t, <i>J</i> = 7.6 Hz, 1H), 7.10 (t, <i>J</i> = 5.6 Hz, 1H), 5.00 (d, <i>J</i> = 5.6 Hz, 2H), 3.98–3.94 (m, 3H), 3.91 (s, 2H), 3.85 (d, <i>J</i> = 5.4 Hz, 2H), 3.11 (s, 3H), 2.81 (t, <i>J</i> = 5.6 Hz, 2H), 2.67 (t, <i>J</i> = 5.6 Hz, 2H). 2 protons could not be detected. <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.3, 140.9, 139.5, 135.6, 134.0, 133.8, 131.6, 130.8, 128.8, 128.6, 126.8, 126.7, 126.1, 125.5, 125.3, 124.9, 123.7, 123.6, 120.8, 119.3, 117.1, 113.2, 61.4, 52.3, 51.1, 50.1, 49.0, 41.1, 40.8, 22.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>32</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 558.21695; found, 558.21688.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(2-Hydroxyethyl)-5-((7-methoxy-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 7-methoxyindole-3-carboxaldehyde (33 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 61 mg (57%) of the title compound <b>25</b> as a pale pink solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.75 (s, 1H), 8.07–8.05 (m, 1H), 7.86–7.84 (m, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.49–7.45 (m, 3H), 7.41–7.38 (m, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.14 (t, <i>J</i> = 5.7 Hz, 1H), 7.10 (d, <i>J</i> = 2.2 Hz, 1H), 7.04 (t, <i>J</i> = 7.9 Hz, 1H), 6.64 (d, <i>J</i> = 7.7 Hz, 1H), 5.00 (d, <i>J</i> = 5.7 Hz, 1H), 3.95 (s, 2H), 3.94 (s, 5H), 3.81 (t, <i>J</i> = 5.2 Hz, 2H), 3.70 (t, <i>J</i> = 5.1 Hz, 2H), 2.73 (t, <i>J</i> = 5.7 Hz, 2H), 2.53 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.3, 146.3, 140.8, 139.8, 133.9, 133.8, 131.6, 129.4, 128.8, 128.6, 126.9, 126.8, 126.7, 126.1, 125.5, 123.8, 123.7, 120.0 117.7, 112.6, 112.1, 101.8, 61.2, 55.4, 52.5, 51.0, 49.9, 48.6, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 510.24997; found, 510.24997.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(2-Hydroxyethyl)-5-((7-methoxy-1-methyl-1<i>H</i>-indol-3-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 7-methoxy-1-methyl-1<i>H</i>-indole-3-carbaldehyde (24 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) gave 26 mg (31%) of the title compound <b>26</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.06 (d, <i>J</i> = 8.1 Hz, 1H), 7.85 (dd, <i>J</i> = 7.4 Hz, 1.4 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.56–7.44 (m, 3H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 7.25 (d, <i>J</i> = 6.5 Hz, 1H), 7.13 (t, <i>J</i> = 5.6 Hz, 1H), 7.01 (s, 1H), 7.00 (t, <i>J</i> = 8.1 Hz, 1H), 6.61 (d, <i>J</i> = 7.7 Hz, 1H), 4.99 (d, <i>J</i> = 5.6 Hz, 2H), 4.03–4.01 (m, 7H), 3.91–3.89 (m, 6H), 3.78 (d, <i>J</i> = 4.5 Hz, 2H), 2.85 (t, <i>J</i> = 4.9 Hz, 2H), 2.70 (t, <i>J</i> = 5.3 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.2, 148.0, 140.9, 139.3, 133.9, 133.7, 131.6, 130.8, 130.7, 128.8, 128.6, 126.8, 126.7 (2× C), 126.0, 125.5, 123.7, 120.1, 116.4, 112.0, 108.7, 102.5, 61.3, 55.5, 51.9, 49.2, 48.4, 41.1, 36.7, 21.9. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 524.26562; found, 524.26560.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Methyl 3-((1-(2-Hydroxyethyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5-yl)methyl)-1<i>H</i>-indole-7-carboxylate (<b>27</b>)</h4><div class="NLM_p last">Compound <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), methyl 1<i>H</i>-indole-7-carboxylate (40 mg, 0.21 mmol, 1.0 equiv), and TEA (21 mg, 0.21 mmol, 1.0 equiv) were dissolved in MeOH (2 mL). 37% aqueous solution of formaldehyde (19 mg, 0.21 mmol, 1.0 equiv) and ZnCl<sub>2</sub> (43 mg, 0.32 mmol, 1.5 equiv) were then added and the resulting mixture was stirred overnight at rt. The reaction mixture was concentrated in vacuo. Purification of the residue by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 50 mg (44%) of the title compound <b>27</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.76 (s, 1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.98 (d, <i>J</i> = 7.7 Hz, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.85 (d, <i>J</i> = 7.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.52–7.46 (m, 3H), 7.40 (t, <i>J</i> = 7.5 Hz, 1H), 7.31 (br s, 1H), 7.14 (t, <i>J</i> = 7.7 Hz, 1H), 7.07 (t, <i>J</i> = 5.5 Hz, 2H), 3.99–3.93 (m, 10H), 3.82 (t, <i>J</i> = 4.9 Hz, 2H), 2.79 (t, <i>J</i> = 5.6 Hz, 2H), 2.64 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 168.0, 162.3, 141.0, 139.7, 136.4, 134.0, 133.8, 131.6, 129.1, 128.8, 128.6, 126.8, 126.7, 126.1, 125.5, 125.4, 125.1, 124.6, 123.8, 119.1, 117.5, 112.6, 112.5, 61.4, 52.5, 52.0, 51.1, 50.0, 48.8, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>32</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 538.24488; found, 538.24484.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-Hydroxyethyl)-5-((1<i>H</i>-indol-2-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), indole-2-carboxaldehyde (30 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) gave 55 mg (53%) of the title compound <b>28</b> as a pale pink solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.82 (s, 1H), 8.09–8.07 (m, 1H), 7.87–7.85 (m, 1H), 7.79 (d, <i>J</i> = 8.2 Hz, 1H), 7.57 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.45 (m, 3H), 7.39–7.34 (m, 2H), 7.17–7.13 (m, 1H), 7.10–7.07 (m, 2H), 6.40 (s, 1H), 4.99 (d, <i>J</i> = 5.8 Hz, 2H), 3.91 (s, 2H), 3.89–3.87 (m, 4H), 3.78 (t, <i>J</i> = 4.8 Hz, 2H), 2.65 (t, <i>J</i> = 5.6 Hz, 2H), 2.49 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.1, 140.8, 139.6, 136.4, 135.8, 134.0, 133.8, 131.6, 128.8, 128.7, 128.5, 127.0, 126.7, 126.1, 125.5, 123.8, 121.7, 120.3, 119.7, 117.3, 111.0, 101.9, 61.2, 54.7, 51.2, 50.4, 48.5, 41.1, 22.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>29</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 480.23940; found, 480.23912.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(2-Hydroxyethyl)-<i>N</i>,5-bis(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (120 mg, 0.31 mmol, 1.0 equiv), TEA (31 mg, 0.31 mmol, 1.0 equiv), 1-naphthaldehyde (48 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (100 mg, 0.46 mmol, 1.5 equiv), and dry THF (5 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 60 mg (39%) of the title compound <b>30</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.30 (dd, <i>J</i> = 7.4 Hz, 2.1 Hz, 1H), 8.08 (d, <i>J</i> = 8.2 Hz, 1H), 7.87–7.83 (m, 2H), 7.80 (d, <i>J</i> = 8.2 Hz, 2H), 7.54–7.46 (m, 6H), 7.42 (ddd, <i>J</i> = 8.0, 7.0, 5.6 Hz, 2H), 7.09 (t, <i>J</i> = 5.7 Hz, 1H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 4.15 (s, 2H), 3.99 (s, 2H), 3.91 (t, <i>J</i> = 4.4 Hz, 2H), 3.82 (t, <i>J</i> = 5.1 Hz, 2H), 2.77 (t, <i>J</i> = 5.7 Hz, 2H), 2.57 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.3, 140.9, 139.9, 134.3, 134.0, 133.9, 133.8, 132.7, 131.6, 128.8, 128.6, 128.5, 128.2, 127.6, 126.8, 126.7, 126.1, 126.0, 125.8, 125.5, 125.4, 124.9, 123.8, 117.7, 61.4, 60.2, 50.9, 50.5, 48.8, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 491.24415; found, 491.24404.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(2-Hydroxyethyl)-5-((4-hydroxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Compound <b>31</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 4-hydroxy-1-naphthaldehyde (27 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 40 mg (49%) of the title compound <b>31</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.09 (s, 1H), 8.41 (t, <i>J</i> = 5.5 Hz, 1H), 8.26–8.09 (m, 3H), 7.96–7.93 (m, 1H), 7.83 (dd, <i>J</i> = 7.1, 2.0 Hz, 1H), 7.60–7.37 (m, 6H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 6.82 (d, <i>J</i> = 7.5 Hz, 1H), 4.89 (t, <i>J</i> = 4.9 Hz, 1H), 4.83 (d, <i>J</i> = 6.1 Hz, 2H), 4.03 (t, <i>J</i> = 4.9 Hz, 2H), 3.95 (s, 2H), 3.77–3.65 (m, 2H), 3.58 (s, 2H), 2.76 (br s, 2H), 2.70 (br s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.5, 153.4, 140.4, 140.0, 135.4, 133.7, 133.7, 131.3, 128.9, 128.6, 127.8, 126.6, 126.3, 126.2, 125.8, 125.8, 125.4, 125.3, 124.8, 124.7, 124.0, 122.7, 116.4, 107.4, 60.5, 60.1, 52.0, 49.8, 49.7, 22.28. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 507.23907; found, 507.23902.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-((4-Hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)methyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>32</b>)</h4><div class="NLM_p last">Compound <b>32</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (360 mg, 0.93 mmol, 1.0 equiv), TEA (93 mg, 0.93 mmol, 1.0 equiv), 4-methoxy-5,6,7,8-tetrahydronaphthalene-1-carbaldehyde (176 mg, 0.93 mmol, 1.0 equiv), AcOH (57 mg, 0.93 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (300 mg, 1.38 mmol, 1.5 equiv), and dry THF (10 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 265 mg (56%) of the title compound <b>32</b> as a pale white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.08 (d, <i>J</i> = 7.9 Hz, 1H), 7.86 (dd, <i>J</i> = 7.3 Hz, 2.0 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.55–7.46 (m, 3H), 7.43–7.40 (m, 1H), 6.64 (d, <i>J</i> = 8.3 Hz, 1H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 3.93 (t, <i>J</i> = 5.1 Hz, 2H), 3.86–3.81 (m, 4H), 3.81 (s, 3H), 3.62 (s, 2H), 2.82 (br s, 2H), 2.71 (t, <i>J</i> = 5.5 Hz, 2H), 2.66 (br s, 2H), 2.60 (t, <i>J</i> = 5.5 Hz, 2H), 1.75 (t, <i>J</i> = 2.9 Hz, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.3, 156.8, 140.9, 139.9, 138.1, 134.0, 133.8, 131.7, 128.8, 128.6, 128.2, 127.8, 126.8, 126.7, 126.4, 126.0, 125.5, 123.8, 117.9, 106.3, 61.4, 59.5, 55.3, 50.9, 50.3, 48.6, 41.1, 26.4, 23.7, 22.9, 22.5 (2× C). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>37</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 525.28602; found, 525.28590.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(2-Hydroxyethyl)-5-((4-(methylthio)naphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>33</b>)</h4><div class="NLM_p last">Compound <b>33</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (60 mg, 0.16 mmol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.0 equiv), 4-methylthio-1-naphthaldehyde (32 mg, 0.16 mmol, 1.0 equiv), AcOH (10 mg, 0.16 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (50 mg, 0.23 mmol, 1.5 equiv), and dry THF (2 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 37 mg (43%) of the title compound <b>33</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.34–8.26 (m, 2H), 8.07 (dd, <i>J</i> = 7.8 Hz, 1.2 Hz, 1H), 7.86 (dd, <i>J</i> = 7.2 Hz, 2.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.56–7.38 (m, 7H), 7.32 (d, <i>J</i> = 7.5 Hz, 1H), 7.09 (t, <i>J</i> = 5.7 Hz, 1H), 5.00 (d, <i>J</i> = 5.7 Hz, 2H), 4.12 (s, 2H), 3.97 (br s, 2H), 3.90 (dd, <i>J</i> = 5.6 Hz, 4.0 Hz, 2H), 3.81 (dd, <i>J</i> = 5.6 Hz, 4.0 Hz, 2H), 2.78 (t, <i>J</i> = 5.6 Hz, 2H), 2.60–2.56 (m, 2H), 2.58 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.3, 140.9, 139.8, 136.1, 134.0, 133.8, 132.8, 132.1, 131.6, 128.8, 128.6, 127.7, 126.8, 126.7, 126.4, 126.1, 126.0, 125.5, 124.8, 123.8, 123.0, 117.4, 61.4, 60.0, 51.0, 50.4, 48.9, 41.1, 22.4, 16.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 537.23187; found, 537.23185.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(2-Hydroxyethyl)-5-((4-(methylsulfinyl)naphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>34</b>)</h4><div class="NLM_p last">Compound <b>34</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-(methylsulfinyl)-1-naphthaldehyde (46 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 56 mg (48%) of the title compound <b>34</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.40–8.38 (m, 1H), 8.11 (d, <i>J</i> = 7.4 Hz, 1H), 8.06 (d, <i>J</i> = 8.1 Hz, 1H), 7.94–7.90 (m, 1H), 7.84 (dd, <i>J</i> = 7.4 Hz, 1.9 Hz, 1H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 7.72 (d, <i>J</i> = 7.0 Hz, 1H), 7.60–7.54 (m, 2H), 7.53–7.44 (m, 3H), 7.39 (dd, <i>J</i> = 8.1 Hz, 7.1 Hz, 1H), 7.17 (t, <i>J</i> = 5.6 Hz, 2H), 4.99 (d, <i>J</i> = 5.6 Hz, 2H), 4.20 (s, 2H), 4.02 (q, <i>J</i> = 14.9 Hz, 2H), 3.93 (t, <i>J</i> = 4.9 Hz, 2H), 3.83 (t, <i>J</i> = 4.9 Hz, 2H), 2.83 (s, 3H), 2.81 (br s, 2H), 2.65 (br s, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.3, 141.5, 140.9, 139.6, 133.9, 133.7, 132.7, 131.6, 129.1, 128.8, 128.6, 127.4, 127.4, 127.2, 126.9, 126.8, 126.7, 126.0, 126.0, 125.5, 123.7, 121.9, 121.8, 117.1, 61.3, 59.8, 51.1, 50.4, 49.0, 43.0, 41.0, 22.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 553.22679; found, 553.22666.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-((4-(Dimethylamino)naphthalen-1-yl)methyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>35</b>)</h4><div class="NLM_p last">Compound <b>78</b> (120 mg, 0.31 mmol, 1.0 equiv) was suspended in dry 1,2-dichloroethane (3 mL), followed by addition of TEA (31 mg, 0.31 mmol, 1.0 equiv). The mixture was stirred for 0.5 h and 4-dimethylaminonaphthaldehyde (62 mg, 0.31 mmol, 1.0 equiv), AcOH (19 mg, 0.31 mmol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (100 mg, 0.46 mmol, 1.5 equiv) were added. After stirring for 12 h, the mixture was quenched with saturated aqueous solution of NaHCO<sub>3</sub> (5 mL) and extracted with DCM (2 × 5 mL). The combined organic extracts were washed with water (5 mL), brine (5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (EtOAc/MeOH/TEA 99:0:1 to 93:6:1) to yield 57 mg (34%) of the title compound <b>35</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28–8.26 (m, 2H), 8.08 (dd, <i>J</i> = 8.1 Hz, 1.1 Hz, 1H), 7.86 (dd, <i>J</i> = 7.5 Hz, 2.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.54–7.45 (m, 5H), 7.40 (d, <i>J</i> = 8.1 Hz, 1H), 7.39 (t, <i>J</i> = 7.5 Hz, 1H), 7.10 (t, <i>J</i> = 5.7 Hz, 1H), 7.01 (d, <i>J</i> = 7.5 Hz, 1H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 4.08 (s, 2H), 3.97 (s, 2H), 3.89 (dd, <i>J</i> = 5.6 Hz, <i>J</i> = 4.0 Hz, 2H), 3.80 (t, <i>J</i> = 5.2 Hz, 2H), 2.90 (s, 6H), 2.78 (t, <i>J</i> = 5.6 Hz, 2H), 2.58 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.3, 151.0, 140.9, 139.9, 134.0, 133.9, 133.8, 131.6, 129.3, 128.8, 128.6, 127.9, 126.8, 126.7, 126.0 (2× C), 125.9, 125.5, 125.3, 125.0, 124.7 (2× C), 123.8, 117.7, 113.4, 61.3, 60.2, 51.0, 50.4, 45.4 (2× C), 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>33</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 534.28635; found, 534.28633.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-Benzyl-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-c]pyridine-3-carboxamide (<b>36</b>)</h4><div class="NLM_p last">Compound <b>36</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), benzaldehyde (22 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 57 mg (62%) of the title compound <b>36</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.87 (dd, <i>J</i> = 7.4 Hz, 1.9 Hz, 1H), 7.81 (d, <i>J</i> = 8.1 Hz, 1H), 7.54–7.47 (m, 3H), 7.44–7.40 (m, 1H), 7.39–7.37 (m, 2H), 7.33 (t, <i>J</i> = 7.4 Hz, 2H), 7.28 (dt, <i>J</i> = 8.2 Hz, 1.8 Hz, 1H), 7.05 (t, <i>J</i> = 7.2 Hz, 1H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 3.96 (t, <i>J</i> = 5.3 Hz, 2H), 3.87 (s, 2H), 3.85 (t, <i>J</i> = 5.6 Hz, 2H), 3.76 (s, 2H), 2.73 (t, <i>J</i> = 5.6 Hz, 2H), 2.66 (t, <i>J</i> = 5.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.2, 141.0, 139.7, 138.2, 134.0, 133.8, 131.6, 129.3 (2× C), 128.8, 128.7, 128.5 (2× C), 127.4, 126.8, 125.7, 126.1, 125.5, 123.8, 117.6, 62.1, 61.4, 51.0, 50.1, 48.8, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 441.22850; found, 441.22865.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-(2-Hydroxyethyl)-5-(4-methylbenzyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>37</b>)</h4><div class="NLM_p last">Compound <b>37</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-methylbenzaldehyde (24 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 54 mg (57%) of the title compound <b>37</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.11–8.04 (m, 1H), 7.88–7.85 (m, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.57–7.37 (m, 4H), 7.26 (d, <i>J</i> = 7.9 Hz, 1H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 7.04 (t, <i>J</i> = 5.7 Hz, 1H), 5.02 (d, <i>J</i> = 5.7 Hz, 2H), 3.99–3.93 (m, 2H), 3.90–3.82 (m, 4H), 3.73 (s, 2H), 2.73 (t, <i>J</i> = 5.1 Hz, 2H), 2.66 (t, <i>J</i> = 5.0 Hz, 2H), 2.35 (s, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.2, 141.0, 139.6, 137.1, 134.6, 134.0, 133.8, 131.6, 129.3 (2× C), 129.3 (2× C), 128.8, 128.6, 126.8, 126.7, 126.1, 125.5, 123.8, 117.3, 61.7, 61.4, 51.1, 50.0, 48.7, 41.1, 22.3, 21.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>28</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 455.24415; found, 455.24392.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-(2-Hydroxyethyl)-5-(4-ethylbenzyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>38</b>)</h4><div class="NLM_p last">Compound <b>38</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-ethylbenzaldehyde (28 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 55 mg (56%) of the title compound <b>38</b> as a pale yellow solid. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 8.2 Hz, 1H), 7.86 (dd, <i>J</i> = 6.7 Hz, 1.9 Hz, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.57–7.37 (m, 4H), 7.29 (d, <i>J</i> = 7.9 Hz, 2H), 7.17 (d, <i>J</i> = 7.9 Hz, 2H), 7.07 (t, <i>J</i> = 5.3 Hz, 1H), 5.01 (t, <i>J</i> = 5.6 Hz, 2H), 3.94 (t, <i>J</i> = 4.8 Hz, 2H), 3.89 (s, 2H), 3.84 (t, <i>J</i> = 4.5 Hz, 2H), 3.74 (s, 2H), 2.89 (br s, 1H), 2.73 (t, <i>J</i> = 5.3 Hz, 2H), 2.68–2.62 (m, 4H), 1.24 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.2, 143.4, 141.0, 139.7, 135.3, 134.0, 133.8, 131.7, 129.3 (2× C), 128.8, 128.6, 128.0 (2× C), 126.8, 126.7, 126.1, 125.5, 123.8, 117.6, 61.7, 61.4, 51.0, 50.0, 48.7, 41.1, 28.7, 22.4, 15.7. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>29</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 469.25980; found, 469.25967.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(2-Hydroxyethyl)-5-(4-isopropylbenzyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>39</b>)</h4><div class="NLM_p last">Compound <b>39</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-isopropylbenzaldehyde (31 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 67 mg (65%) of the title compound <b>39</b> as a white solid. <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>): δ 8.09–8.05 (m, 1H), 7.87–7.78 (m, 2H), 7.54–7.37 (m, 4H), 7.30 (d, <i>J</i> = 8.0 Hz, 2H), 7.19 (d, <i>J</i> = 8.0 Hz, 2H), 7.11 (t, <i>J</i> = 5.4 Hz, 1H), 4.99 (d, <i>J</i> = 5.7 Hz, 2H), 3.87 (br s, 4H), 3.79 (t, <i>J</i> = 5.2 Hz, 2H), 2.91 (sept, <i>J</i> = 6.9 Hz, 1H), 2.72 (t, <i>J</i> = 4.9 Hz, 2H), 2.65 (t, <i>J</i> = 4.9 Hz, 2H), 1.26 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>): δ 162.2, 148.0, 141.0, 139.6, 135.3, 134.0, 133.8, 131.6, 129.3 (2× C), 128.8, 128.6, 126.8, 126.7, 126.6 (2× C), 126.0, 125.5, 123.8, 117.5, 61.7, 61.3, 51.0, 50.0, 48.8, 41.1, 33.9, 24.2 (2× C), 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>35</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 483.27545; found, 483.27524.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 1-(2-Hydroxyethyl)-5-(4-ethoxybenzyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-ethoxybenzaldehyde (33 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 62 mg (63%) of the title compound <b>40</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.87 (dd, <i>J</i> = 7.4 Hz, 2.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.1 Hz, 1H), 7.55–7.45 (m, 3H), 7.42 (dd, <i>J</i> = 8.1 Hz, <i>J</i> = 7.0 Hz, 1H), 7.27 (d, <i>J</i> = 8.9 Hz, 2H), 7.04 (t, <i>J</i> = 5.6 Hz, 1H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 4.03 (q, <i>J</i> = 7.0 Hz. 2H), 3.95 (t, <i>J</i> = 5.3 Hz, 2H), 3.86–3.84 (m, 4H), 3.69 (s, 3H), 2.72 (t, <i>J</i> = 5.5 Hz, 2H), 2.65 (t, <i>J</i> = 5.3 Hz, 2H), 1.41 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.2, 158.3, 140.9, 139.7, 134.0, 133.8, 131.6, 130.5 (2×), 130.1, 128.1, 128.7, 126.8, 126.7, 126.1, 125.5, 123.8, 117.6, 114.4 (2×), 63.5, 61.5, 61.4, 51.0, 50.0, 48.6, 41.1, 22.4, 15.0. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>29</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 485.25472; found, 485.25447.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(2-Hydroxyethyl)-5-(4-chlorobenzyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-chlorobenzaldehyde (29 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 50 mg (50%) of the title compound <b>41</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (t, <i>J</i> = 5.8 Hz, 1H), 8.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.93 (d, <i>J</i> = 7.1 Hz, 1H), 7.82 (t, <i>J</i> = 4.6 Hz, 1H), 7.55–7.51 (m, 2H), 7.45 (d, <i>J</i> = 4.6 Hz, 2H), 7.37 (virt. q, <i>J</i> = <i>J</i> ≈ 8.3 Hz, 4H), 4.90 (t, <i>J</i> = 5.2 Hz, 1H), 4.84 (d, <i>J</i> = 5.8 Hz, 2H), 4.04 (t, <i>J</i> = 5.2 Hz, 2H), 3.71 (d, <i>J</i> = 5.2 Hz, 2H), 3.66 (s, 2H), 3.54 (s, 2H), 2.73–2.70 (m, 4H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.1, 140.3, 139.4, 137.9, 135.0,133.3, 131.5, 130.8, 130.4 (2× C), 128.5, 128.2 (2× C), 127.3, 126.2, 125.7, 125.4 (2× C), 123.5, 115.8, 60.2 (2× C), 51.6, 49.2, 49.2, 21.8. 1 CH<sub>2</sub> group overlaps with the DMSO signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>28</sub>ClN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 475.18953; found, 475.18939.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-(2-Hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-5-(4-(trifluoromethoxy)benzyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 4-trifluoromethyoxybenzaldehyde (37 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 70 mg (64%) of the title compound <b>42</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.08 (dd, <i>J</i> = 8.0 Hz, 1.1 Hz, 1H), 7.87 (dd, <i>J</i> = 7.3 Hz, 2.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.47 (m, 3H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 7.40 (d, <i>J</i> = 8.7 Hz, 2H), 7.18 (d, <i>J</i> = 8.0 Hz, 2H), 7.02 (t, <i>J</i> = 5.7 Hz, 1H), 5.02 (d, <i>J</i> = 5.7 Hz, 2H), 4.00 (d, <i>J</i> = 5.3 Hz, 2H), 3.92–3.89 (m, 2H), 3.88 (s, 2H), 3.76 (s, 2H), 2.74 (t, <i>J</i> = 5.5 Hz, 2H), 2.68 (t, <i>J</i> = 5.5 Hz, 2H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.2, 148.5, 141.0, 139.6, 137.3, 134.0, 133.8, 131.7, 130.3 (2× C), 128.8, 128.7, 126.8, 126.7, 126.1, 125.5, 123.8, 121.0 (2× C), 117.5, 61.4, 61.2, 51.0, 50.1, 49.0, 41.1, 22.5. CF<sub>3</sub> signal could not be detected. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>28</sub>H<sub>28</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 525.21080; found, 525.21064.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-(3,4-Dimethoxybenzyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>43</b>)</h4><div class="NLM_p last">Compound <b>43</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 3,4-dimethoxybenzaldehyde (37 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 34 mg (32%) of the title compound <b>43</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.07 (dd, <i>J</i> = 6.6 Hz, 2.4 Hz, 1H), 7.86 (dd, <i>J</i> = 6.3 Hz, 3.1 Hz, 1H), 7.80 (d, <i>J</i> = 7.9 Hz, 1H), 7.58–7.35 (m, 4H), 7.10 (t, <i>J</i> = 5.6 Hz, 1H), 6.94 (d, 1.6 Hz, 1H), 6.88 (dd, <i>J</i> = 8.1 Hz, 1.6 Hz, 1H), 6.81 (d, <i>J</i> = 8.1 Hz, 1H), 5.00 (d, <i>J</i> = 5.6 Hz, 2H), 3.96–3.88 (m, 3H), 3.87 (s, 3H), 3.87 (s, 3H), 3.85–3.79 (m, 3H), 3.69 (s, 2H), 2.69 (d, <i>J</i> = 4.8 Hz, 2H), 2.64 (d, <i>J</i> = 4.8 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.2, 149.1, 148.4, 141.0, 139.7, 134.0, 133.8, 131.6, 131.0, 128.8, 128.6, 126.8, 126.7, 126.0, 125.5, 123.8, 121.4, 117.6, 112.3, 111.0, 61.8, 61.3, 56.1, 51.0, 50.1, 48.6, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>29</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 501.24963; found, 501.24950.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 5-(3,4-Dichlorobenzyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>44</b>)</h4><div class="NLM_p last">Compound <b>44</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 3,4-dichlorobenzaldehyde (36 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 55 mg (50%) of the title compound <b>44</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 7.86 (dd, <i>J</i> = 6.9 Hz, 2.2 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.53–7.45 (m, 5H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (d, <i>J</i> = 8.1 Hz, 1H), 7.20 (dd, <i>J</i> = 8.1 Hz, 1.8 Hz, 1H), 7.10 (t, <i>J</i> = 5.7 Hz, 1H), 4.99 (d, <i>J</i> = 5.7 Hz), 3.94 (t, <i>J</i> = 4.5 Hz, 2H), 3.85–3.83 (m, 4H), 3.68 (s, 2H), 2.71 (t, <i>J</i> = 5.4 Hz), 2.65 (t, <i>J</i> = 5.4 Hz, 2H), 2.16 (s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.2, 140.0, 139.5, 139.0, 134.0, 133.8, 132.6, 131.6, 131.2, 130.8, 130.5, 128.8, 128.6, 128.3, 126.8, 126.7, 126.1, 125.5, 123.7, 117.3, 61.3, 60.8, 51.0, 50.0, 49.0, 41.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 509.15056; found, 509.15037.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 5-((2,3-Dihydro-1<i>H</i>-inden-2-yl)methyl)-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>45</b>)</h4><div class="NLM_p last">Compound <b>45</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>78</b> (80 mg, 0.21 mmol, 1.0 equiv), TEA (21 mg, 0.21 mmol, 1.0 equiv), 2,3-dihydro-1<i>H</i>-indene-2-carbaldehyde (31 mg, 0.21 mmol, 1.0 equiv), AcOH (13 mg, 0.21 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (67 mg, 0.32 mmol, 1.5 equiv), and dry THF (3 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 95:4:1) gave 71 mg (70%) of the title compound <b>45</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.14–8.05 (m, 1H), 7.87 (dd, <i>J</i> = 7.0 Hz, 2.4 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 1H), 7.58–7.47 (m, 3H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 7.23–7.17 (m, 2H), 7.16–7.11 (m, 2H), 7.05 (t, <i>J</i> = 5.7 Hz, 1H), 5.03 (d, <i>J</i> = 5.7 Hz, 2H), 4.04–3.95 (m, 2H), 3.92–3.85 (m, 4H), 3.12 (d, <i>J</i> = 7.3 Hz, 1H), 3.07 (d, <i>J</i> = 7.6 Hz, 1H), 2.90–2.76 (m, 5H), 2.71 (t, <i>J</i> = 6.5 Hz, 3H), 2.64 (d, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.2, 143.0 (2× C), 140.9, 139.5, 133.9, 133.8, 131.6, 128.8, 128.6, 126.8, 126.7, 126.3 (2× C), 126.0, 125.5, 124.7 (2× C), 123.8, 117.1, 62.8, 61.2, 51.1, 50.1, 49.7, 41.0, 37.9 (2× C), 37.1, 22.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 481.25980; found, 481.25949.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-((4-Methoxynaphthalen-1-yl)methyl)-9-(naphthalen-1-ylmethyl)-1,2,3,4,8,9-hexahydropyrido[4′,3′:3,4]pyrazolo[1,5-<i>a</i>]pyrazin-10(7<i>H</i>)-one (<b>46</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of compound <b>80</b> (75 mg, 0.14 mol, 1.0 equiv), DIPEA (57 mg, 0.44 mmol, 3.0 equiv), and DMAP (1 mg, 5 mol %) in dry DCM (2 mL) was added methanesulfonly chloride (37 mg, 0.28 mmol, 2.0 equiv). The reaction mixture was allowed to reach rt and stirred for 1 h. The solution was washed with water (0.5 mL), brine (0.5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was redissolved in dry toluene (2 × 1 mL) and evaporated in vacuo. The obtained brown oil was dissolved in dry THF (0.5 mL). The solution was cooled (ice-salt bath) and <sup><i>t</i></sup>BuOK (31 mg, 0.28 mmol, 2.0 equiv) was added in portions. The reaction mixture was allowed to warm to rt, stirred overnight followed by quenching with saturated aqueous solution of NH<sub>4</sub>Cl (1 mL). The mixture was extracted with AcOEt (2 × 1 mL) and the combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. Purification of the residue by FC (hexane/EtOAc 1:1 to 0:1) gave 40 mg (57%) of the title compound <b>46</b> as a beige solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.29 (dd, <i>J</i> = 8.5 Hz, 1.2 Hz, 2H), 8.08 (dd, <i>J</i> = 6.7 Hz, 2.2 Hz, 1H), 7.88 (dd, <i>J</i> = 6.7 Hz, 2.9 Hz, 1H), 7.85 (dd, <i>J</i> = 7.5 Hz, 1.9 Hz, 1H), 7.56–7.45 (m, 5H), 7.45 (d, <i>J</i> = 7.0 Hz, 1H), 7.39 (d, <i>J</i> = 7.7 Hz, 1H), 6.76 (d, <i>J</i> = 7.7 Hz, 1H), 5.16 (s, 2H), 4.08 (s, 2H), 4.07 (d, <i>J</i> = 6.2 Hz, 2H), 4.01 (s, 3H), 3.97 (s, 2H), 3.55–3.52 (m, 2H), 2.84 (t, <i>J</i> = 5.7 Hz, 2H), 2.74 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 158.5, 155.4, 148.3, 134.1, 133.5, 131.8, 131.8, 129.3, 128.9, 128.8, 128.1, 127.8, 127.1, 126.5, 126.4, 126.3, 126.1, 125.2, 125.1, 124.8, 123.9, 122.3, 119.1, 103.0, 60.5, 55.6, 50.0 (2× C), 46.9, 46.1, 43.9, 24.0. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 503.24415; found, 503.24455.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 8-((4-Methoxynaphthalen-1-yl)methyl)-2-(naphthalen-1-ylmethyl)-1,2,6,7,8,9-hexahydro-3<i>H</i>-imidazo[1′,5′:1,5]pyrazolo[4,3-<i>c</i>]pyridin-3-one (<b>47</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of compound <b>83</b> (100 mg, 0.22 mmol, 1.0 equiv) in dry DCM (5 mL) was added CDI (42 mg, 0.26 mmol, 1.2 equiv). The reaction mixture was allowed to reach rt, stirred overnight, and evaporated in vacuo. Purification by automated preparative chromatography (SiO<sub>2</sub>, linear gradient hexane/EtOAc 1:0 to 0:1) gave 35 mg (33%) of the title compound <b>47</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31–8.23 (m, 1H), 8.21–8.12 (m, 2H), 7.92–7.92 (m, 2H), 7.59–7.48 (m, 2H), 7.48–7.39 (m, 4H), 7.31 (d, <i>J</i> = 8.5 Hz, 1H), 6.72 (d, <i>J</i> = 7.8 Hz, 1H), 5.12 (s, 2H), 4.03–3.95 (m, 5H), 3.90 (s, 2H), 3.34 (s, 2H), 2.90 (s, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 155.5, 149.4, 135.5 (br s), 134.0, 133.3, 131.4, 131.0, 129.5, 128.8, 127.8, 127.3, 126.5, 126.4, 125.9, 125.1, 124.4 (br s), 123.5, 122.3, 102.8, 76.7 (br s), 60.1, 55.5, 50.5, 47.8 (br s), 46.1, 42.8, 24.4 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 489.22850; found, 489.22856.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(5-((4-Methoxynaphthalen-1-yl)methyl)-3-(((naphthalen-1-ylmethyl)amino)methyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)ethan-1-ol (<b>48</b>)</h4><div class="NLM_p last">Compound <b>48</b> was synthesized by employing the procedure described for compound <b>14</b>, using intermediate <b>86</b> (40 mg, 0.11 mmol, 1.0 equiv), 1-naphthaldehyde (17 mg, 0.11 mmol, 1.0 equiv), AcOH (7 mg, 0.11 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (34 mg, 0.16 mmol, 1.5 equiv), and dry THF (1 mL). Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 17 mg (30%) of the title compound <b>48</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.21 (d, <i>J</i> = 8.5 Hz, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 8.12 (d, <i>J</i> = 7.4 Hz, 1H), 7.91 (dd, <i>J</i> = 6.8 Hz, 2.3 Hz, 1H), 7.81 (d, <i>J</i> = 8.1 Hz, 1H), 7.54–7.37 (m, 7H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 6.87 (d, <i>J</i> = 7.8 Hz, 1H), 4.79 (t, <i>J</i> = 5.4 Hz, 1H), 4.11 (s, 2H), 3.96 (s, 3H), 3.92 (br s, 4H), 3.67–3.60 (m, 4H), 3.41 (s, 2H), 2.73 (t, <i>J</i> = 5.7 Hz, 2H), 2.63 (t, <i>J</i> = 5.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 154.5, 144.9, 137.7, 136.0, 133.4, 132.9, 131.5, 128.3, 127.7, 127.2, 126.2, 126.1, 125.9, 125.8, 125.6, 125.3, 125.2, 125.1, 125.0, 124.2, 121.7, 112.3, 103.4, 60.4, 59.6, 55.5, 50.7, 50.0, 49.5, 48.9, 45.4, 21.8. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>35</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 507.27545; found, 507.27562.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-((1-(2-Hydroxyethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-c]pyridin-3-yl)methyl)naphthalene-1-sulfonamide (<b>49</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of compound <b>86</b> (40 mg, 0.11 mol, 1.0 equiv), TEA (16 mg, 0.16 mmol, 1.5 equiv), and DMAP (1 mg, 5 mol %) in dry DCM (1 mL) was added naphthalene-1-sulfonyl chloride (25 mg, 0.11 mmol, 1.0 equiv). The reaction mixture was allowed to reach rt and stirred overnight. The solution was washed with water (0.5 mL), brine (0.5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (EtOAc/MeOH 99:1 to 95:5) gave 35 mg (57%) of the title compound <b>49</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.61 (d, <i>J</i> = 8.3 Hz, 1H), 8.30 (d, <i>J</i> = 7.9 Hz, 1H), 8.16 (d, <i>J</i> = 7.2 Hz, 1H), 8.12 (d, <i>J</i> = 8.3 Hz, 1H), 7.96 (d, <i>J</i> = 8.3 Hz, 1H), 7.86 (d, <i>J</i> = 7.6 Hz, 1H), 7.59–7.45 (m, 4H), 7.41 (t, <i>J</i> = 7.8 Hz, 1H), 7.32 (d, <i>J</i> = 7.8 Hz, 1H), 6.76 (d, <i>J</i> = 7.8 Hz, 1H), 6.22 (br s, 1H), 4.01 (s, 2H), 3.91 (s, 2H), 3,84 (d, <i>J</i> = 4.9 Hz, 2H), 3.77 (t, <i>J</i> = 4.9 Hz, 2H), 3.62 (t, <i>J</i> = 4.9 Hz, 2H), 3.29 (br s, 2H), 2.66 (t, <i>J</i> = 5.2 Hz, 2H), 2.46 (t, <i>J</i> = 5.5 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 155.6, 142.2, 138.8, 134.6, 134.2, 134.1, 133.4, 129.6, 129.0, 128.3, 128.2, 128.1, 126.9, 126.7, 126.1, 125.2, 124.7, 124.5, 124.2, 122.5, 119.9, 112.9, 103.1, 61.3, 59.7, 55.7, 50.2, 49.1, 48.7, 39.6, 22.0. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup>, 557.22170; found, 557.22161.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-((4-Methoxynaphthalen-1-yl)methyl)-1-(2-(methylamino)ethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>51</b>)</h4><div class="NLM_p last">Compound <b>87</b> (120 mg, 0.18 mmol, 1.0 equiv) was dissolved in DCM (1 mL), followed by addition of 33% ethanolic solution of MeNH<sub>2</sub> (2 mL, 15.60 mmol, 86.6 equiv). The mixture was refluxed for 4 h, cooled to rt, and evaporated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 44 mg (46%) of the title compound <b>51</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42 (t, <i>J</i> = 6.0 Hz, 1H), 8.24 (d, <i>J</i> = 7.9 Hz, 1H), 8.18 (d, <i>J</i> = 8.8 Hz, 1H), 7.93 (dd, <i>J</i> = 6.0 Hz, 3.2 Hz, 1H), 7.86–7.78 (m, 1H), 7.56–7.45 (m, 5H), 7.43 (d, <i>J</i> = 5.3 Hz, 2H), 7.37 (d, <i>J</i> = 7.9 Hz, 1H), 6.90 (d, <i>J</i> = 7.9 Hz, 1H), 4.83 (d, <i>J</i> = 6.0 Hz, 2H), 4.02 (t, <i>J</i> = 6.0 Hz, 2H), 3.98 (s, 2H), 3.96 (s, 2H), 3.58 (s, 2H), 2.80 (d, <i>J</i> = 6.1 Hz, 2H), 2.77 (d, <i>J</i> = 6.1 Hz, 2H), 2.67 (t, <i>J</i> = 5.1 Hz, 2H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.1, 154.5, 139.9, 139.0, 134.9, 133.2, 132.8, 130.8, 128.4, 127.8, 127.3, 126.2, 126.1, 126.0, 125.7, 125.4, 125.3, 125.2, 125.0, 124.9, 123.4, 121.7, 116.0, 103.4, 59.5, 55.4, 51.0, 49.3, 49.2, 48.5, 35.8, 28.1, 21.7. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>33</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 534.28635; found, 534.28647.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(2-(Isopropylamino)ethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>52</b>)</h4><div class="NLM_p last">To a solution of compound <b>50</b> (100 mg, 0.19 mmol) in dry THF (2 mL) was added acetone (11 mg, 0.19 mmol, 1.0 equiv), AcOH (11 mg, 0.19 mol, 1.0 equiv), and NaBH(OAc)<sub>3</sub> (60 mg, 0.28 mmol, 1.5 equiv). The reaction mixture was stirred overnight at rt, followed by addition of saturated aqueous solution of NaHCO<sub>3</sub> (1 mL). The mixture was extracted with EtOAc (2 × 2 mL) and the combined organic phase was washed with water (1 mL), brine (1 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 85 mg (80%) of the title compound <b>52</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (t, <i>J</i> = 6.2 Hz, 1H), 8.24 (d, <i>J</i> = 7.9 Hz, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 2H), 7.92 (dd, <i>J</i> = 6.5 Hz, 2.8 Hz, 1H), 7.84–7.77 (m, 1H), 7.57–7.46 (m, 4H), 7.45–7.40 (m, 2H), 7.37 (d, <i>J</i> = 7.9 Hz, 1H), 6.89 (d, <i>J</i> = 7.9 Hz, 1H), 4.82 (d, <i>J</i> = 6.1 Hz, 2H), 4.00 (t, <i>J</i> = 6.6 Hz, 2H), 3.98 (s, 2H), 3.96 (s, 3H), 3.58 (s, 2H), 2.82 (t, <i>J</i> = 6.6 Hz, 2H), 2.77 (t, <i>J</i> = 5.4 Hz, 2H), 2.68 (t, <i>J</i> = 5.1 Hz, 2H), 2.61 (sept, <i>J</i> = 6.2 Hz, 1H), 0.90 (d, <i>J</i> = 6.2 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.1, 154.5, 139.9, 139.0, 135.0, 133.2, 132.9, 130.8, 128.5, 127.8, 127.3, 126.2, 126.2, 126.0, 125.7, 125.4, 125.2, 125.2, 125.0, 125.0, 123.5, 121.7, 116.0, 103.4, 59.5, 55.5, 49.4, 49.3, 49.3, 47.8, 46.5, 22.8 (2× C), 21.8. 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>35</sub>H<sub>40</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 562.31765; found, 562.31897.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-(Azetidin-3-yl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>53</b>)</h4><div class="NLM_p last">Compound <b>88</b> (240 mg, 0.38 mmol) was stirred in 4 M solution of HCl in 1,4-dioxane (2 mL) for 4 h at rt. The solution was concentrated in vacuo and the residue was partitioned between DCM (2 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (1 mL). The phases were separated and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 93:6:1) gave 123 mg (61%) of the title compound <b>53</b> as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.43 (t, <i>J</i> = 5.9 Hz, 1H), 8.23 (d, <i>J</i> = 7.9 Hz, 1H), 8.17 (d, <i>J</i> = 8.1 Hz, 2H), 7.94–7.92 (m, 1H), 7.82 (t, <i>J</i> = 4.6 Hz, 1H), 7.56–7.41 (m, 6H), 7.37 (d, <i>J</i> = 7.9 Hz, 2H), 6.90 (d, <i>J</i> = 7.9 Hz, 1H), 5.07 (p, <i>J</i> = 7.3 Hz, 1H), 4.85 (d, <i>J</i> = 5.9 Hz, 2H), 3.98 (s, 3H), 3.96 (s, 4H), 3.63 (t, <i>J</i> = 7.3 Hz, 2H), 3.57 (s, 2H), 2.76 (t, <i>J</i> = 5.3 Hz, 2H), 2.65 (t, <i>J</i> = 5.3 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.0, 154.5, 140.1, 138.6, 134.9, 133.2, 132.8, 130.8, 128.5, 127.7, 127.3, 126.2, 126.1, 125.9, 125.7, 125.4, 125.4, 125.2, 125.0, 124.9, 123.4, 121.6, 116.4, 103.4, 59.4, 55.5, 52.7 (2× C), 51.4, 49.1 (2× C), 21.5. 1 signal overlaps with DMSO-<i>d</i><sub>6</sub>. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>33</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 532.27070; found, 532.27141.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(2-(Dimethylamino)ethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>54</b>)</h4><div class="NLM_p last">To a solution of compound <b>50</b> (80 mg, 0.15 mmo) in dry THF (1 mL) was added 37% aqueous solution of formaldehyde (36 mg, 0.46 mmol, 3.0 equiv) and NaBH(OAc)<sub>3</sub> (131 mg, 0.62 mmol, 4.0 equiv). The reaction mixture was stirred overnight at rt, followed by addition of saturated aqueous solution of NaHCO<sub>3</sub> (1 mL). The mixture was extracted with EtOAc (2 × 1 mL) and the combined organic phase was washed with water (1 mL), brine (1 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 68 mg (83%) of the title compound <b>54</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.43 (t, <i>J</i> = 6.2 Hz, 1H), 8.23 (d, <i>J</i> = 7.8 Hz, 1H), 8.17 (d, <i>J</i> = 7.8 Hz, 2H), 7.93 (dd, <i>J</i> = 5.9 Hz, 2.4 Hz, 1H), 7.81 (dd, <i>J</i> = 6.9 Hz, 2.4 Hz, 1H), 7.56–7.44 (m, 4H), 7.44–7.40 (m, 2H), 7.37 (d, <i>J</i> = 7.8 Hz, 1H), 6.90 (d, <i>J</i> = 7.8 Hz, 1H), 4.82 (d, <i>J</i> = 6.2 Hz, 2H), 4.05 (t, <i>J</i> = 6.7 Hz, 2H), 3.98 (s, 2H), 3.96 (s, 3H), 3.57 (s, 2H), 2.77 (t, <i>J</i> = 5.4 Hz, 2H), 2.68 (t, <i>J</i> = 5.4 Hz, 2H), 2.56 (t, <i>J</i> = 6.7 Hz, 2H), 2.12 (s, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.1, 154.4, 139.9, 139.0, 135.0, 133.3, 132.9, 130.8, 128.5, 127.9, 127.3, 126.3, 126.2, 126.0, 125.7, 125.4, 125.3, 125.2, 125.1, 125.0, 123.5, 121.7, 116.1, 103.4, 59.5, 58.4, 55.5, 49.4, 49.3, 47.1 (2× C), 45.3, 21.7. 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>34</sub>H<sub>38</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 548.30200; found, 548.30223.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-(2-(1<i>H</i>-Imidazole-1-yl)ethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>55</b>)</h4><div class="NLM_p last">A mixture of compound <b>87</b> (132 mg, 0.20 mmol, 1 equiv), imidazole (21 mg, 0.30 mmol, 1.5 equiv), and Cs<sub>2</sub>CO<sub>3</sub> (98 mg, 0.30 mmol, 1.5 equiv) in dry DMF (2 mL) was stirred for 2 h at 60 °C. The reaction mixture was cooled and partitioned between EtOAc (15 mL) and water (40 mL). The aqueous phase was extracted with EtOAc (2 × 10 mL). The combined organic layers were washed with water (2 × 10 mL), brine (2 × 10 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 77 mg (67%) of the title compound <b>55</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.27 (d, <i>J</i> = 8.0 Hz, 1H), 8.20 (d, <i>J</i> = 8.2 Hz, 1H), 8.10 (d, <i>J</i> = 8.2 Hz, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.2 Hz, 1H), 7.55 (dd, <i>J</i> = 6.8 Hz, 1.1 Hz, 1H), 7.53–7.48 (m, 3H), 7.48–7.42 (m, 2H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.14 (s, 1H), 7.07 (t, <i>J</i> = 5.6 Hz, 1H), 6.93 (s, 1H), 6.73 (d, <i>J</i> = 7.8 Hz, 1H), 6.43 (s, 1H), 5.03 (d, <i>J</i> = 5.6 Hz, 2H), 4.21 (t, <i>J</i> = 5.2 Hz, 2H), 4.04 (s, 2H), 4.02 (t, <i>J</i> = 5.2 Hz, 2H), 3.98 (s, 3H), 3.92 (s, 2H), 2.05 (t, <i>J</i> = 5.4 Hz, 2H), 1.98 (t, <i>J</i> = 5.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.2, 155.4, 141.6, 140.3, 137.0, 133.9, 133.7, 133.4, 131.6, 129.8, 128.8, 128.7, 128.1, 126.9, 126.8, 126.5, 126.1, 126.0, 125.5, 125.5, 125.1, 124.7, 123.7, 122.3, 119.1, 117.2, 103.0, 59.6, 55.6, 50.0, 49.8, 48.4, 46.6, 41.1, 21.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>35</sub>H<sub>35</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 571.28160; found, 571.28301.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(2-(1<i>H</i>-Pyrazol-1-yl)ethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>56</b>)</h4><div class="NLM_p last">Compound <b>56</b> was synthesized by employing the procedure described for compound <b>55</b>, using intermediate <b>87</b> (132 mg, 0.20 mmol, 1 equiv), pyrazole (21 mg, 0.30 mmol, 1.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (98 mg, 0.30 mmol, 1.5 equiv), and dry DMF (2 mL). Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) gave 66 mg (57%) of the title compound <b>56</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J</i> = 7.8 Hz, 1H), 8.21 (d, <i>J</i> = 7.8 Hz, 1H), 8.12 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.84 (d, <i>J</i> = 8.2 Hz, 1H), 7.60–7.42 (m, 7H), 7.32 (d, <i>J</i> = 6.1 Hz, 1H), 7.08 (t, <i>J</i> = 5.1 Hz, 1H), 6.77 (d, 1.5 Hz, 1H), 6.73 (d, <i>J</i> = 7.8 Hz, 1H), 6.06 (br s, 1H), 5.05 (d, <i>J</i> = 5.5 Hz, 2H), 4.42 (t, <i>J</i> = 5.5 Hz, 2H), 4.22 (t, <i>J</i> = 5.0 Hz, 2H), 4.00 (s, 5H), 3.89 (s, 2H), 2.58 (br s, 2H), 1.98 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 162.4, 155.4, 141.5, 140.5, 140.4, 134.0, 133.8, 133.5, 131.7, 130.3, 128.8, 128.7, 127.8, 126.9, 126.7, 126.4, 126.1 (2× C), 126.1, 125.6, 125.1, 124.8, 123.8, 122.3, 117.0, 105.9, 103.0, 59.7, 55.6, 51.9, 50.0, 49.2, 48.5, 41.1, 21.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>35</sub>H<sub>35</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 571.28160; found, 571.28301.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 5-((4-Methoxynaphthalen-1-yl)methyl)-1-(2-morpholinoethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>57</b>)</h4><div class="NLM_p last">Compound <b>57</b> was synthesized by employing the procedure described for compound <b>55</b>, using intermediate <b>87</b> (132 mg, 0.20 mmol, 1 equiv), morpholine (26 mg, 0.30 mmol, 1.5 equiv), Cs<sub>2</sub>CO<sub>3</sub> (98 mg, 0.30 mmol, 1.5 equiv), and dry DMF (2 mL). Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 98:1:1) gave 41 mg (35%) of the title compound <b>57</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.33–8.27 (m, 2H), 8.13 (d, <i>J</i> = 8.1 Hz, 1H), 7.90 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.84 (d, <i>J</i> = 8.2 Hz, 1H), 7.61–7.43 (m, 6H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.07 (t, <i>J</i> = 5.7 Hz, 1H), 6.78 (d, <i>J</i> = 7.8 Hz, 1H), 5.06 (d, <i>J</i> = 5.7 Hz, 2H), 4.10 (s, 2H), 4.03 (s, 3H), 4.02–3.93 (m, 4H), 3.64 (t, <i>J</i> = 4.7 Hz, 4H), 2.81 (t, <i>J</i> = 5.7 Hz, 2H), 2.71–2.61 (m, 4H), 2.40 (t, <i>J</i> = 4.7 Hz, 4H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.5, 155.3, 140.5, 139.2, 133.9, 133.4, 131.6, 129.8, 128.7, 128.4, 127.7, 126.6, 126.6, 126.4, 126.2, 126.0, 125.9, 125.4, 125.0, 124.7, 123.7, 122.2, 117.5, 102.9, 66.9, 60.0, 58.0, 55.5, 53.8, 50.3, 48.6, 47.0, 40.9, 22.5. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>36</sub>H<sub>40</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 590.31257; found, 590.31338.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-(2-Acetamidoethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>58</b>)</h4><div class="NLM_p last">A solution of compound <b>50</b> (60 mg, 0.11 mmol, 1.0 equiv) in acetic anhydride (100 mg, 0.99 mmol, 9.0 equiv) was heated at 80 °C for 1 h. The mixture was evaporated in vacuo and the residue was purified by FC (EtOAc/MeOH 99:1 to 95:5) to give 45 mg (73%) of the title compound <b>58</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (dd, <i>J</i> = 6.6 Hz, 2.0 Hz, 1H), 8.23 (dd, <i>J</i> = 7.1 Hz, 2.0 Hz, 1H), 8.09 (dd, <i>J</i> = 8.7 Hz, 1.3 Hz, 1H), 7.86 (dd, <i>J</i> = 7.1 Hz, 2.3 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.55–7.38 (m, 6H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 7.08 (t, <i>J</i> = 5.6 Hz, 1H), 6.73 (d, <i>J</i> = 7.8 Hz, 1H), 5.82 (t, <i>J</i> = 5.6 Hz, 1H), 5.01 (d, <i>J</i> = 5.6 Hz, 2H), 4.05 (s, 2H), 4.00 (s, 3H), 3.95–3.88 (m, 4H), 3.48 (q, <i>J</i> = 5.8 Hz, 2H), 2.72 (t, <i>J</i> = 5.5 Hz, 2H), 2.52 (t, <i>J</i> = 5.5 Hz, 2H), 1.75 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 170.6, 162.4, 155.4, 141.0, 139.8, 134.0, 133.9, 133.5, 131.6, 128.9, 128.6, 127.9, 126.9, 126.7, 126.4, 126.1, 126.1, 126.1, 125.6, 125.1, 124.7, 123.7, 122.4, 117.8, 103.0, 60.2, 55.6, 50.2, 48.9, 48.0, 41.1, 39.2, 23.1, 22.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>34</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 562.28127; found, 562.28196.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (2-(5-((4-methoxynaphthalen-1-yl)methyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)ethyl)glycine (<b>59</b>)</h4><div class="NLM_p last">The solution of compound 59 (37 mg, 0.06 mmol, 1.0 equiv) and NaOH (12 mg, 0.30 mmol, 5.0 equiv) in MeOH (1 mL)/water (0.1 mL) was stirred at rt for 2 h. The reaction mixture was evaporated in vacuo and the residue was partitioned between DCM (1 mL) and saturated aqueous solution of NH<sub>4</sub>Cl. The aqueous phase was washed with DCM (2 × 0.5 mL) and the combined organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) gave 20 mg (58%) of the title compound <b>59</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.68 (t, <i>J</i> = 6.2 Hz, 1H), 8.23 (d, <i>J</i> = 8.3 Hz, 1H), 8.18 (dd, <i>J</i> = 12.8 Hz, 8.1 Hz, 2H), 7.92 (d, <i>J</i> = 7.1 Hz, 1H), 7.80 (d, <i>J</i> = 5.0 Hz, 1H), 7.56–7.45 (m, 5H), 7.45–7.41 (m, 2H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 6.90 (d, <i>J</i> = 7.8 Hz, 1H), 4.83 (d, <i>J</i> = 6.2 Hz, 2H), 4.18 (t, <i>J</i> = 6.2 Hz, 2H), 3.99 (s, 2H), 3.96 (s, 3H), 3.58 (s, 2H), 3.25 (s, 2H), 3.17 (t, <i>J</i> = 6.2 Hz, 2H), 2.79 (t, <i>J</i> = 4.3 Hz, 2H), 2.69 (t, <i>J</i> = 4.3 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.1, 161.9, 154.5, 140.2, 139.3, 134.8, 133.2, 132.8, 130.7, 130.5, 128.4, 127.8, 127.2, 126.2, 126.2, 125.9, 125.7, 125.2, 125.1, 125.0, 124.9, 123.5, 121.7, 116.1, 103.4, 59.3, 55.5, 49.7, 49.1 (2× C), 46.8, 46.0, 21.4. 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>34</sub>H<sub>36</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 578.27618; found, 578.27710.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl (2-(5-((4-Methoxynaphthalen-1-yl)methyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)ethyl)glycinate (<b>60</b>)</h4><div class="NLM_p last">A mixture of compound <b>87</b> (70 mg, 0.10 mmol, 1.0 equiv), methyl glycinate hydrochloride (50 mg, 0.40 mmol, 4.0 equiv), and K<sub>2</sub>CO<sub>3</sub> (110 mg, 0.80 mmol, 8.0 equiv) in MeCN (2 mL) was stirred at reflux overnight. The reaction mixture was cooled, filtered, and evaporated in vacuo. The residue was partitioned between AcOEt (2 mL) and water (0.5 mL). The layers were separated and the organic phase was washed with brine (1 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (EtOAc/MeOH 99:1 to 92:8) gave 88 mg (57%) of the title compound <b>60</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.40 (t, <i>J</i> = 6.2 Hz, 1H), 8.23 (d, <i>J</i> = 8.5 Hz, 1H), 8.17 (dd, <i>J</i> = 8.7 Hz, 1.3 Hz, 2H), 7.94–7.91 (m, 1H), 7.82 (dd, <i>J</i> = 7.1 Hz, 2.3 Hz, 1H), 7.56–7.45 (m, 4H), 7.44–7.40 (m, 2H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 6.91 (d, <i>J</i> = 7.8 Hz, 1H), 4.82 (d, <i>J</i> = 6.2 Hz, 2H), 4.03 (t, <i>J</i> = 6.2 Hz, 2H), 3.99 (s, 2H), 3.97 (s, 3H), 3.57 (s, 2H), 3.56 (s, 3H), 3.29 (s, 2H), 2.88 (t, <i>J</i> = 6.3 Hz, 2H), 2,78 (t, <i>J</i> = 5.8 Hz, 2H), 2.69 (t, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.6, 162.1, 154.5, 139.9, 139.1, 134.9, 133.2, 132.8, 130.8, 128.5, 127.8, 127.3, 126.3, 126.2, 126.0, 125.7, 125.4, 125.2 (2× C), 125.1, 125.0, 123.5, 121.7, 116.0, 103.4, 59.5, 55.5, 51.3, 49.7, 49.3, 49.3, 48.9, 48.2, 21.7. 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>35</sub>H<sub>38</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 592.29183; found, 592.29275.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-(2-Hydroxyethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-5-methyl-3-((naphthalen-1-ylmethyl)carbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5-ium Iodide (<b>62</b>)</h4><div class="NLM_p last">To a cooled (ice-salt bath) solution of compound <b>29</b> (100 mg, 0.19 mmol, 1.0 equiv) in acetone (0.5 mL) was added MeI (41 mg, 0.288 mmol, 1.5 equiv). The reaction mixture was allowed to reach rt and stirred overnight. The resulting precipitate was filtered off, washed with EtOAc, and further purified by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 40:60) to give 63 mg (50%) of the title compound <b>62</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.85 (d, <i>J</i> = 6.2 Hz, 1H), 8.32 (d, <i>J</i> = 8.5 Hz, 1H), 8.27 (dd, <i>J</i> = 8.5 Hz, 1.5 Hz, 1H), 8.24 (dd, <i>J</i> = 7.9 Hz, 1.5 Hz, 1H), 7.96 (dd, <i>J</i> = 7.3 Hz, 1.8 Hz, 1H), 7.85 (dd, <i>J</i> = 6.8 Hz, 2.7 Hz, 1H), 7.74 (d, <i>J</i> = 8.1 Hz, 1H), 7.62–7.53 (m, 4H), 7.51–7.45 (m, 2H), 7.12 (d, <i>J</i> = 8.1 Hz, 1H), 5.14 (q, 13.6 Hz, 2H), 4.98 (t, <i>J</i> = 5.6 Hz, 1H), 4.87 (d, <i>J</i> = 6.2 Hz, 2H), 4.73 (q, <i>J</i> = 15.2 Hz, 2H), 4.16 (t, <i>J</i> = 5.2 Hz, 2H), 4.04 (s, 3H), 3.85–3.80 (m, 2H), 3.76 (q, <i>J</i> = 5.4 Hz, 2H), 3.31 (dt, 17.0 Hz, <i>J</i> = 5.0 Hz, 1H), 3.12 (dt, 17.0 Hz, <i>J</i> = 7.5 Hz, 1H), 2.96 (br s, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.3, 156.9, 141.1, 135.9, 134.7, 134.7, 133.9, 133.3, 130.8, 128.5, 127.7, 127.4, 126.2, 125.7, 125.7, 125.5, 125.4, 125.2, 123.8, 123.5, 122.3, 115.5, 109.1, 104.0, 62.6, 62.6, 60.0, 56.7, 56.6, 56.0, 52.3, 45.8, 17.7. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>33</sub>H<sub>35</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 535.27037; found, 535.27027.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-(2-Hydroxyethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide (<b>63</b>)</h4><div class="NLM_p last">Compound <b>63</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>94</b> (226 mg, 0.61 mmol, 1.0 equiv), TEA (62 mg, 0.61 mmol, 1.0 equiv), 4-methoxy-1-naphthaldehyde (114 mg, 0.61 mmol, 1.0 equiv), AcOH (37 mg, 0.61 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (195 mg, 0.92 mmol, 1.5 equiv), and dry THF (5 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 94:5:1) gave 211 mg (68%) of the title compound <b>63</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.38–8.29 (m, 1H), 8.25 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 8.12–8.02 (m, 1H), 7.92–7.84 (m, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.61–7.35 (m, 7H), 7.06 (t, <i>J</i> = 5.7 Hz, 1H), 6.75 (d, <i>J</i> = 7.8 Hz, 1H), 5.01 (d, <i>J</i> = 5.7 Hz, 2H), 4.30 (s, 2H), 4.12–4.06 (s, 2H), 4.02 (s, 3H), 3.88 (td, <i>J</i> = 5.5, 4.9, 2.2 Hz, 2H), 3.84–3.72 (m, 4H), 2.55 (br s, 1H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 161.4, 155.5, 149.0, 139.1, 133.8, 133.6, 133.0, 131.5, 128.7, 128.5, 127.2, 126.8, 126.7, 126.6, 126.2, 126.0, 125.9, 125.4, 125.2, 125.0, 124.1, 123.6, 122.4, 102.8, 61.2, 58.2, 55.5, 53.1, 52.4, 50.7, 41.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 507.23907; found, 507.23903.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(2-Aminoethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide (<b>64</b>)</h4><div class="NLM_p last">To a solution of compound <b>96</b> (64 mg, 0.12 mmol, 1.0 equiv) in THF (0.5 mL) was added PPh<sub>3</sub> (94 mg, 0.36 mmol, 3 equiv). The reaction mixture was stirred for further 1 h, followed by addition of water (65 mg, 3.60 mmol, 10.0 equiv). The solution was then heated to 50 °C for 4 h and concentrated in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 99:0:1 to 98:1:1) gave 39 mg (64%) of the title compound <b>64</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.47 (t, <i>J</i> = 6.1 Hz, 1H), 8.27 (d, <i>J</i> = 8.0 Hz, 1H), 8.22–8.15 (m, 2H), 7.93 (dd, <i>J</i> = 7.1 Hz, 1.9 Hz, 1H), 7.84–7.79 (m, 1H), 7.59–7.48 (m, 5H), 7.44 (dd, <i>J</i> = 5.8 Hz, 2.0 H, 3H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 4.85 (d, <i>J</i> = 6.1 Hz, 2H), 4.24 (s, 2H), 3.97 (s, 3H), 3.94 (t, <i>J</i> = 6.0 Hz, 2H), 3.81 (s, 2H), 3.79 (s, 2H), 2.85 (t, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.3, 154.5, 148.4, 138.4, 134.9, 133.2, 132.5, 130.8, 128.4, 127.3, 127.1, 126.6, 126.3, 126.1, 125.7, 125.4, 125.3, 125.2, 125.1, 124.6, 123.6, 123.5, 121.7, 103.4, 57.5, 55.5, 53.8, 51.9, 50.4, 41.6. 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 506.25505; found, 506.25515.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-(2-((1-Hydroxy-2-methylpropan-2-yl)amino)ethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide (<b>65</b>)</h4><div class="NLM_p last">A mixture of compound <b>95</b> (57 mg, 0.09 mmol, 1.0 equiv), 2-amino-2-methyl-1-propanol (40 mg, 0.45 mmol, 5 equiv), and K<sub>2</sub>CO<sub>3</sub> (30 mg, 0.22 mmol, 2.5 equiv) in CH<sub>3</sub>CN (0.5 mL) was stirred at reflux for 8 h. The reaction mixture was cooled to rt and concentrated in vacuo. The residue was purified by FC (DCM/MeOH/7 M NH<sub>3</sub> in MeOH 99:0:1 to 94:5:1) to yield 40 mg (77%) of <b>65</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.45 (t, <i>J</i> = 6.1 Hz, 1H), 8.27 (d, <i>J</i> = 7.9 Hz, 1H), 8.18 (d, <i>J</i> = 8.3 Hz, 2H), 7.93 (dd, <i>J</i> = 6.8 Hz, 2.0 Hz, 1H), 7.82 (dd, <i>J</i> = 6.1 Hz, 3.1 Hz, 1H), 7.58–7.49 (m, 4H), 7.46–7.41 (m, 3H), 6.91 (d, <i>J</i> = 7.9 Hz, 1H), 4.84 (d, <i>J</i> = 6.1 Hz, 2H), 4.47 (br s, 1H), 4.24 (s, 2H), 4.00–3.97 (m, 5H), 3.82 (s, 2H), 3.78 (s, 2H), 3.09 (s, 2H), 2.77 (t, <i>J</i> = 6.2 Hz, 2H), 0.84 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.3, 154.5, 148.4, 138.2, 134.8, 133.2, 132.5, 130.8, 128.4, 127.3, 127.1, 126.6, 126.2, 126.1, 125.7, 125.4, 125.3, 125.2, 125.1, 124.6, 123.6, 123.5, 121.7, 103.4, 68.0, 57.4, 55.5, 53.3, 52.3, 51.8, 50.6, 41.6, 23.6 (2× C). 1 C atom overlaps with DMSO-<i>d</i><sub>6</sub> signal ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>35</sub>H<sub>40</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 578.31257; found, 578.31258.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 5-(<i>tert</i>-Butyl) 3-Ethyl 1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3,5-dicarboxylate (<b>66</b>)</h4><div class="NLM_p last">To a stirred solution of LHMDS (25.0 mL of 1 M solution in THF, 25.0 mmol, 1.0 equiv) in dry THF (50 mL) at −78 °C was added a solution of 1-boc-4-piperidinone (5.00 g, 25.0 mmol, 1.0 equiv) in dry THF (20 mL), dropwise. The reaction mixture was stirred for further 30 min at −78 °C, followed by a dropwise addition of a diethyl oxalate (3.92 g, 25.0 mmol, 1.0 equiv). The mixture was then warmed to rt and stirred for further 30 min. Subsequently, EtOH (40 mL), AcOH (10 mL), and hydrazine monohydrate (1.50 mL of 80% aqueous solution, 25 mmol, 1.0 equiv) were added. A slightly exothermic reaction was observed. The reaction mixture was then heated to reflux for 1 h, cooled to rt, and concentrated in vacuo. The residue was partitioned between EtOAc (100 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (100 mL). The aqueous phase was extracted with EtOAc (2 × 25 mL). The combined organic extracts were sequentially washed with water (25 mL), 1 M aqueous solution of citric acid (50 mL), water (25 mL), and brine (25 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (hexane/EtOAc 2:1 to 0:1) to yield 4.35 g (59%) of the target compound <b>66</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.70 (br s, 0.3 H), 13.30 (br s, 0.7H), 4.49 (br s, 2H), 4.27 (br s, 2H), 3.59 (t, <i>J</i> = 5.8 Hz, 2H), 2.67 (bst, <i>J</i> = 5.8 Hz, 2H), 1.42 (s, 9H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.7 (br s), 159.5 (br s), 154.6, 147.6 (br s), 138.8 (br s), 128.5 (br s), 117.4 (br s), 115.9 (br s), 79.6, 61.0 (br s), 60.4 (br s), 41.6 (br s), 41.0 (br s), 28.5, 23.5 (br s), 21.4 (br s), 14.6 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>14</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 296.16048; found, 296.16027.</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 5-(<i>tert</i>-Butyl) 3-Ethyl 1-Methyl-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3,5-dicarboxylate (<b>67</b>) and 5-(<i>tert</i>-Butyl) 3-Ethyl 2-Methyl-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3,5-dicarboxylate (<b>68</b>)</h4><div class="NLM_p last">Intermediate <b>66</b> (2.30 g, 7.80 mmol, 1.0 equiv) was dissolved in dry DMF (20 mL). Cs<sub>2</sub>CO<sub>3</sub> (2.54 g, 7.80 mmol, 1.0 equiv) was added followed by MeI (3.33 g, 23.4 mmol, 3.0 equiv). The mixture was stirred at rt overnight and partitioned between water (100 mL) and EtOAc (50 mL). The layers were separated and the aqueous phase was extracted with EtOAc (2 × 15 mL). The combined organic extracts were washed with water (3 × 25 mL) saturated aqueous solution of NH<sub>4</sub>Cl (25 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (hexane/EtOAc 3:1 to 0:1) to yield 1.38 g (57%) of slower eluting <b>67</b> as a pale yellow solid and 0.85 g (35%) of faster eluting N-2 regioisomer <b>68</b> as yellow oil that solidified upon storing in the cold. <b>67</b>: <sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>): δ 4.60 (s, 2H), 4.38 (q, <i>J</i> = 7.1 Hz, 2H), 3.81 (s, 3H), 3.71 (t, <i>J</i> = 5.7 Hz, 2H), 2.67 (t, <i>J</i> = 5.8 Hz, 2H), 1.47 (s, 9H), 1.38 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>): δ 159.6, 155.4, 144.9, 136.9, 116.6, 85.2, 60.0, 41.5, 40.0, 36.4, 28.4, 21.8, 14.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>15</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 310.17613; found, 310.17650. <b>68</b><sup>1</sup>H NMR (250 MHz, CDCl<sub>3</sub>): δ 4.59 (s, 2H), 4.33 (q, <i>J</i> = 7.1 Hz, 2H), 4.12 (s, 3H), 3.67 (t, <i>J</i> = 5.8 Hz, 2H), 2.72 (t, <i>J</i> = 5.8 Hz, 2H), 1.47 (s, 9H), 1.37 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (63 MHz, CDCl<sub>3</sub>): δ 159.9, 155.0, 145.7 (br s), 127.7 (br s), 119.0, 79.9, 60.9, 41.7 (br s), 40.4 (br s), 35.5, 27.4, 22.9 (br s), 14.4. ESI HRMS (<i>m</i>/<i>z</i>) calcd for C<sub>15</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 310.17613; found, 310.17625.</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>tert</i>-Butyl 3-(Benzylcarbamoyl)-2-methyl-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>69</b>)</h4><div class="NLM_p last">A solution of compound <b>68</b> (309 mg, 1.00 mmol, 1.0 equiv), benzylamine (128 mg, 1.00 mmol, 1.2 equiv), and TBD (44 mg, 0.30 mmol, 0.3 equiv) in dry THF (2 mL) was stirred at 60 °C for 12 h. The mixture was concentrated in vacuo and the residue was purified by FC (hexane/EtOAc 2:1 to 1:2) to yield 295 mg (80%) of the title compound <b>69</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.44–7.30 (m, 5H), 5.96 (br s, 0.6H), 5.79 (br s, 0.4H), 4.68–4.46 (m, 4H), 4.12 (s, 3H), 3.67 (m, t, <i>J</i> = 5.5 Hz, 2H), 2.75 (t, <i>J</i> = 5.7 Hz, 2H), 1.48 (s, 9H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 160.0, 155.0 (br s), 145.2 (br s), 137.6, 131.0, 128.9, 127.8, 127.7, 113.3, 80.4, 43.7, 41.9 (br s), 41.0 (br s), 39.2, 28.4, 23.5 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 371.20777; found, 371.20809.</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>tert</i>-Butyl 3-(Benzylcarbamoyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>70</b>)</h4><div class="NLM_p last">Compound <b>70</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>66</b> (2.00 g, 6.78 mmol, 1.0 equiv), benzylamine (0.87 g, 8.14 mmol, 1.2 equiv), TBD (0.34 g, 2.44 mmol, 0.3 equiv), and dry THF (10 mL). Purification by FC (hexane/EtOAc 1:1 to 0:1) gave 2.15 g (89%) of the title compound <b>70</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.04 (br s, 1H), 8.65 (br s, 1H), 7.35–7.27 (m, 4H), 7.23 (td, <i>J</i> = 6.0, 2.7 Hz, 1H), 4.50 (br s, 2H), 4.40 (d, <i>J</i> = 6.4 Hz, 2H), 3.59 (t, <i>J</i> = 5.7 Hz, 2H), 2.68 (t, <i>J</i> = 5.7 Hz, 2H), 1.42 (s, 9H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.8 (br s), 154.6 (br s), 141.5 (br s), 140.5 (br s), 138.7 (br s), 128.7, 127.7, 127.1, 114.2 (br s), 79.5 (br s), 42.1 (br s), 41.7 (br s), 41.1 (br s), 28.5, 21.6 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 357.19212; found, 357.19220.</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>tert</i>-Butyl 3-(Benzylcarbamoyl)-1-(2-ethoxy-2-oxoethyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>71</b>)</h4><div class="NLM_p last">Compound <b>71</b> was synthesized by employing the procedure described for compounds <b>67</b> and <b>68</b>, using intermediate <b>66</b> (1.50 g, 4.21 mmol, 1.0 equiv), Cs<sub>2</sub>CO<sub>3</sub> (1.37 g, 4.21 mmol, 1.0 equiv), ethyl 2-bromoacetate (703 mg, 4.21 mmol, 1.0 equiv), and dry DMF (20 mL). Purification by FC (hexane/EtOAc 3:1 to 1:1) gave 1.65 g (89%) of the title <b>71</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.40–7.31 (m, 4H), 7.32–7.32 (m, 1H), 7.11 (br s, 1H), 4.78 (s, 2H), 4.74 (s, 2H), 4.60 (d, <i>J</i> = 6.0 Hz, 2H), 4.25 (q, <i>J</i> = 7.1 Hz, 2H), 3.74 (t, <i>J</i> = 5.8 Hz, 2H), 2.65 (t, <i>J</i> = 5.7 Hz, 2H), 1.50 (s, 9H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 167.1, 162.0 (br s), 141.4 (br s), 139.9 (br s), 138.3 (br s), 128.7, 127.9, 127.4, 116.6 (br s), 80.2 (br s), 62.2, 50.7, 42.9, 41.3 (br s), 39.7 (br s), 28.5, 21.8 (br s), 14.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 443.22890; found, 443.22895.</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 5-(<i>tert</i>-Butyl) 1-Ethyl 3-(benzylcarbamoyl)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-1,5(4<i>H</i>)-dicarboxylate (<b>72</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of intermediate <b>66</b> (1.00 g, 2.81 mmol, 1.0 equiv) and DIPEA (0.72 g, 5.62 mmol, 2.0 equiv) in dry THF (10 mL) was added ethyl chloroformate (0.31 g, 2.81 mmol, 1.0 equiv), dropwise. The mixture was then warmed to rt overnight and concentrated in vacuo. The residue was purified by FC (hexane/EtOAc 3:1 to 2:1) to yield 1.09 g (91%) of the target compound <b>72</b> as a white solid. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 7.44–7.29 (m, 5H), 4.71 (s, 2H), 4.61 (d, <i>J</i> = 6.1 Hz, 2H), 4.51 (q, <i>J</i> = 7.2 Hz, 2H), 3.71 (t, <i>J</i> = 5.8 Hz, 2H), 3.06 (t, <i>J</i> = 5.8 Hz, 2H), 1.50 (s, 9H), 1.48–1.43 (m, 4H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 161.2 (br s), 154.9 (br s), 149.5, 145.0 (br s), 142.9 (br s), 137.8, 128.7, 128.0, 127.6, 119.3 (br s), 80.3 (br s), 64.9, 43.1, 41.0 (br s), 39.8 (br s), 28.4, 25.2, 14.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>29</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 429.21325; found, 429.21322.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 5-(<i>tert</i>-Butyl) 3-Ethyl 1-(2-Hydroxyethyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3,5-dicarboxylate (73) and 5-(<i>tert</i>-Butyl) 3-Ethyl 2-(2-Hydroxyethyl)-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3,5-dicarboxylate (<b>74</b>)</h4><div class="NLM_p last">Compounds <b>73</b> and <b>74</b> were synthesized by employing the procedure described for compound <b>66</b>, using a solution of LHMDS (37.5 mL of 1 M solution in THF, 37.5 mmol, 1.0 equiv) in dry THF (75 mL), solution of 1-boc-4-piperidinone (7.50 g, 37.5 mmol, 1.0 equiv) in dry THF (50 mL), diethyl oxalate (5.88 g, 37.5 mmol, 1.0 equiv), and 2-hydroxyethylhydrazine (2.85 g, 37.5 mmol, 1.0 equiv). Recrystallization of the reaction mixture from hexane/DCM gave 6.38 g (50%) of the title compound <b>73</b> as a white solid. The filtrate was concentrated in vacuo and the residue was purified by FC (hexane/EtOAc 5:1 to 0:1, then EtOAc/MeOH 95:5) to give further 1.21 g (10%) of <b>73</b> (total yield: 7.59 g, 60%) and 2.00 g (16%) of the N-2 regioisomer <b>74</b> as yellow oil. <b>73</b><sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 4.61 (s, 2H), 4.39 (q, <i>J</i> = 7.1 Hz, 2H), 4.22–4.13 (m, 2H), 4.02 (q, <i>J</i> = 5.0 Hz, 2H), 3.70 (t, <i>J</i> = 5.2 Hz, 2H), 2.82–2.62 (m, 3H), 1.49 (s, 9H), 1.37 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.4, 155.0 (br s), 139.4 (br s), 138.5 (br s), 117.3, 80.2, 61.4, 60.8, 51.4, 41.5 (br s), 39.8 (br s), 28.4, 22.0, 14.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>16</sub>H<sub>26</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 340.18670; found, 340.18670. <b>74</b><sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 4.70 (t, <i>J</i> = 4.7, 2H), 4.63 (br s, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 2H), 4.00 (t, <i>J</i> = 4.9 Hz, 2H), 3.70 (br s, 2H), 3.00 (br s, 1H), 2.76 (t, <i>J</i> = 6.2 Hz, 1H), 1.50 (s, 9H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 160.2, 155.0, 146.6 (br s), 127.9 (br s), 119.3, 80.0, 62.2, 61.2, 53.4, 53.1, 42.0 (br s), 28.4, 23.4 (br s), 14.3 (br s). ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>16</sub>H<sub>26</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 340.18670; found, 340.18669.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Ethyl 5-((1<i>H</i>-Indol-3-yl)methyl)-1-(2-hydroxyethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxylate (<b>75</b>)</h4><div class="NLM_p last">Compound <b>75</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>73</b> (1.30 g, 3.83 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (15 mL), TEA (0.39 g, 3.83 mmol, 1.0 equiv), indole-3-carboxaldehyde (0.55 g, 3.83 mmol, 1.0 equiv), AcOH (0.23 g, 3.83 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (1.22 g, 5.74 mmol, 1.5 equiv), and dry THF (20 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 94:5:1) gave 1.02 g (72%) of the title compound <b>75</b> as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.64 (br s, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.36 (dt, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.30–7.07 (m, 3H), 4.34 (q, <i>J</i> = 7.2 Hz, 2H), 4.12 (t, <i>J</i> = 5.0 Hz, 2H), 4.00 (s, 2H), 3.94 (t, <i>J</i> = 5.0 Hz, 2H), 3.84 (s, 2H), 3.46 (br s, 2H), 2.87 (t, <i>J</i> = 5.8 Hz, 2H), 2.72 (t, <i>J</i> = 5.9 Hz, 2H), 1.32 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.5, 139.4, 138.5, 136.2, 127.9, 124.4, 122.1, 119.7, 119.1, 118.3, 111.4, 111.3, 61.3, 60.7, 52.0, 51.5, 49.6, 48.7, 22.0, 14.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 369.19212; found, 369.19203.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>tert</i>-Butyl 3-(Benzylcarbamoyl)-1-(2-hydroxyethyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>76</b>)</h4><div class="NLM_p">Compound <b>76</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>73</b> (2.30 mg, 8.14 mmol, 1.2 equiv), benzylamine (0.86 g, 6.78 mmol, 1.2 equiv), TBD (0.28 g, 2.03 mmol, 0.3 equiv), and dry THF (5 mL). Purification by FC (hexane/EtOAc 1:1 to 0:1) gave 1.94 g (72%) of the title compound <b>76</b> as a white solid. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ 7.37–7.21 (m, 5H), 7.12 (br s, 1H), 4.70 (s, 2H), 4.59 (d, <i>J</i> = 6.1 Hz, 2H), 4.13–4.07 (m, 2H), 4.05–3.92 (m, 2H), 3.72 (t, <i>J</i> = 5.7 Hz, 2H), 2.81 (t, <i>J</i> = 5.8 Hz, 1H), 2.72 (t, <i>J</i> = 5.8 Hz, 2H), 1.49 (s, 9H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 162.1, 155.1, 140.9, 139.6, 138.4, 128.7, 127.9, 127.4, 116.1, 80.2, 61.4, 51.1, 42.9, 41.3, 40.0, 28.5, 22.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>29</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 401.21833; found, 401.21830.</div><div class="NLM_p last">The free amine hydrochloride used for synthesis of derivatives <b>15–19</b> was obtained by treatment of compound <b>76</b> with 4 M solution of HCl in 1,4-dioxane at rt for 4 h, followed by evaporation of the solvent in vacuo.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1-(2-Hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>78</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>77</b> (2.10 g, 0.47 mmol) in DCM (50 mL) was added slowly 4 M solution of HCl in 1,4-dioxane (20 mL). The mixture was stirred for 3 h at rt, followed by evaporation of the solvent in vacuo to give 1.80 g (quantitative) of the title compound <b>78</b> as a pale yellow solid. 1H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.53 (br s, 2H), 8.73 (t, <i>J</i> = 6.1 Hz, 1H), 8.22 (d, <i>J</i> = 8.7 Hz, 1H), 7.95 (d, <i>J</i> = 8.9 Hz, 1H), 7.84 (dd, <i>J</i> = 6.0, 3.4 Hz, 1H), 7.55 (p, <i>J</i> = 7.2, Hz, 2H), 7.49–7.40 (m, 2H), 4.89 (d, <i>J</i> = 6.1 Hz, 2H), 4.25 (br s, 2H), 4.13 (t, <i>J</i> = 5.2 Hz, 2H), 3.85 (br s, 2H), 3.73 (d, <i>J</i> = 10.4 Hz, 2H), 3.60 (br s, 1H), 3.36 (br s, 2H), 3.02 (t, <i>J</i> = 6.0 Hz, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.0, 141.2, 137.8, 135.2, 133.7, 131.3, 129.0, 127.9, 126.7, 126.2, 125.9, 125.8, 124.0, 110.7, 60.5, 52.3, 19.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>20</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 351.18155; found, 351.18146.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>tert</i>-Butyl 2-(2-Hydroxyethyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>79</b>)</h4><div class="NLM_p last">Compound <b>79</b> was synthesized employing the procedure described for compound <b>69</b>, using intermediate <b>74</b> (600 mg, 1.77 mmol, 1.0 equiv), 1-naphthalenemethylamine (333 mg, 2.12 mmol, 1.2 equiv), TBD (74 mg, 0.53 mmol, 0.3 equiv), and dry THF (5 mL). Purification by FC (EtOAc) gave 670 mg (84%) of the title compound <b>79</b> as a pale yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.07 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.86 (d, <i>J</i> = 8.2 Hz, 1H), 7.59 (ddd, <i>J</i> = 8.4, 6.8, 1.4 Hz, 1H), 7.57–7.54 (m, 1H), 7.54–7.49 (m, 1H), 7.46 (dd, <i>J</i> = 8.2, 6.9 Hz, 1H), 6.73 (br s, 0.5H), 6.53 (br s, 0.5H), 5.07 (d, <i>J</i> = 5.5 Hz, 2H), 4.64–4.33 (m, 4H), 3.99 (t, <i>J</i> = 4.9 Hz, 2H), 3.65 (t, <i>J</i> = 5.7 Hz, 2H), 2.72 (t, <i>J</i> = 5.9 Hz, 2H), 1.54–1.29 (m, 9H). <sup>13</sup>C NMR (91 MHz, CDCl<sub>3</sub>): δ 160.0, 154.8, 134.0, 132.6, 132.4, 131.2, 129.0, 126.9, 126.8, 126.1, 125.4, 123.2, 80.3, 62.3, 52.8, 42.0, 40.6, 28.3, 23.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>25</sub>H<sub>31</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 451.23398; found, 451.23398.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-(2-Hydroxyethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-2<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>80</b>)</h4><div class="NLM_p last">Compound <b>80</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>79</b> (279 mg, 0.62 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (5 mL), TEA (63 mg, 0.62 mmol, 1.0 equiv), 4-methoxy-1-naphthaldehyde (115 mg, 0.62 mmol, 1.0 equiv), AcOH (37 mg, 0.62 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (197 mg, 0.93 mmol, 1.5 equiv), and dry THF (5 mL). Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 94:5:1) gave 131 mg (40%) of the title compound <b>80</b> as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.74 (t, <i>J</i> = 5.6 Hz, 1H), 8.21–8.15 (m, 2H), 8.13–8.07 (m, 1H), 7.99–7.92 (m, 1H), 7.86 (t, <i>J</i> = 4.8 Hz, 1H), 7.54–7.47 (m, 4H), 7.41 (d, <i>J</i> = 5.4 Hz, 2H), 7.28 (d, <i>J</i> = 7.8 Hz, 1H), 6.84 (d, <i>J</i> = 7.8 Hz, 1H), 5.05 (t, <i>J</i> = 5.1 Hz, 1H), 4.87 (d, <i>J</i> = 5.6 Hz, 2H), 4.28 (t, <i>J</i> = 5.8 Hz, 2H), 3.97 (s, 3H), 3.89 (s, 2H), 3.66 (q, <i>J</i> = 5.6 Hz, 2H), 3.55 (s, 2H), 2.73 (t, <i>J</i> = 5.6 Hz, 2H), 2.58 (t, <i>J</i> = 5.2 Hz, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.1, 154.5, 145.2, 134.0, 133.3, 132.8, 132.7, 130.7, 128.5, 127.6, 127.6, 126.2, 126.2, 125.8, 125.8, 125.3, 125.3, 125.2, 125.0, 124.9, 123.4, 121.7, 115.3, 103.3, 60.5, 59.5, 55.5, 52.3, 49.8, 49.0, 40.6, 23.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>32</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 521.25472; found, 521.25468.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>tert</i>-Butyl 3-((Naphthalen-1-ylmethyl)carbamoyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>81</b>)</h4><div class="NLM_p last">Compound <b>81</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>66</b> (720 g, 2.44 mmol, 1.0 equiv), 1-naphthalenemethylamine (460 mg, 2.93 mmol, 1.2 equiv), TBD (102 mg, 0.73 mmol, 0.3 equiv), and dry THF (10 mL). Purification by recrystallization from EtOAc/MeOH gave 610 mg (62%) of the title compound <b>81</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.02 (br s, 1H), 8.61 (br s, 1H), 8.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.96 (d, <i>J</i> = 7.7 Hz, 1H), 7.86–7.82 (m, 1H), 7.62–7.52 (m, 2H), 7.47 (d, <i>J</i> = 5.5 Hz, 2H), 4.89 (d, <i>J</i> = 6.3 Hz, 2H), 4.52 (s, 2H), 3.60 (t, <i>J</i> = 5.8 Hz, 2H), 2.69 (t, <i>J</i> = 5.8 Hz, 2H), 1.42 (s, 9H). <sup>13</sup>C NMR (91 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.8, 154.6, 138.8, 135.4, 133.7, 131.3, 128.9, 127.8, 126.6, 126.2, 125.9, 125.6, 123.9, 114.2, 79.5, 28.6. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 407.20777; found, 407.20791.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 5-((4-Methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>82</b>)</h4><div class="NLM_p last">Compound <b>82</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>81</b> (379 mg, 0.93 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (5 mL), TEA (94 mg, 0.93 mmol, 1.0 equiv), 4-methoxy-1-naphthaldehyde (172 mg, 0.93 mmol, 1.0 equiv), AcOH (56 mg, 0.62 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (296 mg, 1.40 mmol, 1.5 equiv), and dry THF (7 mL). Purification by recrystallization from EtOAc/MeOH gave 245 mg (55%) of the title compound <b>82</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.90 (s, 1H), 8.51 (t, <i>J</i> = 6.1 Hz, 1H), 8.25 (d, <i>J</i> = 7.7 Hz, 1H), 8.21–8.14 (m, 2H), 7.93 (dd, <i>J</i> = 6.2, 3.0 Hz, 1H), 7.81 (d, <i>J</i> = 6.6 Hz, 1H), 7.58–7.35 (m, 7H), 6.91 (d, <i>J</i> = 7.9 Hz, 1H), 4.82 (d, <i>J</i> = 6.0, 2H), 4.00 (s, 2H), 3.97 (s, 3H), 3.59 (s, 2H), 2.77 (t, <i>J</i> = 5.8 Hz, 2H), 2.68 (s, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.9, 155.0, 141.5, 139.0, 135.4, 133.7, 133.3, 131.2, 128.9, 128.2, 127.7, 126.7, 126.6, 126.5, 126.1, 125.8, 125.7, 125.6, 125.5, 125.4, 123.9, 122.1, 115.6, 103.9, 60.0, 56.0, 49.8, 46.0, 22.0. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 477.22850; found, 477.22853.</div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 1-(5-((4-Methoxynaphthalen-1-yl)methyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-3-yl)-<i>N</i>-(naphthalen-1-ylmethyl)methanamine (<b>83</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of compound <b>82</b> (600 mg, 1.26 mmol, 1.0 equiv) in dry THF (15 mL) was added LiAlH<sub>4</sub> (3.15 mL of a 2 M solution in THF, 6.30 mmol, 5.0 equiv). The reaction mixture was allowed to reach rt followed by refluxing overnight. The solution was cooled (ice-salt bath) and water (0.5 mL) was added slowly. The mixture was treated with 15% aqueous solution of NaOH (0.5 mL) and water (1.5 mL), followed by MgSO<sub>4</sub>. Next, DCM (5 mL) and MeOH (5 mL) were added, followed by filtration of the mixture and evaporation in vacuo. Purification by FC (DCM/MeOH/7 M solution of NH<sub>3</sub> in MeOH 94:5:1) gave 380 mg (65%) of the title compound <b>83</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.21 (br s, 0.5H), 12.13 (br s, 0.5H), 8.23 (d, <i>J</i> = 7.8 Hz, 1H), 8.18 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.97–7.86 (m, 1H), 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.58–7.40 (m, 4H), 7.39 (t, <i>J</i> = 7.5 Hz, 1H), 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 6.87 (d, <i>J</i> = 7.8 Hz, 1H), 4.07 (s, 2H), 3.96 (s, 3H), 3.93 (s, 2H), 3.66 (s, 2H), 3.44 (s, 2H),2.73 (t, <i>J</i> = 5.8 Hz, 2H), 2.59 (t, <i>J</i> = 5.7 Hz, 2H), 2.37 (br s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 154.9, 146.4 (br s), 136.5 (br s), 133.8, 133.3, 131.9, 128.8, 128.2, 127.6, 126.6, 126.6, 126.2, 126.1, 126.0, 125.8, 125.7, 125.5, 125.4, 124.6, 122.1, 112.1 (br s), 103.8, 61.2, 60.3 (br s), 56.0, 50.5, 49.4, 45.9 (br s), 43.0 (br s), 29.7. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>30</sub>H<sub>31</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 463.24924; found, 463.25043.</div></div><div id="sec4_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>tert</i>-Butyl 3-Carbamoyl-1-(2-hydroxyethyl)-1,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (<b>84</b>)</h4><div class="NLM_p last">The solution of compound <b>73</b> (1.50 g, 4.42 mmol) in 7 M methanolic solution of NH<sub>3</sub> (20 mL) was refluxed in a sealed pressure tube for 2 days. The mixture was cooled and evaporated in vacuo. The residue was heated with diethyl ether and the resulting solid was filtered and dried in vacuo to give 1.36 g (quantitative) of the title compound <b>84</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.34 (s, 1H), 7.16 (s, 1H), 4.91 (t, <i>J</i> = 5.4 Hz, 1H), 4.48 (s, 2H), 4.06 (t, <i>J</i> = 5.4 Hz, 2H), 3.72 (q, <i>J</i> = 5.4 Hz, 2H), 3.59 (t, <i>J</i> = 5.7 Hz, 2H), 2.72 (t, <i>J</i> = 5.7 Hz, 2H), 1.42 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.4, 154.6, 140.8, 139.7, 115.0, 79.5, 60.6, 52.0, 41.7, 41.1, 28.6, 22.0.</div></div><div id="sec4_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 1-(2-Hydroxyethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-3-carboxamide (<b>85</b>)</h4><div class="NLM_p last">Compound <b>85</b> was synthesized by employing the procedure described for compound <b>2</b>, using intermediate <b>84</b> (728 mg, 2.35 mmol, 1.0 equiv), 4 M solution of HCl in 1,4-dioxane (5 mL), TEA (237 mg, 2.35 mmol, 1.0 equiv), 4-methoxy-1-naphthtaldehyde (437 mg, 2.35 mmol, 1.0 equiv), AcOH (141 mg, 2.35 mmol, 1.0 equiv), NaBH(OAc)<sub>3</sub> (747 mg, 3.52 mmol, 1.5 equiv), and dry THF (15 mL). Purification by FC (DCM/MeOH 99:1 to 95:5) gave 557 mg (62%) of the title compound <b>85</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.30 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 8.23 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 7.56–7.42 (m, 2H), 7.37 (d, <i>J</i> = 7.8 Hz, 1H), 6.76 (d, <i>J</i> = 7.8 Hz, 1H), 6.62 (br s, 1H), 5.45 (br s, 1H), 4.09–4.02 (m, 4H), 4.02 (s, 3H), 3.95 (dd, <i>J</i> = 5.7, 4.0 Hz, 2H), 3.88 (s, 2H), 2.91 (br s, 1H), 2.78 (t, <i>J</i> = 5.7 Hz, 2H), 2.63 (t, <i>J</i> = 5.8 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 164.5, 155.3, 140.2, 139.9, 133.4, 127.7, 126.4, 126.0, 125.0, 124.6, 122.3, 117.8, 102.9, 76.7, 61.3, 59.8, 55.5, 51.0, 50.1, 48.5, 22.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 381.19212; found, 381.19212.</div></div><div id="sec4_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 2-(3-(Aminomethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)ethan-1-ol (<b>86</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of compound <b>85</b> (545 mg, 1.43 mmol, 1.0 equiv) in dry THF (10 mL) was added LiAlH<sub>4</sub> (2.89 mL of a 2 M solution in THF, 5.74 mmol, 4.0 equiv). The reaction mixture was allowed to reach rt followed by refluxing overnight. The solution was cooled (ice-salt bath) and water (0.5 mL) was added slowly. The mixture was treated with 15% aqueous solution of NaOH (0.5 mL) and water (1.5 mL), followed by MgSO<sub>4</sub>. The solids were filtered off and the resulting solution was evaporated in vacuo. Purification by automated preparative chromatography (RP-C18, linear gradient from water/MeOH 90:10 to 15:85) gave 220 mg (42%) of the title compound <b>86</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.18 (d, <i>J</i> = 7.9 Hz, 1H), 7.61–7.43 (m, 2H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 6.91 (d, <i>J</i> = 7.8 Hz, 1H), 4.77 (br s, 1H), 3.97 (s, 3H), 3.96–3.93 (m, 2H), 3.89 (t, <i>J</i> = 5.8 Hz, 2H), 3.63 (t, <i>J</i> = 5.8 Hz, 2H), 3.52 (s, 2H), 3.46 (s, 2H), 2.71 (t, <i>J</i> = 5.8 Hz, 2H), 2.60 (t, <i>J</i> = 5.8 Hz, 2H), 1.86 (br s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 155.0, 148.2, 138.0, 133.4, 128.2, 126.7, 126.6, 125.7, 125.5, 125.4, 122.1, 112.0, 103.9, 60.8, 60.0, 56.0, 51.1, 49.8, 49.3, 39.0, 22.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 367.21285; found, 367.21289.</div></div><div id="sec4_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>tert</i>-Butyl 3-(5-((4-methoxynaphthalen-1-yl)methyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-1-yl)azetidine-1-carboxylate (<b>88</b>)</h4><div class="NLM_p last">A mixture of compound <b>82</b> (270 mg, 0.57 mmol, 1.0 equiv), <i>tert</i>-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate (231 mg, 0.86 mmol, 1.5 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (336 mg, 1.14 mmol, 2.0 equiv) in dry DMF (4 mL) was stirred at 95 °C overnight. The mixture was cooled and partitioned between water (30 mL) and EtOAc (5 mL). The aqueous layer was extracted with EtOAc (3 × 5 mL) and the combined organic phase was washed with water (3 × 5 mL), brine (3 × 5 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo. Purification by FC (hexane/EtOAc 2:1 to 0:1) gave 300 mg (83%) of the title compound <b>88</b> as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (dd, <i>J</i> = 7.7, 2.1 Hz, 1H), 8.28–8.23 (m, 1H), 8.18–8.11 (m, 1H), 7.91 (dd, <i>J</i> = 7.6, 2.0 Hz, 1H), 7.85 (d, <i>J</i> = 8.2 Hz, 1H), 7.61–7.44 (m, 6H), 7.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.18 (t, <i>J</i> = 5.7 Hz, 1H), 6.77 (d, <i>J</i> = 7.9 Hz, 1H), 5.09 (d, <i>J</i> = 5.7 Hz, 2H), 4.82 (tt, <i>J</i> = 8.0, 5.6 Hz, 1H), 4.36–4.28 (m, 2H), 4.23 (t, <i>J</i> = 8.5 Hz, 2H), 4.09 (s, 2H), 4.03 (s, 3H), 3.98 (s, 2H), 2.79 (t, <i>J</i> = 5.7 Hz, 2H), 2.57 (t, <i>J</i> = 5.7 Hz, 2H), 1.41 (s, 9H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.2, 156.1, 155.4, 141.2, 139.2, 133.9, 133.8, 133.4, 131.6, 128.7, 128.5, 127.7, 126.7, 126.6, 126.4, 126.1, 126.03, 125.9, 125.5, 125.0, 124.7, 123.7, 122.3, 118.2, 102.9, 80.0, 60.1, 55.9 (br s), 55.5, 50.2, 48.5, 46.8, 40.9, 28.3, 22.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>38</sub>H<sub>42</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 632.32313; found, 632.32395.</div></div><div id="sec4_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Ethyl 1-(2-Acetoxyethyl)-5-benzyl-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxylate (<b>89</b>), Ethyl 2-(2-Acetoxyethyl)-5-benzyl-2,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxylate (<b>90</b>) and 2-Benzyl-2,3,6,7-tetrahydropyrrolo[3′,4′:3,4]pyrazolo[5,1-<i>c</i>][1,4]oxazin-9(1<i>H</i>)-one (91)</h4><div class="NLM_p last">To a stirred solution of DIPA (8.84 g, 68.5 mmol, 1.2 equiv) in dry THF (100 mL) at −78 °C was added <i>n</i>-BuLi (25.1 mL of 2.5 M solution in hexane, 62.8 mmol, 1.1 equiv). After stirring at −78 °C for 45 min, a solution of 1-benzylpyrrolidin-3-one (10.0 g, 57.1 mmol, 1.0 equiv) in dry THF (50 mL) was added dropwise. The reaction mixture was stirred for further 30 min at −78 °C, followed by a dropwise addition of a solution of diethyl oxalate (8.34 mL, 57.1 mmol, 1.0 equiv) in dry THF (50 mL). The mixture was then warmed to rt and stirred for further 30 min. Subsequently, EtOH (40 mL), AcOH (40 mL), and hydroxyethylhydrazine (3.87 mL, 57.1 mmol, 1.0 equiv) were added. The reaction mixture was then heated to reflux for 1 h, cooled to rt, and concentrated in vacuo. The residue was dissolved in AcOH (40 mL) and refluxed for further 4 h after which TLC (EtOAc) showed a formation of a predominant spot (<i>R</i><sub><i>f</i></sub> ≈ 0.2). The solution was evaporated in vacuo and the resulting oil was partitioned between EtOAc (100 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (70 mL). The aqueous phase was extracted with EtOAc (2 × 25 mL). The combined organic extracts were washed with water (25 mL), brine (25 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by FC (hexane/EtOAc 1:1 to 0:1, then EtOAc/MeOH 99:1 to 95:5) which gave 5.82 g of oil. LC/MS (ESI<sup>+</sup>) analysis of this material showed the presence of both tetrahydropyrrolo[3,4-<i>c</i>]pyrazole (<i>m</i>/<i>z</i> = 316 [M + H]<sup>+</sup>) and the corresponding acyclic hydrazone species (<i>m</i>/<i>z</i> = 334 [M + H]<sup>+</sup>). To achieve a full cyclization, the oil was again dissolved in AcOH (50 mL) and refluxed for 14 h. The solution was evaporated in vacuo and the resulting oil was partitioned between EtOAc (100 mL) and saturated aqueous solution of NaHCO<sub>3</sub> (70 mL). The aqueous phase was extracted with EtOAc (2 × 25 mL). The combined organic extracts were washed with water (25 mL), brine (25 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification of the residue by FC (hexane/EtOAc 3:1 to 0:1) gave the title acetylated derivatives <b>89</b> (3.51 g, 17%, brown oil) and <b>90</b> (0.84 g, 4%, yellow oil) along with the cyclic lactone <b>91</b> (0.60 g, 4%, brown solid). <b>89</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45–7.34 (m, 4H), 7.34–7.29 (m, 1H), 4.43–4.34 (m, 4H), 4.34–4.29 (m, 2H), 4.04–3.98 (m, 4H), 3.87 (br s, 2H), 2.01 (s, 3H), 1.37 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 170.3, 162.0, 148.1, 138.2, 136.7, 128.7, 128.6, 127.5, 126.8, 62.8, 60.9, 60.3, 52.6, 51.1, 50.6, 20.7, 14.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 358.17613; found, 358.17639. <b>90</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.46–7.41 (m, 2H), 7.38 (ddd, <i>J</i> = 7.8, 6.8, 0.9 Hz, 2H), 7.34–7.29 (m, 1H), 4.79 (t, <i>J</i> = 5.4 Hz, 2H), 4.47–4.38 (m, 2H), 4.31 (q, <i>J</i> = 7.1 Hz, 2H), 4.01 (s, 2H), 3.95 (s, 2H), 3.87 (s, 2H), 2.02 (s, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 170.7, 159.6, 156.1 (br s), 138.4 (br s), 128.7, 128.5, 127.4, 126.0, 63.3, 61.0, 60.3, 52.5, 51.9, 50.4, 20.8, 14.3. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>19</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 358.17613; found, 358.17630. <b>91</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.41 (d, <i>J</i> = 7.2 Hz, 2H), 7.37 (t, <i>J</i> = 7.6 Hz, 2H), 7.34–7.27 (m, 1H), 4.74–4.65 (m, 2H), 4.47–4.41 (m, 2H), 4.01 (s, 2H), 3.99 (s, 2H), 3.89 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.1, 157.1, 138.2, 128.7, 128.6, 127.4, 127.2, 123.1, 66.3, 60.2, 51.7, 51.5, 46.0. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>15</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 270.12370; found, 270.12378.</div></div><div id="sec4_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Ethyl 5-Benzyl-1-(2-hydroxyethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxylate (<b>92</b>)</h4><div class="NLM_p last">A mixture of compound <b>90</b> (3.46, 9.69 mmol, 1.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.34 g, 9.69 mmol, 1.0 equiv), and EtOH (15 mL) was stirred for 0.5 h at 60 °C. The reaction mixture was cooled, filtered, and evaporated in vacuo. Purification of the residue by FC (EtOAc/MeOH 99:1 to 95:5) gave 2.93 g (96%) of the title compound <b>92</b> as brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.43–7.34 (m, 4H), 7.34–7.30 (m, 1H), 4.36 (q, <i>J</i> = 7.2 Hz, 2H), 4.20–4.14 (m, 2H), 4.04–3.96 (m, 6H), 3.93 (t, <i>J</i> = 2.2 Hz, 2H), 2.88 (br s, 1H), 1.36 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 162.0, 148.2, 137.9, 136.4, 128.8, 128.6, 127.6, 126.2, 76.7, 61.4, 60.9, 60.3, 53.7, 52.6, 51.2, 14.4. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 316.16557; found, 316.16540.</div></div><div id="sec4_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 5-Benzyl-1-(2-hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide (<b>93</b>)</h4><div class="NLM_p last">Compound <b>93</b> was synthesized by employing the procedure described for compound <b>69</b>, using intermediate <b>92</b> (1.97 g, 5.68 mmol, 1.0 equiv), 1-naphthalenemethylamine (1.34 g, 8.52 mmol, 1.5 equiv), TBD (0.24 g, 1.70 mmol, 0.3 equiv), and dry THF (5 mL). Purification by FC (EtOAc) gave 1.14 mg (47%) of the title compound <b>93</b> as a beige solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.49 (t, <i>J</i> = 6.2 Hz, 1H), 8.21 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.95 (dd, <i>J</i> = 7.6, 1.9 Hz, 1H), 7.84 (dt, <i>J</i> = 6.2, 3.5 Hz, 1H), 7.60–7.50 (m, 2H), 7.50–7.42 (m, 2H), 7.42–7.32 (m, 4H), 7.30–7.24 (m, 1H), 4.92 (t, <i>J</i> = 5.4 Hz, 1H), 4.86 (d, <i>J</i> = 6.2 Hz, 2H), 4.06 (t, <i>J</i> = 5.2 Hz, 2H), 3.92 (s, 2H), 3.85–3.76 (m, 4H), 3.68 (q, <i>J</i> = 5.3 Hz, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.8, 149.2, 139.6, 138.8, 135.4, 133.7, 131.3, 129.0, 128.9, 128.8, 127.8, 127.4, 126.6, 126.2, 125.9, 125.8, 124.1, 124.0, 60.4, 59.90, 54.2, 52.5, 51.2. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>26</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 427.21285; found, 427.21280.</div></div><div id="sec4_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 1-(2-Hydroxyethyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide Hydrochloride (<b>94</b>)</h4><div class="NLM_p last">The mixture of compound <b>94</b> (1.10 g, 2.58 mmol, 1.0 equiv), 1,4-cyclohexadiene (2.07 g, 25.80 mmol, 10.0 equiv), 10% Pd/C (0.11 g), and MeOH (15 mL, degassed by bubbling argon through for 1 h) was stirred for 4 h at 70 °C in a sealed pressure tube. The mixture was then cooled, filtered through a pad of Celite, and evaporated in vacuo. The residue was dissolved in DCM (10 mL) and cooled (ice-salt bath), followed by treatment with 1 M solution of hydrochloric acid in Et<sub>2</sub>O (5 mL). The solvents were evaporated in vacuo to give 0.91 g (quantitative) of the title compound <b>94</b> as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.59 (s, 2H), 8.78 (t, <i>J</i> = 6.1 Hz, 1H), 8.22 (d, <i>J</i> = 8.2 Hz, 1H), 7.95 (d, <i>J</i> = 7.9 Hz, 1H), 7.84 (dd, <i>J</i> = 6.5, 3.1 Hz, 1H), 7.62–7.51 (m, 2H), 7.51–7.43 (m, 2H), 5.15 (t, <i>J</i> = 5.2 Hz, 1H), 4.88 (d, <i>J</i> = 6.1 Hz, 2H), 4.45 (s, 2H), 4.35 (s, 2H), 4.18 (t, <i>J</i> = 4.9 Hz, 2H), 3.72 (q, <i>J</i> = 5.0 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.0, 145.9, 139.3, 135.1, 133.7, 131.3, 129.0, 127.9, 126.7, 126.2, 125.9, 124.0, 121.4, 60.3, 54.6, 44.9, 43.7. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 337.16590; found, 337.16568.</div></div><div id="sec4_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 2-(5-((4-Methoxynaphthalen-1-yl)methyl)-3-((naphthalen-1-ylmethyl)carbamoyl)-5,6-dihydropyrrolo[3,4-<i>c</i>]pyrazol-1(4<i>H</i>)-yl)ethyl 4-Methylbenzenesulfonate (<b>95</b>)</h4><div class="NLM_p last">To a stirred, cooled (ice-salt bath) solution of <b>63</b> (193 mg, 0.38 mmol, 1 equiv), and DMAP (2 mg, 0.02 mmol, 5 mol %) in dry DCM (5 mL) was added 4-toluenesulfonyl chloride (80 mg, 0.42 mmol, 1.1 equiv) and TEA (58 mg, 0.57 mmol, 1.5 equiv). The solution was allowed to warm up to rt then stirred overnight. The reaction mixture was washed with water (20 mL), brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (EtOAc/MeOH/TEA 99:0:1 to 94:5:1) gave 191 mg (76%) of the title compound <b>95</b> as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.34 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 8.28 (d, <i>J</i> = 8.3 Hz, 1H), 8.10 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.84 (d, <i>J</i> = 8.1 Hz, 1H), 7.63–7.49 (m, 7H), 7.46 (dd, <i>J</i> = 8.1, 7.0 Hz, 1H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.12 (d, <i>J</i> = 8.0 Hz, 2H), 6.89 (t, <i>J</i> = 5.8 Hz, 1H), 6.79 (d, <i>J</i> = 7.8 Hz, 1H), 5.02 (d, <i>J</i> = 5.8 Hz, 2H), 4.33–4.24 (m, 4H), 4.06 (t, <i>J</i> = 5.0 Hz, 2H), 4.05 (s, 3H), 3.99 (t, <i>J</i> = 2.4 Hz, 2H), 3.76 (s, 2H), 2.34 (s, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 162.5, 161.2, 155.5, 149.2, 145.3, 139.4, 133.9, 133.7, 133.02, 132.04, 131.51, 129.83, 128.76, 128.58, 127.64, 127.14, 126.76, 126.65, 126.02, 126.0, 125.4, 125.2, 124.2, 123.6, 122.4, 102.9, 67.8, 58.3, 55.6, 52.2, 50.6, 50.0, 41.1, 21.6. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>38</sub>H<sub>37</sub>N<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, 661.24792; found, 661.24811.</div></div><div id="sec4_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 1-(2-Azidoethyl)-5-((4-methoxynaphthalen-1-yl)methyl)-<i>N</i>-(naphthalen-1-ylmethyl)-1,4,5,6-tetrahydropyrrolo[3,4-<i>c</i>]pyrazole-3-carboxamide (<b>96</b>)</h4><div class="NLM_p last">A mixture of compound <b>95</b> (114 mg, 0.17 mmol) and NaN<sub>3</sub> (56 mg, 0.86 mmol, 5.0 equiv) in dry DMF (2 mL) was vigorously stirred at 70 °C for 4 h. The reaction mixture was partitioned between EtOAc (5 mL) and water (10 mL) and the aqueous layer was extracted with EtOAc (2 × 2 mL). The combined organic extracts were washed with water (2 × 2 mL), brine (2 × 2 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by FC (hexane/EtOAc 1:1 to 0:1) gave 81 mg (78%) of the title compound <b>96</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.36–8.29 (m, 1H), 8.27 (d, <i>J</i> = 8.3 Hz, 1H), 8.11 (ddd, <i>J</i> = 7.8, 0.8 Hz, 1H), 7.90 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.84 (dt, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.60–7.49 (m, 5H), 7.48–7.41 (m, 2H), 7.01 (t, <i>J</i> = 5.7 Hz, 1H), 6.78 (d, <i>J</i> = 7.8 Hz, 1H), 5.05 (d, <i>J</i> = 5.6 Hz, 2H), 4.36 (s, 2H), 4.15 (s, 2H), 4.04 (s, 3H), 3.98 (dd, <i>J</i> = 6.2, 5.1 Hz, 2H), 3.85 (s, 2H), 3.63 (dd, <i>J</i> = 6.2, 5.1 Hz, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 161.4, 155.5, 149.0, 139.5, 133.9, 133.7, 133.0, 131.6, 128.7, 128.5, 127.1, 126.7, 126.7, 126.6, 126.5, 126.0, 126.0, 125.4, 125.2, 124.2, 123.7, 122.4, 102.9, 58.4, 55.5, 52.4, 50.6, 50.4, 50.2, 41.1. ESI HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>31</sub>H<sub>30</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 532.24555; found, 532.24615.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Protein Expression and Purification</h3><div class="NLM_p last">Human, <i>T. cruzi,</i> and <i>T. brucei</i> N-His-PEX14 (19–84) proteins were cloned into a pETM-11 (EMBL) vector and expressed in a standard <i>Escherichia coli</i> BL21 system using an autoinduction medium.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The proteins were initially purified by affinity chromatography using a NiNTA column. Following dialysis to TEV cleavage buffer (50 mM Tris pH 8.0, 1 mM EDTA, 5 mM β-mercaptoethanol), the TEV protease was added and the reaction was allowed to proceed overnight at room temperature. This step was omitted when the proteins were prepared for AlphaScreen assay that requires presence of a His-tag. Next, the proteins were purified by size exclusion chromatography into either PBS buffer or crystallization buffer (5 mM Tris pH 8.0, 50 mM NaCl, 5 mM β-mercaptoethanol).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> AlphaScreen—Based Competition Assays</h3><div class="NLM_p last">To determine the compounds’ effective concentration (EC<sub>50</sub>) values against PEX14–PEX5 PPI, an AlphaScreen-based assay was developed according to a PerkinElmer manual. The assay mixture was composed of 3 nM N-His-PEX14 (21–84) and 10 nM of biotinylated PEX5-derived peptide (ALSENWAQEFLA) in a PBS buffer supplemented with 5 mg/mL of BSA and 0.01% (v/v) Tween-80. The assay employed 5 μg/mL of streptavidin donor beads and 5 μg/mL of nickel chelate acceptor beads (PerkinElmer). Compound was added to the assay mixture as a DMSO solution. DMSO concentration was kept constant at 5% (v/v). This concentration was shown to have no effect on the assay readout. The competition curves were measured using a serial dilution of the inhibitor (12 points) while keeping the concentrations of all other assay components constant. The inhibitor EC<sub>50</sub> was calculated from the Hill sigmoidal fit of the experimental data with asymptotes fixed at maximal assay signal (no inhibitor added) and 0, respectively, using OriginLab OriginPro 9.0.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Crystallization and X-ray Structure Solution</h3><div class="NLM_p last">The purified protein was mixed with 10-fold molar excess of ligand (50 mM solution in DMSO) in storage buffer (10 mM Tris pH 8.0, 100 mM NaCl and 5 mM β-mercaptoethanol) with 3% DMSO and the mixture was incubated for 1 h at room temperature. The excess ligand and DMSO were removed by washing the complex at 4 °C on a 10 kDa-cutoff Centricon concentrator with storage buffer. Prior to crystallization the complex was concentrated to about 30 mg/mL. Initial crystallization trials were set up using commercial kits and TTP LabTech Mosquito automated crystallization workstation. Crystals suitable for diffraction testing appeared under different conditions, after few days. They were transferred into a cryoprotectant solution containing the harvesting solution and 25% (v/v) glycerol and cryocooled in liquid nitrogen. Diffraction data were collected at the European Synchrotron Radiation Facility (ESRF, Grenoble, France) beamline ID29. The best diffracting crystal was obtained at room temperature in 0.2 M MgCl<sub>2</sub>, 0.1 M Tris pH 8.0, and 20% (w/v) PEG 6000. The experimental data were processed using XDS and XSCALE software.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Crystals of TbPEX14–ligand complex diffracted up to 1.2 Å resolution and belonged to the orthorhombic <i>P</i>3<sub>2</sub>21 space group. The Matthews coefficient analysis suggested the presence of one molecule in the asymmetric unit.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The structure was solved by molecular replacement using Phaser<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> with the TbPEX14 structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AON">5AON</a><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a>) as a search model. The analysis of the electron density calculated with (<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) and (2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>) coefficients allowed to build the initial model and to unambiguously place the ligand using COOT.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The starting model was refined by iterations of manual and automated refinement using Refmac5.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Throughout the refinement, 5% of the reflections were used for the crossvalidation analysis,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and the behavior of <i>R</i><sub>free</sub> was employed to monitor the refinement strategy. Water molecules were added using Arp/Warp<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and subsequently manually inspected. Hydrogens were generated and refined using Refmac5. Detailed information on data collection and refinement statistics are reported in Table S2—see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> MDs Simulations</h3><div class="NLM_p last">The PDB files of the three different ligand–protein complexes (TbPEX14-<b>50</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V">5N8V</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and TbPEX14-<b>61</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a>, TbPEX14-<b>29</b> complex structure was generated in Maestro v11.1<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> by replacing the nitrogen of the pendant amine of <b>50</b> in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V">5N8V</a> with the oxygen, assuming the same consensus-binding mode) were prepared adding missing sidechains and hydrogens using YASARA Biosciences YASARA Structure’s<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> clean built-in command. Structures were then imported into Schrödinger Maestro version 2018.3<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and further refined using the Maestro v11.1 “Protein Preparation Wizard”.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Protonation states were calculated using PROPKA<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> at pH 7.0 ± 2.0 and minimization of hydrogen positions with restrained backbone was performed using OPLS_2005 FF<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> in order to optimize the hydrogen bonding network. All the systems were then prepared for simulation using Maestro v11.1 “System Builder” GUI using a TIP4P solvent model<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> (crystallographic water molecules were deleted) in an automatically generated cubic cell with periodic boundary conditions. In addition to the solvated complex, Na<sup>+</sup> and Cl<sup>–</sup> ions corresponding to a 150 mM buffer were placed in the cell in order to set the total net charge to zero. MDs simulations were run using Schrödinger Maestro Desmond Molecular Dynamics Package version 2018.3<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> on a NVIDIA 1060 graphics processing unit using the Desmond graphical user interface for a total simulation time of 50 ns to ensure system convergence, with <i>xyz</i> coordinates recording interval every 50 ps (1000 snapshots in total) and 1.2 ps for potential energy calculations of the ensemble. Ensemble class was set to <i>NPT</i> at a temperature of 300 K and pressure of 1.01 bar, force cutoff radius was set to 9.0 Å and each solvated model was relaxed with the Desmond default relaxation protocol before starting the actual simulation.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> In Vitro Trypanocidal Activity of Compounds Against <i>T. b. brucei</i></h3><div class="NLM_p last"><i>T. b. brucei</i> bloodstream form (Lister 427, MITat 1.2) parasites were grown in a HMI-11 medium<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> containing 10% fetal bovine serum (FBS) at 37 °C with 5% CO<sub>2</sub>. Antitrypanosomal activities of the compounds were tested using resazurin-based 96-well plate assay. Twofold serial dilutions of each compound (10 wells in each row) were prepared in 96-well plates in HMI-11 medium (100 μL/well, quadruplicates). As controls, each row included a well without compound and a well with medium alone. 100 μL of parasite cultures (4 × 10<sup>3</sup>/mL) were inoculated in all wells, except in the well with media alone. Final concentration of parasites was 2 × 10<sup>3</sup>/mL. The plates were incubated for 66 h. Resazurin (25 μL of 0.1 mg/mL in Hanks Balanced Salt Solution) was added to all wells and the plates were further incubated until 72 h timepoint. Reduction of resazurin by living cells was quantified by measuring the fluorescence with a Synergy H1 microplate reader (excitation 530 nm, emission 585 nm). After subtracting the background fluorescence of the well with media alone, percent survival values were calculated by setting the fluorescence of the wells without compound to “100% survival”. Nonlinear regression graphs were plotted in GraphPad Software GraphPad Prism 6.04<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> to yield sigmoidal dose–response curves and half-maximal effective concentration (EC<sub>50</sub>) values were determined.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Cytotoxicity of Compounds against HepG2 Cells</h3><div class="NLM_p last">HepG2 (Hepatocyte) cells were seeded in 96-well plates (5000 cells/well in rows B–H) and grown overnight at 37 °C in humidified incubator with 5% CO<sub>2</sub>. Compounds were tested in triplicate from 100 to 3.125 μM (twofold serial dilutions, from row H to row C). Row A contained medium alone and served as a negative control. Row B contained cells alone without inhibitors and served as a positive control. Hygromycin B (InvivoGen) was used as a positive control for cytotoxicity. After incubation for 66 h, 25 μL of 0.1 mg/mL resazurin (dissolved in Hanks Balanced Salt Solution HBSS, Sigma) was added to all wells. Plates were further incubated for 6 h. Fluorescence was measured and data processed as described above for the <i>T. b. brucei</i> cytotoxicity assay.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> In Vitro Trypanocidal Activity of Compounds Against <i>T. b. rhodesiense</i> STIB900</h3><div class="NLM_p last">This stock was isolated in 1982 from a human patient in Tanzania and after several mouse passages cloned and adapted to axenic culture conditions.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Minimum essential medium (50 μL) supplemented with 25 mM HEPES, 1 g/L additional glucose, 1% MEM nonessential amino acids (100×), 0.2 mM β-mercaptoethanol, 1 mM Na-pyruvate, and 15% heat-inactivated horse serum was added to each well of a 96-well microtiter plate. Serial drug dilutions of eleven threefold dilution steps covering a range from 100 to 0.002 μg/mL were prepared. Next, 4 × 10<sup>3</sup> bloodstream forms of <i>T. b. rhodesiense</i> STIB 900 in 50 μL was added to each well and the plate incubated at 37 °C under a 5% CO<sub>2</sub> atmosphere for 70 h. Alamar Blue (resazurin, 10 μL of 12.5 mg solution in 100 mL double-distilled water) was then added to each well and incubation was continued for a further 2–4 h.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Subsequently, the plates were read with a Molecular Devices SpectraMax Gemini XS microplate fluorometer, using an excitation wave length of 536 nm and an emission wave length of 588 nm. The IC<sub>50</sub> values were calculated by linear regression<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> from the sigmoidal dose inhibition curves using Molecular Devices SoftmaxPro software.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> In Vitro Trypanocidal Activity of Compounds Against <i>T. Cruzi</i></h3><div class="NLM_p last">Rat skeletal myoblasts (L-6 cells) were seeded in 96-well microtitre plates at 2000 cells/well in 100 μL RPMI 1640 medium with 10% FBS and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. After 24 h, the medium was removed and replaced with 100 μL per well of 5000 trypomastigote forms of <i>T. cruzi</i> Tulahuen strain C2C4 expressing the β-galactosidase (Lac Z) gene.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> After 48 h, the medium was removed from the wells and replaced by 100 μL fresh medium with or without a serial drug dilution of eleven threefold dilution steps covering a range from 100 to 0.002 μg/mL. After 96 h of incubation the plates were inspected under an inverted microscope to assure growth of the controls and sterility. Then the substrate CPRG/Nonidet (50 μL) was added to all wells. A color reaction developed within 2–6 h and was read photometrically at 540 nm. Data were analyzed with Molecular Devices Softmax Pro software, which calculated the IC<sub>50</sub> values by linear regression<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> from the sigmoidal dose inhibition curves.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01876" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01876?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01876</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystal structure data collection and refinement statistics for TbPEX14-<b>61</b> complex structure; details on MDs simulations performed for TbPEX14-<b>50</b>, TbPEX14-<b>61</b>, and TbPEX14-<b>20</b> complexes; and <sup>1</sup>H and <sup>13</sup>C NMR spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">PDB File of the TbPEX14 model used for docking (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf">jm9b01876_si_001.pdf (17.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_002.csv">jm9b01876_si_002.csv (8.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_003.pdb">jm9b01876_si_003.pdb (65.57 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates of the crystal structures have been deposited to the RCSB Protein Data Bank under the following accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a> (TbPEX14-<b>61</b>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01876" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maciej Dawidowski</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7262-5718" title="Orcid link">http://orcid.org/0000-0002-7262-5718</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#761b17151f131c581217011f121901051d1f3601031b5813120358061a"><span class="__cf_email__" data-cfemail="5a373b39333f30743e3b2d333e352d2931331a2d2f37743f3e2f742a36">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Sattler</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1594-0527" title="Orcid link">http://orcid.org/0000-0002-1594-0527</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6516041111090017250d0009080d0a09111f480810000b060d000b4b0100"><span class="__cf_email__" data-cfemail="e2918396968e8790a28a878e8f8a8d8e9698cf8f97878c818a878ccc8687">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grzegorz M. Popowicz</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b4d3c6ced1d3dbc6ce9ac4dbc4dbc3ddd7cef4dcd1d8d9dcdbd8c0ce99d9c1d1dad7dcd1da9ad0d1"><span class="__cf_email__" data-cfemail="7413060e11131b060e5a041b041b031d170e341c1118191c1b18000e591901111a171c111a5a1011">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal C. Kalel</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry,
Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Napolitano</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, Krakow 30-387, Poland</span>; 
    <span class="hlFld-Affiliation affiliation">Małopolska
Center of Biotechnology, Jagiellonian University
in Kraków, Gronostajowa
7, Kraków 30-387, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Fino</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Schorpp</span> - <span class="hlFld-Affiliation affiliation">Assay Development and Screening Platform,
Institute
of Molecular Toxicology and Pharmacology, , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonidas Emmanouilidis</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span>; 
    <span>Present Address:
                        Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zürich, Hönggerbergring 64, 8093 Zürich, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominik Lenhart</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    Institute of Medicinal Chemistry, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Ostertag</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Integrated Protein Science Munich at Chair of Biomolecular NMR,
Department Chemie, Technische Universität
München, Lichtenbergstrasse
4, 85747 Garching, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcel Kaiser</span> - <span class="hlFld-Affiliation affiliation">Swiss
Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Basel, 4001 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Kolonko</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Faculty of Chemistry, Wrocław
University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bettina Tippler</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry,
Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wolfgang Schliebs</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry,
Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grzegorz Dubin</span> - <span class="hlFld-Affiliation affiliation">Małopolska
Center of Biotechnology, Jagiellonian University
in Kraków, Gronostajowa
7, Kraków 30-387, Poland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Mäser</span> - <span class="hlFld-Affiliation affiliation">Swiss
Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Basel, 4001 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3122-1941" title="Orcid link">http://orcid.org/0000-0003-3122-1941</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor V. Tetko</span> - <span class="hlFld-Affiliation affiliation">Institute of Structural Biology, , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamyar Hadian</span> - <span class="hlFld-Affiliation affiliation">Assay Development and Screening Platform,
Institute
of Molecular Toxicology and Pharmacology, , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8727-2575" title="Orcid link">http://orcid.org/0000-0001-8727-2575</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Plettenburg</span> - <span class="hlFld-Affiliation affiliation">Institute of Medicinal Chemistry, 
    , , and , Helmholtz Zentrum München, Ingolstädter Landstrasse 1, Neuherberg 85764, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Organic Chemistry, Leibniz
Universität Hannover, Schneiderberg 1b, Hannover 30167, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9671-278X" title="Orcid link">http://orcid.org/0000-0001-9671-278X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Erdmann</span> - <span class="hlFld-Affiliation affiliation">Institute
of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry,
Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all the authors. All the authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i123">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge financial support from grant UMO-2018/31/B/NZ7/02089 (to M.D.) and 2017/26/M/NZ1/00797 (to G.D.) from the National Science Center, Poland. This project has received funding from the European Union’s Framework Programme for Research and Innovation Horizon 2020 (2014–2020) under the Marie Skłodowska-Curie grant agreement no. 675555, Accelerated Early staGe drug discovery (AEGIS). MCB Structural Biology Core Facility (supported by the TEAM TECH CORE FACILITY/2017-4/6 grant from the Foundation for Polish Science) is acknowledged for valuable support. The work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant FOR1905 to R.E. and M.S.; FoRUM grants of the Ruhr-University Bochum F883-2016 and F913-2017 to R.E., W.S., and V.C.K. M.K. was supported by Wrocław Centre of Biotechnology program, The Leading National Research Centre (KNOW) for years 2014–2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">NECT</td><td class="NLM_def"><p class="first last">nifurtimox–eflornithine combination therapy</p></td></tr><tr><td class="NLM_term">DNDi</td><td class="NLM_def"><p class="first last">Drugs for Neglected Diseases initiative</p></td></tr><tr><td class="NLM_term">PEX</td><td class="NLM_def"><p class="first last">peroxin</p></td></tr><tr><td class="NLM_term">PTS</td><td class="NLM_def"><p class="first last">peroxisome targeting sequences</p></td></tr><tr><td class="NLM_term">CSP</td><td class="NLM_def"><p class="first last">chemical shift perturbation</p></td></tr><tr><td class="NLM_term">TBD</td><td class="NLM_def"><p class="first last">1,5,7-triazabicyclo[4.4.0]dec-5-ene</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropyl-<i>N</i>-ethylamine</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr><tr><td class="NLM_term">dd</td><td class="NLM_def"><p class="first last">doublet of doublets</p></td></tr><tr><td class="NLM_term">dt</td><td class="NLM_def"><p class="first last">doublet of triplets</p></td></tr><tr><td class="NLM_term">bs</td><td class="NLM_def"><p class="first last">broad signal</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">TbPEX14</td><td class="NLM_def"><p class="first last"><i>T. brucei</i> PEX14 N-terminal domain</p></td></tr><tr><td class="NLM_term">HsPEX14</td><td class="NLM_def"><p class="first last">human PEX14 N-terminal domain</p></td></tr><tr><td class="NLM_term">TcPEX14</td><td class="NLM_def"><p class="first last"><i>T. cruzi</i> PEX14 N-terminal domain</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 73 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molyneux, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, D.</span></span> <span> </span><span class="NLM_article-title">Neglected tropical diseases: progress towards addressing the chronic pandemic</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(16)30171-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2816%2930171-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27639954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC2svhsFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=312-325&author=D.+H.+Molyneuxauthor=L.+Savioliauthor=D.+Engels&title=Neglected+tropical+diseases%3A+progress+towards+addressing+the+chronic+pandemic&doi=10.1016%2Fs0140-6736%2816%2930171-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neglected tropical diseases: progress towards addressing the chronic pandemic</span></div><div class="casAuthors">Molyneux David H; Savioli Lorenzo; Engels Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10066</span>),
    <span class="NLM_cas:pages">312-325</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The concept of neglected tropical diseases (NTDs) emerged more than a decade ago and has been recognised as a valid way to categorise diseases that affect the poorest individuals.  Substantial progress in control and elimination has been achieved and policy momentum has been generated through continued bilateral, philanthropic, and non-governmental development organisation (NGDO) support, and donations of drugs from pharmaceutical companies.  WHO has defined a Roadmap to reach 2020 targets, which was endorsed by member states in a World Health Assembly Resolution in 2013.  NTDs have been included within the Sustainable Development Goal targets and are a crucial component of universal health coverage, conceptualised as "leaving no one behind".  WHO reported that more than 1 billion people in 88 countries have benefited from preventive chemotherapy in 2014.  The research agenda has defined the need for affordable products (diagnostics, drugs and insecticides).  However challenges such as insecurity and weak health systems continue to prevail in the poorest countries, inhibiting progress in scaling up and also in achieving Roadmap goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVM9uO0YK6f7t7lRqEFUJVfW6udTcc2ebZprtrFDpCGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svhsFGlsQ%253D%253D&md5=999893ecea92bdf9f0e5fb1cecaa18d1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930171-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930171-4%26sid%3Dliteratum%253Aachs%26aulast%3DMolyneux%26aufirst%3DD.%2BH.%26aulast%3DSavioli%26aufirst%3DL.%26aulast%3DEngels%26aufirst%3DD.%26atitle%3DNeglected%2520tropical%2520diseases%253A%2520progress%2520towards%2520addressing%2520the%2520chronic%2520pandemic%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D312%26epage%3D325%26doi%3D10.1016%2Fs0140-6736%2816%2930171-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">WHO</span>.  <i>Research Priorities for Chagas Disease,
Human African Trypanosomiasis
and Leishmaniasis. World Health Organization Technical Report Series</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2012</span>; (975),
Vol.  <span class="NLM_volume">v–xii</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">100</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-100&author=WHO&title=Research+Priorities+for+Chagas+Disease%2C%0AHuman+African+Trypanosomiasis%0Aand+Leishmaniasis.+World+Health+Organization+Technical+Report+Series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DResearch%2520Priorities%2520for%2520Chagas%2520Disease%252C%250AHuman%2520African%2520Trypanosomiasis%250Aand%2520Leishmaniasis.%2520World%2520Health%2520Organization%2520Technical%2520Report%2520Series%26pub%3DWHO%26date%3D2012%26volume%3Dv%25E2%2580%2593xii%26spage%3D1%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">Trypanosomiasis,
Human African Trypanosomiasis (Sleeping Sickness),
Fact Sheet</span>. <a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trypanosomiasis%2C%0AHuman+African+Trypanosomiasis+%28Sleeping+Sickness%29%2C%0AFact+Sheet.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+April+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTrypanosomiasis%252C%250AHuman%2520African%2520Trypanosomiasis%2520%2528Sleeping%2520Sickness%2529%252C%250AFact%2520Sheet" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span> </span><span class="NLM_article-title">Chagas Disease (American
Trypanosomiasis), Fact Sheet</span>. <a href="http://www.who.int/mediacentre/factsheets/fs340/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs340/en/</a> (accessed
April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chagas+Disease+%28American%0ATrypanosomiasis%29%2C+Fact+Sheet.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs340%2Fen%2F+%28accessed%0AApril+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DChagas%2520Disease%2520%2528American%250ATrypanosomiasis%2529%252C%2520Fact%2520Sheet" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koning, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span> <span> </span><span class="NLM_article-title">The animal trypanosomiases and their chemotherapy: a review</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1017/s0031182016001268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182016001268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27719692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC2svnsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2016&pages=1862-1889&author=F.+Giordaniauthor=L.+J.+Morrisonauthor=T.+G.+Rowanauthor=H.+P.+De+Koningauthor=M.+P.+Barrett&title=The+animal+trypanosomiases+and+their+chemotherapy%3A+a+review&doi=10.1017%2Fs0031182016001268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The animal trypanosomiases and their chemotherapy: a review</span></div><div class="casAuthors">Giordani Federica; DE Koning Harry P; Barrett Michael P; Morrison Liam J; Rowan Tim G</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1862-1889</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pathogenic animal trypanosomes affecting livestock have represented a major constraint to agricultural development in Africa for centuries, and their negative economic impact is increasing in South America and Asia.  Chemotherapy and chemoprophylaxis represent the main means of control.  However, research into new trypanocides has remained inadequate for decades, leading to a situation where the few compounds available are losing efficacy due to the emergence of drug-resistant parasites.  In this review, we provide a comprehensive overview of the current options available for the treatment and prophylaxis of the animal trypanosomiases, with a special focus on the problem of resistance.  The key issues surrounding the main economically important animal trypanosome species and the diseases they cause are also presented.  As new investment becomes available to develop improved tools to control the animal trypanosomiases, we stress that efforts should be directed towards a better understanding of the biology of the relevant parasite species and strains, to identify new drug targets and interrogate resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ06QITPuBK1sK3uFsUIZtkfW6udTcc2eYIwP1_b5Clabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svnsV2hsQ%253D%253D&md5=9bd3bf096493efeb13061501c2943672</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1017%2FS0031182016001268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182016001268%26sid%3Dliteratum%253Aachs%26aulast%3DGiordani%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DL.%2BJ.%26aulast%3DRowan%26aufirst%3DT.%2BG.%26aulast%3DDe%2BKoning%26aufirst%3DH.%2BP.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26atitle%3DThe%2520animal%2520trypanosomiases%2520and%2520their%2520chemotherapy%253A%2520a%2520review%26jtitle%3DParasitology%26date%3D2016%26volume%3D143%26spage%3D1862%26epage%3D1889%26doi%3D10.1017%2Fs0031182016001268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Büscher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamonneau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priotto, G.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)31510-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2931510-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28673422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC1cjktFCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=2397-2409&author=P.+B%C3%BCscherauthor=G.+Cecchiauthor=V.+Jamonneauauthor=G.+Priotto&title=Human+African+trypanosomiasis&doi=10.1016%2Fs0140-6736%2817%2931510-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human African trypanosomiasis</span></div><div class="casAuthors">Buscher Philippe; Cecchi Giuliano; Jamonneau Vincent; Priotto Gerardo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10110</span>),
    <span class="NLM_cas:pages">2397-2409</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated.  Human African trypanosomiasis caused devastating epidemics during the 20th century.  Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level.  Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO.  Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa.  Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas.  In the absence of a vaccine, disease control relies on case detection and treatment, and vector control.  Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBg2yQ4XqfsRgd2Wuil24tfW6udTcc2eYU545MTdfmurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjktFCrsw%253D%253D&md5=521e7f5c04b32c04763c6b7a65af6439</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2931510-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252931510-6%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCscher%26aufirst%3DP.%26aulast%3DCecchi%26aufirst%3DG.%26aulast%3DJamonneau%26aufirst%3DV.%26aulast%3DPriotto%26aufirst%3DG.%26atitle%3DHuman%2520African%2520trypanosomiasis%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D2397%26epage%3D2409%26doi%3D10.1016%2Fs0140-6736%2817%2931510-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caljon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stijlemans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radwanska, M.</span></span> <span> </span><span class="NLM_article-title">Current status of vaccination against African trypanosomiasis</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1017/s0031182010000223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182010000223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20441680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3cbntlCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2010&pages=2017-2027&author=S.+Magezauthor=G.+Caljonauthor=T.+Tranauthor=B.+Stijlemansauthor=M.+Radwanska&title=Current+status+of+vaccination+against+African+trypanosomiasis&doi=10.1017%2Fs0031182010000223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current status of vaccination against African trypanosomiasis</span></div><div class="casAuthors">Magez Stefan; Caljon Guy; Tran Thao; Stijlemans Benoit; Radwanska Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2017-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anti-trypanosomiasis vaccination still remains the best theoretical option in the fight against a disease that is continuously hovering between its wildlife reservoir and its reservoir in man and livestock.  While antigenic variation of the parasite surface coat has been considered the major obstacle in the development of a functional vaccine, recent research into the biology of B cells has indicated that the problems might go further than that.  This paper reviews past and current attempts to design both anti-trypanosome vaccines, as well as vaccines directed towards the inhibition of infection-associated pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6yIp2p7gVpr7NkxioyDXTfW6udTcc2eYU545MTdfmurntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbntlCmuw%253D%253D&md5=c037e34e20e13b0a18f352703ae96fa1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1017%2FS0031182010000223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182010000223%26sid%3Dliteratum%253Aachs%26aulast%3DMagez%26aufirst%3DS.%26aulast%3DCaljon%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DStijlemans%26aufirst%3DB.%26aulast%3DRadwanska%26aufirst%3DM.%26atitle%3DCurrent%2520status%2520of%2520vaccination%2520against%2520African%2520trypanosomiasis%26jtitle%3DParasitology%26date%3D2010%26volume%3D137%26spage%3D2017%26epage%3D2027%26doi%3D10.1017%2Fs0031182010000223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stijlemans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radwanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Trez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magez, S.</span></span> <span> </span><span class="NLM_article-title">African trypanosomes undermine humoral responses and vaccine development: link with inflammatory responses?</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.3389%2Ffimmu.2017.00582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28149297" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1-14&author=B.+Stijlemansauthor=M.+Radwanskaauthor=C.+De+Trezauthor=S.+Magez&title=African+trypanosomes+undermine+humoral+responses+and+vaccine+development%3A+link+with+inflammatory+responses%3F&doi=10.3389%2Ffimmu.2017.00582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00582%26sid%3Dliteratum%253Aachs%26aulast%3DStijlemans%26aufirst%3DB.%26aulast%3DRadwanska%26aufirst%3DM.%26aulast%3DDe%2BTrez%26aufirst%3DC.%26aulast%3DMagez%26aufirst%3DS.%26atitle%3DAfrican%2520trypanosomes%2520undermine%2520humoral%2520responses%2520and%2520vaccine%2520development%253A%2520link%2520with%2520inflammatory%2520responses%253F%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffimmu.2017.00582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, P. G.</span></span> <span> </span><span class="NLM_article-title">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70296-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS1474-4422%2812%2970296-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23260189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=186-194&author=P.+G.+Kennedy&title=Clinical+features%2C+diagnosis%2C+and+treatment+of+human+African+trypanosomiasis+%28sleeping+sickness%29&doi=10.1016%2Fs1474-4422%2812%2970296-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span></div><div class="casAuthors">Kennedy Peter Ge</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis, or sleeping sickness, is caused by infection with parasites of the genus Trypanosoma, transmitted by the tsetse fly.  The disease has two forms, Trypanosoma brucei (T b) rhodesiense and T b gambiense; and is almost always fatal if untreated.  Despite a recent reduction in the number of reported cases, patients with African trypanosomiasis continue to present major challenges to clinicians.  Because treatment for CNS-stage disease can be very toxic, diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic.  Melarsoprol is the only available treatment for late-stage T b rhodesiense infection, but can be lethal to 5% of patients owing to post-treatment reactive encephalopathy.  Eflornithine combined with nifurtimox is the first-line treatment for late-stage T b gambiense.  New drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDi0PRo3CXkCEJCPKhJPuqfW6udTcc2eZ-cMlSQvxiDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D&md5=c9ac342f345240d413300c17cd1ae80f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970296-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970296-X%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DP.%2BG.%26atitle%3DClinical%2520features%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%2520%2528sleeping%2520sickness%2529%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D186%26epage%3D194%26doi%3D10.1016%2Fs1474-4422%2812%2970296-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesu, V. K. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalonji, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardonneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordt, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhomme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuziena, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubaki, J.-P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuvu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngima, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbembo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilunga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonama, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heradi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomo, J. L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandula, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badibabi, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dama, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tete, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumbala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarral, A.</span></span> <span> </span><span class="NLM_article-title">Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)32758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2932758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29113731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=144-154&author=V.+K.+B.+K.+Mesuauthor=W.+M.+Kalonjiauthor=C.+Bardonneauauthor=O.+V.+Mordtauthor=S.+Blessonauthor=F.+Simonauthor=S.+Delhommeauthor=S.+Bernhardauthor=W.+Kuzienaauthor=J.-P.+F.+Lubakiauthor=S.+L.+Vuvuauthor=P.+N.+Ngimaauthor=H.+M.+Mbemboauthor=M.+Ilungaauthor=A.+K.+Bonamaauthor=J.+A.+Heradiauthor=J.+L.+L.+Solomoauthor=G.+Mandulaauthor=L.+K.+Badibabiauthor=F.+R.+Damaauthor=P.+K.+Lukulaauthor=D.+N.+Teteauthor=C.+Lumbalaauthor=B.+Scherrerauthor=N.+Strub-Wourgaftauthor=A.+Tarral&title=Oral+fexinidazole+for+late-stage+African+Trypanosoma+brucei+gambiense+trypanosomiasis%3A+a+pivotal+multicentre%2C+randomised%2C+non-inferiority+trial&doi=10.1016%2Fs0140-6736%2817%2932758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial</span></div><div class="casAuthors">Mesu, Victor Kande Betu Ku; Kalonji, Wilfried Mutombo; Bardonneau, Clelia; Mordt, Olaf Valverde; Blesson, Severine; Simon, Francois; Delhomme, Sophie; Bernhard, Sonja; Kuziena, Willy; Lubaki, Jean-Pierre Fina; Vuvu, Steven Lumeya; Ngima, Pathou Nganzobo; Mbembo, Helene Mahenzi; Ilunga, Medard; Bonama, Augustin Kasongo; Heradi, Josue Amici; Solomo, Jean Louis Lumaliza; Mandula, Guylain; Badibabi, Lewis Kaninda; Dama, Francis Regongbenga; Lukula, Papy Kavunga; Tete, Digas Ngolo; Lumbala, Crispin; Scherrer, Bruno; Strub-Wourgaft, Nathalie; Tarral, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10116</span>),
    <span class="NLM_cas:pages">144-154</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Few therapeutic options are available to treat late-stage human African trypanosomiasis, a neglected tropical disease caused by Trypanosoma brucei gambiense (g-HAT).  The firstline treatment nifurtimox eflornithine combination therapy needs to be administered i.v. in a hospital setting by trained personnel, which is not optimal, given that patients often live in remote areas with few health resources.  Therefore, we aimed to assess the safety and efficacy of an oral regimen of fexinidazole (a 2-substituted 5-nitroimidazole with proven trypanocidal activity) vs. nifurtimox eflornithine combination therapy in patients with late-stage g-HAT.  In this randomised, phase 2/3, open-label, non-inferiority trial, we recruited patients aged 15 years and older with late-stage g-HAT from g-HAT treatment centers in the Democratic Republic of the Congo (n=9) and the Central African Republic (n=1).  Patients were randomly assigned (2:1) to receive either fexinidazole or nifurtimox eflornithine combination therapy according to a predefined randomisation list (block size six).  The funder, data management personnel, and study statisticians were masked to treatment.  Oral fexinidazole was given once a day (days 1-4: 1800 mg, days 5-10: 1200 mg).  Oral nifurtimox was given three times a day (days 1-10: 15 mg/kg per day) with eflornithine twice a day as 2 h infusions (days 1-7: 400 mg/kg per day).  The primary endpoint was success at 18 mo (ie, deemed as patients being alive, having no evidence of trypanosomes in any body fluid, not requiring rescue medication, and having a cerebrospinal fluid white blood cell count ≤20 cells per μL).  Safety was assessed through routine monitoring.  Primary efficacy anal. was done in the modified intention-to-treat population and safety analyses in the intention-to-treat population.  The acceptable margin for the difference in success rates was defined as 13%.  This study has been completed and is registered with ClinicalTrials.gov, no. NCT01685827.  Between Oct., 2012, and Nov., 2016, 419 patients were pre-screened.  Of the 409 eligible patients, 14 were not included because they did not meet all inclusion criteria (n=12) or for another reason (n=2).  Therefore, 394 patients were randomly assigned, 264 to receive fexinidazole and 130 to receive nifurtimox eflornithine combination therapy.  Success at 18 mo was recorded in 239 (91%) patients given fexinidazole and 124 (98%) patients given nifurtimox eflornithine combination therapy, within the margin of acceptable difference of -6·4% (97·06% CI -11·2 to -1·6; p=0·0029).  We noted no difference in the proportion of patients who experienced treatment-related adverse events (215 [81%] in the fexinidazole group vs 102 [79%] in the nifurtimox eflornithine combination therapy group).  Treatment discontinuations were unrelated to treatment (n=2 [1%] in the fexinidazole group).  Temporary nifurtimox eflornithine combination therapy interruption occurred in three (2%) patients. 11 patients died during the study (nine [3%] in the fexinidazole group vs two [2%] in the nifurtimox eflornithine combination therapy group).  Our findings show that oral fexinidazole is effective and safe for the treatment of T b gambiense infection compared with nifurtimox eflornithine combination therapy in late-stage HAT patients.  Fexinidazole could be a key asset in the elimination of this fatal neglected disease.  Drugs for Neglected Diseases initiative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragrgvd5-lcbVg90H21EOLACvtfcHk0lh5RcG7noFC3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymt7zO&md5=3022f3915faaaadecbc387f4ba367bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932758-7%26sid%3Dliteratum%253Aachs%26aulast%3DMesu%26aufirst%3DV.%2BK.%2BB.%2BK.%26aulast%3DKalonji%26aufirst%3DW.%2BM.%26aulast%3DBardonneau%26aufirst%3DC.%26aulast%3DMordt%26aufirst%3DO.%2BV.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DDelhomme%26aufirst%3DS.%26aulast%3DBernhard%26aufirst%3DS.%26aulast%3DKuziena%26aufirst%3DW.%26aulast%3DLubaki%26aufirst%3DJ.-P.%2BF.%26aulast%3DVuvu%26aufirst%3DS.%2BL.%26aulast%3DNgima%26aufirst%3DP.%2BN.%26aulast%3DMbembo%26aufirst%3DH.%2BM.%26aulast%3DIlunga%26aufirst%3DM.%26aulast%3DBonama%26aufirst%3DA.%2BK.%26aulast%3DHeradi%26aufirst%3DJ.%2BA.%26aulast%3DSolomo%26aufirst%3DJ.%2BL.%2BL.%26aulast%3DMandula%26aufirst%3DG.%26aulast%3DBadibabi%26aufirst%3DL.%2BK.%26aulast%3DDama%26aufirst%3DF.%2BR.%26aulast%3DLukula%26aufirst%3DP.%2BK.%26aulast%3DTete%26aufirst%3DD.%2BN.%26aulast%3DLumbala%26aufirst%3DC.%26aulast%3DScherrer%26aufirst%3DB.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DTarral%26aufirst%3DA.%26atitle%3DOral%2520fexinidazole%2520for%2520late-stage%2520African%2520Trypanosoma%2520brucei%2520gambiense%2520trypanosomiasis%253A%2520a%2520pivotal%2520multicentre%252C%2520randomised%252C%2520non-inferiority%2520trial%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D144%26epage%3D154%26doi%3D10.1016%2Fs0140-6736%2817%2932758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollastri, M. P.</span></span> <span> </span><span class="NLM_article-title">Fexinidazole: a new drug for African sleeping sickness on the horizon</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2017.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pt.2017.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29275007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOhsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=178-179&author=M.+P.+Pollastri&title=Fexinidazole%3A+a+new+drug+for+African+sleeping+sickness+on+the+horizon&doi=10.1016%2Fj.pt.2017.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon</span></div><div class="casAuthors">Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-179</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Decades after the last new chem. entity was added to the pharmacopeia for human African trypanosomiasis (or sleeping sickness), orally dosed fexinidazole stands poised to replace the current treatment regimen for Trypanosoma brucei gambiense infections, following a pos. Phase 2/3 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0dzkKzgAQ8LVg90H21EOLACvtfcHk0lhVmAwWVPaK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOhsLjK&md5=90c0d6e87ec827b9b788152db9aff51e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2017.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2017.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DFexinidazole%253A%2520a%2520new%2520drug%2520for%2520African%2520sleeping%2520sickness%2520on%2520the%2520horizon%26jtitle%3DTrends%2520Parasitol.%26date%3D2018%26volume%3D34%26spage%3D178%26epage%3D179%26doi%3D10.1016%2Fj.pt.2017.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pt.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24776300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=289-298&author=S.+Pattersonauthor=S.+Wyllie&title=Nitro+drugs+for+the+treatment+of+trypanosomatid+diseases%3A+past%2C+present%2C+and+future+prospects&doi=10.1016%2Fj.pt.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an urgent need for new, safer, and effective treatments for the diseases caused by the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.  In the search for more effective drugs to treat these 'neglected diseases' researchers have chosen to reassess the therapeutic value of nitroarom. compds.  Previously avoided in drug discovery programs owing to potential toxicity issues, a nitro drug is now being used successfully as part of a combination therapy for human African trypanosomiasis.  We describe here the rehabilitation of nitro drugs for the treatment of trypanosomatid diseases and discuss the future prospects for this compd. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomh5yhGW-6mrVg90H21EOLACvtfcHk0lhVmAwWVPaK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D&md5=041606bd13d4f709723aa61f1100873b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DNitro%2520drugs%2520for%2520the%2520treatment%2520of%2520trypanosomatid%2520diseases%253A%2520past%252C%2520present%252C%2520and%2520future%2520prospects%26jtitle%3DTrends%2520Parasitol.%26date%3D2014%26volume%3D30%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.pt.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Fexinidazole: First Global Approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-1051-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2Fs40265-019-1051-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=30635838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFOqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=215-220&author=E.+D.+Deeks&title=Fexinidazole%3A+First+Global+Approval&doi=10.1007%2Fs40265-019-1051-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole: First Global Approval</span></div><div class="casAuthors">Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Fexinidazole Winthrop (hereafter referred to as fexinidazole) is a DNA synthesis inhibitor developed by the Drugs for Neglected Diseases initiative (DNDi), in collaboration with Sanofi, for the oral treatment of human African trypanosomiasis (HAT) [commonly known as 'sleeping sickness'] and Chagas' disease.  The drug is a 5-nitroimidazole deriv. first discovered by Hoechst AG (now part of Sanofi) and was identified by the DNDi in 2005 as having activity against Trypanosoma brucei gambiense and T. b. rhodesiense.  Under Article 58 of Regulation (EC) no. 726/2004 (a regulatory mechanism for reviewing new medicines destined for use outside of the EU), fexinidazole has been granted a pos. opinion by the EMA for the treatment of both the first-stage (haemo-lymphatic) and second-stage (meningo-encephalitic) of HAT due to T. b. gambiense (g-HAT) in adults and children aged ≥ 6 years and weighing ≥ 20 kg.  This approval will facilitate and support marketing authorization application in endemic countries in 2019; following registration, fexinidazole will be distributed via the WHO to endemic countries for g-HAT.  Phase 3 evaluation of fexinidazole for g-HAT is ongoing in the Democratic Republic of the Congo and Guinea and the drug is also in development for Chagas' disease, with a study currently ongoing in Spain.  Clin. development for visceral leishmaniasis is discontinued.  This article summarizes the milestones in the development of fexinidazole leading to this first approval for g-HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokgB3zQEcHLVg90H21EOLACvtfcHk0ljUEzhIi5dhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFOqsb4%253D&md5=811084e7ee200cae20c16e54dce026cd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-1051-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-1051-6%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DFexinidazole%253A%2520First%2520Global%2520Approval%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D215%26epage%3D220%26doi%3D10.1007%2Fs40265-019-1051-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foth, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1093%2Fjac%2Fdkv376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26581221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=625-634&author=S.+Wyllieauthor=B.+J.+Fothauthor=A.+Kelnerauthor=A.+Y.+Sokolovaauthor=M.+Berrimanauthor=A.+H.+Fairlamb&title=Nitroheterocyclic+drug+resistance+mechanisms+in+Trypanosoma+brucei&doi=10.1093%2Fjac%2Fdkv376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei</span></div><div class="casAuthors">Wyllie, Susan; Foth, Bernardo J.; Kelner, Anna; Sokolova, Antoaneta Y.; Berriman, Matthew; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to identify the mechanisms of resistance to nifurtimox and fexinidazole in African trypanosomes.  Bloodstream-form Trypanosoma brucei were selected for resistance to nifurtimox and fexinidazole by stepwise exposure to increasing drug concns.  Clones were subjected to WGS to identify putative resistance genes.  Transgenic parasites modulating expression of genes of interest were generated and drug susceptibility phenotypes detd.  Nifurtimox-resistant (NfxR) and fexinidazole-resistant (FxR) parasites shared reciprocal cross-resistance, suggestive of a common mechanism of action.  Previously, a type I nitroreductase (NTR) has been implicated in nitro drug activation.  WGS of resistant clones revealed that NfxR parasites had lost >100 kb from one copy of chromosome 7, rendering them hemizygous for NTR as well as over 30 other genes.  FxR parasites retained both copies of NTR, but lost >70 kb downstream of one NTR allele, decreasing NTR transcription by half.  A single knockout line of NTR displayed 1.6- and 1.9-fold resistance to nifurtimox and fexinidazole, resp.  Since NfxR and FxR parasites are ∼6- and 20-fold resistant to nifurtimox and fexinidazole, resp., addnl. factors must be involved.  Overexpression and knockout studies ruled out a role for a putative oxidoreductase (Tb927.7.7410) and a hypothetical gene (Tb927.1.1050), previously identified in a genome-scale RNAi screen.  Thus, NTR was confirmed as a key resistance determinant, either by loss of one gene copy or loss of gene expression.  Further work is required to identify which of the many dozens of SNPs identified in the drug-resistant cell lines contribute to the overall resistance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJv31KEMIC7Vg90H21EOLACvtfcHk0ljUEzhIi5dhoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtbbK&md5=ff71afe820933da38f7b590aaf5c37cf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv376%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DFoth%26aufirst%3DB.%2BJ.%26aulast%3DKelner%26aufirst%3DA.%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DNitroheterocyclic%2520drug%2520resistance%2520mechanisms%2520in%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D625%26epage%3D634%26doi%3D10.1093%2Fjac%2Fdkv376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2893</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/aac.00332-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1128%2FAAC.00332-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20439607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2893-2900&author=A.+Y.+Sokolovaauthor=S.+Wyllieauthor=S.+Pattersonauthor=S.+L.+Ozaauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Cross-resistance+to+nitro+drugs+and+implications+for+treatment+of+human+African+trypanosomiasis&doi=10.1128%2Faac.00332-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span></div><div class="casAuthors">Sokolova, Antoaneta Y.; Wyllie, Susan; Patterson, Stephen; Oza, Sandra L.; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2893-2900</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis (HAT) has renewed interest in the potential of nitro drugs as chemotherapeutics.  In order to study the implications of the more widespread use of nitro drugs against these parasites, we examd. the in vivo and in vitro resistance potentials of nifurtimox and fexinidazole and its metabolites.  Following selection in vitro by exposure to increasing concns. of nifurtimox, Trypanosoma brucei brucei nifurtimox-resistant clones designated NfxR1 and NfxR2 were generated.  Both cell lines were found to be 8-fold less sensitive to nifurtimox than parental cells and demonstrated cross-resistance to a no. of other nitro drugs, most notably the clin. trial candidate fexinidazole (∼27-fold more resistant than parental cells).  Studies of mice confirmed that the generation of nifurtimox resistance in these parasites did not compromise virulence, and NfxR1 remained resistant to both nifurtimox and fexinidazole in vivo.  In the case of fexinidazole, drug metab. and pharmacokinetic studies indicate that the parent drug is rapidly metabolized to the sulfoxide and sulfone form of this compd.  These metabolites retained trypanocidal activity but were less effective in nifurtimox-resistant lines.  Significantly, trypanosomes selected for resistance to fexinidazole were 10-fold more resistant to nifurtimox than parental cells.  This reciprocal cross-resistance has important implications for the therapeutic use of nifurtimox in a clin. setting and highlights a potential danger in the use of fexinidazole as a monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwMvjfLmRaLVg90H21EOLACvtfcHk0lgV5CLbbDXFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D&md5=3e34cfad24c02c4f41f5289b30fd9ad5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00332-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00332-10%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DOza%26aufirst%3DS.%2BL.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DCross-resistance%2520to%2520nitro%2520drugs%2520and%2520implications%2520for%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2893%26epage%3D2900%26doi%3D10.1128%2Faac.00332-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0lgV5CLbbDXFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span> </span><span class="NLM_article-title">DNDi Announces Successful Completion of
SCYX-7158 Phase I Study for
Treatment of Sleeping Sickness</span>. <a href="https://www.news-medical.net/news/20150909/DNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx" class="extLink">https://www.news-medical.net/news/20150909/DNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx</a> (accessed April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DNDi+Announces+Successful+Completion+of%0ASCYX-7158+Phase+I+Study+for%0ATreatment+of+Sleeping+Sickness.+https%3A%2F%2Fwww.news-medical.net%2Fnews%2F20150909%2FDNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx+%28accessed+April+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DDNDi%2520Announces%2520Successful%2520Completion%2520of%250ASCYX-7158%2520Phase%2520I%2520Study%2520for%250ATreatment%2520of%2520Sleeping%2520Sickness" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón
de Noya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Bello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenares, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Guevara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauriello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavala-Jaspe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranjo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Márques, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquatella, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noya, O.</span></span> <span> </span><span class="NLM_article-title">Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>201</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1086/651608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1086%2F651608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20307205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jsFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2010&pages=1308-1315&author=B.+Alarc%C3%B3n%0Ade+Noyaauthor=Z.+D%C3%ADaz-Belloauthor=C.+Colmenaresauthor=R.+Ruiz-Guevaraauthor=L.+Maurielloauthor=R.+Zavala-Jaspeauthor=J.+A.+Suarezauthor=T.+Abateauthor=L.+Naranjoauthor=M.+Paivaauthor=L.+Rivasauthor=J.+Castroauthor=J.+M%C3%A1rquesauthor=I.+Mendozaauthor=H.+Acquatellaauthor=J.+Torresauthor=O.+Noya&title=Large+urban+outbreak+of+orally+acquired+acute+Chagas+disease+at+a+school+in+Caracas%2C+Venezuela&doi=10.1086%2F651608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela</span></div><div class="casAuthors">Alarcon de Noya Belkisyole; Diaz-Bello Zoraida; Colmenares Cecilia; Ruiz-Guevara Raiza; Mauriello Luciano; Zavala-Jaspe Reinaldo; Suarez Jose Antonio; Abate Teresa; Naranjo Laura; Paiva Manuel; Rivas Lavinia; Castro Julio; Marques Juan; Mendoza Ivan; Acquatella Harry; Torres Jaime; Noya Oscar</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1308-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Trypanosoma cruzi oral transmission is possible through food contamination by vector's feces.  Little is known about the epidemiology and clinical features of microepidemics of orally acquired acute Chagas disease (CD).  METHODS:  A case-control, cohort-nested, epidemiological study was conducted during an outbreak of acute CD that affected a school community.  Structured interviews were designed to identify symptoms and sources of infection.  Electrocardiograms were obtained for all patients.  Specific serum antibodies were assessed by immunoenzimatic and indirect hemagglutination tests.  In some cases, parasitemia was tested directly or by culture, animal inoculation, and/or a polymerase chain reaction technique.  RESULTS:  Infection was confirmed in 103 of 1000 exposed individuals.  Of those infected, 75% were symptomatic, 20.3% required hospitalization, 59% showed ECG abnormalities, parasitemia was documented in 44, and 1 child died.  Clinical features differed from those seen in vectorial transmission.  The infection rate was significantly higher among younger children.  An epidemiological investigation incriminated contaminated fresh guava juice as the sole source of infection.  CONCLUSIONS:  This outbreak was unique, because it affected a large, urban, predominantly young, middle-class, otherwise healthy population and resulted in an unprecedented public health emergency.  Rapid diagnosis and treatment avoided higher lethality.  Food-borne transmission of T. cruzi may occur more often than is currently recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpsIaQ7_r3bOLt9HypzAgQfW6udTcc2eblAg8Wvc6-07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jsFKhuw%253D%253D&md5=b1f887be29a03920450995c4ec0a5e6c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1086%2F651608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F651608%26sid%3Dliteratum%253Aachs%26aulast%3DAlarc%25C3%25B3n%2Bde%2BNoya%26aufirst%3DB.%26aulast%3DD%25C3%25ADaz-Bello%26aufirst%3DZ.%26aulast%3DColmenares%26aufirst%3DC.%26aulast%3DRuiz-Guevara%26aufirst%3DR.%26aulast%3DMauriello%26aufirst%3DL.%26aulast%3DZavala-Jaspe%26aufirst%3DR.%26aulast%3DSuarez%26aufirst%3DJ.%2BA.%26aulast%3DAbate%26aufirst%3DT.%26aulast%3DNaranjo%26aufirst%3DL.%26aulast%3DPaiva%26aufirst%3DM.%26aulast%3DRivas%26aufirst%3DL.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DM%25C3%25A1rques%26aufirst%3DJ.%26aulast%3DMendoza%26aufirst%3DI.%26aulast%3DAcquatella%26aufirst%3DH.%26aulast%3DTorres%26aufirst%3DJ.%26aulast%3DNoya%26aufirst%3DO.%26atitle%3DLarge%2520urban%2520outbreak%2520of%2520orally%2520acquired%2520acute%2520Chagas%2520disease%2520at%2520a%2520school%2520in%2520Caracas%252C%2520Venezuela%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D201%26spage%3D1308%26epage%3D1315%26doi%3D10.1086%2F651608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Molina, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I.</span></span> <span> </span><span class="NLM_article-title">Chagas disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)31612-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2931612-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28673423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC1cjktFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=82-94&author=J.+A.+P%C3%A9rez-Molinaauthor=I.+Molina&title=Chagas+disease&doi=10.1016%2Fs0140-6736%2817%2931612-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas disease</span></div><div class="casAuthors">Perez-Molina Jose A; Molina Israel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10115</span>),
    <span class="NLM_cas:pages">82-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration.  It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century.  Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke.  Even after more than a century, many challenges remain unresolved, since epidemiological control and diagnostic, therapeutic, and prognostic methods must be improved.  In particular, the efficacy and tolerability profile of therapeutic agents is far from ideal.  Furthermore, the population affected is older and more complex (eg, immunosuppressed patients and patients with cancer).  Nevertheless, in recent years, our knowledge of Chagas disease has expanded, and the international networking needed to change the course of this deadly disease during the 21st century has begun.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBg2yQ4XqfsXELvajU9pjPfW6udTcc2eblAg8Wvc6-07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjktFCrsA%253D%253D&md5=780546343990bf2d1774a418bf7f8091</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2931612-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252931612-4%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Molina%26aufirst%3DJ.%2BA.%26aulast%3DMolina%26aufirst%3DI.%26atitle%3DChagas%2520disease%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D82%26epage%3D94%26doi%3D10.1016%2Fs0140-6736%2817%2931612-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Alvarez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdron-Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caceres, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, M. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concepcion, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinones, W.</span></span> <span> </span><span class="NLM_article-title">Glycosomal targets for anti-trypanosomatid drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.2174/09298673113209990139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.2174%2F09298673113209990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23834165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlaitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1679-1706&author=X.+Barros-Alvarezauthor=M.+Gualdron-Lopezauthor=H.+Acostaauthor=A.+J.+Caceresauthor=M.+A.+S.+Graminhaauthor=P.+A.+M.+Michelsauthor=J.+L.+Concepcionauthor=W.+Quinones&title=Glycosomal+targets+for+anti-trypanosomatid+drug+discovery&doi=10.2174%2F09298673113209990139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosomal targets for anti-trypanosomatid drug discovery</span></div><div class="casAuthors">Barros-Alvarez, X.; Gualdron-Lopez, M.; Acosta, H.; Caceres, A. J.; Graminha, M. A. S.; Michels, P. A. M.; Concepcion, J. L.; Quinones, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1679-1706</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycosomes are peroxisome-related organelles found in all kinetoplastid protists, including the human pathogenic species of the family Trypanosomatidae: Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp.  Glycosomes are unique in contg. the majority of the glycolytic/gluconeogenic enzymes, but they also possess enzymes of several other important catabolic and anabolic pathways.  The different metabolic processes are connected by shared cofactors and some metabolic intermediates, and their relative importance differs between the parasites or their distinct lifecycle stages, dependent on the environmental conditions encountered.  By genetic or chem. means, a variety of glycosomal enzymes participating in different processes have been validated as drug targets.  For several of these enzymes, as well as others that are likely crucial for proliferation, viability or virulence of the parasites, inhibitors have been obtained by different approaches such as compd. libraries screening or design and synthesis.  The efficacy and selectivity of some initially obtained inhibitors of parasite enzymes were further optimized by structure-activity relationship anal., using available protein crystal structures.  Several of the inhibitors cause growth inhibition of the clin. relevant stages of one or more parasitic trypanosomatid species and in some cases exert therapeutic effects in infected animals.  The integrity of glycosomes and proper compartmentalization of at least several matrix enzymes is also crucial for the viability of the parasites.  Therefore, proteins involved in the assembly of the organelles and transmembrane passage of substrates and products of glycosomal metab. offer also promise as drug targets.  Natural products with trypanocidal activity by affecting glycosomal integrity have been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNdPzMK_ou7Vg90H21EOLACvtfcHk0lidCJjfpDWE6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlaitro%253D&md5=5ee74c0728cd91872599387835e28651</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990139%26sid%3Dliteratum%253Aachs%26aulast%3DBarros-Alvarez%26aufirst%3DX.%26aulast%3DGualdron-Lopez%26aufirst%3DM.%26aulast%3DAcosta%26aufirst%3DH.%26aulast%3DCaceres%26aufirst%3DA.%2BJ.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DConcepcion%26aufirst%3DJ.%2BL.%26aulast%3DQuinones%26aufirst%3DW.%26atitle%3DGlycosomal%2520targets%2520for%2520anti-trypanosomatid%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1679%26epage%3D1706%26doi%3D10.2174%2F09298673113209990139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smirlis, D.</span>; <span class="NLM_string-name">Soares, M. B. P.</span></span> <span> </span><span class="NLM_article-title">Selection of Molecular Targets for Drug Development Against Trypanosomatids</span>. In  <i>Proteins and Proteomics of Leishmania and Trypanosoma</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. L. S.</span>, <span class="NLM_string-name">Branquinha, M. H.</span>, <span class="NLM_string-name">d’Avila-Levy, C. M.</span>, <span class="NLM_string-name">Kneipp, L. F.</span>, <span class="NLM_string-name">Sodré, C. L.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Netherlands</span>: <span class="NLM_publisher-loc">Dordrecht</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">76</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2F978-94-007-7305-9_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-76&author=D.+Smirlis&author=M.+B.+P.+Soaresauthor=A.+L.+S.+Santos&author=M.+H.+Branquinha&author=C.+M.+d%E2%80%99Avila-Levy&author=L.+F.+Kneipp&author=C.+L.+Sodr%C3%A9&title=Proteins+and+Proteomics+of+Leishmania+and+Trypanosoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-7305-9_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-007-7305-9_2%26sid%3Dliteratum%253Aachs%26aulast%3DSmirlis%26aufirst%3DD.%26atitle%3DSelection%2520of%2520Molecular%2520Targets%2520for%2520Drug%2520Development%2520Against%2520Trypanosomatids%26btitle%3DProteins%2520and%2520Proteomics%2520of%2520Leishmania%2520and%2520Trypanosoma%26aulast%3DSantos%26aufirst%3DA.%2BL.%2BS.%26pub%3DSpringer%2520Netherlands%26date%3D2014%26spage%3D43%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Sayed, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renauld, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertz-Fowler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghedin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peacock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeu, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsmark, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angiuoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anupama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bringaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerqueira, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creasy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delcher, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djikeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embley, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummerfeld, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira-Leal, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shallom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westenberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melville, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, N.</span></span> <span> </span><span class="NLM_article-title">Comparative genomics of trypanosomatid parasitic protozoa</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1126/science.1112181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1126%2Fscience.1112181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=16020724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=404-409&author=N.+M.+El-Sayedauthor=P.+J.+Mylerauthor=G.+Blandinauthor=M.+Berrimanauthor=J.+Crabtreeauthor=G.+Aggarwalauthor=E.+Calerauthor=H.+Renauldauthor=E.+A.+Wortheyauthor=C.+Hertz-Fowlerauthor=E.+Ghedinauthor=C.+Peacockauthor=D.+C.+Bartholomeuauthor=B.+J.+Haasauthor=A.+N.+Tranauthor=J.+R.+Wortmanauthor=U.+C.+Alsmarkauthor=S.+Angiuoliauthor=A.+Anupamaauthor=J.+Badgerauthor=F.+Bringaudauthor=E.+Cadagauthor=J.+M.+Carltonauthor=G.+C.+Cerqueiraauthor=T.+Creasyauthor=A.+L.+Delcherauthor=A.+Djikengauthor=T.+M.+Embleyauthor=C.+Hauserauthor=A.+C.+Ivensauthor=S.+K.+Kummerfeldauthor=J.+B.+Pereira-Lealauthor=D.+Nilssonauthor=J.+Petersonauthor=S.+L.+Salzbergauthor=J.+Shallomauthor=J.+C.+Silvaauthor=J.+Sundaramauthor=S.+Westenbergerauthor=O.+Whiteauthor=S.+E.+Melvilleauthor=J.+E.+Donelsonauthor=B.+Anderssonauthor=K.+D.+Stuartauthor=N.+Hall&title=Comparative+genomics+of+trypanosomatid+parasitic+protozoa&doi=10.1126%2Fscience.1112181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Genomics of Trypanosomatid Parasitic Protozoa</span></div><div class="casAuthors">El-Sayed, Najib M.; Myler, Peter J.; Blandin, Gaelle; Berriman, Matthew; Crabtree, Jonathan; Aggarwal, Gautam; Caler, Elisabet; Renauld, Hubert; Worthey, Elizabeth A.; Hertz-Fowler, Christiane; Ghedin, Elodie; Peacock, Christopher; Bartholomeu, Daniella C.; Haas, Brian J.; Tran, Anh-Nhi; Wortman, Jennifer R.; Alsmark, U. Cecilia M.; Angiuoli, Samuel; Anupama, Atashi; Badger, Jonathan; Bringaud, Frederic; Cadag, Eithon; Carlton, Jane M.; Cerqueira, Gustavo C.; Creasy, Todd; Delcher, Arthur L.; Djikeng, Appolinaire; Embley, T. Martin; Hauser, Christopher; Ivens, Alasdair C.; Kummerfeld, Sarah K.; Pereira-Leal, Jose B.; Nilsson, Daniel; Peterson, Jeremy; Salzberg, Steven L.; Shallom, Joshua; Silva, Joana C.; Sundaram, Jaideep; Westenberger, Scott; White, Owen; Melville, Sara E.; Donelson, John E.; Andersson, Bjoern; Stuart, Kenneth D.; Hall, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5733</span>),
    <span class="NLM_cas:pages">404-409</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A comparison of gene content and genome architecture of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, three related pathogens with different life cycles and disease pathol., revealed a conserved core proteome of about 6200 genes in large syntenic polycistronic gene clusters.  Many species-specific genes, esp. large surface antigen families, occur at nonsyntenic chromosome-internal and subtelomeric regions.  Retroelements, structural RNAs, and gene family expansion are often assocd. with syntenic discontinuities that-along with gene divergence, acquisition and loss, and rearrangement within the syntenic regions-have shaped the genomes of each parasite.  Contrary to recent reports, the analyses reveal no evidence that these species are descended from an ancestor that contained a photosynthetic endosymbiont.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBNWr2-XgiPrVg90H21EOLACvtfcHk0ljTvYHe--upmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVersbo%253D&md5=4383ec045835bdc2cddb9f6011b392eb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1112181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1112181%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Sayed%26aufirst%3DN.%2BM.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DBlandin%26aufirst%3DG.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DCrabtree%26aufirst%3DJ.%26aulast%3DAggarwal%26aufirst%3DG.%26aulast%3DCaler%26aufirst%3DE.%26aulast%3DRenauld%26aufirst%3DH.%26aulast%3DWorthey%26aufirst%3DE.%2BA.%26aulast%3DHertz-Fowler%26aufirst%3DC.%26aulast%3DGhedin%26aufirst%3DE.%26aulast%3DPeacock%26aufirst%3DC.%26aulast%3DBartholomeu%26aufirst%3DD.%2BC.%26aulast%3DHaas%26aufirst%3DB.%2BJ.%26aulast%3DTran%26aufirst%3DA.%2BN.%26aulast%3DWortman%26aufirst%3DJ.%2BR.%26aulast%3DAlsmark%26aufirst%3DU.%2BC.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DAnupama%26aufirst%3DA.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBringaud%26aufirst%3DF.%26aulast%3DCadag%26aufirst%3DE.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DCerqueira%26aufirst%3DG.%2BC.%26aulast%3DCreasy%26aufirst%3DT.%26aulast%3DDelcher%26aufirst%3DA.%2BL.%26aulast%3DDjikeng%26aufirst%3DA.%26aulast%3DEmbley%26aufirst%3DT.%2BM.%26aulast%3DHauser%26aufirst%3DC.%26aulast%3DIvens%26aufirst%3DA.%2BC.%26aulast%3DKummerfeld%26aufirst%3DS.%2BK.%26aulast%3DPereira-Leal%26aufirst%3DJ.%2BB.%26aulast%3DNilsson%26aufirst%3DD.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26aulast%3DShallom%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DJ.%2BC.%26aulast%3DSundaram%26aufirst%3DJ.%26aulast%3DWestenberger%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DO.%26aulast%3DMelville%26aufirst%3DS.%2BE.%26aulast%3DDonelson%26aufirst%3DJ.%2BE.%26aulast%3DAndersson%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DK.%2BD.%26aulast%3DHall%26aufirst%3DN.%26atitle%3DComparative%2520genomics%2520of%2520trypanosomatid%2520parasitic%2520protozoa%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D404%26epage%3D409%26doi%3D10.1126%2Fscience.1112181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gürtler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarleton, R.</span></span> <span> </span><span class="NLM_article-title">Kinetoplastids: related protozoan pathogens, different diseases</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1310</span>, <span class="refDoi"> DOI: 10.1172/jci33945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1172%2Fjci33945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=18382742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1CntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1301-1310&author=K.+Stuartauthor=R.+Brunauthor=S.+Croftauthor=A.+Fairlambauthor=R.+E.+G%C3%BCrtlerauthor=J.+McKerrowauthor=S.+Reedauthor=R.+Tarleton&title=Kinetoplastids%3A+related+protozoan+pathogens%2C+different+diseases&doi=10.1172%2Fjci33945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetoplastids: related protozoan pathogens, different diseases</span></div><div class="casAuthors">Stuart, Ken; Brun, Reto; Croft, Simon; Fairlamb, Alan; Gurtler, Ricardo E.; McKerrow, Jim; Reed, Steve; Tarleton, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1301-1310</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Kinetoplastids are a group of flagellated protozoans that include the species Trypanosoma and Leishmania, which are human pathogens with devastating health and economic effects.  The sequencing of the genomes of some of these species has highlighted their genetic relatedness and underlined differences in the diseases that they cause.  As we discuss in this Review, steady progress using a combination of mol., genetic, immunol., and clin. approaches has substantially increased understanding of these pathogens and important aspects of the diseases that they cause.  Consequently, the paths for developing addnl. measures to control these "neglected diseases" are becoming increasingly clear, and we believe that the opportunities for developing the drugs, diagnostics, vaccines, and other tools necessary to expand the armamentarium to combat these diseases have never been better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptkkuBVHbO1LVg90H21EOLACvtfcHk0ljTvYHe--upmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1CntLc%253D&md5=de0d99f9fc15e0388f3705f8874acd20</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2Fjci33945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci33945%26sid%3Dliteratum%253Aachs%26aulast%3DStuart%26aufirst%3DK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCroft%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%26aulast%3DG%25C3%25BCrtler%26aufirst%3DR.%2BE.%26aulast%3DMcKerrow%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DS.%26aulast%3DTarleton%26aufirst%3DR.%26atitle%3DKinetoplastids%253A%2520related%2520protozoan%2520pathogens%252C%2520different%2520diseases%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1301%26epage%3D1310%26doi%3D10.1172%2Fjci33945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myburgh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature19339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnature19339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27501246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=229-233&author=S.+Khareauthor=A.+S.+Nagleauthor=A.+Biggartauthor=Y.+H.+Laiauthor=F.+Liangauthor=L.+C.+Davisauthor=S.+W.+Barnesauthor=C.+J.+N.+Mathisonauthor=E.+Myburghauthor=M.-Y.+Gaoauthor=J.+R.+Gillespieauthor=X.+Liuauthor=J.+L.+Tanauthor=M.+Stinsonauthor=I.+C.+Riveraauthor=J.+Ballardauthor=V.+Yehauthor=T.+Groesslauthor=G.+Federeauthor=H.+X.+Y.+Kohauthor=J.+D.+Venableauthor=B.+Bursulayaauthor=M.+Shapiroauthor=P.+K.+Mishraauthor=G.+Spraggonauthor=A.+Brockauthor=J.+C.+Mottramauthor=F.+S.+Bucknerauthor=S.+P.+S.+Raoauthor=B.+G.+Wenauthor=J.+R.+Walkerauthor=T.+Tuntlandauthor=V.+Molteniauthor=R.+J.+Glynneauthor=F.+Supek&title=Proteasome+inhibition+for+treatment+of+leishmaniasis%2C+Chagas+disease+and+sleeping+sickness&doi=10.1038%2Fnature19339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span></div><div class="casAuthors">Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually.  The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., resp.  These parasites have similar biol. and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target.  However, no such mol. targets or broad spectrum drugs have been identified to date.  Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection.  GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice.  Our data provide genetic and chem. validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PXMn1-tj_7Vg90H21EOLACvtfcHk0lj7SXRidKgkzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL&md5=a05e7ce0f6b912b3003c5b3f42a005bb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature19339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19339%26sid%3Dliteratum%253Aachs%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DNagle%26aufirst%3DA.%2BS.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DMyburgh%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DJ.%2BL.%26aulast%3DStinson%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DI.%2BC.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DFedere%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DH.%2BX.%2BY.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBrock%26aufirst%3DA.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DWen%26aufirst%3DB.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26atitle%3DProteasome%2520inhibition%2520for%2520treatment%2520of%2520leishmaniasis%252C%2520Chagas%2520disease%2520and%2520sleeping%2520sickness%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature19339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newson, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani
Khajouei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flematti, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piggott, M. J.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization of a novel class of potent, broad-spectrum trypanosomacides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9686</span>– <span class="NLM_lpage">9720</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyqsrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9686-9720&author=S.+Russellauthor=R.+Rahmaniauthor=A.+J.+Jonesauthor=H.+L.+Newsonauthor=K.+Neildeauthor=I.+Cotilloauthor=M.+Rahmani%0AKhajoueiauthor=L.+Ferrinsauthor=S.+Qureishiauthor=N.+Nguyenauthor=M.+S.+Martinez-Martinezauthor=D.+F.+Weaverauthor=M.+Kaiserauthor=J.+Rileyauthor=J.+Thomasauthor=M.+De+Ryckerauthor=K.+D.+Readauthor=G.+R.+Flemattiauthor=E.+Ryanauthor=S.+Tangheauthor=A.+Rodriguezauthor=S.+A.+Charmanauthor=A.+Kesslerauthor=V.+M.+Averyauthor=J.+B.+Baellauthor=M.+J.+Piggott&title=Hit-to-lead+optimization+of+a+novel+class+of+potent%2C+broad-spectrum+trypanosomacides&doi=10.1021%2Facs.jmedchem.6b00442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides</span></div><div class="casAuthors">Russell, Stephanie; Rahmani, Raphael; Jones, Amy J.; Newson, Harriet L.; Neilde, Kevin; Cotillo, Ignacio; Rahmani Khajouei, Marzieh; Ferrins, Lori; Qureishi, Sana; Nguyen, Nghi; Martinez-Martinez, Maria S.; Weaver, Donald F.; Kaiser, Marcel; Riley, Jennifer; Thomas, John; De Rycker, Manu; Read, Kevin D.; Flematti, Gavin R.; Ryan, Eileen; Tanghe, Scott; Rodriguez, Ana; Charman, Susan A.; Kessler, Albane; Avery, Vicky M.; Baell, Jonathan B.; Piggott, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9686-9720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease.  Drugs currently available to treat these neglected diseases leave much to be desired.  Herein the authors report optimization of a novel class of N-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates and ureas, which rapidly, selectively, and potently kill both species of trypanosome.  The mode of action of these compds. is unknown, but does not involve CYP51 inhibition.  They do, however, exhibit clear structure-activity relationships, consistent across both trypanosome species.  Favorable physicochem. parameters place the best compds. in CNS drug-like chem. space but, as a class, they exhibit poor metabolic stability.  One of the best compds. I cleared all signs of T. cruzi infection in mice when CYP metab. was inhibited, with sterile cure achieved in one mouse.  This family of compds. thus shows significant promise for trypanosomiasis drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYfrbSB3QoOrVg90H21EOLACvtfcHk0liL_l2Wqs0pTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyqsrzP&md5=20f09884a0423c78f2bebf876b7f018f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00442%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DNewson%26aufirst%3DH.%2BL.%26aulast%3DNeilde%26aufirst%3DK.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DRahmani%2BKhajouei%26aufirst%3DM.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DQureishi%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DMartinez-Martinez%26aufirst%3DM.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFlematti%26aufirst%3DG.%2BR.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DTanghe%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DPiggott%26aufirst%3DM.%2BJ.%26atitle%3DHit-to-lead%2520optimization%2520of%2520a%2520novel%2520class%2520of%2520potent%252C%2520broad-spectrum%2520trypanosomacides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9686%26epage%3D9720%26doi%3D10.1021%2Facs.jmedchem.6b00442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, E. F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulloch, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharova, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, G. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of broad spectrum trypanosomatid selective inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00187</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=560-567&author=A.+L.+Fraserauthor=S.+K.+Menziesauthor=E.+F.+B.+Kingauthor=L.+B.+Tullochauthor=E.+R.+Gouldauthor=M.+K.+Zacharovaauthor=T.+K.+Smithauthor=G.+J.+Florence&title=Design+and+synthesis+of+broad+spectrum+trypanosomatid+selective+inhibitors&doi=10.1021%2Facsinfecdis.7b00187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Broad Spectrum Trypanosomatid Selective Inhibitors</span></div><div class="casAuthors">Fraser, Andrew L.; Menzies, Stefanie K.; King, Elizabeth F. B.; Tulloch, Lindsay B.; Gould, Eoin R.; Zacharova, Marija K.; Smith, Terry K.; Florence, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">560-567</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neglected tropical diseases caused by parasitic infections are an ongoing and increasing concern that have a devastating effect on the developing world due to their burden on human and animal health.  In this work, we detail the prepn. of a focused library of substituted-tetrahydropyran derivs. and their evaluation as selective chem. tools for trypanosomatid inhibition and the follow-on development of photoaffinity probes capable of labeling target protein(s) in vitro.  Several of these functionalized compds. maintain low micromolar activity against Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, and Leishmania donovani.  In addn., we demonstrate the utility of the photoaffinity probes for target identification through preliminary cellular localization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXs53azWknLVg90H21EOLACvtfcHk0liL_l2Wqs0pTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFagtA%253D%253D&md5=bc1ac8d984b482d7b95e01e4e495ee99</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00187%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DA.%2BL.%26aulast%3DMenzies%26aufirst%3DS.%2BK.%26aulast%3DKing%26aufirst%3DE.%2BF.%2BB.%26aulast%3DTulloch%26aufirst%3DL.%2BB.%26aulast%3DGould%26aufirst%3DE.%2BR.%26aulast%3DZacharova%26aufirst%3DM.%2BK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DFlorence%26aufirst%3DG.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520broad%2520spectrum%2520trypanosomatid%2520selective%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D560%26epage%3D567%26doi%3D10.1021%2Facsinfecdis.7b00187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente-García, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenguer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayago, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.ejmech.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26479031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=120-137&author=O.+Di%0APietroauthor=E.+Vicente-Garc%C3%ADaauthor=M.+C.+Taylorauthor=D.+Berenguerauthor=E.+Viaynaauthor=A.+Lanzoniauthor=I.+Solaauthor=H.+Sayagoauthor=C.+Rieraauthor=R.+Fisaauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=J.+M.+Kellyauthor=R.+Lavillaauthor=D.+Mu%C3%B1oz-Torrero&title=Multicomponent+reaction-based+synthesis+and+biological+evaluation+of+tricyclic+heterofused+quinolines+with+multi-trypanosomatid+activity&doi=10.1016%2Fj.ejmech.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span></div><div class="casAuthors">Di Pietro, Ornella; Vicente-Garcia, Esther; Taylor, Martin C.; Berenguer, Diana; Viayna, Elisabet; Lanzoni, Anna; Sola, Irene; Sayago, Helena; Riera, Cristina; Fisa, Roser; Clos, M. Victoria; Perez, Belen; Kelly, John M.; Lavilla, Rodolfo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-137</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, which are caused by the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi and Leishmania species, are among the most deadly neglected tropical diseases.  The development of drugs that are active against several trypanosomatids is appealing from a clin. and economic viewpoint, and seems feasible, as these parasites share metabolic pathways and hence might be treatable by common drugs.  From benzonaphthyridine (I), an inhibitor of acetylcholinesterase (AChE) for which we have found a remarkable trypanocidal activity, we have designed and synthesized novel benzo[h][1,6]naphthyridines, pyrrolo[3,2-c]quinolines, azepino[3,2-c]quinolines, and pyrano[3,2-c]quinolines through 2-4-step sequences featuring an initial multicomponent Povarov reaction as the key step.  To assess the therapeutic potential of the novel compds., we have evaluated their in vitro activity against T. brucei, T. cruzi, and Leishmania infantum, as well as their brain permeability, which is of specific interest for the treatment of late-stage HAT.  To assess their potential toxicity, we have detd. their cytotoxicity against rat myoblast L6 cells and their AChE inhibitory activity.  Several tricyclic heterofused quinoline derivs. were found to display an interesting multi-trypanosomatid profile, with one-digit micromolar potencies against two of these parasites and two-digit micromolar potency against the other.  Pyranoquinoline (II), which displays IC50 values of 1.5 μM, 6.1 μM and 29.2 μM against T. brucei, L. infantum and T. cruzi, resp., brain permeability, better drug-like properties (lower lipophilicity and mol. wt. and higher CNS MPO desirability score) than hit 1, and the lowest AChE inhibitory activity of the series (IC50 > 30 μM), emerges as an interesting multi-trypanosomatid lead, amenable to further optimization particularly in terms of its selectivity index over mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSElDBXWPo0LVg90H21EOLACvtfcHk0ljeXIUgK4pNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK&md5=8e483f32d39b7526dceac3ad35e8cd38</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DVicente-Garc%25C3%25ADa%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DBerenguer%26aufirst%3DD.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DLanzoni%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DSayago%26aufirst%3DH.%26aulast%3DRiera%26aufirst%3DC.%26aulast%3DFisa%26aufirst%3DR.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMulticomponent%2520reaction-based%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tricyclic%2520heterofused%2520quinolines%2520with%2520multi-trypanosomatid%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D105%26spage%3D120%26epage%3D137%26doi%3D10.1016%2Fj.ejmech.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haanstra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Marcano, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdrón-López, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2015.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bbamcr.2015.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26384872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFarurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=1038-1048&author=J.+R.+Haanstraauthor=E.+B.+Gonz%C3%A1lez-Marcanoauthor=M.+Gualdr%C3%B3n-L%C3%B3pezauthor=P.+A.+M.+Michels&title=Biogenesis%2C+maintenance+and+dynamics+of+glycosomes+in+trypanosomatid+parasites&doi=10.1016%2Fj.bbamcr.2015.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites</span></div><div class="casAuthors">Haanstra, Jurgen R.; Gonzalez-Marcano, Eglys B.; Gualdron-Lopez, Melisa; Michels, Paul A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peroxisomes of organisms belonging to the protist group Kinetoplastea, which include trypanosomatid parasites of the genera Trypanosoma and Leishmania, are unique in playing a crucial role in glycolysis and other parts of intermediary metab.  They sequester the majority of the glycolytic enzymes and hence are called glycosomes.  Their glycosomal enzyme content can vary strongly, particularly quant., between different trypanosomatid species, and within each species during its life cycle.  Turnover of glycosomes by autophagy of redundant ones and biogenesis of a new population of organelles play a pivotal role in the efficient adaptation of the glycosomal metabolic repertoire to the sudden, major nutritional changes encountered during the transitions in their life cycle.  The overall mechanism of glycosome biogenesis is similar to that of peroxisomes in other organisms, but the homologous peroxins involved display low sequence conservation as well as variations in motifs mediating crucial protein-protein interactions in the process.  The correct compartmentalization of enzymes is essential for the regulation of the trypanosomatids' metab. and consequently for their viability.  For Trypanosoma brucei it was shown that glycosomes also play a crucial role in its life-cycle regulation: a crucial developmental control switch involves the translocation of a protein phosphatase from the cytosol into the organelles.  Many glycosomal proteins are differentially phosphorylated in different life-cycle stages, possibly indicative of regulation of enzyme activities as an addnl. means to adapt the metabolic network to the different environmental conditions encountered.  This article is part of a Special Issue entitled: Peroxisomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EK5kD9XgbVg90H21EOLACvtfcHk0ljeXIUgK4pNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFarurjO&md5=a9533e763de4f1c427fe46f14fa87032</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DHaanstra%26aufirst%3DJ.%2BR.%26aulast%3DGonz%25C3%25A1lez-Marcano%26aufirst%3DE.%2BB.%26aulast%3DGualdr%25C3%25B3n-L%25C3%25B3pez%26aufirst%3DM.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DBiogenesis%252C%2520maintenance%2520and%2520dynamics%2520of%2520glycosomes%2520in%2520trypanosomatid%2520parasites%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2016%26volume%3D1863%26spage%3D1038%26epage%3D1048%26doi%3D10.1016%2Fj.bbamcr.2015.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gualdrón-lópez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avilán, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1017/s0031182012001278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182012001278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=22914253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12mug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=1-20&author=M.+Gualdr%C3%B3n-l%C3%B3pezauthor=A.+Brennandauthor=L.+Avil%C3%A1nauthor=P.+A.+M.+Michels&title=Translocation+of+solutes+and+proteins+across+the+glycosomal+membrane+of+trypanosomes%3B+possibilities+and+limitations+for+targeting+with+trypanocidal+drugs&doi=10.1017%2Fs0031182012001278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs</span></div><div class="casAuthors">Gualdron-Lopez, Melisa; Brennand, Ana; Avilan, Luisana; Michels, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">PARAAE</span>;
        ISSN:<span class="NLM_cas:issn">0031-1820</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Glycosomes are specialized peroxisomes found in all kinetoplastid organisms.  The organelles are unique in harbouring most enzymes of the glycolytic pathway.  Matrix proteins, synthesized in the cytosol, cofactors and metabolites have to be transported across the membrane.  Recent research on Trypanosoma brucei has provided insight into how these translocations across the membrane occur, although many details remain to be elucidated.  Proteins are imported by a cascade of reactions performed by specialized proteins, called peroxins, in which a cytosolic receptor with bound matrix protein inserts itself in the membrane to deliver its cargo into the organelle and is subsequently retrieved from the glycosome to perform further rounds of import.  Bulky solutes, such as cofactors and acyl-CoAs, seem to be translocated by specific transporter mols., whereas smaller solutes such as glycolytic intermediates probably cross the membrane through pore-forming channels.  The presence of such channels is in apparent contradiction with previous results that suggested a low permeability of the glycosomal membrane.  We propose 3 possible, not mutually exclusive, solns. for this paradox.  Glycosomal glycolytic enzymes have been validated as drug targets against trypanosomatid-borne diseases.  We discuss the possible implications of the new data for the design of drugs to be delivered into glycosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7NPS4Rewb7Vg90H21EOLACvtfcHk0ljrnzYt-Wzb1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12mug%253D%253D&md5=f45ff171b85fb230b3588070879a6f84</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1017%2FS0031182012001278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182012001278%26sid%3Dliteratum%253Aachs%26aulast%3DGualdr%25C3%25B3n-l%25C3%25B3pez%26aufirst%3DM.%26aulast%3DBrennand%26aufirst%3DA.%26aulast%3DAvil%25C3%25A1n%26aufirst%3DL.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DTranslocation%2520of%2520solutes%2520and%2520proteins%2520across%2520the%2520glycosomal%2520membrane%2520of%2520trypanosomes%253B%2520possibilities%2520and%2520limitations%2520for%2520targeting%2520with%2520trypanocidal%2520drugs%26jtitle%3DParasitology%26date%3D2013%26volume%3D140%26spage%3D1%26epage%3D20%26doi%3D10.1017%2Fs0031182012001278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span> <span> </span><span class="NLM_article-title">Sleeping sickness: PEX and drugs</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1763</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2005.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bbamcr.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=16473137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlClu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1763&publication_year=2006&pages=4-5&author=W.+Schliebs&title=Sleeping+sickness%3A+PEX+and+drugs&doi=10.1016%2Fj.bbamcr.2005.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Sleeping sickness: PEX and drugs</span></div><div class="casAuthors">Schliebs, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1763</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-5</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Finding new ways in the treatment of fatal parasitic diseases like the human sleeping sickness is a major challenge of biomedical research.  The growing body of knowledge about the biogenesis of the glycosome, a peroxisome-related organelle of trypanosomes, might allow defining novel targets for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7qVT4cURre7Vg90H21EOLACvtfcHk0ljrnzYt-Wzb1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlClu7w%253D&md5=a80c29f03a8c8cbdea053ed889d199ee</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchliebs%26aufirst%3DW.%26atitle%3DSleeping%2520sickness%253A%2520PEX%2520and%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1763%26spage%3D4%26epage%3D5%26doi%3D10.1016%2Fj.bbamcr.2005.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moyersoen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voncken, F. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Characterization of Trypanosoma brucei PEX14 and its role in the import of glycosomal matrix proteins</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">2059</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1033.2003.03582.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1046%2Fj.1432-1033.2003.03582.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12709066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=2059-2067&author=J.+Moyersoenauthor=J.+Choeauthor=A.+Kumarauthor=F.+G.+J.+Vonckenauthor=W.+G.+J.+Holauthor=P.+A.+M.+Michels&title=Characterization+of+Trypanosoma+brucei+PEX14+and+its+role+in+the+import+of+glycosomal+matrix+proteins&doi=10.1046%2Fj.1432-1033.2003.03582.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Trypanosoma brucei PEX14 and its role in the import of glycosomal matrix proteins</span></div><div class="casAuthors">Moyersoen, Juliette; Choe, Jungwoo; Kumar, Abhinav; Voncken, Frank G. J.; Hol, Wim G. J.; Michels, Paul A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2059-2067</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">It has been shown previously in various organisms that the peroxin PEX14 is a component of a docking complex at the peroxisomal membrane, where it is involved in the import of matrix proteins into the organelle after their synthesis in the cytosol and recognition by a receptor.  Here we present a characterization of the Trypanosoma brucei homolog of PEX14.  It is shown that the protein is assocd. with glycosomes, the peroxisome-like organelles of trypanosomatids in which most glycolytic enzymes are compartmentalized.  The N-terminal part of the protein binds specifically to TbPEX5, the cytosolic receptor for glycosomal matrix proteins with a peroxisome-targeting signal type 1 (PTS-1).  TbPEX14 mRNA depletion by RNA interference results, in both bloodstream-form and procyclic, insect-stage T. brucei, in mislocalization of glycosomal proteins to the cytosol.  The mislocalization was obsd. for different classes of matrix proteins: proteins with a C-terminal PTS-1, a N-terminal PTS-2 and a polypeptide internal I-PTS.  The RNA interference expts. also showed that TbPEX14 is essential for the survival of bloodstream-form and procyclic trypanosomes.  These data indicate the protein's great potential as a target for selective trypanocidal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOFWjStpBALrVg90H21EOLACvtfcHk0lgCk7UshkyZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGmsb4%253D&md5=19fb4d91b1209ae4d6ead20363c1b731</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03582.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03582.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoyersoen%26aufirst%3DJ.%26aulast%3DChoe%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DVoncken%26aufirst%3DF.%2BG.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DCharacterization%2520of%2520Trypanosoma%2520brucei%2520PEX14%2520and%2520its%2520role%2520in%2520the%2520import%2520of%2520glycosomal%2520matrix%2520proteins%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D2059%26epage%3D2067%26doi%3D10.1046%2Fj.1432-1033.2003.03582.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haanstra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tuijl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reijnders, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerhoff, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, B. M.</span></span> <span> </span><span class="NLM_article-title">Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17718</span>– <span class="NLM_lpage">17723</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806664105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.0806664105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19008351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCmur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17718-17723&author=J.+R.+Haanstraauthor=A.+Van+Tuijlauthor=P.+Kesslerauthor=W.+Reijndersauthor=P.+A.+M.+Michelsauthor=H.+V.+Westerhoffauthor=M.+Parsonsauthor=B.+M.+Bakker&title=Compartmentation+prevents+a+lethal+turbo-explosion+of+glycolysis+in+trypanosomes&doi=10.1073%2Fpnas.0806664105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes</span></div><div class="casAuthors">Haanstra, Jurgen R.; van Tuijl, Arjen; Kessler, Peter; Reijnders, Willem; Michels, Paul A. M.; Westerhoff, Hans V.; Parsons, Marilyn; Bakker, Barbara M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">17718-17723</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">ATP generation by both glycolysis and glycerol catabolism is autocatalytic, because the first kinases of these pathways are fueled by ATP produced downstream.  Previous modeling studies predicted that either feedback inhibition or compartmentation of glycolysis can protect cells from accumulation of intermediates.  The deadly parasite Trypanosoma brucei lacks feedback regulation of early steps in glycolysis yet sequesters the relevant enzymes within organelles called glycosomes, leading to the proposal that compartmentation prevents toxic accumulation of intermediates.  Here, we show that glucose 6-phosphate indeed accumulates upon glucose addn. to PEX14 deficient trypanosomes, which are impaired in glycosomal protein import.  With glycerol catabolism, both in silico and in vivo, loss of glycosomal compartmentation led to dramatic increases of glycerol 3-phosphate upon addn. of glycerol.  As predicted by the model, depletion of glycerol kinase rescued PEX14-deficient cells of glycerol toxicity.  This provides the first exptl. support for our hypothesis that pathway compartmentation is an alternative to allosteric regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocMbuADiKeaLVg90H21EOLACvtfcHk0lgCk7UshkyZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCmur7M&md5=d90e0b738dd03ecef63c0856d0e0130e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806664105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806664105%26sid%3Dliteratum%253Aachs%26aulast%3DHaanstra%26aufirst%3DJ.%2BR.%26aulast%3DVan%2BTuijl%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DP.%26aulast%3DReijnders%26aufirst%3DW.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DWesterhoff%26aufirst%3DH.%2BV.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DBakker%26aufirst%3DB.%2BM.%26atitle%3DCompartmentation%2520prevents%2520a%2520lethal%2520turbo-explosion%2520of%2520glycolysis%2520in%2520trypanosomes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17718%26epage%3D17723%26doi%3D10.1073%2Fpnas.0806664105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span> <span> </span><span class="NLM_article-title">Probing the role of compartmentation of glycolysis in procyclic form Trypanosoma brucei: RNA interference studies of PEX14, hexokinase, and phosphofructokinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">9030</span>– <span class="NLM_lpage">9036</span>, <span class="refDoi"> DOI: 10.1074/jbc.m412033200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1074%2Fjbc.M412033200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=15637070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVCit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9030-9036&author=P.+S.+Kesslerauthor=M.+Parsons&title=Probing+the+role+of+compartmentation+of+glycolysis+in+procyclic+form+Trypanosoma+brucei%3A+RNA+interference+studies+of+PEX14%2C+hexokinase%2C+and+phosphofructokinase&doi=10.1074%2Fjbc.m412033200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Role of Compartmentation of Glycolysis in Procyclic Form Trypanosoma brucei: RNA interference studies of pex14, hexokinase, and phosphofructokinase</span></div><div class="casAuthors">Kessler, Peter S.; Parsons, Marilyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9030-9036</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Trypanosoma brucei and related organisms contain an organelle evolutionarily related to peroxisomes that sequesters glycolysis, among other pathways.  We have shown previously that disruption of protein import into this organelle, the glycosome, can be accomplished through RNA interference (RNAi)-mediated knockdown of the peroxin PEX14.  Decreased PEX14 in turn leads to cell death, which, at least in the procyclic stage, can be triggered by the presence of glucose.  Here we show that fructose, which is taken up and metabolized by procyclic form T. brucei, and glycerol, which interfaces with the glycosomal glycolytic pathway, are also toxic during PEX14 RNAi.  Earlier computer modeling studies predicted that glycolysis would be toxic to T. brucei in the absence of glycosomal compartmentation because of the intrinsic lack of feedback regulation of the parasite hexokinase and phosphofructokinase.  To further test this hypothesis, we performed double RNAi, targeting hexokinase and PEX14.  Knockdown of hexokinase rescued PEX14 knockdown cells from glucose toxicity, even though glycosomal proteins continue to be mislocalized to the cytosol.  Knockdown of phosphofructokinase was benign in the absence of glucose but toxic in the presence of glucose.  When PEX14 and phosphofructokinase mRNAs were jointly targeted for RNAi, glycerol remained toxic to the parasites.  Taken together, these data indicate that the glycosome provides significant, but not complete, protection of trypanosomes from the dangerous design of glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRsi75GkfLCbVg90H21EOLACvtfcHk0liFyXRijCLUdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVCit7o%253D&md5=0c8416b4a7d9c805fe056ea3603ed7fa</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412033200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412033200%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DP.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26atitle%3DProbing%2520the%2520role%2520of%2520compartmentation%2520of%2520glycolysis%2520in%2520procyclic%2520form%2520Trypanosoma%2520brucei%253A%2520RNA%2520interference%2520studies%2520of%2520PEX14%252C%2520hexokinase%252C%2520and%2520phosphofructokinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9030%26epage%3D9036%26doi%3D10.1074%2Fjbc.m412033200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnaufer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crudder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span> <span> </span><span class="NLM_article-title">Glucose is toxic to glycosome-deficient trypanosomes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">14177</span>– <span class="NLM_lpage">14182</span>, <span class="refDoi"> DOI: 10.1073/pnas.222454899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.222454899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12386344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2itLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14177-14182&author=T.+Furuyaauthor=P.+Kesslerauthor=A.+Jardimauthor=A.+Schnauferauthor=C.+Crudderauthor=M.+Parsons&title=Glucose+is+toxic+to+glycosome-deficient+trypanosomes&doi=10.1073%2Fpnas.222454899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose is toxic to glycosome-deficient trypanosomes</span></div><div class="casAuthors">Furuya, Tetsuya; Kessler, Peter; Jardim, Armando; Schnaufer, Achim; Crudder, Christopher; Parsons, Marilyn</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14177-14182</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Trypanosomatids, the etiol. agents of sleeping sickness, leishmaniasis, and Chagas' disease, compartmentalize glycolysis within glycosomes, metabolic organelles related to peroxisomes.  Here, we identify a trypanosome homolog of PEX14, one of the components of the peroxisomal protein import docking complex.  We have used double-stranded RNA interference to target the PEX14 transcript for degrdn.  Glycosomal matrix protein import was compromised, and both glycolytic bloodstream stage parasites and mitochondrially respiring procyclic stage parasites were killed.  Thus, unlike peroxisomes, glycosomes are essential organelles.  Surprisingly, procyclic forms, which can grow in the absence of glucose, were killed by PEX14 RNA interference only when simple sugars were present.  Thus, interference with glycosome protein import makes glucose toxic to trypanosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJrFl3gwXkrVg90H21EOLACvtfcHk0liFyXRijCLUdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2itLo%253D&md5=5827450d346bfc6e039e0ca879fc9c72</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.222454899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.222454899%26sid%3Dliteratum%253Aachs%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DKessler%26aufirst%3DP.%26aulast%3DJardim%26aufirst%3DA.%26aulast%3DSchnaufer%26aufirst%3DA.%26aulast%3DCrudder%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DM.%26atitle%3DGlucose%2520is%2520toxic%2520to%2520glycosome-deficient%2520trypanosomes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D14177%26epage%3D14182%26doi%3D10.1073%2Fpnas.222454899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawidowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmanouilidis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalel, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripsianes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolonko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1126/science.aal1807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1126%2Fscience.aal1807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28360328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1416-1420&author=M.+Dawidowskiauthor=L.+Emmanouilidisauthor=V.+C.+Kalelauthor=K.+Tripsianesauthor=K.+Schorppauthor=K.+Hadianauthor=M.+Kaiserauthor=P.+M%C3%A4serauthor=M.+Kolonkoauthor=S.+Tangheauthor=A.+Rodriguezauthor=W.+Schliebsauthor=R.+Erdmannauthor=M.+Sattlerauthor=G.+M.+Popowicz&title=Inhibitors+of+PEX14+disrupt+protein+import+into+glycosomes+and+kill+Trypanosoma+parasites&doi=10.1126%2Fscience.aal1807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites</span></div><div class="casAuthors">Dawidowski, M.; Emmanouilidis, L.; Kalel, V. C.; Tripsianes, K.; Schorpp, K.; Hadian, K.; Kaiser, M.; Maeser, P.; Kolonko, M.; Tanghe, S.; Rodriguez, A.; Schliebs, W.; Erdmann, R.; Sattler, M.; Popowicz, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1416-1420</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We report a way to selectively kill Trypanosoma by blocking glycosomal/peroxisomal import that depends on the PEX14-PEX5 protein-protein interaction.  We developed small mols. that efficiently disrupt the PEX14-PEX5 interaction.  This results in mislocalization of glycosomal enzymes, causing metabolic catastrophe, and it kills the parasite.  High-resoln. x-ray structures and NMR data enabled the efficient design of inhibitors wit trypanocidal activities comparable to approved medications.  These results identify PEX14 as an Achilles' heel of the Trypanosoma suitable for the development of new therapies against trypanosomiasis and provide the structural basis for their development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhy7dxPoBTxrVg90H21EOLACvtfcHk0ljNgfkxI-MfUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhurc%253D&md5=c647e3a1811975658bb39b09e558f161</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fscience.aal1807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aal1807%26sid%3Dliteratum%253Aachs%26aulast%3DDawidowski%26aufirst%3DM.%26aulast%3DEmmanouilidis%26aufirst%3DL.%26aulast%3DKalel%26aufirst%3DV.%2BC.%26aulast%3DTripsianes%26aufirst%3DK.%26aulast%3DSchorpp%26aufirst%3DK.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DKolonko%26aufirst%3DM.%26aulast%3DTanghe%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DErdmann%26aufirst%3DR.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26atitle%3DInhibitors%2520of%2520PEX14%2520disrupt%2520protein%2520import%2520into%2520glycosomes%2520and%2520kill%2520Trypanosoma%2520parasites%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1416%26epage%3D1420%26doi%3D10.1126%2Fscience.aal1807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipp, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshapur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmanns, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for competitive interactions of Pex14 with the import receptors Pex5 and Pex19</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Femboj.2009.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19197237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=745-754&author=C.+Neufeldauthor=F.+V.+Filippauthor=B.+Simonauthor=A.+Neuhausauthor=N.+Sch%C3%BCllerauthor=C.+Davidauthor=H.+Kooshapurauthor=T.+Madlauthor=R.+Erdmannauthor=W.+Schliebsauthor=M.+Wilmannsauthor=M.+Sattler&title=Structural+basis+for+competitive+interactions+of+Pex14+with+the+import+receptors+Pex5+and+Pex19&doi=10.1038%2Femboj.2009.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for competitive interactions of Pex14 with the import receptors Pex5 and Pex19</span></div><div class="casAuthors">Neufeld, Christian; Filipp, Fabian V.; Simon, Bernd; Neuhaus, Alexander; Schueller, Nicole; David, Christine; Kooshapur, Hamed; Madl, Tobias; Erdmann, Ralf; Schliebs, Wolfgang; Wilmanns, Matthias; Sattler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">745-754</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein import into peroxisomes depends on a complex and dynamic network of protein-protein interactions.  Pex14 is a central component of the peroxisomal import machinery and binds the sol. receptors Pex5 and Pex19, which have important function in the assembly of peroxisome matrix and membrane, resp.  We show that the N-terminal domain of Pex14, Pex14(N), adopts a three-helical fold.  Pex5 and Pex19 ligand helixes bind competitively to the same surface in Pex14(N) albeit with opposite directionality.  The mol. recognition involves conserved arom. side chains in the Pex5 WxxxF/Y motif and a newly identified F/YFxxxF sequence in Pex19.  The Pex14-Pex5 complex structure reveals mol. details for a crit. interaction in docking Pex5 to the peroxisomal membrane.  We show that mutations of Pex14 residues located in the Pex5/Pex19 binding region disrupt Pex5 and/or Pex19 binding in vitro.  The corresponding full-length Pex14 variants are impaired in peroxisomal membrane localization in vivo, showing that the mol. interactions mediated by the N-terminal domain modulate peroxisomal targeting of Pex14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqzaNFsOK2rVg90H21EOLACvtfcHk0ljNgfkxI-MfUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCrsLk%253D&md5=581683eb23edff5445559bbcb418bc17</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.7%26sid%3Dliteratum%253Aachs%26aulast%3DNeufeld%26aufirst%3DC.%26aulast%3DFilipp%26aufirst%3DF.%2BV.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DNeuhaus%26aufirst%3DA.%26aulast%3DSch%25C3%25BCller%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DKooshapur%26aufirst%3DH.%26aulast%3DMadl%26aufirst%3DT.%26aulast%3DErdmann%26aufirst%3DR.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DWilmanns%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520competitive%2520interactions%2520of%2520Pex14%2520with%2520the%2520import%2520receptors%2520Pex5%2520and%2520Pex19%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D745%26epage%3D754%26doi%3D10.1038%2Femboj.2009.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, K.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the conserved N-terminal domain of the peroxisomal matrix protein import receptor, Pex14p</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1073/pnas.0808681106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.0808681106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19122147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=417-421&author=J.-R.+Suauthor=K.+Takedaauthor=S.+Tamuraauthor=Y.+Fujikiauthor=K.+Miki&title=Crystal+structure+of+the+conserved+N-terminal+domain+of+the+peroxisomal+matrix+protein+import+receptor%2C+Pex14p&doi=10.1073%2Fpnas.0808681106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the conserved N-terminal domain of the peroxisomal matrix protein import receptor, Pex14p</span></div><div class="casAuthors">Su, Jian-Rong; Takeda, Kazuki; Tamura, Shigehiko; Fujiki, Yukio; Miki, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-421</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Pex14p is a central component of the peroxisomal protein import machinery, in which the conserved N-terminal domain mediates dynamic interactions with other peroxins including Pex5p, Pex13p, and Pex19p.  Here, we report the crystal structure of the conserved N-terminal domain of Pex14p with a three-helix bundle.  A hydrophobic surface is composed of the conserved residues, of which two phenylalanine residues (Phe-35 and Phe-52) protrude to the solvent.  Consequently, two putative binding pockets suitable for recognizing the helical WXXXF/Y motif of Pex5p are formed on the surface by the two phenylalanine residues accompanying with pos. charged residues.  The structural feature agrees well with our earlier findings where F35A/L36A and F52A/L53A mutants were impaired in the interactions with other peroxins such as Pex5p and Pex13p.  Pex14p variants each with Phe-to-Ala mutation at positions 35, 52, and 35/52, resp., were defective in restoring the impaired peroxisomal protein import in pex14 Chinese hamster ovary mutant ZP161 cells.  Moreover, in GST pull-down assays His6-Pex5pL bound only to GST-Pex14p(25-70), not to any of GST-Pex14p(25-70)F35A, GST-Pex14p(25-70)F52A, and GST-Pex14p(25-70)F35A/F52A.  Endogenous Pex5p was recruited to FLAG-Pex14p on peroxisomes in vivo but barely to FLAG-Pex14pF35A, FLAG-Pex14pF52A, and FLAG-Pex14pF35A/F52A.  Collectively, Phe-35 and Phe-52 are essential for the Pex14p functions, including the interaction between Pex14p and Pex5p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCQ-QbgMcLbVg90H21EOLACvtfcHk0ljftgHN5uCpYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelsLY%253D&md5=036665ae80929651726456adee267c87</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808681106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808681106%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-R.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DFujiki%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520conserved%2520N-terminal%2520domain%2520of%2520the%2520peroxisomal%2520matrix%2520protein%2520import%2520receptor%252C%2520Pex14p%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D417%26epage%3D421%26doi%3D10.1073%2Fpnas.0808681106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshapur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidowsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambruch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span> <span> </span><span class="NLM_article-title">A novel Pex14 protein-interacting site of human Pex5 is critical for matrix protein import into peroxisomes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.499707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1074%2Fjbc.M113.499707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24235149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=437-448&author=A.+Neuhausauthor=H.+Kooshapurauthor=J.+Wolfauthor=N.+H.+Meyerauthor=T.+Madlauthor=J.+Saidowskyauthor=E.+Hambruchauthor=A.+Lazamauthor=M.+Jungauthor=M.+Sattlerauthor=W.+Schliebsauthor=R.+Erdmann&title=A+novel+Pex14+protein-interacting+site+of+human+Pex5+is+critical+for+matrix+protein+import+into+peroxisomes&doi=10.1074%2Fjbc.m113.499707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes</span></div><div class="casAuthors">Neuhaus, Alexander; Kooshapur, Hamed; Wolf, Janina; Meyer, N. Helge; Madl, Tobias; Saidowsky, Jurgen; Hambruch, Eva; Lazam, Anissa; Jung, Martin; Sattler, Michael; Schliebs, Wolfgang; Erdmann, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">437-448</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein import into peroxisomes relies on the import receptor Pex5, which recognizes proteins with a peroxisomal targeting signal 1 (PTS1) in the cytosol and directs them to a docking complex at the peroxisomal membrane.  Receptor-cargo docking occurs at the membrane-assocd. protein Pex14.  In human cells, this interaction is mediated by seven conserved diarom. pentapeptide motifs (WXXX(F/Y) motifs) in the N-terminal half of Pex5 and the N-terminal domain of Pex14.  A systematic screening of a Pex5 peptide library by ligand blot anal. revealed a novel Pex5-Pex14 interaction site of Pex5.  The novel motif composes the sequence LVAEF with the evolutionarily conserved consensus sequence LVXEF.  Replacement of the amino acid LVAEF sequence by alanines strongly affects matrix protein import into peroxisomes in vivo.  The NMR structure of a complex of Pex5-(57-71) with the Pex14-N-terminal domain showed that the novel motif binds in a similar α-helical orientation as the WXXX(F/Y) motif but that the tryptophan pocket is now occupied by a leucine residue.  Surface plasmon resonance analyses revealed 33 times faster dissocn. rates for the LVXEF ligand when compared with a WXXX(F/Y) motif.  Surprisingly, substitution of the novel motif with the higher affinity WXXX(F/Y) motif impairs protein import into peroxisomes.  These data indicate that the distinct kinetic properties of the novel Pex14-binding site in Pex5 are important for processing of the peroxisomal targeting signal 1 receptor at the peroxisomal membrane.  The novel Pex14-binding site may represent the initial tethering site of Pex5 from which the cargo-loaded receptor is further processed in a sequential manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQw3kjT-BJ7Vg90H21EOLACvtfcHk0ljftgHN5uCpYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSmug%253D%253D&md5=5d716ee7b8078c26cbd112f5d246613e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.499707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.499707%26sid%3Dliteratum%253Aachs%26aulast%3DNeuhaus%26aufirst%3DA.%26aulast%3DKooshapur%26aufirst%3DH.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DN.%2BH.%26aulast%3DMadl%26aufirst%3DT.%26aulast%3DSaidowsky%26aufirst%3DJ.%26aulast%3DHambruch%26aufirst%3DE.%26aulast%3DLazam%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DErdmann%26aufirst%3DR.%26atitle%3DA%2520novel%2520Pex14%2520protein-interacting%2520site%2520of%2520human%2520Pex5%2520is%2520critical%2520for%2520matrix%2520protein%2520import%2520into%2520peroxisomes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D437%26epage%3D448%26doi%3D10.1074%2Fjbc.m113.499707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein–protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein%E2%80%93protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0li2mw1ZtNvd0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein%25E2%2580%2593protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rew, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small molecule MDM2 inhibitor (AMG 232) for treating cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6332</span>– <span class="NLM_lpage">6341</span>, <span class="refDoi"> DOI: 10.1021/jm500627s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500627s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGlu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6332-6341&author=Y.+Rewauthor=D.+Sun&title=Discovery+of+a+small+molecule+MDM2+inhibitor+%28AMG+232%29+for+treating+cancer&doi=10.1021%2Fjm500627s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6332-6341</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  We recently reported the discovery of AMG 232 (1), a potent and selective piperidinone inhibitor of the MDM2-p53 protein-protein interaction.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.  This article provides an overview of its discovery from the de novo design of the piperidinone series to the structure-activity studies leading to the identification of 1.  In addn., this article also describes the preclin. pharmacol. and pharmacokinetics of 1, along with its drug metab. and safety assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6moQsRdmtLVg90H21EOLACvtfcHk0li2mw1ZtNvd0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGlu7jM&md5=07628b602fba44634add7d235751daf7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm500627s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500627s%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520MDM2%2520inhibitor%2520%2528AMG%2520232%2529%2520for%2520treating%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6332%26epage%3D6341%26doi%3D10.1021%2Fjm500627s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2–p53 protein–protein interaction (MDM2 inhibitors) in clinical trials for cancer treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1021/jm501092z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501092z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1038-1052&author=Y.+Zhaoauthor=A.+Aguilarauthor=D.+Bernardauthor=S.+Wang&title=Small-molecule+inhibitors+of+the+MDM2%E2%80%93p53+protein%E2%80%93protein+interaction+%28MDM2+inhibitors%29+in+clinical+trials+for+cancer+treatment&doi=10.1021%2Fjm501092z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment</span></div><div class="casAuthors">Zhao, Yujun; Aguilar, Angelo; Bernard, Denzil; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Design of small-mol. inhibitors (MDM2 inhibitors) to block the MDM2-p53 protein-protein interaction has been pursued as a new cancer therapeutic strategy.  In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compds. have been advanced into early phase clin. trials for the treatment of human cancers.  Here, we review the design, synthesis, properties, preclin., and clin. studies of these clin.-stage MDM2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNa9aW1Kz1Q7Vg90H21EOLACvtfcHk0lhkU-9iMTd1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P&md5=2e58318782d7e0a04bf3398db8782984</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501092z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2%25E2%2580%2593p53%2520protein%25E2%2580%2593protein%2520interaction%2520%2528MDM2%2520inhibitors%2529%2520in%2520clinical%2520trials%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1038%26epage%3D1052%26doi%3D10.1021%2Fjm501092z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiedel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewings, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, C. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluck, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorah, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mapp, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">BET bromodomain ligands: probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bmc.2018.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29776834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2937-2957&author=L.+E.+Jenningsauthor=M.+Schiedelauthor=D.+S.+Hewingsauthor=S.+Picaudauthor=C.+M.+C.+Laurinauthor=P.+A.+Brunoauthor=J.+P.+Bluckauthor=A.+R.+Scorahauthor=L.+Seeauthor=J.+K.+Reynoldsauthor=M.+Morogluauthor=I.+N.+Mistryauthor=A.+Hicksauthor=P.+Guzanovauthor=J.+Claytonauthor=C.+N.+G.+Evansauthor=G.+Staziauthor=P.+C.+Bigginauthor=A.+K.+Mappauthor=E.+M.+Hammondauthor=P.+G.+Humphreysauthor=P.+Filippakopoulosauthor=S.+J.+Conway&title=BET+bromodomain+ligands%3A+probing+the+WPF+shelf+to+improve+BRD4+bromodomain+affinity+and+metabolic+stability&doi=10.1016%2Fj.bmc.2018.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability</span></div><div class="casAuthors">Jennings, Laura E.; Schiedel, Matthias; Hewings, David S.; Picaud, Sarah; Laurin, Corentine M. C.; Bruno, Paul A.; Bluck, Joseph P.; Scorah, Amy R.; See, Larissa; Reynolds, Jessica K.; Moroglu, Mustafa; Mistry, Ishna N.; Hicks, Amy; Guzanov, Pavel; Clayton, James; Evans, Charles N. G.; Stazi, Giulia; Biggin, Philip C.; Mapp, Anna K.; Hammond, Ester M.; Humphreys, Philip G.; Filippakopoulos, Panagis; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2937-2957</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ligands for the bromodomain and extra-terminal domain (BET) family of bromodomains have shown promise as useful therapeutic agents for treating a range of cancers and inflammation.  Here the authors report that the previously developed 3,5-dimethylisoxazole-based BET bromodomain ligand (OXFBD02) inhibits interactions of BRD4(1) with the RelA subunit of NF-κB, in addn. to histone H4.  This ligand shows a promising profile in a screen of the NCI-60 panel but was rapidly metabolized (t1/2=39.8 min).  Structure-guided optimization of compd. properties led to the development of the 3-pyridyl-derived OXFBD04 (3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[hydroxy(pyridin-3-yl)methyl]phenol).  Mol. dynamics simulations assisted the authors' understanding of the role played by an internal hydrogen bond in altering the affinity of this series of mols. for BRD4(1).  OXFBD04 shows improved BRD4(1) affinity (IC50=166 nM), optimized physicochem. properties (LE=0.43; LLE=5.74; SFI=5.96), and greater metabolic stability (t1/2=388 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYjNvb4_o4CbVg90H21EOLACvtfcHk0lhkU-9iMTd1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFOqsrg%253D&md5=8b4a1a90a2440662430b90bb3c84c404</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DLaurin%26aufirst%3DC.%2BM.%2BC.%26aulast%3DBruno%26aufirst%3DP.%2BA.%26aulast%3DBluck%26aufirst%3DJ.%2BP.%26aulast%3DScorah%26aufirst%3DA.%2BR.%26aulast%3DSee%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DJ.%2BK.%26aulast%3DMoroglu%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DI.%2BN.%26aulast%3DHicks%26aufirst%3DA.%26aulast%3DGuzanov%26aufirst%3DP.%26aulast%3DClayton%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DC.%2BN.%2BG.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DBiggin%26aufirst%3DP.%2BC.%26aulast%3DMapp%26aufirst%3DA.%2BK.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DBET%2520bromodomain%2520ligands%253A%2520probing%2520the%2520WPF%2520shelf%2520to%2520improve%2520BRD4%2520bromodomain%2520affinity%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D2937%26epage%3D2957%26doi%3D10.1016%2Fj.bmc.2018.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, N. P.</span></span> <span> </span><span class="NLM_article-title">AlphaScreen-based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1439</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3673-1_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2F978-1-4939-3673-1_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27316989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Wlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1439&publication_year=2016&pages=77-98&author=A.+Yasgarauthor=A.+Jadhavauthor=A.+Simeonovauthor=N.+P.+Coussens&title=AlphaScreen-based+assays%3A+ultra-high-throughput+screening+for+small-molecule+inhibitors+of+challenging+enzymes+and+protein-protein+interactions&doi=10.1007%2F978-1-4939-3673-1_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Alphascreen-based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions</span></div><div class="casAuthors">Yasgar, Adam; Jadhav, Ajit; Simeonov, Anton; Coussens, Nathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1439</span>
        (<span class="NLM_cas:issue">High Throughput Screening</span>),
    <span class="NLM_cas:pages">77-98</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">AlphaScreen technol. has been routinely utilized in high-throughput screening assays to quantify analyte accumulation or depletion, bimol. interactions, and post-translational modifications.  The high signal-to-background, dynamic range, and sensitivity assocd. with AlphaScreens as well as the homogenous assay format and reagent stability make the technol. particularly well suited for high-throughput screening applications.  Here, we describe the development of AlphaScreen assays to identify small-mol. inhibitors of enzymes and protein-protein interactions using the highly miniaturized 1536-well format.  The subsequent implementation of counter assays to identify false-pos. compds. is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXoZP2Z8ySrVg90H21EOLACvtfcHk0lhkU-9iMTd1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Wlsw%253D%253D&md5=beb19b375f3f596086d8ccd8db22ba45</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3673-1_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3673-1_5%26sid%3Dliteratum%253Aachs%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DCoussens%26aufirst%3DN.%2BP.%26atitle%3DAlphaScreen-based%2520assays%253A%2520ultra-high-throughput%2520screening%2520for%2520small-molecule%2520inhibitors%2520of%2520challenging%2520enzymes%2520and%2520protein-protein%2520interactions%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1439%26spage%3D77%26epage%3D98%26doi%3D10.1007%2F978-1-4939-3673-1_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimmer, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Paying the price of desolvation in solvent-exposed protein pockets: impact of distal solubilizing groups on affinity and binding thermodynamics in a series of thermolysin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5791</span>– <span class="NLM_lpage">5799</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00490</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00490" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVeqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5791-5799&author=J.+Cramerauthor=S.+G.+Krimmerauthor=A.+Heineauthor=G.+Klebe&title=Paying+the+price+of+desolvation+in+solvent-exposed+protein+pockets%3A+impact+of+distal+solubilizing+groups+on+affinity+and+binding+thermodynamics+in+a+series+of+thermolysin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors</span></div><div class="casAuthors">Cramer, Jonathan; Krimmer, Stefan G.; Heine, Andreas; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5791-5799</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In lead optimization, open, solvent-exposed protein pockets are often disregarded as prospective binding sites.  Because of bulk-solvent proximity, researchers are instead enticed to attach charged polar groups at inhibitor scaffolds to improve soly. and pharmacokinetic properties.  It is rarely considered that solvent effects from water reorganization in the first hydration shell of protein-ligand complexes can have a significant impact on binding.  The authors investigate the thermodn. fingerprint of thermolysin inhibitors featuring terminal charged ammonium groups that are gradually pulled from a distal, solvent-exposed position into the flat, bowl-shaped S2' pocket.  Even for the most remote attachment, costs for partial desolvation of the polar group next to the protein-solvent interface are difficult to compensate by interactions with the protein or surrounding water mols.  Through direct comparison with hydrophobic analogs, a significant 180-fold affinity loss was recorded, which questions popular strategies to attach polar ligand-solubilizing groups at the exposed terminus of substituents accommodated in flat open pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATxTWUYuldbVg90H21EOLACvtfcHk0ljqwzwEbdJCbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVeqtLs%253D&md5=1e36b68aa48a4133f77097343a48230e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00490%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DJ.%26aulast%3DKrimmer%26aufirst%3DS.%2BG.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DPaying%2520the%2520price%2520of%2520desolvation%2520in%2520solvent-exposed%2520protein%2520pockets%253A%2520impact%2520of%2520distal%2520solubilizing%2520groups%2520on%2520affinity%2520and%2520binding%2520thermodynamics%2520in%2520a%2520series%2520of%2520thermolysin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5791%26epage%3D5799%26doi%3D10.1021%2Facs.jmedchem.7b00490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D. K.</span>; <span class="NLM_string-name">Kuduk, S.</span></span> <span> </span><span class="NLM_article-title">Derivatives and methods of treating Hepatitis B infections</span>. U.S. Patent <span class="NLM_patent">2,016,185,777 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+D.+K.+Hartman&author=S.+Kuduk&title=Derivatives+and+methods+of+treating+Hepatitis+B+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DG.%2BD.%2BK.%26atitle%3DDerivatives%2520and%2520methods%2520of%2520treating%2520Hepatitis%2520B%2520infections%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mioskowski, C.</span></span> <span> </span><span class="NLM_article-title">A convenient aminolysis of esters catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3863</span>– <span class="NLM_lpage">3866</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.03.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.tetlet.2007.03.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFyqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3863-3866&author=C.+Sabotauthor=K.+A.+Kumarauthor=S.+Meunierauthor=C.+Mioskowski&title=A+convenient+aminolysis+of+esters+catalyzed+by+1%2C5%2C7-triazabicyclo%5B4.4.0%5Ddec-5-ene+%28TBD%29+under+solvent-free+conditions&doi=10.1016%2Fj.tetlet.2007.03.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient aminolysis of esters catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free conditions</span></div><div class="casAuthors">Sabot, Cyrille; Kumar, Kanduluru Ananda; Meunier, Stephane; Mioskowski, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3863-3866</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aminolysis of esters by using the organocatalyst 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) is reported.  Secondary and tertiary amides were synthesized from alkyl or aryl esters with a variety of primary and secondary amines in good to excellent yields (60-94%) under solvent-free conditions (SFC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpWg2wOwFmFLVg90H21EOLACvtfcHk0lhMxSactfrNLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFyqs70%253D&md5=3d668f04b0b3a294db6822d467a04876</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.03.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.03.146%26sid%3Dliteratum%253Aachs%26aulast%3DSabot%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DMeunier%26aufirst%3DS.%26aulast%3DMioskowski%26aufirst%3DC.%26atitle%3DA%2520convenient%2520aminolysis%2520of%2520esters%2520catalyzed%2520by%25201%252C5%252C7-triazabicyclo%255B4.4.0%255Ddec-5-ene%2520%2528TBD%2529%2520under%2520solvent-free%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D3863%26epage%3D3866%26doi%3D10.1016%2Fj.tetlet.2007.03.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. S.</span></span> <span> </span><span class="NLM_article-title">Efficient and practical synthesis of mannich bases related to gramine mediated by zinc chloride</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1835</span>, <span class="refDoi"> DOI: 10.1080/00397910600602503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1080%2F00397910600602503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=1829-1835&author=H.+G.+Daiauthor=J.+T.+Liauthor=T.+S.+Li&title=Efficient+and+practical+synthesis+of+mannich+bases+related+to+gramine+mediated+by+zinc+chloride&doi=10.1080%2F00397910600602503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and practical synthesis of Mannich bases related to gramine mediated by zinc chloride</span></div><div class="casAuthors">Dai, Hong-Guang; Li, Ji-Tai; Li, Tong-Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1829-1835</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">An efficient and practical procedure for the Mannich reaction of secondary amines, formaldehyde, and indole or N-methylindole employing zinc chloride is presented.  A series of gramine derivs. were obtained in 58-98% yields at room temp. in EtOH by using this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboWlHV_I1MbVg90H21EOLACvtfcHk0lhMxSactfrNLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWitLs%253D&md5=b53d259da574a46b96dfec0050ffbcfe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F00397910600602503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910600602503%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.%2BG.%26aulast%3DLi%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DT.%2BS.%26atitle%3DEfficient%2520and%2520practical%2520synthesis%2520of%2520mannich%2520bases%2520related%2520to%2520gramine%2520mediated%2520by%2520zinc%2520chloride%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D1829%26epage%3D1835%26doi%3D10.1080%2F00397910600602503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the rule of 5: lessons learned from AbbVie’s drugs and compound collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2636-2651&author=D.+A.+DeGoeyauthor=H.-J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+rule+of+5%3A+lessons+learned+from+AbbVie%E2%80%99s+drugs+and+compound+collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection</span></div><div class="casAuthors">DeGoey, David A.; Chen, Hui-Ju; Cox, Philip B.; Wendt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2636-2651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing focus on the pursuit of targets considered to be less druggable that offer potential for development of promising new therapeutic agents for the treatment of diseases with large unmet medical need, particularly in the areas of oncol. and virol.  However, conducting drug discovery campaigns in "beyond rule of 5" (bRo5) chem. space presents a significant drug design and development challenge to medicinal chemists to achieve acceptable oral pharmacokinetics.  Retrospective anal. of past successes and failures in drug discovery bRo5 may shed light on the key principles that contribute to the oral bioavailability of successful bRo5 compds. and improve the efficiency of drug design for future projects.  We present here highlights and case studies of lessons learned from discovery of bRo5 compds.  A simple multiparametric scoring function (AB-MPS) was devised that correlated preclin. PK results with cLogD, no. of rotatable bonds, and no. of arom. rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHuaXbtjlALVg90H21EOLACvtfcHk0lifTJP8bDo8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ&md5=48984dc65410d83d4ac8ddaca030b024</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.-J.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520rule%2520of%25205%253A%2520lessons%2520learned%2520from%2520AbbVie%25E2%2580%2599s%2520drugs%2520and%2520compound%2520collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2636%26epage%3D2651%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Studier, F. W.</span></span> <span> </span><span class="NLM_article-title">Protein production by auto-induction in high density shaking cultures</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pep.2005.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=15915565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=207-234&author=F.+W.+Studier&title=Protein+production+by+auto-induction+in+high+density+shaking+cultures&doi=10.1016%2Fj.pep.2005.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Protein production by auto-induction in high-density shaking cultures</span></div><div class="casAuthors">Studier, F. William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-234</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inducible expression systems in which T7 RNA polymerase transcribes coding sequences cloned under control of a T7lac promoter efficiently produce a wide variety of proteins in Escherichia coli.  Investigation of factors that affect stability, growth, and induction of T7 expression strains in shaking vessels led to the recognition that sporadic, unintended induction of expression in complex media, previously reported by others, is almost certainly caused by small amts. of lactose.  Glucose prevents induction by lactose by well-studied mechanisms.  Amino acids also inhibit induction by lactose during log-phase growth, and high rates of aeration inhibit induction at low lactose concns.  These observations, and metabolic balancing of pH, allowed development of reliable non-inducing and auto-inducing media in which batch cultures grow to high densities.  Expression strains grown to satn. in non-inducing media retain plasmid and remain fully viable for weeks in the refrigerator, making it easy to prep. many freezer stocks in parallel and use working stocks for an extended period.  Auto-induction allows efficient screening of many clones in parallel for expression and soly., as cultures have only to be inoculated and grown to satn., and yields of target protein are typically several-fold higher than obtained by conventional IPTG induction.  Auto-inducing media have been developed for labeling proteins with selenomethionine, 15N or 13C, and for prodn. of target proteins by arabinose induction of T7 RNA polymerase from the pBAD promoter in BL21-AI.  Selenomethionine labeling was equally efficient in the commonly used methionine auxotroph B834(DE3)(found to be metE) or the prototroph BL21(DE3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNqgn15xP_bVg90H21EOLACvtfcHk0lifTJP8bDo8vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D&md5=d31b76747c808ce6fbb27c7a1192b6b8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DStudier%26aufirst%3DF.%2BW.%26atitle%3DProtein%2520production%2520by%2520auto-induction%2520in%2520high%2520density%2520shaking%2520cultures%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D41%26spage%3D207%26epage%3D234%26doi%3D10.1016%2Fj.pep.2005.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span> <i>OriginPro, 9.0</i>; <span class="NLM_publisher-name">OriginLab
Corporation</span>: <span class="NLM_publisher-loc">Northampton, MA, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OriginPro%2C+9.0%3B+OriginLab%0ACorporation%3A+Northampton%2C+MA%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOriginPro%252C%25209.0%26pub%3DOriginLab%250ACorporation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/s0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2Fs0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgvVqMQjGkFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2Fs0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kantardjieff, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, B.</span></span> <span> </span><span class="NLM_article-title">Matthews coefficient probabilities: improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1865</span>– <span class="NLM_lpage">1871</span>, <span class="refDoi"> DOI: 10.1110/ps.0350503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1110%2Fps.0350503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12930986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1865-1871&author=K.+A.+Kantardjieffauthor=B.+Rupp&title=Matthews+coefficient+probabilities%3A+improved+estimates+for+unit+cell+contents+of+proteins%2C+DNA%2C+and+protein-nucleic+acid+complex+crystals&doi=10.1110%2Fps.0350503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals</span></div><div class="casAuthors">Kantardjieff, Katherine A.; Rupp, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1865-1871</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Estg. the no. of mols. in the crystallog. asym. unit is one of the first steps in a macromol. structure detn.  Based on a survey of 15,641 crystallog. Protein Data Bank (PDB) entries the distribution of VM, the crystal vol. per unit of protein mol. wt., known as Matthews coeff., has been reanalyzed.  The range of values and frequencies has changed in the 30 yr since Matthews first anal. of protein crystal solvent content.  In the statistical anal., complexes of proteins and nucleic acids have been treated as a sep. group.  In addn., the VM distribution for nucleic acid crystals has been examd. for the first time.  Observing that resoln. is a significant discriminator of VM, an improved estimator for the probabilities of the no. of mols. in the crystallog. asym. unit has been implemented, using resoln. as addnl. information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZvSs0__vK7rVg90H21EOLACvtfcHk0lgvVqMQjGkFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsrw%253D&md5=63589787961a8f694f0d5f39850610d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1110%2Fps.0350503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.0350503%26sid%3Dliteratum%253Aachs%26aulast%3DKantardjieff%26aufirst%3DK.%2BA.%26aulast%3DRupp%26aufirst%3DB.%26atitle%3DMatthews%2520coefficient%2520probabilities%253A%2520improved%2520estimates%2520for%2520unit%2520cell%2520contents%2520of%2520proteins%252C%2520DNA%252C%2520and%2520protein-nucleic%2520acid%2520complex%2520crystals%26jtitle%3DProtein%2520Sci.%26date%3D2003%26volume%3D12%26spage%3D1865%26epage%3D1871%26doi%3D10.1110%2Fps.0350503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0liwDeA_DPLurQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanaka, T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1002%2F1873-3468.12044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26762183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Cru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2016&pages=242-250&author=Y.+Watanabeauthor=K.+Kawaguchiauthor=N.+Okuyamaauthor=Y.+Sugawaraauthor=T.+Obitaauthor=M.+Mizuguchiauthor=M.+Moritaauthor=T.+Imanaka&title=Characterization+of+the+interaction+between+Trypanosoma+brucei+Pex5p+and+its+receptor+Pex14p&doi=10.1002%2F1873-3468.12044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p</span></div><div class="casAuthors">Watanabe, Yuichi; Kawaguchi, Kosuke; Okuyama, Naoki; Sugawara, Yuri; Obita, Takayuki; Mizuguchi, Mineyuki; Morita, Masashi; Imanaka, Tsuneo</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-250</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The interaction of Trypanosoma brucei (Tb) Pex5p and its receptor TbPex14p is essential for the translocation of newly synthesized matrix proteins into the glycosome.  Here, we reveal that only the 3rd WXXXF/Y motif of TbPex5p is involved in the interaction and that neg. charge of the 4th amino acid is important.  We suggest that Phe35 and Phe52 of TbPex14p interact with Trp318 and Phe322 in the 3rd motif and that the Lys56 adjacent to Phe35/Phe52 assocs. with the 4th Glu in the motif to make the complex.  This information is expected to be useful for developing anti-trypanosomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56GcTq5FHB7Vg90H21EOLACvtfcHk0liwDeA_DPLurQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Cru7bK&md5=74107d32639407a39062d9e557ae6e92</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12044%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DKawaguchi%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DN.%26aulast%3DSugawara%26aufirst%3DY.%26aulast%3DObita%26aufirst%3DT.%26aulast%3DMizuguchi%26aufirst%3DM.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DImanaka%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520the%2520interaction%2520between%2520Trypanosoma%2520brucei%2520Pex5p%2520and%2520its%2520receptor%2520Pex14p%26jtitle%3DFEBS%2520Lett.%26date%3D2016%26volume%3D590%26spage%3D242%26epage%3D250%26doi%3D10.1002%2F1873-3468.12044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liwDeA_DPLurQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/s0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2Fs0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0li46uGAtgRbCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2Fs0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brünger, A. T.</span></span> <span> </span><span class="NLM_article-title">Free R value: a novel statistical quantity for assessing the accuracy of crystal structures</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1038/355472a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2F355472a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=18481394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK38XktFOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=472-475&author=A.+T.+Br%C3%BCnger&title=Free+R+value%3A+a+novel+statistical+quantity+for+assessing+the+accuracy+of+crystal+structures&doi=10.1038%2F355472a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Free R value:  a novel statistical quantity for assessing the accuracy of crystal structures</span></div><div class="casAuthors">Bruenger, Axel T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6359</span>),
    <span class="NLM_cas:pages">472-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A reliable and unbiased indicator of the accuracy is proposed for fitting at. models for macromol. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCvKGOC-AKrVg90H21EOLACvtfcHk0li46uGAtgRbCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktFOrsrc%253D&md5=a382d593937b2394d9354ccba49cdbc3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2F355472a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F355472a0%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26atitle%3DFree%2520R%2520value%253A%2520a%2520novel%2520statistical%2520quantity%2520for%2520assessing%2520the%2520accuracy%2520of%2520crystal%2520structures%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D472%26epage%3D475%26doi%3D10.1038%2F355472a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamzin, V. S.</span></span> <span> </span><span class="NLM_article-title">ARP/wARP and automatic interpretation of protein electron density maps</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(03)74011-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0076-6879%2803%2974011-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=14696376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=229-244&author=R.+J.+Morrisauthor=A.+Perrakisauthor=V.+S.+Lamzin&title=ARP%2FwARP+and+automatic+interpretation+of+protein+electron+density+maps&doi=10.1016%2Fs0076-6879%2803%2974011-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">ARP/wARP and automatic interpretation of protein electron density maps</span></div><div class="casAuthors">Morris, Richard J.; Perrakis, Anastassis; Lamzin, Victor S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part D</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The unified process of phase improvement, coupled with automated map interpretation and model building, is described within the framework of the Automated Refinement Procedure, ARP/wARP software, suite.  ARP/wARP is a software suite based on the paradigm of viewing model building and refinement as one unified procedure for optimizing phase ests.  The current version, ARP/wARP 6.0, works with d. recognition-driven procedures for placing and removing atoms and is therefore limited to diffraction data extending to about 2.5 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphsTDGGoRLy7Vg90H21EOLACvtfcHk0lgdVKJAZVKC5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlygtQ%253D%253D&md5=bc260a20be6b71e053ada934ac851cea</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2803%2974011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252803%252974011-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BJ.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26atitle%3DARP%252FwARP%2520and%2520automatic%2520interpretation%2520of%2520protein%2520electron%2520density%2520maps%26jtitle%3DMethods%2520Enzymol.%26date%3D2003%26volume%3D374%26spage%3D229%26epage%3D244%26doi%3D10.1016%2Fs0076-6879%2803%2974011-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span> <i>Schrödinger
Release 2018.3</i>; <span class="NLM_publisher-name">Maestro Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,
2019, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0ARelease+2018.3%3B+Maestro+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C%0A2019%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250ARelease%25202018.3%26pub%3DMaestro%2520Schr%25C3%25B6dinger%252C%250ALLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">YASARA View—molecular graphics for all devices—from smartphones to workstations</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1093%2Fbioinformatics%2Fbtu426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24996895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gjs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=2981-2982&author=E.+Kriegerauthor=G.+Vriend&title=YASARA+View%E2%80%94molecular+graphics+for+all+devices%E2%80%94from+smartphones+to+workstations&doi=10.1093%2Fbioinformatics%2Fbtu426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">YASARA view-molecular graphics for all devices-from smartphones to workstations</span></div><div class="casAuthors">Krieger, Elmar; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2981-2982</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Today's graphics processing units (GPUs) compose the scene from individual triangles.  As about 320 triangles are needed to approx. a single sphere-an atom-in a convincing way, visualizing larger proteins with at. details requires tens of millions of triangles, far too many for smooth interactive frame rates.We describe a new approach to solve this -∼mol. graphics problem', which shares the work between GPU and multiple CPU cores, generates high-quality results with perfectly round spheres, shadows and ambient lighting and requires only OpenGL 1.0 functionality, without any pixel shader Z-buffer access (a feature which ismissing inmost mobile devices).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHYmHSnUAZrVg90H21EOLACvtfcHk0lgdVKJAZVKC5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gjs77O&md5=43fdaf50b31738820d4bce5ade23b27c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu426%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DYASARA%2520View%25E2%2580%2594molecular%2520graphics%2520for%2520all%2520devices%25E2%2580%2594from%2520smartphones%2520to%2520workstations%26jtitle%3DBioinformatics%26date%3D2014%26volume%3D30%26spage%3D2981%26epage%3D2982%26doi%3D10.1093%2Fbioinformatics%2Fbtu426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lg90q4YpVr9xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+S%C3%B8ndergaardauthor=M.+H.+M.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0lg90q4YpVr9xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0lh6t7t6Dx7_Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span> <span> </span><span class="NLM_article-title">The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1021/ja00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL1cXht1yjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=1657-1666&author=W.+L.+Jorgensenauthor=J.+Tirado-Rives&title=The+OPLS+%5Boptimized+potentials+for+liquid+simulations%5D+potential+functions+for+proteins%2C+energy+minimizations+for+crystals+of+cyclic+peptides+and+crambin&doi=10.1021%2Fja00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin</span></div><div class="casAuthors">Jorgensen, William L.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1657-66</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A complete set of intermol. potential functions was developed for use in computer simulations of proteins in their native environment.  Parameters are reported for 25 peptide residues as well as the common neutral and charged terminal groups.  The potential functions have the simple Coulomb plus Lennard-Jones form and are compatible with the widely used models for water, TIP4P, TIP3P, and SPC.  The parameters were obtained and tested primarily in conjunction with Monte Carlo statistical mechanics simulations of 36 pure org. liqs. and numerous aq. solns. of org. ions representative of subunits in the side chains and backbones of proteins.  Bond stretch, angle bend, and torsional terms were adopted from the AMBER united-atom force field.  As reported here, further testing involved studies of conformational energy surfaces and optimizations of the crystal structures for 4 cyclic hexapeptides and a cyclic pentapeptide.  The av. root mean square deviation from the x-ray structures of the crystals is only 0.17 Å for the at. positions and 3% for the unit cell vols.  A more crit. test was then provided by performing energy minimizations for the complete crystal of the protein crambin, including 182 water mols. that were initially placed via a Monte Carlo simulation.  The resultant root mean square deviation for the non-H atoms is still only 0.17 Å and the variation in the errors for charged, polar, and nonpolar residues is small.  Significant improvement is apparent over the AMBER united-atom force field which was previously demonstrated to be superior to many alternatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ6an38QWApbVg90H21EOLACvtfcHk0lh6t7t6Dx7_Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXht1yjt7Y%253D&md5=b6c901d8c295b3b37329a7faef527e12</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DThe%2520OPLS%2520%255Boptimized%2520potentials%2520for%2520liquid%2520simulations%255D%2520potential%2520functions%2520for%2520proteins%252C%2520energy%2520minimizations%2520for%2520crystals%2520of%2520cyclic%2520peptides%2520and%2520crambin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D1657%26epage%3D1666%26doi%3D10.1021%2Fja00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. L.</span></span> <span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1063/1.445869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water&doi=10.1063%2F1.445869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0lgIgUfHihhz8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935%26doi%3D10.1063%2F1.445869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span> <span> </span><span class="NLM_article-title">Temperature and size dependence for Monte Carlo simulations of TIP4P water</span>. <i>Mol. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1080/00268978500103111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1080%2F00268978500103111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL28XhtlKgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1985&pages=1381-1392&author=W.+L.+Jorgensenauthor=J.+D.+Madura&title=Temperature+and+size+dependence+for+Monte+Carlo+simulations+of+TIP4P+water&doi=10.1080%2F00268978500103111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Temperature and size dependence for Monte Carlo simulations of TIP4P water</span></div><div class="casAuthors">Jorgensen, William L.; Madura, Jeffry D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Physics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1381-92</span>CODEN:
                <span class="NLM_cas:coden">MOPHAM</span>;
        ISSN:<span class="NLM_cas:issn">0026-8976</span>.
    </div><div class="casAbstract">The TIP4P model potential (J., et al., 1983) was used in Monte-Carlo simulations on liq. water, which were done to study the effects of temp. (-25 to +100°) and system size (64 to 512 mols.) on calcd. thermodn. and structural properties (including intermol. potential energy, heats of vaporization and H-bonding, d., isothermal compressibility, and radial distribution functions).  The results were compared with the existing exptl. data and other published simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW0gx3dh2BVLVg90H21EOLACvtfcHk0lgIgUfHihhz8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtlKgurw%253D&md5=9173de8795087ef8c2bf007c92133cc2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1080%2F00268978500103111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00268978500103111%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26atitle%3DTemperature%2520and%2520size%2520dependence%2520for%2520Monte%2520Carlo%2520simulations%2520of%2520TIP4P%2520water%26jtitle%3DMol.%2520Phys.%26date%3D1985%26volume%3D56%26spage%3D1381%26epage%3D1392%26doi%3D10.1080%2F00268978500103111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span>; <span class="NLM_string-name">Chow, E.</span>; <span class="NLM_string-name">Xu, H.</span>; <span class="NLM_string-name">Dror, R. O.</span>; <span class="NLM_string-name">Eastwood, M. P.</span>; <span class="NLM_string-name">Gregersen, B. A.</span>; <span class="NLM_string-name">Klepeis, J. L.</span>; <span class="NLM_string-name">Kolossvary, I.</span>; <span class="NLM_string-name">Moraes, M. A.</span>; <span class="NLM_string-name">Sacerdoti, F. D.</span>; <span class="NLM_string-name">Salmon, J. K.</span>; <span class="NLM_string-name">Shan, Y.</span>; <span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters</span>. In  <i>Proceedings of the 2006 ACM/IEEE Conference on Supercomputing</i>; <span class="NLM_publisher-name">ACM</span>: <span class="NLM_publisher-loc">Tampa, Florida</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+J.+Bowers&author=E.+Chow&author=H.+Xu&author=R.+O.+Dror&author=M.+P.+Eastwood&author=B.+A.+Gregersen&author=J.+L.+Klepeis&author=I.+Kolossvary&author=M.+A.+Moraes&author=F.+D.+Sacerdoti&author=J.+K.+Salmon&author=Y.+Shan&author=D.+E.+Shaw&title=Scalable+Algorithms+for+Molecular+Dynamics+Simulations+on+Commodity+Clusters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26atitle%3DScalable%2520Algorithms%2520for%2520Molecular%2520Dynamics%2520Simulations%2520on%2520Commodity%2520Clusters%26jtitle%3DProceedings%2520of%2520the%25202006%2520ACM%252FIEEE%2520Conference%2520on%2520Supercomputing%26pub%3DACM%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirumi, K.</span></span> <span> </span><span class="NLM_article-title">Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers</span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.2307/3282883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.2307%2F3282883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=2614608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADyaK3c7jtlaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1989&pages=985-989&author=H.+Hirumiauthor=K.+Hirumi&title=Continuous+cultivation+of+Trypanosoma+brucei+blood+stream+forms+in+a+medium+containing+a+low+concentration+of+serum+protein+without+feeder+cell+layers&doi=10.2307%2F3282883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers</span></div><div class="casAuthors">Hirumi H; Hirumi K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Blood stream forms (BSF) of Trypanosoma brucei brucei GUT at 3.1 were propagated in vitro in the absence of feeder layer cells at 37 C, using a modified Iscove's medium (HMI-18).  The medium was supplemented with 0.05 mM bathocuproine sulfonate, 1.5 mM L-cysteine, 1 mM hypoxanthine, 0.2 mM 2-mercaptoethanol, 1 mM sodium pyruvate. 0.16 mM thymidine, and 20% (v/v) Serum Plus (SP) (Hazleton Biologics, Lenexa, Kansas).  The latter contained a low level of serum proteins (13 micrograms/ml).  Each primary culture was initiated by placing 3.5-4 x 10(6) BSFs isolated from infected mice in a flask containing 5 ml of the medium (HMI-9) supplemented with 10% fetal bovine serum (FBS) and 10% SP.  The cultures were maintained by replacing the medium every 24 hr for 5-7 days.  During this period, many BSFs died.  However, from day 4 onward, long slender BSFs increased in number.  On days 5-7, trypanosome suspensions were pooled and cell debris was removed by means of diethylaminoethyl cellulose (DE52) column chromatography.  Blood stream forms then were collected by centrifugation, resuspended in fresh medium at 7-9 x 10(5)/ml, and transferred to new flasks.  Subcultures were maintained by readjusting the BSF density to 7-9 x 10(5)/ml every 24 hr.  Concentrations of FBS were reduced gradually at 5-7-day intervals by alternating the amounts of FBS and SP in HMI-9 with 5% FBS and 15% SP, with 2% FBS and 18% SP, and finally with 20% SP (HMI-18).  By this method, 2-3 x 10(6) VSFs/ml were obtained consistently every 24 hr. for more than 80 days.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-hsI_lV2EcpPlX7E30qdzfW6udTcc2eb8mnKQoDFjbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7jtlaksw%253D%253D&md5=a5ec1c8efb4c6572ef8ff09ad88edeb0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2307%2F3282883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3282883%26sid%3Dliteratum%253Aachs%26aulast%3DHirumi%26aufirst%3DH.%26aulast%3DHirumi%26aufirst%3DK.%26atitle%3DContinuous%2520cultivation%2520of%2520Trypanosoma%2520brucei%2520blood%2520stream%2520forms%2520in%2520a%2520medium%2520containing%2520a%2520low%2520concentration%2520of%2520serum%2520protein%2520without%2520feeder%2520cell%2520layers%26jtitle%3DJ.%2520Parasitol.%26date%3D1989%26volume%3D75%26spage%3D985%26epage%3D989%26doi%3D10.2307%2F3282883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span> <i>GraphPad Prism, 6.04</i>; <span class="NLM_publisher-name">GraphPad Software,
Inc</span>: <span class="NLM_publisher-loc">San Diego, CA, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GraphPad+Prism%2C+6.04%3B+GraphPad+Software%2C%0AInc%3A+San+Diego%2C+CA%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGraphPad%2520Prism%252C%25206.04%26pub%3DGraphPad%2520Software%252C%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baltz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giroud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crockett, J.</span></span> <span> </span><span class="NLM_article-title">Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1985.tb03772.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1002%2Fj.1460-2075.1985.tb03772.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=4006919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL2MXlslGhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1985&pages=1273-1277&author=T.+Baltzauthor=D.+Baltzauthor=C.+Giroudauthor=J.+Crockett&title=Cultivation+in+a+semi-defined+medium+of+animal+infective+forms+of+Trypanosoma+brucei%2C+T.+equiperdum%2C+T.+evansi%2C+T.+rhodesiense+and+T.+gambiense&doi=10.1002%2Fj.1460-2075.1985.tb03772.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense</span></div><div class="casAuthors">Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-7</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    </div><div class="casAbstract">A semi-defined medium for the cultivation of bloodstream forms of the African trypanosome brucei subgroup was developed.  Out of 14 different strains tested, 10 could be cultured including T. brucei, T. equiperdum, T. evansi, T. rhodesiense, and T. gambiense.  The presence of a reducing agent (2-mercaptoethanol or thioglycerol) was essential for growth.  The std. medium consisted of Hepes buffered min. essential medium with Earle's salts supplemented with 0.2 mM 2-mercaptoethanol, 2 mM pyruvate and 10% inactivated serum either from rabbit (T. brucei, T. equiperdum, T. evansi, and T. rhodesiense) or human (T. grambiense).  Although a general medium could be defined for the long-term maintenance of trypanosome cultures, the initiation to culture nevertheless required particular conditions for the different strains.  The cultured trypanosomes had all the characteristics of the in vivo bloodstream forms including: morphol., infectivity, antigenic variation and glucose metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9zVzQmi2a5LVg90H21EOLACvtfcHk0lh6--QJFOhrXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslGhtb8%253D&md5=f5eac106bf83676bcec41105092c4f7c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1985.tb03772.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1985.tb03772.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaltz%26aufirst%3DT.%26aulast%3DBaltz%26aufirst%3DD.%26aulast%3DGiroud%26aufirst%3DC.%26aulast%3DCrockett%26aufirst%3DJ.%26atitle%3DCultivation%2520in%2520a%2520semi-defined%2520medium%2520of%2520animal%2520infective%2520forms%2520of%2520Trypanosoma%2520brucei%252C%2520T.%2520equiperdum%252C%2520T.%2520evansi%252C%2520T.%2520rhodesiense%2520and%2520T.%2520gambiense%26jtitle%3DEMBO%2520J.%26date%3D1985%26volume%3D4%26spage%3D1273%26epage%3D1277%26doi%3D10.1002%2Fj.1460-2075.1985.tb03772.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Räz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grether-Bühler, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span> <span> </span><span class="NLM_article-title">The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/s0001-706x(97)00079-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0001-706X%2897%2900079-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=9386789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1997&pages=139-147&author=B.+R%C3%A4zauthor=M.+Itenauthor=Y.+Grether-B%C3%BChlerauthor=R.+Kaminskyauthor=R.+Brun&title=The+Alamar+Blue+assay+to+determine+drug+sensitivity+of+African+trypanosomes+%28T.b.+rhodesiense+and+T.b.+gambiense%29+in+vitro&doi=10.1016%2Fs0001-706x%2897%2900079-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro</span></div><div class="casAuthors">Raz, B.; Iten, M.; Grether-Buhler, Y.; Kaminsky, R.; Brun, R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Alamar Blue, an indicator for metabolic cell function, was evaluated as a fluorescent and as a colorimetric dye in drug sensitivity assays for human pathogenic African trypanosomes, Trypanosoma brucei rhodesiense and T.b. gambiense.  The exptl. conditions were adjusted to find those where the relationship between trypanosome no. and Alamar Blue signal was linear over the widest possible range.  Fluorescent signals correlated to trypanosome nos. from 104 trypanosomes/mL (T.b. rhodesiense) and 105 trypanosomes/mL (T.b. gambiense) up to 2-3×106 trypanosomes/mL when trypanosomes were incubated for 2 h with 10 Alamar Blue.  Trypanocidal activity of common drugs (melarsoprol, DFMO, suramin, pentamidine and diminazene aceturate) was detd. employing this assay.  The IC50 values obtained were comparable to those obtained with another fluorochrome, BCECF-AM.  The Alamar Blue assay can be applied for drug screening, since it is simple, reproducible and economical.  The assay can also be used in field sites with less equipped labs., because in addn. to fluorometric endpoint detn., a colorimetric reading is possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi-5OGHtif-rVg90H21EOLACvtfcHk0lhJQI6USWDSsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXns1Wms7Y%253D&md5=ffbfe3f890d45919b685d051375769ec</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0001-706X%2897%2900079-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0001-706X%252897%252900079-X%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25A4z%26aufirst%3DB.%26aulast%3DIten%26aufirst%3DM.%26aulast%3DGrether-B%25C3%25BChler%26aufirst%3DY.%26aulast%3DKaminsky%26aufirst%3DR.%26aulast%3DBrun%26aufirst%3DR.%26atitle%3DThe%2520Alamar%2520Blue%2520assay%2520to%2520determine%2520drug%2520sensitivity%2520of%2520African%2520trypanosomes%2520%2528T.b.%2520rhodesiense%2520and%2520T.b.%2520gambiense%2529%2520in%2520vitro%26jtitle%3DActa%2520Trop.%26date%3D1997%26volume%3D68%26spage%3D139%26epage%3D147%26doi%3D10.1016%2Fs0001-706x%2897%2900079-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706x(93)90083-n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2F0001-706x%2893%2990083-n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+EC50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706x%2893%2990083-n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2eYFu7HbVwqhtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0001-706x%2893%2990083-n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706x%252893%252990083-n%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520EC50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706x%2893%2990083-n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Flamme, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2592</span>– <span class="NLM_lpage">2597</span>, <span class="refDoi"> DOI: 10.1128/aac.40.11.2592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1128%2FAAC.40.11.2592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=8913471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK28Xms1Smsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=2592-2597&author=F.+S.+Bucknerauthor=C.+L.+Verlindeauthor=A.+C.+La+Flammeauthor=W.+C.+Van+Voorhis&title=Efficient+technique+for+screening+drugs+for+activity+against+Trypanosoma+cruzi+using+parasites+expressing+beta-galactosidase&doi=10.1128%2Faac.40.11.2592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase</span></div><div class="casAuthors">Buckner, Frederick S.; Verlinde, Christophe L. M. J.; la Flamme, Anne C.; van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2592-2597</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A new drug screening method was devised utilizing Trypanosoma cruzi cells that express the Escherichia coli β-galactosidase gene.  Transfected parasites catalyze a colorimetric reaction with chlorophenol red β-D-galactopyranoside as substrate.  Parasite growth in the presence of drugs in microtiter plates was quantitated with an ELISA reader.  The assay was performed with the mammalian form of T. cruzi that requires intracellular growth on a monolayer of fibroblast cells.  To det. if selective toxicity to the parasites was occurring, the viability of the host cells in the drug was assayed with AlamarBlue.  The drugs benznidazole, fluconazole, and amphotericin B were shown to inhibit the parasites at concns. similar to those previously reported.  Several compds. were tested that are inhibitors of glyceraldehyde-3-phosphate dehydrogenase of the related organisms Leishmania mexicana and Trypanosoma brucei.  One of these compds., 2-guanidinobenzimidazole, had a 50% inhibitory concn. of 10 μM in our assay.  Two derivs. of this compd. were identified with in vitro activity at even lower concns.  In addn., the assay was modified for testing compds. for lytic activity against the bloodstream form of the parasite under conditions used for storing blood products.  Thus, an assay with β-galactosidase-expressing T. cruzi greatly simplifies screening drugs for selective anti-T. cruzi activity, and three promising new compds. have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcRR1mgX3GyLVg90H21EOLACvtfcHk0li--KsrcSnZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1Smsbk%253D&md5=0ec1b723ed87c29e5f38f2d46d732c7e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.11.2592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.11.2592%26sid%3Dliteratum%253Aachs%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DLa%2BFlamme%26aufirst%3DA.%2BC.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DEfficient%2520technique%2520for%2520screening%2520drugs%2520for%2520activity%2520against%2520Trypanosoma%2520cruzi%2520using%2520parasites%2520expressing%2520beta-galactosidase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D2592%26epage%3D2597%26doi%3D10.1128%2Faac.40.11.2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gary Mathieu, Heena Patel, <span class="NLM_string-name hlFld-ContribAuthor">Hélène Lebel</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Continuous Flow Synthesis of N-Methyl Secondary Amines from Alkyl Mesylates and Epoxides. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (10)
                                     , 2157-2168. <a href="https://doi.org/10.1021/acs.oprd.0c00193" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00193%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DConvenient%252BContinuous%252BFlow%252BSynthesis%252Bof%252BN-Methyl%252BSecondary%252BAmines%252Bfrom%252BAlkyl%252BMesylates%252Band%252BEpoxides%26aulast%3DMathieu%26aufirst%3DGary%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18042020%26date%3D10092020%26date%3D25082020%26volume%3D24%26issue%3D10%26spage%3D2157%26epage%3D2168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anh Minh Thao  Nguyen</span>, <span class="hlFld-ContribAuthor ">Skye  Brettell</span>, <span class="hlFld-ContribAuthor ">Noélie  Douanne</span>, <span class="hlFld-ContribAuthor ">Claudia  Duquette</span>, <span class="hlFld-ContribAuthor ">Audrey  Corbeil</span>, <span class="hlFld-ContribAuthor ">Emanuella F.  Fajardo</span>, <span class="hlFld-ContribAuthor ">Martin  Olivier</span>, <span class="hlFld-ContribAuthor ">Christopher  Fernandez-Prada</span>, <span class="hlFld-ContribAuthor ">William D.  Lubell</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of N-Methylation and Conformation on Almiramide Anti-Leishmanial Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (12)
                                     , 3606. <a href="https://doi.org/10.3390/molecules26123606" title="DOI URL">https://doi.org/10.3390/molecules26123606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26123606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26123606%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DInfluence%252Bof%252BN-Methylation%252Band%252BConformation%252Bon%252BAlmiramide%252BAnti-Leishmanial%252BActivity%26aulast%3DNguyen%26aufirst%3DAnh%2BMinh%2BThao%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D12%26spage%3D3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingxin  Xue</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Heyi  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Prostate Cancer Growth Inhibition by 1-(3,5-Dimethylphenyl)–6-methyl-1H-pyrazolo[4,3-c]pyridin-4(5H)-one via Down-regulation of Phosphorylation PI3K/AKT and STA3/JAK2. </span><span class="cited-content_cbyCitation_journal-name">Doklady Biochemistry and Biophysics</span><span> <strong>2020,</strong> <em>495 </em>
                                    (1)
                                     , 347-353. <a href="https://doi.org/10.1134/S160767292006006X" title="DOI URL">https://doi.org/10.1134/S160767292006006X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S160767292006006X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS160767292006006X%26sid%3Dliteratum%253Aachs%26jtitle%3DDoklady%2520Biochemistry%2520and%2520Biophysics%26atitle%3DProstate%252BCancer%252BGrowth%252BInhibition%252Bby%252B1-%2525283%25252C5-Dimethylphenyl%252529%2525E2%252580%2525936-methyl-1H-pyrazolo%25255B4%25252C3-c%25255Dpyridin-4%2525285H%252529-one%252Bvia%252BDown-regulation%252Bof%252BPhosphorylation%252BPI3K%25252FAKT%252Band%252BSTA3%25252FJAK2%26aulast%3DXue%26aufirst%3DJingxin%26date%3D2020%26date%3D2020%26volume%3D495%26issue%3D1%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina L.  Ratkova</span>, <span class="hlFld-ContribAuthor ">Maciej  Dawidowski</span>, <span class="hlFld-ContribAuthor ">Valeria  Napolitano</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Dubin</span>, <span class="hlFld-ContribAuthor ">Roberto  Fino</span>, <span class="hlFld-ContribAuthor ">Michael S.  Ostertag</span>, <span class="hlFld-ContribAuthor ">Michael  Sattler</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Popowicz</span>, <span class="hlFld-ContribAuthor ">Igor V.  Tetko</span>. </span><span class="cited-content_cbyCitation_article-title">Water envelope has a critical impact on the design of protein–protein interaction inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (31)
                                     , 4360-4363. <a href="https://doi.org/10.1039/C9CC07714F" title="DOI URL">https://doi.org/10.1039/C9CC07714F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC07714F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC07714F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DWater%252Benvelope%252Bhas%252Ba%252Bcritical%252Bimpact%252Bon%252Bthe%252Bdesign%252Bof%252Bprotein%2525E2%252580%252593protein%252Binteraction%252Binhibitors%26aulast%3DRatkova%26aufirst%3DEkaterina%2BL.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D31%26spage%3D4360%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of drugs used for the treatment of <i>Trypanosoma</i>-related diseases and clinical candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural basis for PEX14–PEX5 PPI interface targeting. Left: Solution NMR structure of the HsPEX14 NTD in complex with the di-aromatic WXXXF pentapeptide motif of PEX5 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84">2W84</a><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a>). PEX14 is shown in light blue, whereas PEX5 is shown in magenta. Two hydrophobic cavities on the PEX14 surface accommodating Trp103 and Phe107 residues of PEX5 WXXXF are separated by two π-stacked phenylalanine side chains (Phe17 and Phe34). Right: Superposition of the solution NMR structures of HsPEX14 (light blue, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84">2W84</a>) and TbPEX14 (gold, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMC">5MMC</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>) NTDs. The polar residues (represented as sticks) surrounding the binding pocket are significantly different in both species. Bottom: Sequence alignment of HsPEX14, TbPEX14, and TcPEX14.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure, properties, and proposed derivatization sites of the pyrazolo[4,3-<i>c</i>]pyridine in silico hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking poses of <b>1</b> to the TbPEX14–PEX5 PPI interface. Top: Phenyl residue of <b>1</b> occupies the Trp pocket while the indole is positioned in the Phe pocket on the PEX14 surface. Bottom: The “reversed” binding mode of <b>1</b> to the TbPEX14–PEX5 PPI interface. Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of TbPEX14 in complex with <b>13</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L87">5L87</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Left: surface representation of TbPEX14 (gold). A highly conserved water molecule is represented as a sphere. Right: cartoon representation of TbPEX14; relevant residues are shown as sticks. A water-mediated hydrogen bond between the PEX14 N13 side chain and the amide nitrogen of <b>13</b> is presented (gray dashed line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Top: Crystal structure of TbPEX14 in complex with <b>20</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L8A">5L8A</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Bottom: overlay of the binding poses of <b>13</b> (purple) and <b>20</b> (green). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. High resolution crystal structure of N-terminal domain of TbPEX14 in complex with compound <b>50</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V">5N8V</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. High resolution crystal structure of N-terminal domain of TbPEX14 in the complex with compound <b>61</b> (1.2 Å, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a>). Surface (left) and cartoon (right) representation of TbPEX14 (gold).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ligand interaction diagrams of the final MDs simulations snapshots. The MDs were performed for TbPEX14-<b>29</b> (A), TbPEX14-<b>50</b> (B), and TbPEX14-<b>61</b> (C) complexes. Blue lines represent H-bonding interactions, red cation−π, and green π–π interactions. Introduction of alkylamine residues at N-1 pyrazolo position leads to formation of direct and water-mediated interaction patterns significantly improving compound affinity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to the in Silico Hit <b>1</b> and Its C-2 Regioisomer <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LHMDS, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (b) hydrazine hydrate, THF, EtOH, AcOH, reflux; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, then MeI, DMF, rt; (d) benzylamine, TBD, THF, 60 °C; (e) 4 M HCl, 1,4-dioxane, rt; (f) TEA, THF, rt, then AcOH, indole-3-carboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes Employed for the Initial Optimization Trials (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzylamine, TBD, THF, 60 °C; (b) 4 M HCl, 1,4-dioxane, rt; (c) TEA, THF, rt, then AcOH, indole-3-carboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt; (d) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, then ethyl 2-bromoacetate, DMF, rt (for <b>71</b>) or ethyl chloroformate, DIPEA, 0 °C to rt (for <b>72</b>); (e) KOH, EtOH/H<sub>2</sub>O, rt, then NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O, rt; (f) LHMDS, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (g) 2-hydrazinoethanol, THF, EtOH, AcOH, reflux; (h) amine, TBD, THF, 60 °C; (i) TEA, THF, rt, then AcOH, aldehyde, NaBH(OAc)<sub>3</sub>, THF, rt.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes Employed for the Optimization of the Residue Addressing the Phe Pocket (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 4 M HCl, 1,4-dioxane, rt; (b) TEA, THF, rt, then AcOH, aldehyde, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>14</b>, <b>21–26</b>, <b>28</b>, and <b>30–45</b>) or 7-methoxycarbonyl-1<i>H</i>-indole, HCHO<sub>aq</sub>, ZnCl<sub>2</sub>, EtOH, rt (for <b>27</b>).</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Routes Employed for the Optimization around the Trp Pocket (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-naphthalenemethylamine, TBD, THF, 60 °C; (b) 4 M HCl, 1,4-dioxane, rt; (c) TEA, THF, rt, then AcOH, 4-methoxy-1-naphthaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt; (d) MsCl, DIPEA, DMAP, DCM, 0 °C to rt; (e) <sup><i>t</i></sup>BuOK, THF, 0 °C to rt; (f) LiAlH<sub>4</sub>, THF, rt, then reflux; (g) CDI, DCM, rt; (h) NH<sub>3aq</sub>, EtOH, reflux; (i) TEA, THF, rt, then AcOH, 1-naphthalenecarboxaldehyde, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>48</b>), or 1-naphthalenesulfonyl chloride, TEA, DMAP, DCM, 0 °C to rt (for <b>49</b>).</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes Employed for the Secondary Optimization of the Pyrazole N-Substituent (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeNH<sub>2</sub>, DCM/EtOH, reflux (for <b>51</b>), imidazole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>55</b>), pyrazole, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>56</b>), morpholine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C (for <b>57</b>), methyl glycinate hydrochloride, K<sub>2</sub>CO<sub>3</sub>, MeCN, reflux (for <b>59</b>); (b) NaOH, MeOH/H<sub>2</sub>O, rt; (c) acetone, AcOH, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>52</b>), HCHO<sub>aq</sub>, AcOH, NaBH(OAc)<sub>3</sub>, THF, rt (for <b>54</b>) or Ac<sub>2</sub>O (neat), 80 °C (for <b>58</b>); (d) <i>tert</i>-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C; (e) 4 M HCl, 1,4-dioxane, rt, then K<sub>2</sub>CO<sub>3</sub>, rt.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/medium/jm9b01876_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Routes Employed for the Optimization of the Central Scaffold (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01876/20200715/images/large/jm9b01876_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01876&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeI, CHCl<sub>3</sub>, rt; (b) LDA, THF, −78 °C, then (COOEt)<sub>2</sub>, THF, −78 °C to rt; (c) 2-hydroxyethylhydrazine, THF, EtOH, AcOH, reflux; (d) AcOH, reflux; (e) K<sub>2</sub>CO<sub>3</sub>, EtOH, 60 °C; (f) 1-naphthalenemetylamine, TBD, THF, 60 °C; (g) 1,4-cyclohexadiene, 10% Pd/C, MeOH, reflux; (h) HCl, Et<sub>2</sub>O, DCM, 0 °C to rt; (i) 4-methoxy-1-naphthaldehyde, NaBH(OAc)<sub>3</sub>, AcOH, THF, rt; (j) TsCl, TEA, DMAP, DCM, 0 °C to rt; (k) NaN<sub>3</sub>, DMF, 70 °C; (l) PPh<sub>3</sub>, THF, rt, then H<sub>2</sub>O, THF, 50 °C; (m) 2-amino-2-methyl-1-propanol, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 73 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molyneux, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savioli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, D.</span></span> <span> </span><span class="NLM_article-title">Neglected tropical diseases: progress towards addressing the chronic pandemic</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(16)30171-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2816%2930171-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27639954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC2svhsFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=312-325&author=D.+H.+Molyneuxauthor=L.+Savioliauthor=D.+Engels&title=Neglected+tropical+diseases%3A+progress+towards+addressing+the+chronic+pandemic&doi=10.1016%2Fs0140-6736%2816%2930171-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Neglected tropical diseases: progress towards addressing the chronic pandemic</span></div><div class="casAuthors">Molyneux David H; Savioli Lorenzo; Engels Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10066</span>),
    <span class="NLM_cas:pages">312-325</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The concept of neglected tropical diseases (NTDs) emerged more than a decade ago and has been recognised as a valid way to categorise diseases that affect the poorest individuals.  Substantial progress in control and elimination has been achieved and policy momentum has been generated through continued bilateral, philanthropic, and non-governmental development organisation (NGDO) support, and donations of drugs from pharmaceutical companies.  WHO has defined a Roadmap to reach 2020 targets, which was endorsed by member states in a World Health Assembly Resolution in 2013.  NTDs have been included within the Sustainable Development Goal targets and are a crucial component of universal health coverage, conceptualised as "leaving no one behind".  WHO reported that more than 1 billion people in 88 countries have benefited from preventive chemotherapy in 2014.  The research agenda has defined the need for affordable products (diagnostics, drugs and insecticides).  However challenges such as insecurity and weak health systems continue to prevail in the poorest countries, inhibiting progress in scaling up and also in achieving Roadmap goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVM9uO0YK6f7t7lRqEFUJVfW6udTcc2eaiQmhb0bu17bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svhsFGlsQ%253D%253D&md5=999893ecea92bdf9f0e5fb1cecaa18d1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2930171-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252930171-4%26sid%3Dliteratum%253Aachs%26aulast%3DMolyneux%26aufirst%3DD.%2BH.%26aulast%3DSavioli%26aufirst%3DL.%26aulast%3DEngels%26aufirst%3DD.%26atitle%3DNeglected%2520tropical%2520diseases%253A%2520progress%2520towards%2520addressing%2520the%2520chronic%2520pandemic%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D312%26epage%3D325%26doi%3D10.1016%2Fs0140-6736%2816%2930171-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">WHO</span>.  <i>Research Priorities for Chagas Disease,
Human African Trypanosomiasis
and Leishmaniasis. World Health Organization Technical Report Series</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2012</span>; (975),
Vol.  <span class="NLM_volume">v–xii</span>, pp  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">100</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=1-100&author=WHO&title=Research+Priorities+for+Chagas+Disease%2C%0AHuman+African+Trypanosomiasis%0Aand+Leishmaniasis.+World+Health+Organization+Technical+Report+Series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DResearch%2520Priorities%2520for%2520Chagas%2520Disease%252C%250AHuman%2520African%2520Trypanosomiasis%250Aand%2520Leishmaniasis.%2520World%2520Health%2520Organization%2520Technical%2520Report%2520Series%26pub%3DWHO%26date%3D2012%26volume%3Dv%25E2%2580%2593xii%26spage%3D1%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">Trypanosomiasis,
Human African Trypanosomiasis (Sleeping Sickness),
Fact Sheet</span>. <a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trypanosomiasis%2C%0AHuman+African+Trypanosomiasis+%28Sleeping+Sickness%29%2C%0AFact+Sheet.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+April+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DTrypanosomiasis%252C%250AHuman%2520African%2520Trypanosomiasis%2520%2528Sleeping%2520Sickness%2529%252C%250AFact%2520Sheet" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span> </span><span class="NLM_article-title">Chagas Disease (American
Trypanosomiasis), Fact Sheet</span>. <a href="http://www.who.int/mediacentre/factsheets/fs340/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs340/en/</a> (accessed
April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chagas+Disease+%28American%0ATrypanosomiasis%29%2C+Fact+Sheet.+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs340%2Fen%2F+%28accessed%0AApril+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DChagas%2520Disease%2520%2528American%250ATrypanosomiasis%2529%252C%2520Fact%2520Sheet" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koning, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span> <span> </span><span class="NLM_article-title">The animal trypanosomiases and their chemotherapy: a review</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1862</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1017/s0031182016001268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182016001268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27719692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC2svnsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2016&pages=1862-1889&author=F.+Giordaniauthor=L.+J.+Morrisonauthor=T.+G.+Rowanauthor=H.+P.+De+Koningauthor=M.+P.+Barrett&title=The+animal+trypanosomiases+and+their+chemotherapy%3A+a+review&doi=10.1017%2Fs0031182016001268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The animal trypanosomiases and their chemotherapy: a review</span></div><div class="casAuthors">Giordani Federica; DE Koning Harry P; Barrett Michael P; Morrison Liam J; Rowan Tim G</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1862-1889</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pathogenic animal trypanosomes affecting livestock have represented a major constraint to agricultural development in Africa for centuries, and their negative economic impact is increasing in South America and Asia.  Chemotherapy and chemoprophylaxis represent the main means of control.  However, research into new trypanocides has remained inadequate for decades, leading to a situation where the few compounds available are losing efficacy due to the emergence of drug-resistant parasites.  In this review, we provide a comprehensive overview of the current options available for the treatment and prophylaxis of the animal trypanosomiases, with a special focus on the problem of resistance.  The key issues surrounding the main economically important animal trypanosome species and the diseases they cause are also presented.  As new investment becomes available to develop improved tools to control the animal trypanosomiases, we stress that efforts should be directed towards a better understanding of the biology of the relevant parasite species and strains, to identify new drug targets and interrogate resistance mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ06QITPuBK1sK3uFsUIZtkfW6udTcc2eZCRbbxXqYXwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svnsV2hsQ%253D%253D&md5=9bd3bf096493efeb13061501c2943672</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1017%2FS0031182016001268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182016001268%26sid%3Dliteratum%253Aachs%26aulast%3DGiordani%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DL.%2BJ.%26aulast%3DRowan%26aufirst%3DT.%2BG.%26aulast%3DDe%2BKoning%26aufirst%3DH.%2BP.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26atitle%3DThe%2520animal%2520trypanosomiases%2520and%2520their%2520chemotherapy%253A%2520a%2520review%26jtitle%3DParasitology%26date%3D2016%26volume%3D143%26spage%3D1862%26epage%3D1889%26doi%3D10.1017%2Fs0031182016001268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Büscher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cecchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamonneau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priotto, G.</span></span> <span> </span><span class="NLM_article-title">Human African trypanosomiasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)31510-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2931510-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28673422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC1cjktFCrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2017&pages=2397-2409&author=P.+B%C3%BCscherauthor=G.+Cecchiauthor=V.+Jamonneauauthor=G.+Priotto&title=Human+African+trypanosomiasis&doi=10.1016%2Fs0140-6736%2817%2931510-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Human African trypanosomiasis</span></div><div class="casAuthors">Buscher Philippe; Cecchi Giuliano; Jamonneau Vincent; Priotto Gerardo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue">10110</span>),
    <span class="NLM_cas:pages">2397-2409</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated.  Human African trypanosomiasis caused devastating epidemics during the 20th century.  Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level.  Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO.  Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa.  Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas.  In the absence of a vaccine, disease control relies on case detection and treatment, and vector control.  Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBg2yQ4XqfsRgd2Wuil24tfW6udTcc2eY07Po-TA--3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjktFCrsw%253D%253D&md5=521e7f5c04b32c04763c6b7a65af6439</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2931510-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252931510-6%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCscher%26aufirst%3DP.%26aulast%3DCecchi%26aufirst%3DG.%26aulast%3DJamonneau%26aufirst%3DV.%26aulast%3DPriotto%26aufirst%3DG.%26atitle%3DHuman%2520African%2520trypanosomiasis%26jtitle%3DLancet%26date%3D2017%26volume%3D390%26spage%3D2397%26epage%3D2409%26doi%3D10.1016%2Fs0140-6736%2817%2931510-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caljon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stijlemans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radwanska, M.</span></span> <span> </span><span class="NLM_article-title">Current status of vaccination against African trypanosomiasis</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1017/s0031182010000223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182010000223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20441680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3cbntlCmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2010&pages=2017-2027&author=S.+Magezauthor=G.+Caljonauthor=T.+Tranauthor=B.+Stijlemansauthor=M.+Radwanska&title=Current+status+of+vaccination+against+African+trypanosomiasis&doi=10.1017%2Fs0031182010000223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Current status of vaccination against African trypanosomiasis</span></div><div class="casAuthors">Magez Stefan; Caljon Guy; Tran Thao; Stijlemans Benoit; Radwanska Magdalena</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2017-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anti-trypanosomiasis vaccination still remains the best theoretical option in the fight against a disease that is continuously hovering between its wildlife reservoir and its reservoir in man and livestock.  While antigenic variation of the parasite surface coat has been considered the major obstacle in the development of a functional vaccine, recent research into the biology of B cells has indicated that the problems might go further than that.  This paper reviews past and current attempts to design both anti-trypanosome vaccines, as well as vaccines directed towards the inhibition of infection-associated pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6yIp2p7gVpr7NkxioyDXTfW6udTcc2eY07Po-TA--3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbntlCmuw%253D%253D&md5=c037e34e20e13b0a18f352703ae96fa1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1017%2FS0031182010000223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182010000223%26sid%3Dliteratum%253Aachs%26aulast%3DMagez%26aufirst%3DS.%26aulast%3DCaljon%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DStijlemans%26aufirst%3DB.%26aulast%3DRadwanska%26aufirst%3DM.%26atitle%3DCurrent%2520status%2520of%2520vaccination%2520against%2520African%2520trypanosomiasis%26jtitle%3DParasitology%26date%3D2010%26volume%3D137%26spage%3D2017%26epage%3D2027%26doi%3D10.1017%2Fs0031182010000223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stijlemans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radwanska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Trez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magez, S.</span></span> <span> </span><span class="NLM_article-title">African trypanosomes undermine humoral responses and vaccine development: link with inflammatory responses?</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.3389%2Ffimmu.2017.00582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28149297" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1-14&author=B.+Stijlemansauthor=M.+Radwanskaauthor=C.+De+Trezauthor=S.+Magez&title=African+trypanosomes+undermine+humoral+responses+and+vaccine+development%3A+link+with+inflammatory+responses%3F&doi=10.3389%2Ffimmu.2017.00582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00582%26sid%3Dliteratum%253Aachs%26aulast%3DStijlemans%26aufirst%3DB.%26aulast%3DRadwanska%26aufirst%3DM.%26aulast%3DDe%2BTrez%26aufirst%3DC.%26aulast%3DMagez%26aufirst%3DS.%26atitle%3DAfrican%2520trypanosomes%2520undermine%2520humoral%2520responses%2520and%2520vaccine%2520development%253A%2520link%2520with%2520inflammatory%2520responses%253F%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffimmu.2017.00582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, P. G.</span></span> <span> </span><span class="NLM_article-title">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/s1474-4422(12)70296-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS1474-4422%2812%2970296-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23260189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=186-194&author=P.+G.+Kennedy&title=Clinical+features%2C+diagnosis%2C+and+treatment+of+human+African+trypanosomiasis+%28sleeping+sickness%29&doi=10.1016%2Fs1474-4422%2812%2970296-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</span></div><div class="casAuthors">Kennedy Peter Ge</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human African trypanosomiasis, or sleeping sickness, is caused by infection with parasites of the genus Trypanosoma, transmitted by the tsetse fly.  The disease has two forms, Trypanosoma brucei (T b) rhodesiense and T b gambiense; and is almost always fatal if untreated.  Despite a recent reduction in the number of reported cases, patients with African trypanosomiasis continue to present major challenges to clinicians.  Because treatment for CNS-stage disease can be very toxic, diagnostic staging to distinguish early-stage from late-stage disease when the CNS in invaded is crucial but remains problematic.  Melarsoprol is the only available treatment for late-stage T b rhodesiense infection, but can be lethal to 5% of patients owing to post-treatment reactive encephalopathy.  Eflornithine combined with nifurtimox is the first-line treatment for late-stage T b gambiense.  New drugs are in the pipeline for treatment of CNS human African trypanosomiasis, giving rise to cautious optimism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDi0PRo3CXkCEJCPKhJPuqfW6udTcc2ebJ3HlVag_-r7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3ktVCgsQ%253D%253D&md5=c9ac342f345240d413300c17cd1ae80f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970296-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970296-X%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DP.%2BG.%26atitle%3DClinical%2520features%252C%2520diagnosis%252C%2520and%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%2520%2528sleeping%2520sickness%2529%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D186%26epage%3D194%26doi%3D10.1016%2Fs1474-4422%2812%2970296-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesu, V. K. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalonji, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardonneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordt, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhomme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuziena, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubaki, J.-P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuvu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngima, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mbembo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilunga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonama, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heradi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomo, J. L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandula, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badibabi, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dama, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukula, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tete, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumbala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarral, A.</span></span> <span> </span><span class="NLM_article-title">Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)32758-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2932758-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29113731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=144-154&author=V.+K.+B.+K.+Mesuauthor=W.+M.+Kalonjiauthor=C.+Bardonneauauthor=O.+V.+Mordtauthor=S.+Blessonauthor=F.+Simonauthor=S.+Delhommeauthor=S.+Bernhardauthor=W.+Kuzienaauthor=J.-P.+F.+Lubakiauthor=S.+L.+Vuvuauthor=P.+N.+Ngimaauthor=H.+M.+Mbemboauthor=M.+Ilungaauthor=A.+K.+Bonamaauthor=J.+A.+Heradiauthor=J.+L.+L.+Solomoauthor=G.+Mandulaauthor=L.+K.+Badibabiauthor=F.+R.+Damaauthor=P.+K.+Lukulaauthor=D.+N.+Teteauthor=C.+Lumbalaauthor=B.+Scherrerauthor=N.+Strub-Wourgaftauthor=A.+Tarral&title=Oral+fexinidazole+for+late-stage+African+Trypanosoma+brucei+gambiense+trypanosomiasis%3A+a+pivotal+multicentre%2C+randomised%2C+non-inferiority+trial&doi=10.1016%2Fs0140-6736%2817%2932758-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial</span></div><div class="casAuthors">Mesu, Victor Kande Betu Ku; Kalonji, Wilfried Mutombo; Bardonneau, Clelia; Mordt, Olaf Valverde; Blesson, Severine; Simon, Francois; Delhomme, Sophie; Bernhard, Sonja; Kuziena, Willy; Lubaki, Jean-Pierre Fina; Vuvu, Steven Lumeya; Ngima, Pathou Nganzobo; Mbembo, Helene Mahenzi; Ilunga, Medard; Bonama, Augustin Kasongo; Heradi, Josue Amici; Solomo, Jean Louis Lumaliza; Mandula, Guylain; Badibabi, Lewis Kaninda; Dama, Francis Regongbenga; Lukula, Papy Kavunga; Tete, Digas Ngolo; Lumbala, Crispin; Scherrer, Bruno; Strub-Wourgaft, Nathalie; Tarral, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10116</span>),
    <span class="NLM_cas:pages">144-154</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Few therapeutic options are available to treat late-stage human African trypanosomiasis, a neglected tropical disease caused by Trypanosoma brucei gambiense (g-HAT).  The firstline treatment nifurtimox eflornithine combination therapy needs to be administered i.v. in a hospital setting by trained personnel, which is not optimal, given that patients often live in remote areas with few health resources.  Therefore, we aimed to assess the safety and efficacy of an oral regimen of fexinidazole (a 2-substituted 5-nitroimidazole with proven trypanocidal activity) vs. nifurtimox eflornithine combination therapy in patients with late-stage g-HAT.  In this randomised, phase 2/3, open-label, non-inferiority trial, we recruited patients aged 15 years and older with late-stage g-HAT from g-HAT treatment centers in the Democratic Republic of the Congo (n=9) and the Central African Republic (n=1).  Patients were randomly assigned (2:1) to receive either fexinidazole or nifurtimox eflornithine combination therapy according to a predefined randomisation list (block size six).  The funder, data management personnel, and study statisticians were masked to treatment.  Oral fexinidazole was given once a day (days 1-4: 1800 mg, days 5-10: 1200 mg).  Oral nifurtimox was given three times a day (days 1-10: 15 mg/kg per day) with eflornithine twice a day as 2 h infusions (days 1-7: 400 mg/kg per day).  The primary endpoint was success at 18 mo (ie, deemed as patients being alive, having no evidence of trypanosomes in any body fluid, not requiring rescue medication, and having a cerebrospinal fluid white blood cell count ≤20 cells per μL).  Safety was assessed through routine monitoring.  Primary efficacy anal. was done in the modified intention-to-treat population and safety analyses in the intention-to-treat population.  The acceptable margin for the difference in success rates was defined as 13%.  This study has been completed and is registered with ClinicalTrials.gov, no. NCT01685827.  Between Oct., 2012, and Nov., 2016, 419 patients were pre-screened.  Of the 409 eligible patients, 14 were not included because they did not meet all inclusion criteria (n=12) or for another reason (n=2).  Therefore, 394 patients were randomly assigned, 264 to receive fexinidazole and 130 to receive nifurtimox eflornithine combination therapy.  Success at 18 mo was recorded in 239 (91%) patients given fexinidazole and 124 (98%) patients given nifurtimox eflornithine combination therapy, within the margin of acceptable difference of -6·4% (97·06% CI -11·2 to -1·6; p=0·0029).  We noted no difference in the proportion of patients who experienced treatment-related adverse events (215 [81%] in the fexinidazole group vs 102 [79%] in the nifurtimox eflornithine combination therapy group).  Treatment discontinuations were unrelated to treatment (n=2 [1%] in the fexinidazole group).  Temporary nifurtimox eflornithine combination therapy interruption occurred in three (2%) patients. 11 patients died during the study (nine [3%] in the fexinidazole group vs two [2%] in the nifurtimox eflornithine combination therapy group).  Our findings show that oral fexinidazole is effective and safe for the treatment of T b gambiense infection compared with nifurtimox eflornithine combination therapy in late-stage HAT patients.  Fexinidazole could be a key asset in the elimination of this fatal neglected disease.  Drugs for Neglected Diseases initiative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragrgvd5-lcbVg90H21EOLACvtfcHk0lglctDXMMVNaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymt7zO&md5=3022f3915faaaadecbc387f4ba367bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2932758-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252932758-7%26sid%3Dliteratum%253Aachs%26aulast%3DMesu%26aufirst%3DV.%2BK.%2BB.%2BK.%26aulast%3DKalonji%26aufirst%3DW.%2BM.%26aulast%3DBardonneau%26aufirst%3DC.%26aulast%3DMordt%26aufirst%3DO.%2BV.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DDelhomme%26aufirst%3DS.%26aulast%3DBernhard%26aufirst%3DS.%26aulast%3DKuziena%26aufirst%3DW.%26aulast%3DLubaki%26aufirst%3DJ.-P.%2BF.%26aulast%3DVuvu%26aufirst%3DS.%2BL.%26aulast%3DNgima%26aufirst%3DP.%2BN.%26aulast%3DMbembo%26aufirst%3DH.%2BM.%26aulast%3DIlunga%26aufirst%3DM.%26aulast%3DBonama%26aufirst%3DA.%2BK.%26aulast%3DHeradi%26aufirst%3DJ.%2BA.%26aulast%3DSolomo%26aufirst%3DJ.%2BL.%2BL.%26aulast%3DMandula%26aufirst%3DG.%26aulast%3DBadibabi%26aufirst%3DL.%2BK.%26aulast%3DDama%26aufirst%3DF.%2BR.%26aulast%3DLukula%26aufirst%3DP.%2BK.%26aulast%3DTete%26aufirst%3DD.%2BN.%26aulast%3DLumbala%26aufirst%3DC.%26aulast%3DScherrer%26aufirst%3DB.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DTarral%26aufirst%3DA.%26atitle%3DOral%2520fexinidazole%2520for%2520late-stage%2520African%2520Trypanosoma%2520brucei%2520gambiense%2520trypanosomiasis%253A%2520a%2520pivotal%2520multicentre%252C%2520randomised%252C%2520non-inferiority%2520trial%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D144%26epage%3D154%26doi%3D10.1016%2Fs0140-6736%2817%2932758-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollastri, M. P.</span></span> <span> </span><span class="NLM_article-title">Fexinidazole: a new drug for African sleeping sickness on the horizon</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2017.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pt.2017.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29275007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOhsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=178-179&author=M.+P.+Pollastri&title=Fexinidazole%3A+a+new+drug+for+African+sleeping+sickness+on+the+horizon&doi=10.1016%2Fj.pt.2017.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon</span></div><div class="casAuthors">Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">178-179</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Decades after the last new chem. entity was added to the pharmacopeia for human African trypanosomiasis (or sleeping sickness), orally dosed fexinidazole stands poised to replace the current treatment regimen for Trypanosoma brucei gambiense infections, following a pos. Phase 2/3 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0dzkKzgAQ8LVg90H21EOLACvtfcHk0lgiXHEBWJ9iRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOhsLjK&md5=90c0d6e87ec827b9b788152db9aff51e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2017.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2017.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DFexinidazole%253A%2520a%2520new%2520drug%2520for%2520African%2520sleeping%2520sickness%2520on%2520the%2520horizon%26jtitle%3DTrends%2520Parasitol.%26date%3D2018%26volume%3D34%26spage%3D178%26epage%3D179%26doi%3D10.1016%2Fj.pt.2017.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span> <span> </span><span class="NLM_article-title">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pt.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24776300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=289-298&author=S.+Pattersonauthor=S.+Wyllie&title=Nitro+drugs+for+the+treatment+of+trypanosomatid+diseases%3A+past%2C+present%2C+and+future+prospects&doi=10.1016%2Fj.pt.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  There is an urgent need for new, safer, and effective treatments for the diseases caused by the protozoan parasites Trypanosoma brucei, Trypanosoma cruzi, and Leishmania spp.  In the search for more effective drugs to treat these 'neglected diseases' researchers have chosen to reassess the therapeutic value of nitroarom. compds.  Previously avoided in drug discovery programs owing to potential toxicity issues, a nitro drug is now being used successfully as part of a combination therapy for human African trypanosomiasis.  We describe here the rehabilitation of nitro drugs for the treatment of trypanosomatid diseases and discuss the future prospects for this compd. class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomh5yhGW-6mrVg90H21EOLACvtfcHk0lgiXHEBWJ9iRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWlsL4%253D&md5=041606bd13d4f709723aa61f1100873b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26atitle%3DNitro%2520drugs%2520for%2520the%2520treatment%2520of%2520trypanosomatid%2520diseases%253A%2520past%252C%2520present%252C%2520and%2520future%2520prospects%26jtitle%3DTrends%2520Parasitol.%26date%3D2014%26volume%3D30%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.pt.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Fexinidazole: First Global Approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-1051-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2Fs40265-019-1051-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=30635838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFOqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=215-220&author=E.+D.+Deeks&title=Fexinidazole%3A+First+Global+Approval&doi=10.1007%2Fs40265-019-1051-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole: First Global Approval</span></div><div class="casAuthors">Deeks, Emma D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Fexinidazole Winthrop (hereafter referred to as fexinidazole) is a DNA synthesis inhibitor developed by the Drugs for Neglected Diseases initiative (DNDi), in collaboration with Sanofi, for the oral treatment of human African trypanosomiasis (HAT) [commonly known as 'sleeping sickness'] and Chagas' disease.  The drug is a 5-nitroimidazole deriv. first discovered by Hoechst AG (now part of Sanofi) and was identified by the DNDi in 2005 as having activity against Trypanosoma brucei gambiense and T. b. rhodesiense.  Under Article 58 of Regulation (EC) no. 726/2004 (a regulatory mechanism for reviewing new medicines destined for use outside of the EU), fexinidazole has been granted a pos. opinion by the EMA for the treatment of both the first-stage (haemo-lymphatic) and second-stage (meningo-encephalitic) of HAT due to T. b. gambiense (g-HAT) in adults and children aged ≥ 6 years and weighing ≥ 20 kg.  This approval will facilitate and support marketing authorization application in endemic countries in 2019; following registration, fexinidazole will be distributed via the WHO to endemic countries for g-HAT.  Phase 3 evaluation of fexinidazole for g-HAT is ongoing in the Democratic Republic of the Congo and Guinea and the drug is also in development for Chagas' disease, with a study currently ongoing in Spain.  Clin. development for visceral leishmaniasis is discontinued.  This article summarizes the milestones in the development of fexinidazole leading to this first approval for g-HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokgB3zQEcHLVg90H21EOLACvtfcHk0lh5T93IanOEBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFOqsb4%253D&md5=811084e7ee200cae20c16e54dce026cd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-1051-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-1051-6%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DFexinidazole%253A%2520First%2520Global%2520Approval%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D215%26epage%3D220%26doi%3D10.1007%2Fs40265-019-1051-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foth, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1093%2Fjac%2Fdkv376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26581221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2mtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=625-634&author=S.+Wyllieauthor=B.+J.+Fothauthor=A.+Kelnerauthor=A.+Y.+Sokolovaauthor=M.+Berrimanauthor=A.+H.+Fairlamb&title=Nitroheterocyclic+drug+resistance+mechanisms+in+Trypanosoma+brucei&doi=10.1093%2Fjac%2Fdkv376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei</span></div><div class="casAuthors">Wyllie, Susan; Foth, Bernardo J.; Kelner, Anna; Sokolova, Antoaneta Y.; Berriman, Matthew; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to identify the mechanisms of resistance to nifurtimox and fexinidazole in African trypanosomes.  Bloodstream-form Trypanosoma brucei were selected for resistance to nifurtimox and fexinidazole by stepwise exposure to increasing drug concns.  Clones were subjected to WGS to identify putative resistance genes.  Transgenic parasites modulating expression of genes of interest were generated and drug susceptibility phenotypes detd.  Nifurtimox-resistant (NfxR) and fexinidazole-resistant (FxR) parasites shared reciprocal cross-resistance, suggestive of a common mechanism of action.  Previously, a type I nitroreductase (NTR) has been implicated in nitro drug activation.  WGS of resistant clones revealed that NfxR parasites had lost >100 kb from one copy of chromosome 7, rendering them hemizygous for NTR as well as over 30 other genes.  FxR parasites retained both copies of NTR, but lost >70 kb downstream of one NTR allele, decreasing NTR transcription by half.  A single knockout line of NTR displayed 1.6- and 1.9-fold resistance to nifurtimox and fexinidazole, resp.  Since NfxR and FxR parasites are ∼6- and 20-fold resistant to nifurtimox and fexinidazole, resp., addnl. factors must be involved.  Overexpression and knockout studies ruled out a role for a putative oxidoreductase (Tb927.7.7410) and a hypothetical gene (Tb927.1.1050), previously identified in a genome-scale RNAi screen.  Thus, NTR was confirmed as a key resistance determinant, either by loss of one gene copy or loss of gene expression.  Further work is required to identify which of the many dozens of SNPs identified in the drug-resistant cell lines contribute to the overall resistance phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZJv31KEMIC7Vg90H21EOLACvtfcHk0lh5T93IanOEBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2mtbbK&md5=ff71afe820933da38f7b590aaf5c37cf</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv376%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DFoth%26aufirst%3DB.%2BJ.%26aulast%3DKelner%26aufirst%3DA.%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DNitroheterocyclic%2520drug%2520resistance%2520mechanisms%2520in%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D625%26epage%3D634%26doi%3D10.1093%2Fjac%2Fdkv376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2893</span>– <span class="NLM_lpage">2900</span>, <span class="refDoi"> DOI: 10.1128/aac.00332-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1128%2FAAC.00332-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20439607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2893-2900&author=A.+Y.+Sokolovaauthor=S.+Wyllieauthor=S.+Pattersonauthor=S.+L.+Ozaauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Cross-resistance+to+nitro+drugs+and+implications+for+treatment+of+human+African+trypanosomiasis&doi=10.1128%2Faac.00332-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis</span></div><div class="casAuthors">Sokolova, Antoaneta Y.; Wyllie, Susan; Patterson, Stephen; Oza, Sandra L.; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2893-2900</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis (HAT) has renewed interest in the potential of nitro drugs as chemotherapeutics.  In order to study the implications of the more widespread use of nitro drugs against these parasites, we examd. the in vivo and in vitro resistance potentials of nifurtimox and fexinidazole and its metabolites.  Following selection in vitro by exposure to increasing concns. of nifurtimox, Trypanosoma brucei brucei nifurtimox-resistant clones designated NfxR1 and NfxR2 were generated.  Both cell lines were found to be 8-fold less sensitive to nifurtimox than parental cells and demonstrated cross-resistance to a no. of other nitro drugs, most notably the clin. trial candidate fexinidazole (∼27-fold more resistant than parental cells).  Studies of mice confirmed that the generation of nifurtimox resistance in these parasites did not compromise virulence, and NfxR1 remained resistant to both nifurtimox and fexinidazole in vivo.  In the case of fexinidazole, drug metab. and pharmacokinetic studies indicate that the parent drug is rapidly metabolized to the sulfoxide and sulfone form of this compd.  These metabolites retained trypanocidal activity but were less effective in nifurtimox-resistant lines.  Significantly, trypanosomes selected for resistance to fexinidazole were 10-fold more resistant to nifurtimox than parental cells.  This reciprocal cross-resistance has important implications for the therapeutic use of nifurtimox in a clin. setting and highlights a potential danger in the use of fexinidazole as a monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwMvjfLmRaLVg90H21EOLACvtfcHk0liHWPokCRLLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVeltrY%253D&md5=3e34cfad24c02c4f41f5289b30fd9ad5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.00332-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00332-10%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%2BY.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DOza%26aufirst%3DS.%2BL.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DCross-resistance%2520to%2520nitro%2520drugs%2520and%2520implications%2520for%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2893%26epage%3D2900%26doi%3D10.1128%2Faac.00332-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0liHWPokCRLLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span> </span><span class="NLM_article-title">DNDi Announces Successful Completion of
SCYX-7158 Phase I Study for
Treatment of Sleeping Sickness</span>. <a href="https://www.news-medical.net/news/20150909/DNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx" class="extLink">https://www.news-medical.net/news/20150909/DNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx</a> (accessed April 10, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DNDi+Announces+Successful+Completion+of%0ASCYX-7158+Phase+I+Study+for%0ATreatment+of+Sleeping+Sickness.+https%3A%2F%2Fwww.news-medical.net%2Fnews%2F20150909%2FDNDi-announces-successful-completion-of-SCYX-7158-Phase-I-study-for-treatment-of-sleeping-sickness.aspx+%28accessed+April+10%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DDNDi%2520Announces%2520Successful%2520Completion%2520of%250ASCYX-7158%2520Phase%2520I%2520Study%2520for%250ATreatment%2520of%2520Sleeping%2520Sickness" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón
de Noya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz-Bello, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colmenares, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Guevara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauriello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zavala-Jaspe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naranjo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Márques, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acquatella, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noya, O.</span></span> <span> </span><span class="NLM_article-title">Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>201</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1086/651608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1086%2F651608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20307205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jsFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2010&pages=1308-1315&author=B.+Alarc%C3%B3n%0Ade+Noyaauthor=Z.+D%C3%ADaz-Belloauthor=C.+Colmenaresauthor=R.+Ruiz-Guevaraauthor=L.+Maurielloauthor=R.+Zavala-Jaspeauthor=J.+A.+Suarezauthor=T.+Abateauthor=L.+Naranjoauthor=M.+Paivaauthor=L.+Rivasauthor=J.+Castroauthor=J.+M%C3%A1rquesauthor=I.+Mendozaauthor=H.+Acquatellaauthor=J.+Torresauthor=O.+Noya&title=Large+urban+outbreak+of+orally+acquired+acute+Chagas+disease+at+a+school+in+Caracas%2C+Venezuela&doi=10.1086%2F651608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela</span></div><div class="casAuthors">Alarcon de Noya Belkisyole; Diaz-Bello Zoraida; Colmenares Cecilia; Ruiz-Guevara Raiza; Mauriello Luciano; Zavala-Jaspe Reinaldo; Suarez Jose Antonio; Abate Teresa; Naranjo Laura; Paiva Manuel; Rivas Lavinia; Castro Julio; Marques Juan; Mendoza Ivan; Acquatella Harry; Torres Jaime; Noya Oscar</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">201</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1308-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Trypanosoma cruzi oral transmission is possible through food contamination by vector's feces.  Little is known about the epidemiology and clinical features of microepidemics of orally acquired acute Chagas disease (CD).  METHODS:  A case-control, cohort-nested, epidemiological study was conducted during an outbreak of acute CD that affected a school community.  Structured interviews were designed to identify symptoms and sources of infection.  Electrocardiograms were obtained for all patients.  Specific serum antibodies were assessed by immunoenzimatic and indirect hemagglutination tests.  In some cases, parasitemia was tested directly or by culture, animal inoculation, and/or a polymerase chain reaction technique.  RESULTS:  Infection was confirmed in 103 of 1000 exposed individuals.  Of those infected, 75% were symptomatic, 20.3% required hospitalization, 59% showed ECG abnormalities, parasitemia was documented in 44, and 1 child died.  Clinical features differed from those seen in vectorial transmission.  The infection rate was significantly higher among younger children.  An epidemiological investigation incriminated contaminated fresh guava juice as the sole source of infection.  CONCLUSIONS:  This outbreak was unique, because it affected a large, urban, predominantly young, middle-class, otherwise healthy population and resulted in an unprecedented public health emergency.  Rapid diagnosis and treatment avoided higher lethality.  Food-borne transmission of T. cruzi may occur more often than is currently recognized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpsIaQ7_r3bOLt9HypzAgQfW6udTcc2ebO0Fvq7QIzarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jsFKhuw%253D%253D&md5=b1f887be29a03920450995c4ec0a5e6c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1086%2F651608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F651608%26sid%3Dliteratum%253Aachs%26aulast%3DAlarc%25C3%25B3n%2Bde%2BNoya%26aufirst%3DB.%26aulast%3DD%25C3%25ADaz-Bello%26aufirst%3DZ.%26aulast%3DColmenares%26aufirst%3DC.%26aulast%3DRuiz-Guevara%26aufirst%3DR.%26aulast%3DMauriello%26aufirst%3DL.%26aulast%3DZavala-Jaspe%26aufirst%3DR.%26aulast%3DSuarez%26aufirst%3DJ.%2BA.%26aulast%3DAbate%26aufirst%3DT.%26aulast%3DNaranjo%26aufirst%3DL.%26aulast%3DPaiva%26aufirst%3DM.%26aulast%3DRivas%26aufirst%3DL.%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DM%25C3%25A1rques%26aufirst%3DJ.%26aulast%3DMendoza%26aufirst%3DI.%26aulast%3DAcquatella%26aufirst%3DH.%26aulast%3DTorres%26aufirst%3DJ.%26aulast%3DNoya%26aufirst%3DO.%26atitle%3DLarge%2520urban%2520outbreak%2520of%2520orally%2520acquired%2520acute%2520Chagas%2520disease%2520at%2520a%2520school%2520in%2520Caracas%252C%2520Venezuela%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D201%26spage%3D1308%26epage%3D1315%26doi%3D10.1086%2F651608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Molina, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I.</span></span> <span> </span><span class="NLM_article-title">Chagas disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(17)31612-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0140-6736%2817%2931612-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28673423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADC%252BC1cjktFCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2018&pages=82-94&author=J.+A.+P%C3%A9rez-Molinaauthor=I.+Molina&title=Chagas+disease&doi=10.1016%2Fs0140-6736%2817%2931612-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas disease</span></div><div class="casAuthors">Perez-Molina Jose A; Molina Israel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">10115</span>),
    <span class="NLM_cas:pages">82-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration.  It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century.  Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke.  Even after more than a century, many challenges remain unresolved, since epidemiological control and diagnostic, therapeutic, and prognostic methods must be improved.  In particular, the efficacy and tolerability profile of therapeutic agents is far from ideal.  Furthermore, the population affected is older and more complex (eg, immunosuppressed patients and patients with cancer).  Nevertheless, in recent years, our knowledge of Chagas disease has expanded, and the international networking needed to change the course of this deadly disease during the 21st century has begun.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBg2yQ4XqfsXELvajU9pjPfW6udTcc2ebNqXj_fAFSu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjktFCrsA%253D%253D&md5=780546343990bf2d1774a418bf7f8091</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2817%2931612-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252817%252931612-4%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Molina%26aufirst%3DJ.%2BA.%26aulast%3DMolina%26aufirst%3DI.%26atitle%3DChagas%2520disease%26jtitle%3DLancet%26date%3D2018%26volume%3D391%26spage%3D82%26epage%3D94%26doi%3D10.1016%2Fs0140-6736%2817%2931612-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barros-Alvarez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdron-Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caceres, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graminha, M. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Concepcion, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinones, W.</span></span> <span> </span><span class="NLM_article-title">Glycosomal targets for anti-trypanosomatid drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.2174/09298673113209990139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.2174%2F09298673113209990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23834165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlaitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1679-1706&author=X.+Barros-Alvarezauthor=M.+Gualdron-Lopezauthor=H.+Acostaauthor=A.+J.+Caceresauthor=M.+A.+S.+Graminhaauthor=P.+A.+M.+Michelsauthor=J.+L.+Concepcionauthor=W.+Quinones&title=Glycosomal+targets+for+anti-trypanosomatid+drug+discovery&doi=10.2174%2F09298673113209990139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosomal targets for anti-trypanosomatid drug discovery</span></div><div class="casAuthors">Barros-Alvarez, X.; Gualdron-Lopez, M.; Acosta, H.; Caceres, A. J.; Graminha, M. A. S.; Michels, P. A. M.; Concepcion, J. L.; Quinones, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1679-1706</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycosomes are peroxisome-related organelles found in all kinetoplastid protists, including the human pathogenic species of the family Trypanosomatidae: Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp.  Glycosomes are unique in contg. the majority of the glycolytic/gluconeogenic enzymes, but they also possess enzymes of several other important catabolic and anabolic pathways.  The different metabolic processes are connected by shared cofactors and some metabolic intermediates, and their relative importance differs between the parasites or their distinct lifecycle stages, dependent on the environmental conditions encountered.  By genetic or chem. means, a variety of glycosomal enzymes participating in different processes have been validated as drug targets.  For several of these enzymes, as well as others that are likely crucial for proliferation, viability or virulence of the parasites, inhibitors have been obtained by different approaches such as compd. libraries screening or design and synthesis.  The efficacy and selectivity of some initially obtained inhibitors of parasite enzymes were further optimized by structure-activity relationship anal., using available protein crystal structures.  Several of the inhibitors cause growth inhibition of the clin. relevant stages of one or more parasitic trypanosomatid species and in some cases exert therapeutic effects in infected animals.  The integrity of glycosomes and proper compartmentalization of at least several matrix enzymes is also crucial for the viability of the parasites.  Therefore, proteins involved in the assembly of the organelles and transmembrane passage of substrates and products of glycosomal metab. offer also promise as drug targets.  Natural products with trypanocidal activity by affecting glycosomal integrity have been reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNdPzMK_ou7Vg90H21EOLACvtfcHk0lg9VPlP9uUukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlaitro%253D&md5=5ee74c0728cd91872599387835e28651</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990139%26sid%3Dliteratum%253Aachs%26aulast%3DBarros-Alvarez%26aufirst%3DX.%26aulast%3DGualdron-Lopez%26aufirst%3DM.%26aulast%3DAcosta%26aufirst%3DH.%26aulast%3DCaceres%26aufirst%3DA.%2BJ.%26aulast%3DGraminha%26aufirst%3DM.%2BA.%2BS.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DConcepcion%26aufirst%3DJ.%2BL.%26aulast%3DQuinones%26aufirst%3DW.%26atitle%3DGlycosomal%2520targets%2520for%2520anti-trypanosomatid%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1679%26epage%3D1706%26doi%3D10.2174%2F09298673113209990139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smirlis, D.</span>; <span class="NLM_string-name">Soares, M. B. P.</span></span> <span> </span><span class="NLM_article-title">Selection of Molecular Targets for Drug Development Against Trypanosomatids</span>. In  <i>Proteins and Proteomics of Leishmania and Trypanosoma</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. L. S.</span>, <span class="NLM_string-name">Branquinha, M. H.</span>, <span class="NLM_string-name">d’Avila-Levy, C. M.</span>, <span class="NLM_string-name">Kneipp, L. F.</span>, <span class="NLM_string-name">Sodré, C. L.</span></span>, Eds.; <span class="NLM_publisher-name">Springer Netherlands</span>: <span class="NLM_publisher-loc">Dordrecht</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">76</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2F978-94-007-7305-9_2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-76&author=D.+Smirlis&author=M.+B.+P.+Soaresauthor=A.+L.+S.+Santos&author=M.+H.+Branquinha&author=C.+M.+d%E2%80%99Avila-Levy&author=L.+F.+Kneipp&author=C.+L.+Sodr%C3%A9&title=Proteins+and+Proteomics+of+Leishmania+and+Trypanosoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-7305-9_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-007-7305-9_2%26sid%3Dliteratum%253Aachs%26aulast%3DSmirlis%26aufirst%3DD.%26atitle%3DSelection%2520of%2520Molecular%2520Targets%2520for%2520Drug%2520Development%2520Against%2520Trypanosomatids%26btitle%3DProteins%2520and%2520Proteomics%2520of%2520Leishmania%2520and%2520Trypanosoma%26aulast%3DSantos%26aufirst%3DA.%2BL.%2BS.%26pub%3DSpringer%2520Netherlands%26date%3D2014%26spage%3D43%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Sayed, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blandin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renauld, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worthey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertz-Fowler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghedin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peacock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeu, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortman, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsmark, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angiuoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anupama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bringaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadag, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerqueira, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creasy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delcher, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djikeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embley, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivens, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummerfeld, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira-Leal, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shallom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundaram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westenberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melville, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, N.</span></span> <span> </span><span class="NLM_article-title">Comparative genomics of trypanosomatid parasitic protozoa</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">404</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1126/science.1112181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1126%2Fscience.1112181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=16020724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=404-409&author=N.+M.+El-Sayedauthor=P.+J.+Mylerauthor=G.+Blandinauthor=M.+Berrimanauthor=J.+Crabtreeauthor=G.+Aggarwalauthor=E.+Calerauthor=H.+Renauldauthor=E.+A.+Wortheyauthor=C.+Hertz-Fowlerauthor=E.+Ghedinauthor=C.+Peacockauthor=D.+C.+Bartholomeuauthor=B.+J.+Haasauthor=A.+N.+Tranauthor=J.+R.+Wortmanauthor=U.+C.+Alsmarkauthor=S.+Angiuoliauthor=A.+Anupamaauthor=J.+Badgerauthor=F.+Bringaudauthor=E.+Cadagauthor=J.+M.+Carltonauthor=G.+C.+Cerqueiraauthor=T.+Creasyauthor=A.+L.+Delcherauthor=A.+Djikengauthor=T.+M.+Embleyauthor=C.+Hauserauthor=A.+C.+Ivensauthor=S.+K.+Kummerfeldauthor=J.+B.+Pereira-Lealauthor=D.+Nilssonauthor=J.+Petersonauthor=S.+L.+Salzbergauthor=J.+Shallomauthor=J.+C.+Silvaauthor=J.+Sundaramauthor=S.+Westenbergerauthor=O.+Whiteauthor=S.+E.+Melvilleauthor=J.+E.+Donelsonauthor=B.+Anderssonauthor=K.+D.+Stuartauthor=N.+Hall&title=Comparative+genomics+of+trypanosomatid+parasitic+protozoa&doi=10.1126%2Fscience.1112181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Genomics of Trypanosomatid Parasitic Protozoa</span></div><div class="casAuthors">El-Sayed, Najib M.; Myler, Peter J.; Blandin, Gaelle; Berriman, Matthew; Crabtree, Jonathan; Aggarwal, Gautam; Caler, Elisabet; Renauld, Hubert; Worthey, Elizabeth A.; Hertz-Fowler, Christiane; Ghedin, Elodie; Peacock, Christopher; Bartholomeu, Daniella C.; Haas, Brian J.; Tran, Anh-Nhi; Wortman, Jennifer R.; Alsmark, U. Cecilia M.; Angiuoli, Samuel; Anupama, Atashi; Badger, Jonathan; Bringaud, Frederic; Cadag, Eithon; Carlton, Jane M.; Cerqueira, Gustavo C.; Creasy, Todd; Delcher, Arthur L.; Djikeng, Appolinaire; Embley, T. Martin; Hauser, Christopher; Ivens, Alasdair C.; Kummerfeld, Sarah K.; Pereira-Leal, Jose B.; Nilsson, Daniel; Peterson, Jeremy; Salzberg, Steven L.; Shallom, Joshua; Silva, Joana C.; Sundaram, Jaideep; Westenberger, Scott; White, Owen; Melville, Sara E.; Donelson, John E.; Andersson, Bjoern; Stuart, Kenneth D.; Hall, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">5733</span>),
    <span class="NLM_cas:pages">404-409</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A comparison of gene content and genome architecture of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, three related pathogens with different life cycles and disease pathol., revealed a conserved core proteome of about 6200 genes in large syntenic polycistronic gene clusters.  Many species-specific genes, esp. large surface antigen families, occur at nonsyntenic chromosome-internal and subtelomeric regions.  Retroelements, structural RNAs, and gene family expansion are often assocd. with syntenic discontinuities that-along with gene divergence, acquisition and loss, and rearrangement within the syntenic regions-have shaped the genomes of each parasite.  Contrary to recent reports, the analyses reveal no evidence that these species are descended from an ancestor that contained a photosynthetic endosymbiont.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBNWr2-XgiPrVg90H21EOLACvtfcHk0ljFadRLDX0Acw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVersbo%253D&md5=4383ec045835bdc2cddb9f6011b392eb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscience.1112181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1112181%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Sayed%26aufirst%3DN.%2BM.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DBlandin%26aufirst%3DG.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DCrabtree%26aufirst%3DJ.%26aulast%3DAggarwal%26aufirst%3DG.%26aulast%3DCaler%26aufirst%3DE.%26aulast%3DRenauld%26aufirst%3DH.%26aulast%3DWorthey%26aufirst%3DE.%2BA.%26aulast%3DHertz-Fowler%26aufirst%3DC.%26aulast%3DGhedin%26aufirst%3DE.%26aulast%3DPeacock%26aufirst%3DC.%26aulast%3DBartholomeu%26aufirst%3DD.%2BC.%26aulast%3DHaas%26aufirst%3DB.%2BJ.%26aulast%3DTran%26aufirst%3DA.%2BN.%26aulast%3DWortman%26aufirst%3DJ.%2BR.%26aulast%3DAlsmark%26aufirst%3DU.%2BC.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DAnupama%26aufirst%3DA.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBringaud%26aufirst%3DF.%26aulast%3DCadag%26aufirst%3DE.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DCerqueira%26aufirst%3DG.%2BC.%26aulast%3DCreasy%26aufirst%3DT.%26aulast%3DDelcher%26aufirst%3DA.%2BL.%26aulast%3DDjikeng%26aufirst%3DA.%26aulast%3DEmbley%26aufirst%3DT.%2BM.%26aulast%3DHauser%26aufirst%3DC.%26aulast%3DIvens%26aufirst%3DA.%2BC.%26aulast%3DKummerfeld%26aufirst%3DS.%2BK.%26aulast%3DPereira-Leal%26aufirst%3DJ.%2BB.%26aulast%3DNilsson%26aufirst%3DD.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26aulast%3DShallom%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DJ.%2BC.%26aulast%3DSundaram%26aufirst%3DJ.%26aulast%3DWestenberger%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DO.%26aulast%3DMelville%26aufirst%3DS.%2BE.%26aulast%3DDonelson%26aufirst%3DJ.%2BE.%26aulast%3DAndersson%26aufirst%3DB.%26aulast%3DStuart%26aufirst%3DK.%2BD.%26aulast%3DHall%26aufirst%3DN.%26atitle%3DComparative%2520genomics%2520of%2520trypanosomatid%2520parasitic%2520protozoa%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D404%26epage%3D409%26doi%3D10.1126%2Fscience.1112181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gürtler, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarleton, R.</span></span> <span> </span><span class="NLM_article-title">Kinetoplastids: related protozoan pathogens, different diseases</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">1301</span>– <span class="NLM_lpage">1310</span>, <span class="refDoi"> DOI: 10.1172/jci33945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1172%2Fjci33945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=18382742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1CntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1301-1310&author=K.+Stuartauthor=R.+Brunauthor=S.+Croftauthor=A.+Fairlambauthor=R.+E.+G%C3%BCrtlerauthor=J.+McKerrowauthor=S.+Reedauthor=R.+Tarleton&title=Kinetoplastids%3A+related+protozoan+pathogens%2C+different+diseases&doi=10.1172%2Fjci33945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetoplastids: related protozoan pathogens, different diseases</span></div><div class="casAuthors">Stuart, Ken; Brun, Reto; Croft, Simon; Fairlamb, Alan; Gurtler, Ricardo E.; McKerrow, Jim; Reed, Steve; Tarleton, Rick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1301-1310</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Kinetoplastids are a group of flagellated protozoans that include the species Trypanosoma and Leishmania, which are human pathogens with devastating health and economic effects.  The sequencing of the genomes of some of these species has highlighted their genetic relatedness and underlined differences in the diseases that they cause.  As we discuss in this Review, steady progress using a combination of mol., genetic, immunol., and clin. approaches has substantially increased understanding of these pathogens and important aspects of the diseases that they cause.  Consequently, the paths for developing addnl. measures to control these "neglected diseases" are becoming increasingly clear, and we believe that the opportunities for developing the drugs, diagnostics, vaccines, and other tools necessary to expand the armamentarium to combat these diseases have never been better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptkkuBVHbO1LVg90H21EOLACvtfcHk0lh7vg_0pWlqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1CntLc%253D&md5=de0d99f9fc15e0388f3705f8874acd20</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2Fjci33945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci33945%26sid%3Dliteratum%253Aachs%26aulast%3DStuart%26aufirst%3DK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCroft%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%26aulast%3DG%25C3%25BCrtler%26aufirst%3DR.%2BE.%26aulast%3DMcKerrow%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DS.%26aulast%3DTarleton%26aufirst%3DR.%26atitle%3DKinetoplastids%253A%2520related%2520protozoan%2520pathogens%252C%2520different%2520diseases%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D1301%26epage%3D1310%26doi%3D10.1172%2Fjci33945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myburgh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature19339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnature19339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27501246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=229-233&author=S.+Khareauthor=A.+S.+Nagleauthor=A.+Biggartauthor=Y.+H.+Laiauthor=F.+Liangauthor=L.+C.+Davisauthor=S.+W.+Barnesauthor=C.+J.+N.+Mathisonauthor=E.+Myburghauthor=M.-Y.+Gaoauthor=J.+R.+Gillespieauthor=X.+Liuauthor=J.+L.+Tanauthor=M.+Stinsonauthor=I.+C.+Riveraauthor=J.+Ballardauthor=V.+Yehauthor=T.+Groesslauthor=G.+Federeauthor=H.+X.+Y.+Kohauthor=J.+D.+Venableauthor=B.+Bursulayaauthor=M.+Shapiroauthor=P.+K.+Mishraauthor=G.+Spraggonauthor=A.+Brockauthor=J.+C.+Mottramauthor=F.+S.+Bucknerauthor=S.+P.+S.+Raoauthor=B.+G.+Wenauthor=J.+R.+Walkerauthor=T.+Tuntlandauthor=V.+Molteniauthor=R.+J.+Glynneauthor=F.+Supek&title=Proteasome+inhibition+for+treatment+of+leishmaniasis%2C+Chagas+disease+and+sleeping+sickness&doi=10.1038%2Fnature19339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span></div><div class="casAuthors">Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually.  The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., resp.  These parasites have similar biol. and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target.  However, no such mol. targets or broad spectrum drugs have been identified to date.  Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection.  GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice.  Our data provide genetic and chem. validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PXMn1-tj_7Vg90H21EOLACvtfcHk0lh7vg_0pWlqfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL&md5=a05e7ce0f6b912b3003c5b3f42a005bb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature19339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19339%26sid%3Dliteratum%253Aachs%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DNagle%26aufirst%3DA.%2BS.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DMyburgh%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DJ.%2BL.%26aulast%3DStinson%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DI.%2BC.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DFedere%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DH.%2BX.%2BY.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBrock%26aufirst%3DA.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DWen%26aufirst%3DB.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26atitle%3DProteasome%2520inhibition%2520for%2520treatment%2520of%2520leishmaniasis%252C%2520Chagas%2520disease%2520and%2520sleeping%2520sickness%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature19339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newson, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neilde, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotillo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani
Khajouei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qureishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flematti, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piggott, M. J.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization of a novel class of potent, broad-spectrum trypanosomacides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9686</span>– <span class="NLM_lpage">9720</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyqsrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9686-9720&author=S.+Russellauthor=R.+Rahmaniauthor=A.+J.+Jonesauthor=H.+L.+Newsonauthor=K.+Neildeauthor=I.+Cotilloauthor=M.+Rahmani%0AKhajoueiauthor=L.+Ferrinsauthor=S.+Qureishiauthor=N.+Nguyenauthor=M.+S.+Martinez-Martinezauthor=D.+F.+Weaverauthor=M.+Kaiserauthor=J.+Rileyauthor=J.+Thomasauthor=M.+De+Ryckerauthor=K.+D.+Readauthor=G.+R.+Flemattiauthor=E.+Ryanauthor=S.+Tangheauthor=A.+Rodriguezauthor=S.+A.+Charmanauthor=A.+Kesslerauthor=V.+M.+Averyauthor=J.+B.+Baellauthor=M.+J.+Piggott&title=Hit-to-lead+optimization+of+a+novel+class+of+potent%2C+broad-spectrum+trypanosomacides&doi=10.1021%2Facs.jmedchem.6b00442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides</span></div><div class="casAuthors">Russell, Stephanie; Rahmani, Raphael; Jones, Amy J.; Newson, Harriet L.; Neilde, Kevin; Cotillo, Ignacio; Rahmani Khajouei, Marzieh; Ferrins, Lori; Qureishi, Sana; Nguyen, Nghi; Martinez-Martinez, Maria S.; Weaver, Donald F.; Kaiser, Marcel; Riley, Jennifer; Thomas, John; De Rycker, Manu; Read, Kevin D.; Flematti, Gavin R.; Ryan, Eileen; Tanghe, Scott; Rodriguez, Ana; Charman, Susan A.; Kessler, Albane; Avery, Vicky M.; Baell, Jonathan B.; Piggott, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9686-9720</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease.  Drugs currently available to treat these neglected diseases leave much to be desired.  Herein the authors report optimization of a novel class of N-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates and ureas, which rapidly, selectively, and potently kill both species of trypanosome.  The mode of action of these compds. is unknown, but does not involve CYP51 inhibition.  They do, however, exhibit clear structure-activity relationships, consistent across both trypanosome species.  Favorable physicochem. parameters place the best compds. in CNS drug-like chem. space but, as a class, they exhibit poor metabolic stability.  One of the best compds. I cleared all signs of T. cruzi infection in mice when CYP metab. was inhibited, with sterile cure achieved in one mouse.  This family of compds. thus shows significant promise for trypanosomiasis drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYfrbSB3QoOrVg90H21EOLACvtfcHk0ljm6KmfdgLo5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyqsrzP&md5=20f09884a0423c78f2bebf876b7f018f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00442%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DNewson%26aufirst%3DH.%2BL.%26aulast%3DNeilde%26aufirst%3DK.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DRahmani%2BKhajouei%26aufirst%3DM.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DQureishi%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DMartinez-Martinez%26aufirst%3DM.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFlematti%26aufirst%3DG.%2BR.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DTanghe%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DPiggott%26aufirst%3DM.%2BJ.%26atitle%3DHit-to-lead%2520optimization%2520of%2520a%2520novel%2520class%2520of%2520potent%252C%2520broad-spectrum%2520trypanosomacides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9686%26epage%3D9720%26doi%3D10.1021%2Facs.jmedchem.6b00442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, E. F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulloch, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharova, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, G. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of broad spectrum trypanosomatid selective inhibitors</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00187</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFagtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=560-567&author=A.+L.+Fraserauthor=S.+K.+Menziesauthor=E.+F.+B.+Kingauthor=L.+B.+Tullochauthor=E.+R.+Gouldauthor=M.+K.+Zacharovaauthor=T.+K.+Smithauthor=G.+J.+Florence&title=Design+and+synthesis+of+broad+spectrum+trypanosomatid+selective+inhibitors&doi=10.1021%2Facsinfecdis.7b00187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Broad Spectrum Trypanosomatid Selective Inhibitors</span></div><div class="casAuthors">Fraser, Andrew L.; Menzies, Stefanie K.; King, Elizabeth F. B.; Tulloch, Lindsay B.; Gould, Eoin R.; Zacharova, Marija K.; Smith, Terry K.; Florence, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">560-567</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neglected tropical diseases caused by parasitic infections are an ongoing and increasing concern that have a devastating effect on the developing world due to their burden on human and animal health.  In this work, we detail the prepn. of a focused library of substituted-tetrahydropyran derivs. and their evaluation as selective chem. tools for trypanosomatid inhibition and the follow-on development of photoaffinity probes capable of labeling target protein(s) in vitro.  Several of these functionalized compds. maintain low micromolar activity against Trypanosoma brucei, Trypanosoma cruzi, Leishmania major, and Leishmania donovani.  In addn., we demonstrate the utility of the photoaffinity probes for target identification through preliminary cellular localization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwXs53azWknLVg90H21EOLACvtfcHk0lgDWN7QLBck1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFagtA%253D%253D&md5=bc1ac8d984b482d7b95e01e4e495ee99</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00187%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DA.%2BL.%26aulast%3DMenzies%26aufirst%3DS.%2BK.%26aulast%3DKing%26aufirst%3DE.%2BF.%2BB.%26aulast%3DTulloch%26aufirst%3DL.%2BB.%26aulast%3DGould%26aufirst%3DE.%2BR.%26aulast%3DZacharova%26aufirst%3DM.%2BK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DFlorence%26aufirst%3DG.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520broad%2520spectrum%2520trypanosomatid%2520selective%2520inhibitors%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2018%26volume%3D4%26spage%3D560%26epage%3D567%26doi%3D10.1021%2Facsinfecdis.7b00187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente-García, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenguer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanzoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayago, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.ejmech.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26479031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=120-137&author=O.+Di%0APietroauthor=E.+Vicente-Garc%C3%ADaauthor=M.+C.+Taylorauthor=D.+Berenguerauthor=E.+Viaynaauthor=A.+Lanzoniauthor=I.+Solaauthor=H.+Sayagoauthor=C.+Rieraauthor=R.+Fisaauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=J.+M.+Kellyauthor=R.+Lavillaauthor=D.+Mu%C3%B1oz-Torrero&title=Multicomponent+reaction-based+synthesis+and+biological+evaluation+of+tricyclic+heterofused+quinolines+with+multi-trypanosomatid+activity&doi=10.1016%2Fj.ejmech.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span></div><div class="casAuthors">Di Pietro, Ornella; Vicente-Garcia, Esther; Taylor, Martin C.; Berenguer, Diana; Viayna, Elisabet; Lanzoni, Anna; Sola, Irene; Sayago, Helena; Riera, Cristina; Fisa, Roser; Clos, M. Victoria; Perez, Belen; Kelly, John M.; Lavilla, Rodolfo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-137</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, which are caused by the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi and Leishmania species, are among the most deadly neglected tropical diseases.  The development of drugs that are active against several trypanosomatids is appealing from a clin. and economic viewpoint, and seems feasible, as these parasites share metabolic pathways and hence might be treatable by common drugs.  From benzonaphthyridine (I), an inhibitor of acetylcholinesterase (AChE) for which we have found a remarkable trypanocidal activity, we have designed and synthesized novel benzo[h][1,6]naphthyridines, pyrrolo[3,2-c]quinolines, azepino[3,2-c]quinolines, and pyrano[3,2-c]quinolines through 2-4-step sequences featuring an initial multicomponent Povarov reaction as the key step.  To assess the therapeutic potential of the novel compds., we have evaluated their in vitro activity against T. brucei, T. cruzi, and Leishmania infantum, as well as their brain permeability, which is of specific interest for the treatment of late-stage HAT.  To assess their potential toxicity, we have detd. their cytotoxicity against rat myoblast L6 cells and their AChE inhibitory activity.  Several tricyclic heterofused quinoline derivs. were found to display an interesting multi-trypanosomatid profile, with one-digit micromolar potencies against two of these parasites and two-digit micromolar potency against the other.  Pyranoquinoline (II), which displays IC50 values of 1.5 μM, 6.1 μM and 29.2 μM against T. brucei, L. infantum and T. cruzi, resp., brain permeability, better drug-like properties (lower lipophilicity and mol. wt. and higher CNS MPO desirability score) than hit 1, and the lowest AChE inhibitory activity of the series (IC50 > 30 μM), emerges as an interesting multi-trypanosomatid lead, amenable to further optimization particularly in terms of its selectivity index over mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSElDBXWPo0LVg90H21EOLACvtfcHk0lgDWN7QLBck1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK&md5=8e483f32d39b7526dceac3ad35e8cd38</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DVicente-Garc%25C3%25ADa%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DBerenguer%26aufirst%3DD.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DLanzoni%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DSayago%26aufirst%3DH.%26aulast%3DRiera%26aufirst%3DC.%26aulast%3DFisa%26aufirst%3DR.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMulticomponent%2520reaction-based%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tricyclic%2520heterofused%2520quinolines%2520with%2520multi-trypanosomatid%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D105%26spage%3D120%26epage%3D137%26doi%3D10.1016%2Fj.ejmech.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haanstra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Marcano, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualdrón-López, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2015.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bbamcr.2015.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26384872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFarurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=1038-1048&author=J.+R.+Haanstraauthor=E.+B.+Gonz%C3%A1lez-Marcanoauthor=M.+Gualdr%C3%B3n-L%C3%B3pezauthor=P.+A.+M.+Michels&title=Biogenesis%2C+maintenance+and+dynamics+of+glycosomes+in+trypanosomatid+parasites&doi=10.1016%2Fj.bbamcr.2015.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites</span></div><div class="casAuthors">Haanstra, Jurgen R.; Gonzalez-Marcano, Eglys B.; Gualdron-Lopez, Melisa; Michels, Paul A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Peroxisomes of organisms belonging to the protist group Kinetoplastea, which include trypanosomatid parasites of the genera Trypanosoma and Leishmania, are unique in playing a crucial role in glycolysis and other parts of intermediary metab.  They sequester the majority of the glycolytic enzymes and hence are called glycosomes.  Their glycosomal enzyme content can vary strongly, particularly quant., between different trypanosomatid species, and within each species during its life cycle.  Turnover of glycosomes by autophagy of redundant ones and biogenesis of a new population of organelles play a pivotal role in the efficient adaptation of the glycosomal metabolic repertoire to the sudden, major nutritional changes encountered during the transitions in their life cycle.  The overall mechanism of glycosome biogenesis is similar to that of peroxisomes in other organisms, but the homologous peroxins involved display low sequence conservation as well as variations in motifs mediating crucial protein-protein interactions in the process.  The correct compartmentalization of enzymes is essential for the regulation of the trypanosomatids' metab. and consequently for their viability.  For Trypanosoma brucei it was shown that glycosomes also play a crucial role in its life-cycle regulation: a crucial developmental control switch involves the translocation of a protein phosphatase from the cytosol into the organelles.  Many glycosomal proteins are differentially phosphorylated in different life-cycle stages, possibly indicative of regulation of enzyme activities as an addnl. means to adapt the metabolic network to the different environmental conditions encountered.  This article is part of a Special Issue entitled: Peroxisomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob8EK5kD9XgbVg90H21EOLACvtfcHk0liPO5o45GDkNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFarurjO&md5=a9533e763de4f1c427fe46f14fa87032</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2015.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2015.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DHaanstra%26aufirst%3DJ.%2BR.%26aulast%3DGonz%25C3%25A1lez-Marcano%26aufirst%3DE.%2BB.%26aulast%3DGualdr%25C3%25B3n-L%25C3%25B3pez%26aufirst%3DM.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DBiogenesis%252C%2520maintenance%2520and%2520dynamics%2520of%2520glycosomes%2520in%2520trypanosomatid%2520parasites%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2016%26volume%3D1863%26spage%3D1038%26epage%3D1048%26doi%3D10.1016%2Fj.bbamcr.2015.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gualdrón-lópez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avilán, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1017/s0031182012001278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1017%2FS0031182012001278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=22914253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkt12mug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=1-20&author=M.+Gualdr%C3%B3n-l%C3%B3pezauthor=A.+Brennandauthor=L.+Avil%C3%A1nauthor=P.+A.+M.+Michels&title=Translocation+of+solutes+and+proteins+across+the+glycosomal+membrane+of+trypanosomes%3B+possibilities+and+limitations+for+targeting+with+trypanocidal+drugs&doi=10.1017%2Fs0031182012001278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs</span></div><div class="casAuthors">Gualdron-Lopez, Melisa; Brennand, Ana; Avilan, Luisana; Michels, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">PARAAE</span>;
        ISSN:<span class="NLM_cas:issn">0031-1820</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  Glycosomes are specialized peroxisomes found in all kinetoplastid organisms.  The organelles are unique in harbouring most enzymes of the glycolytic pathway.  Matrix proteins, synthesized in the cytosol, cofactors and metabolites have to be transported across the membrane.  Recent research on Trypanosoma brucei has provided insight into how these translocations across the membrane occur, although many details remain to be elucidated.  Proteins are imported by a cascade of reactions performed by specialized proteins, called peroxins, in which a cytosolic receptor with bound matrix protein inserts itself in the membrane to deliver its cargo into the organelle and is subsequently retrieved from the glycosome to perform further rounds of import.  Bulky solutes, such as cofactors and acyl-CoAs, seem to be translocated by specific transporter mols., whereas smaller solutes such as glycolytic intermediates probably cross the membrane through pore-forming channels.  The presence of such channels is in apparent contradiction with previous results that suggested a low permeability of the glycosomal membrane.  We propose 3 possible, not mutually exclusive, solns. for this paradox.  Glycosomal glycolytic enzymes have been validated as drug targets against trypanosomatid-borne diseases.  We discuss the possible implications of the new data for the design of drugs to be delivered into glycosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7NPS4Rewb7Vg90H21EOLACvtfcHk0liPO5o45GDkNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkt12mug%253D%253D&md5=f45ff171b85fb230b3588070879a6f84</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1017%2FS0031182012001278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182012001278%26sid%3Dliteratum%253Aachs%26aulast%3DGualdr%25C3%25B3n-l%25C3%25B3pez%26aufirst%3DM.%26aulast%3DBrennand%26aufirst%3DA.%26aulast%3DAvil%25C3%25A1n%26aufirst%3DL.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DTranslocation%2520of%2520solutes%2520and%2520proteins%2520across%2520the%2520glycosomal%2520membrane%2520of%2520trypanosomes%253B%2520possibilities%2520and%2520limitations%2520for%2520targeting%2520with%2520trypanocidal%2520drugs%26jtitle%3DParasitology%26date%3D2013%26volume%3D140%26spage%3D1%26epage%3D20%26doi%3D10.1017%2Fs0031182012001278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span> <span> </span><span class="NLM_article-title">Sleeping sickness: PEX and drugs</span>. <i>Biochim. Biophys. Acta</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1763</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2005.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bbamcr.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=16473137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlClu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1763&publication_year=2006&pages=4-5&author=W.+Schliebs&title=Sleeping+sickness%3A+PEX+and+drugs&doi=10.1016%2Fj.bbamcr.2005.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Sleeping sickness: PEX and drugs</span></div><div class="casAuthors">Schliebs, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1763</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-5</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Finding new ways in the treatment of fatal parasitic diseases like the human sleeping sickness is a major challenge of biomedical research.  The growing body of knowledge about the biogenesis of the glycosome, a peroxisome-related organelle of trypanosomes, might allow defining novel targets for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7qVT4cURre7Vg90H21EOLACvtfcHk0lhzx88p27YoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlClu7w%253D&md5=a80c29f03a8c8cbdea053ed889d199ee</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchliebs%26aufirst%3DW.%26atitle%3DSleeping%2520sickness%253A%2520PEX%2520and%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1763%26spage%3D4%26epage%3D5%26doi%3D10.1016%2Fj.bbamcr.2005.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moyersoen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voncken, F. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hol, W. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span> <span> </span><span class="NLM_article-title">Characterization of Trypanosoma brucei PEX14 and its role in the import of glycosomal matrix proteins</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">2059</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1033.2003.03582.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1046%2Fj.1432-1033.2003.03582.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12709066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslGmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=2003&pages=2059-2067&author=J.+Moyersoenauthor=J.+Choeauthor=A.+Kumarauthor=F.+G.+J.+Vonckenauthor=W.+G.+J.+Holauthor=P.+A.+M.+Michels&title=Characterization+of+Trypanosoma+brucei+PEX14+and+its+role+in+the+import+of+glycosomal+matrix+proteins&doi=10.1046%2Fj.1432-1033.2003.03582.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Trypanosoma brucei PEX14 and its role in the import of glycosomal matrix proteins</span></div><div class="casAuthors">Moyersoen, Juliette; Choe, Jungwoo; Kumar, Abhinav; Voncken, Frank G. J.; Hol, Wim G. J.; Michels, Paul A. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2059-2067</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">It has been shown previously in various organisms that the peroxin PEX14 is a component of a docking complex at the peroxisomal membrane, where it is involved in the import of matrix proteins into the organelle after their synthesis in the cytosol and recognition by a receptor.  Here we present a characterization of the Trypanosoma brucei homolog of PEX14.  It is shown that the protein is assocd. with glycosomes, the peroxisome-like organelles of trypanosomatids in which most glycolytic enzymes are compartmentalized.  The N-terminal part of the protein binds specifically to TbPEX5, the cytosolic receptor for glycosomal matrix proteins with a peroxisome-targeting signal type 1 (PTS-1).  TbPEX14 mRNA depletion by RNA interference results, in both bloodstream-form and procyclic, insect-stage T. brucei, in mislocalization of glycosomal proteins to the cytosol.  The mislocalization was obsd. for different classes of matrix proteins: proteins with a C-terminal PTS-1, a N-terminal PTS-2 and a polypeptide internal I-PTS.  The RNA interference expts. also showed that TbPEX14 is essential for the survival of bloodstream-form and procyclic trypanosomes.  These data indicate the protein's great potential as a target for selective trypanocidal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOFWjStpBALrVg90H21EOLACvtfcHk0lhzx88p27YoDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslGmsb4%253D&md5=19fb4d91b1209ae4d6ead20363c1b731</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2003.03582.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2003.03582.x%26sid%3Dliteratum%253Aachs%26aulast%3DMoyersoen%26aufirst%3DJ.%26aulast%3DChoe%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DVoncken%26aufirst%3DF.%2BG.%2BJ.%26aulast%3DHol%26aufirst%3DW.%2BG.%2BJ.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26atitle%3DCharacterization%2520of%2520Trypanosoma%2520brucei%2520PEX14%2520and%2520its%2520role%2520in%2520the%2520import%2520of%2520glycosomal%2520matrix%2520proteins%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2003%26volume%3D270%26spage%3D2059%26epage%3D2067%26doi%3D10.1046%2Fj.1432-1033.2003.03582.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haanstra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tuijl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reijnders, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, P. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerhoff, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, B. M.</span></span> <span> </span><span class="NLM_article-title">Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">17718</span>– <span class="NLM_lpage">17723</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806664105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.0806664105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19008351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCmur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17718-17723&author=J.+R.+Haanstraauthor=A.+Van+Tuijlauthor=P.+Kesslerauthor=W.+Reijndersauthor=P.+A.+M.+Michelsauthor=H.+V.+Westerhoffauthor=M.+Parsonsauthor=B.+M.+Bakker&title=Compartmentation+prevents+a+lethal+turbo-explosion+of+glycolysis+in+trypanosomes&doi=10.1073%2Fpnas.0806664105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Compartmentation prevents a lethal turbo-explosion of glycolysis in trypanosomes</span></div><div class="casAuthors">Haanstra, Jurgen R.; van Tuijl, Arjen; Kessler, Peter; Reijnders, Willem; Michels, Paul A. M.; Westerhoff, Hans V.; Parsons, Marilyn; Bakker, Barbara M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">17718-17723</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">ATP generation by both glycolysis and glycerol catabolism is autocatalytic, because the first kinases of these pathways are fueled by ATP produced downstream.  Previous modeling studies predicted that either feedback inhibition or compartmentation of glycolysis can protect cells from accumulation of intermediates.  The deadly parasite Trypanosoma brucei lacks feedback regulation of early steps in glycolysis yet sequesters the relevant enzymes within organelles called glycosomes, leading to the proposal that compartmentation prevents toxic accumulation of intermediates.  Here, we show that glucose 6-phosphate indeed accumulates upon glucose addn. to PEX14 deficient trypanosomes, which are impaired in glycosomal protein import.  With glycerol catabolism, both in silico and in vivo, loss of glycosomal compartmentation led to dramatic increases of glycerol 3-phosphate upon addn. of glycerol.  As predicted by the model, depletion of glycerol kinase rescued PEX14-deficient cells of glycerol toxicity.  This provides the first exptl. support for our hypothesis that pathway compartmentation is an alternative to allosteric regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocMbuADiKeaLVg90H21EOLACvtfcHk0ljNDPTSX4L4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCmur7M&md5=d90e0b738dd03ecef63c0856d0e0130e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806664105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806664105%26sid%3Dliteratum%253Aachs%26aulast%3DHaanstra%26aufirst%3DJ.%2BR.%26aulast%3DVan%2BTuijl%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DP.%26aulast%3DReijnders%26aufirst%3DW.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DWesterhoff%26aufirst%3DH.%2BV.%26aulast%3DParsons%26aufirst%3DM.%26aulast%3DBakker%26aufirst%3DB.%2BM.%26atitle%3DCompartmentation%2520prevents%2520a%2520lethal%2520turbo-explosion%2520of%2520glycolysis%2520in%2520trypanosomes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D17718%26epage%3D17723%26doi%3D10.1073%2Fpnas.0806664105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span> <span> </span><span class="NLM_article-title">Probing the role of compartmentation of glycolysis in procyclic form Trypanosoma brucei: RNA interference studies of PEX14, hexokinase, and phosphofructokinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">9030</span>– <span class="NLM_lpage">9036</span>, <span class="refDoi"> DOI: 10.1074/jbc.m412033200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1074%2Fjbc.M412033200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=15637070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVCit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=9030-9036&author=P.+S.+Kesslerauthor=M.+Parsons&title=Probing+the+role+of+compartmentation+of+glycolysis+in+procyclic+form+Trypanosoma+brucei%3A+RNA+interference+studies+of+PEX14%2C+hexokinase%2C+and+phosphofructokinase&doi=10.1074%2Fjbc.m412033200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Role of Compartmentation of Glycolysis in Procyclic Form Trypanosoma brucei: RNA interference studies of pex14, hexokinase, and phosphofructokinase</span></div><div class="casAuthors">Kessler, Peter S.; Parsons, Marilyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">9030-9036</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Trypanosoma brucei and related organisms contain an organelle evolutionarily related to peroxisomes that sequesters glycolysis, among other pathways.  We have shown previously that disruption of protein import into this organelle, the glycosome, can be accomplished through RNA interference (RNAi)-mediated knockdown of the peroxin PEX14.  Decreased PEX14 in turn leads to cell death, which, at least in the procyclic stage, can be triggered by the presence of glucose.  Here we show that fructose, which is taken up and metabolized by procyclic form T. brucei, and glycerol, which interfaces with the glycosomal glycolytic pathway, are also toxic during PEX14 RNAi.  Earlier computer modeling studies predicted that glycolysis would be toxic to T. brucei in the absence of glycosomal compartmentation because of the intrinsic lack of feedback regulation of the parasite hexokinase and phosphofructokinase.  To further test this hypothesis, we performed double RNAi, targeting hexokinase and PEX14.  Knockdown of hexokinase rescued PEX14 knockdown cells from glucose toxicity, even though glycosomal proteins continue to be mislocalized to the cytosol.  Knockdown of phosphofructokinase was benign in the absence of glucose but toxic in the presence of glucose.  When PEX14 and phosphofructokinase mRNAs were jointly targeted for RNAi, glycerol remained toxic to the parasites.  Taken together, these data indicate that the glycosome provides significant, but not complete, protection of trypanosomes from the dangerous design of glycolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRsi75GkfLCbVg90H21EOLACvtfcHk0ljNDPTSX4L4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVCit7o%253D&md5=0c8416b4a7d9c805fe056ea3603ed7fa</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M412033200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M412033200%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DP.%2BS.%26aulast%3DParsons%26aufirst%3DM.%26atitle%3DProbing%2520the%2520role%2520of%2520compartmentation%2520of%2520glycolysis%2520in%2520procyclic%2520form%2520Trypanosoma%2520brucei%253A%2520RNA%2520interference%2520studies%2520of%2520PEX14%252C%2520hexokinase%252C%2520and%2520phosphofructokinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D9030%26epage%3D9036%26doi%3D10.1074%2Fjbc.m412033200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnaufer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crudder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, M.</span></span> <span> </span><span class="NLM_article-title">Glucose is toxic to glycosome-deficient trypanosomes</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">14177</span>– <span class="NLM_lpage">14182</span>, <span class="refDoi"> DOI: 10.1073/pnas.222454899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.222454899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12386344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD38XosF2itLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=14177-14182&author=T.+Furuyaauthor=P.+Kesslerauthor=A.+Jardimauthor=A.+Schnauferauthor=C.+Crudderauthor=M.+Parsons&title=Glucose+is+toxic+to+glycosome-deficient+trypanosomes&doi=10.1073%2Fpnas.222454899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose is toxic to glycosome-deficient trypanosomes</span></div><div class="casAuthors">Furuya, Tetsuya; Kessler, Peter; Jardim, Armando; Schnaufer, Achim; Crudder, Christopher; Parsons, Marilyn</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14177-14182</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Trypanosomatids, the etiol. agents of sleeping sickness, leishmaniasis, and Chagas' disease, compartmentalize glycolysis within glycosomes, metabolic organelles related to peroxisomes.  Here, we identify a trypanosome homolog of PEX14, one of the components of the peroxisomal protein import docking complex.  We have used double-stranded RNA interference to target the PEX14 transcript for degrdn.  Glycosomal matrix protein import was compromised, and both glycolytic bloodstream stage parasites and mitochondrially respiring procyclic stage parasites were killed.  Thus, unlike peroxisomes, glycosomes are essential organelles.  Surprisingly, procyclic forms, which can grow in the absence of glucose, were killed by PEX14 RNA interference only when simple sugars were present.  Thus, interference with glycosome protein import makes glucose toxic to trypanosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJrFl3gwXkrVg90H21EOLACvtfcHk0lgj8Pv1OlFXBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosF2itLo%253D&md5=5827450d346bfc6e039e0ca879fc9c72</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.222454899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.222454899%26sid%3Dliteratum%253Aachs%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DKessler%26aufirst%3DP.%26aulast%3DJardim%26aufirst%3DA.%26aulast%3DSchnaufer%26aufirst%3DA.%26aulast%3DCrudder%26aufirst%3DC.%26aulast%3DParsons%26aufirst%3DM.%26atitle%3DGlucose%2520is%2520toxic%2520to%2520glycosome-deficient%2520trypanosomes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D14177%26epage%3D14182%26doi%3D10.1073%2Fpnas.222454899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawidowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmanouilidis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalel, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripsianes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolonko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popowicz, G. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1420</span>, <span class="refDoi"> DOI: 10.1126/science.aal1807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1126%2Fscience.aal1807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=28360328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVWhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2017&pages=1416-1420&author=M.+Dawidowskiauthor=L.+Emmanouilidisauthor=V.+C.+Kalelauthor=K.+Tripsianesauthor=K.+Schorppauthor=K.+Hadianauthor=M.+Kaiserauthor=P.+M%C3%A4serauthor=M.+Kolonkoauthor=S.+Tangheauthor=A.+Rodriguezauthor=W.+Schliebsauthor=R.+Erdmannauthor=M.+Sattlerauthor=G.+M.+Popowicz&title=Inhibitors+of+PEX14+disrupt+protein+import+into+glycosomes+and+kill+Trypanosoma+parasites&doi=10.1126%2Fscience.aal1807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of PEX14 disrupt protein import into glycosomes and kill Trypanosoma parasites</span></div><div class="casAuthors">Dawidowski, M.; Emmanouilidis, L.; Kalel, V. C.; Tripsianes, K.; Schorpp, K.; Hadian, K.; Kaiser, M.; Maeser, P.; Kolonko, M.; Tanghe, S.; Rodriguez, A.; Schliebs, W.; Erdmann, R.; Sattler, M.; Popowicz, G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6332</span>),
    <span class="NLM_cas:pages">1416-1420</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We report a way to selectively kill Trypanosoma by blocking glycosomal/peroxisomal import that depends on the PEX14-PEX5 protein-protein interaction.  We developed small mols. that efficiently disrupt the PEX14-PEX5 interaction.  This results in mislocalization of glycosomal enzymes, causing metabolic catastrophe, and it kills the parasite.  High-resoln. x-ray structures and NMR data enabled the efficient design of inhibitors wit trypanocidal activities comparable to approved medications.  These results identify PEX14 as an Achilles' heel of the Trypanosoma suitable for the development of new therapies against trypanosomiasis and provide the structural basis for their development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhy7dxPoBTxrVg90H21EOLACvtfcHk0lgj8Pv1OlFXBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVWhurc%253D&md5=c647e3a1811975658bb39b09e558f161</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fscience.aal1807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aal1807%26sid%3Dliteratum%253Aachs%26aulast%3DDawidowski%26aufirst%3DM.%26aulast%3DEmmanouilidis%26aufirst%3DL.%26aulast%3DKalel%26aufirst%3DV.%2BC.%26aulast%3DTripsianes%26aufirst%3DK.%26aulast%3DSchorpp%26aufirst%3DK.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DM%25C3%25A4ser%26aufirst%3DP.%26aulast%3DKolonko%26aufirst%3DM.%26aulast%3DTanghe%26aufirst%3DS.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DErdmann%26aufirst%3DR.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DPopowicz%26aufirst%3DG.%2BM.%26atitle%3DInhibitors%2520of%2520PEX14%2520disrupt%2520protein%2520import%2520into%2520glycosomes%2520and%2520kill%2520Trypanosoma%2520parasites%26jtitle%3DScience%26date%3D2017%26volume%3D355%26spage%3D1416%26epage%3D1420%26doi%3D10.1126%2Fscience.aal1807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neufeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipp, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schüller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshapur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilmanns, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for competitive interactions of Pex14 with the import receptors Pex5 and Pex19</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Femboj.2009.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19197237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=745-754&author=C.+Neufeldauthor=F.+V.+Filippauthor=B.+Simonauthor=A.+Neuhausauthor=N.+Sch%C3%BCllerauthor=C.+Davidauthor=H.+Kooshapurauthor=T.+Madlauthor=R.+Erdmannauthor=W.+Schliebsauthor=M.+Wilmannsauthor=M.+Sattler&title=Structural+basis+for+competitive+interactions+of+Pex14+with+the+import+receptors+Pex5+and+Pex19&doi=10.1038%2Femboj.2009.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for competitive interactions of Pex14 with the import receptors Pex5 and Pex19</span></div><div class="casAuthors">Neufeld, Christian; Filipp, Fabian V.; Simon, Bernd; Neuhaus, Alexander; Schueller, Nicole; David, Christine; Kooshapur, Hamed; Madl, Tobias; Erdmann, Ralf; Schliebs, Wolfgang; Wilmanns, Matthias; Sattler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">745-754</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein import into peroxisomes depends on a complex and dynamic network of protein-protein interactions.  Pex14 is a central component of the peroxisomal import machinery and binds the sol. receptors Pex5 and Pex19, which have important function in the assembly of peroxisome matrix and membrane, resp.  We show that the N-terminal domain of Pex14, Pex14(N), adopts a three-helical fold.  Pex5 and Pex19 ligand helixes bind competitively to the same surface in Pex14(N) albeit with opposite directionality.  The mol. recognition involves conserved arom. side chains in the Pex5 WxxxF/Y motif and a newly identified F/YFxxxF sequence in Pex19.  The Pex14-Pex5 complex structure reveals mol. details for a crit. interaction in docking Pex5 to the peroxisomal membrane.  We show that mutations of Pex14 residues located in the Pex5/Pex19 binding region disrupt Pex5 and/or Pex19 binding in vitro.  The corresponding full-length Pex14 variants are impaired in peroxisomal membrane localization in vivo, showing that the mol. interactions mediated by the N-terminal domain modulate peroxisomal targeting of Pex14.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnqzaNFsOK2rVg90H21EOLACvtfcHk0litjOizFMPwIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCrsLk%253D&md5=581683eb23edff5445559bbcb418bc17</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.7%26sid%3Dliteratum%253Aachs%26aulast%3DNeufeld%26aufirst%3DC.%26aulast%3DFilipp%26aufirst%3DF.%2BV.%26aulast%3DSimon%26aufirst%3DB.%26aulast%3DNeuhaus%26aufirst%3DA.%26aulast%3DSch%25C3%25BCller%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DKooshapur%26aufirst%3DH.%26aulast%3DMadl%26aufirst%3DT.%26aulast%3DErdmann%26aufirst%3DR.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DWilmanns%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520competitive%2520interactions%2520of%2520Pex14%2520with%2520the%2520import%2520receptors%2520Pex5%2520and%2520Pex19%26jtitle%3DEMBO%2520J.%26date%3D2009%26volume%3D28%26spage%3D745%26epage%3D754%26doi%3D10.1038%2Femboj.2009.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, K.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the conserved N-terminal domain of the peroxisomal matrix protein import receptor, Pex14p</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1073/pnas.0808681106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1073%2Fpnas.0808681106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19122147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=417-421&author=J.-R.+Suauthor=K.+Takedaauthor=S.+Tamuraauthor=Y.+Fujikiauthor=K.+Miki&title=Crystal+structure+of+the+conserved+N-terminal+domain+of+the+peroxisomal+matrix+protein+import+receptor%2C+Pex14p&doi=10.1073%2Fpnas.0808681106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the conserved N-terminal domain of the peroxisomal matrix protein import receptor, Pex14p</span></div><div class="casAuthors">Su, Jian-Rong; Takeda, Kazuki; Tamura, Shigehiko; Fujiki, Yukio; Miki, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">417-421</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Pex14p is a central component of the peroxisomal protein import machinery, in which the conserved N-terminal domain mediates dynamic interactions with other peroxins including Pex5p, Pex13p, and Pex19p.  Here, we report the crystal structure of the conserved N-terminal domain of Pex14p with a three-helix bundle.  A hydrophobic surface is composed of the conserved residues, of which two phenylalanine residues (Phe-35 and Phe-52) protrude to the solvent.  Consequently, two putative binding pockets suitable for recognizing the helical WXXXF/Y motif of Pex5p are formed on the surface by the two phenylalanine residues accompanying with pos. charged residues.  The structural feature agrees well with our earlier findings where F35A/L36A and F52A/L53A mutants were impaired in the interactions with other peroxins such as Pex5p and Pex13p.  Pex14p variants each with Phe-to-Ala mutation at positions 35, 52, and 35/52, resp., were defective in restoring the impaired peroxisomal protein import in pex14 Chinese hamster ovary mutant ZP161 cells.  Moreover, in GST pull-down assays His6-Pex5pL bound only to GST-Pex14p(25-70), not to any of GST-Pex14p(25-70)F35A, GST-Pex14p(25-70)F52A, and GST-Pex14p(25-70)F35A/F52A.  Endogenous Pex5p was recruited to FLAG-Pex14p on peroxisomes in vivo but barely to FLAG-Pex14pF35A, FLAG-Pex14pF52A, and FLAG-Pex14pF35A/F52A.  Collectively, Phe-35 and Phe-52 are essential for the Pex14p functions, including the interaction between Pex14p and Pex5p.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCQ-QbgMcLbVg90H21EOLACvtfcHk0litjOizFMPwIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelsLY%253D&md5=036665ae80929651726456adee267c87</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0808681106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0808681106%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DJ.-R.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DTamura%26aufirst%3DS.%26aulast%3DFujiki%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520conserved%2520N-terminal%2520domain%2520of%2520the%2520peroxisomal%2520matrix%2520protein%2520import%2520receptor%252C%2520Pex14p%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D417%26epage%3D421%26doi%3D10.1073%2Fpnas.0808681106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshapur, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidowsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambruch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schliebs, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, R.</span></span> <span> </span><span class="NLM_article-title">A novel Pex14 protein-interacting site of human Pex5 is critical for matrix protein import into peroxisomes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">448</span>, <span class="refDoi"> DOI: 10.1074/jbc.m113.499707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1074%2Fjbc.M113.499707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24235149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=437-448&author=A.+Neuhausauthor=H.+Kooshapurauthor=J.+Wolfauthor=N.+H.+Meyerauthor=T.+Madlauthor=J.+Saidowskyauthor=E.+Hambruchauthor=A.+Lazamauthor=M.+Jungauthor=M.+Sattlerauthor=W.+Schliebsauthor=R.+Erdmann&title=A+novel+Pex14+protein-interacting+site+of+human+Pex5+is+critical+for+matrix+protein+import+into+peroxisomes&doi=10.1074%2Fjbc.m113.499707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes</span></div><div class="casAuthors">Neuhaus, Alexander; Kooshapur, Hamed; Wolf, Janina; Meyer, N. Helge; Madl, Tobias; Saidowsky, Jurgen; Hambruch, Eva; Lazam, Anissa; Jung, Martin; Sattler, Michael; Schliebs, Wolfgang; Erdmann, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">437-448</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Protein import into peroxisomes relies on the import receptor Pex5, which recognizes proteins with a peroxisomal targeting signal 1 (PTS1) in the cytosol and directs them to a docking complex at the peroxisomal membrane.  Receptor-cargo docking occurs at the membrane-assocd. protein Pex14.  In human cells, this interaction is mediated by seven conserved diarom. pentapeptide motifs (WXXX(F/Y) motifs) in the N-terminal half of Pex5 and the N-terminal domain of Pex14.  A systematic screening of a Pex5 peptide library by ligand blot anal. revealed a novel Pex5-Pex14 interaction site of Pex5.  The novel motif composes the sequence LVAEF with the evolutionarily conserved consensus sequence LVXEF.  Replacement of the amino acid LVAEF sequence by alanines strongly affects matrix protein import into peroxisomes in vivo.  The NMR structure of a complex of Pex5-(57-71) with the Pex14-N-terminal domain showed that the novel motif binds in a similar α-helical orientation as the WXXX(F/Y) motif but that the tryptophan pocket is now occupied by a leucine residue.  Surface plasmon resonance analyses revealed 33 times faster dissocn. rates for the LVXEF ligand when compared with a WXXX(F/Y) motif.  Surprisingly, substitution of the novel motif with the higher affinity WXXX(F/Y) motif impairs protein import into peroxisomes.  These data indicate that the distinct kinetic properties of the novel Pex14-binding site in Pex5 are important for processing of the peroxisomal targeting signal 1 receptor at the peroxisomal membrane.  The novel Pex14-binding site may represent the initial tethering site of Pex5 from which the cargo-loaded receptor is further processed in a sequential manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQw3kjT-BJ7Vg90H21EOLACvtfcHk0lghf9l0UqyRfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSmug%253D%253D&md5=5d716ee7b8078c26cbd112f5d246613e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.499707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.499707%26sid%3Dliteratum%253Aachs%26aulast%3DNeuhaus%26aufirst%3DA.%26aulast%3DKooshapur%26aufirst%3DH.%26aulast%3DWolf%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DN.%2BH.%26aulast%3DMadl%26aufirst%3DT.%26aulast%3DSaidowsky%26aufirst%3DJ.%26aulast%3DHambruch%26aufirst%3DE.%26aulast%3DLazam%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DSchliebs%26aufirst%3DW.%26aulast%3DErdmann%26aufirst%3DR.%26atitle%3DA%2520novel%2520Pex14%2520protein-interacting%2520site%2520of%2520human%2520Pex5%2520is%2520critical%2520for%2520matrix%2520protein%2520import%2520into%2520peroxisomes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D437%26epage%3D448%26doi%3D10.1074%2Fjbc.m113.499707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein–protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein%E2%80%93protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0lh7bZVbiuQigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein%25E2%2580%2593protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rew, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small molecule MDM2 inhibitor (AMG 232) for treating cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6332</span>– <span class="NLM_lpage">6341</span>, <span class="refDoi"> DOI: 10.1021/jm500627s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500627s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGlu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6332-6341&author=Y.+Rewauthor=D.+Sun&title=Discovery+of+a+small+molecule+MDM2+inhibitor+%28AMG+232%29+for+treating+cancer&doi=10.1021%2Fjm500627s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer</span></div><div class="casAuthors">Rew, Yosup; Sun, Daqing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6332-6341</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  We recently reported the discovery of AMG 232 (1), a potent and selective piperidinone inhibitor of the MDM2-p53 protein-protein interaction.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.  This article provides an overview of its discovery from the de novo design of the piperidinone series to the structure-activity studies leading to the identification of 1.  In addn., this article also describes the preclin. pharmacol. and pharmacokinetics of 1, along with its drug metab. and safety assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_6moQsRdmtLVg90H21EOLACvtfcHk0lh7bZVbiuQigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGlu7jM&md5=07628b602fba44634add7d235751daf7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm500627s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500627s%26sid%3Dliteratum%253Aachs%26aulast%3DRew%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520MDM2%2520inhibitor%2520%2528AMG%2520232%2529%2520for%2520treating%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6332%26epage%3D6341%26doi%3D10.1021%2Fjm500627s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2–p53 protein–protein interaction (MDM2 inhibitors) in clinical trials for cancer treatment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1038</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1021/jm501092z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501092z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1038-1052&author=Y.+Zhaoauthor=A.+Aguilarauthor=D.+Bernardauthor=S.+Wang&title=Small-molecule+inhibitors+of+the+MDM2%E2%80%93p53+protein%E2%80%93protein+interaction+%28MDM2+inhibitors%29+in+clinical+trials+for+cancer+treatment&doi=10.1021%2Fjm501092z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment</span></div><div class="casAuthors">Zhao, Yujun; Aguilar, Angelo; Bernard, Denzil; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Design of small-mol. inhibitors (MDM2 inhibitors) to block the MDM2-p53 protein-protein interaction has been pursued as a new cancer therapeutic strategy.  In recent years, potent, selective, and efficacious MDM2 inhibitors have been successfully obtained and seven such compds. have been advanced into early phase clin. trials for the treatment of human cancers.  Here, we review the design, synthesis, properties, preclin., and clin. studies of these clin.-stage MDM2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNa9aW1Kz1Q7Vg90H21EOLACvtfcHk0ljG58WZPxePDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFagt77P&md5=2e58318782d7e0a04bf3398db8782984</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm501092z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501092z%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2%25E2%2580%2593p53%2520protein%25E2%2580%2593protein%2520interaction%2520%2528MDM2%2520inhibitors%2529%2520in%2520clinical%2520trials%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1038%26epage%3D1052%26doi%3D10.1021%2Fjm501092z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiedel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewings, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, C. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluck, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorah, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroglu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stazi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mapp, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span> <span> </span><span class="NLM_article-title">BET bromodomain ligands: probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2957</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.bmc.2018.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=29776834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=2937-2957&author=L.+E.+Jenningsauthor=M.+Schiedelauthor=D.+S.+Hewingsauthor=S.+Picaudauthor=C.+M.+C.+Laurinauthor=P.+A.+Brunoauthor=J.+P.+Bluckauthor=A.+R.+Scorahauthor=L.+Seeauthor=J.+K.+Reynoldsauthor=M.+Morogluauthor=I.+N.+Mistryauthor=A.+Hicksauthor=P.+Guzanovauthor=J.+Claytonauthor=C.+N.+G.+Evansauthor=G.+Staziauthor=P.+C.+Bigginauthor=A.+K.+Mappauthor=E.+M.+Hammondauthor=P.+G.+Humphreysauthor=P.+Filippakopoulosauthor=S.+J.+Conway&title=BET+bromodomain+ligands%3A+probing+the+WPF+shelf+to+improve+BRD4+bromodomain+affinity+and+metabolic+stability&doi=10.1016%2Fj.bmc.2018.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability</span></div><div class="casAuthors">Jennings, Laura E.; Schiedel, Matthias; Hewings, David S.; Picaud, Sarah; Laurin, Corentine M. C.; Bruno, Paul A.; Bluck, Joseph P.; Scorah, Amy R.; See, Larissa; Reynolds, Jessica K.; Moroglu, Mustafa; Mistry, Ishna N.; Hicks, Amy; Guzanov, Pavel; Clayton, James; Evans, Charles N. G.; Stazi, Giulia; Biggin, Philip C.; Mapp, Anna K.; Hammond, Ester M.; Humphreys, Philip G.; Filippakopoulos, Panagis; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2937-2957</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ligands for the bromodomain and extra-terminal domain (BET) family of bromodomains have shown promise as useful therapeutic agents for treating a range of cancers and inflammation.  Here the authors report that the previously developed 3,5-dimethylisoxazole-based BET bromodomain ligand (OXFBD02) inhibits interactions of BRD4(1) with the RelA subunit of NF-κB, in addn. to histone H4.  This ligand shows a promising profile in a screen of the NCI-60 panel but was rapidly metabolized (t1/2=39.8 min).  Structure-guided optimization of compd. properties led to the development of the 3-pyridyl-derived OXFBD04 (3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[hydroxy(pyridin-3-yl)methyl]phenol).  Mol. dynamics simulations assisted the authors' understanding of the role played by an internal hydrogen bond in altering the affinity of this series of mols. for BRD4(1).  OXFBD04 shows improved BRD4(1) affinity (IC50=166 nM), optimized physicochem. properties (LE=0.43; LLE=5.74; SFI=5.96), and greater metabolic stability (t1/2=388 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYjNvb4_o4CbVg90H21EOLACvtfcHk0ljG58WZPxePDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFOqsrg%253D&md5=8b4a1a90a2440662430b90bb3c84c404</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DSchiedel%26aufirst%3DM.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DLaurin%26aufirst%3DC.%2BM.%2BC.%26aulast%3DBruno%26aufirst%3DP.%2BA.%26aulast%3DBluck%26aufirst%3DJ.%2BP.%26aulast%3DScorah%26aufirst%3DA.%2BR.%26aulast%3DSee%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DJ.%2BK.%26aulast%3DMoroglu%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DI.%2BN.%26aulast%3DHicks%26aufirst%3DA.%26aulast%3DGuzanov%26aufirst%3DP.%26aulast%3DClayton%26aufirst%3DJ.%26aulast%3DEvans%26aufirst%3DC.%2BN.%2BG.%26aulast%3DStazi%26aufirst%3DG.%26aulast%3DBiggin%26aufirst%3DP.%2BC.%26aulast%3DMapp%26aufirst%3DA.%2BK.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DBET%2520bromodomain%2520ligands%253A%2520probing%2520the%2520WPF%2520shelf%2520to%2520improve%2520BRD4%2520bromodomain%2520affinity%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D2937%26epage%3D2957%26doi%3D10.1016%2Fj.bmc.2018.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasgar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jadhav, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, N. P.</span></span> <span> </span><span class="NLM_article-title">AlphaScreen-based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1439</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3673-1_5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2F978-1-4939-3673-1_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=27316989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Wlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1439&publication_year=2016&pages=77-98&author=A.+Yasgarauthor=A.+Jadhavauthor=A.+Simeonovauthor=N.+P.+Coussens&title=AlphaScreen-based+assays%3A+ultra-high-throughput+screening+for+small-molecule+inhibitors+of+challenging+enzymes+and+protein-protein+interactions&doi=10.1007%2F978-1-4939-3673-1_5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Alphascreen-based assays: ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions</span></div><div class="casAuthors">Yasgar, Adam; Jadhav, Ajit; Simeonov, Anton; Coussens, Nathan P.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1439</span>
        (<span class="NLM_cas:issue">High Throughput Screening</span>),
    <span class="NLM_cas:pages">77-98</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">AlphaScreen technol. has been routinely utilized in high-throughput screening assays to quantify analyte accumulation or depletion, bimol. interactions, and post-translational modifications.  The high signal-to-background, dynamic range, and sensitivity assocd. with AlphaScreens as well as the homogenous assay format and reagent stability make the technol. particularly well suited for high-throughput screening applications.  Here, we describe the development of AlphaScreen assays to identify small-mol. inhibitors of enzymes and protein-protein interactions using the highly miniaturized 1536-well format.  The subsequent implementation of counter assays to identify false-pos. compds. is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLXoZP2Z8ySrVg90H21EOLACvtfcHk0liNxQpUIBaNQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Wlsw%253D%253D&md5=beb19b375f3f596086d8ccd8db22ba45</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3673-1_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3673-1_5%26sid%3Dliteratum%253Aachs%26aulast%3DYasgar%26aufirst%3DA.%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DCoussens%26aufirst%3DN.%2BP.%26atitle%3DAlphaScreen-based%2520assays%253A%2520ultra-high-throughput%2520screening%2520for%2520small-molecule%2520inhibitors%2520of%2520challenging%2520enzymes%2520and%2520protein-protein%2520interactions%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1439%26spage%3D77%26epage%3D98%26doi%3D10.1007%2F978-1-4939-3673-1_5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimmer, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Paying the price of desolvation in solvent-exposed protein pockets: impact of distal solubilizing groups on affinity and binding thermodynamics in a series of thermolysin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5791</span>– <span class="NLM_lpage">5799</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00490</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00490" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsVeqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5791-5799&author=J.+Cramerauthor=S.+G.+Krimmerauthor=A.+Heineauthor=G.+Klebe&title=Paying+the+price+of+desolvation+in+solvent-exposed+protein+pockets%3A+impact+of+distal+solubilizing+groups+on+affinity+and+binding+thermodynamics+in+a+series+of+thermolysin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Paying the Price of Desolvation in Solvent-Exposed Protein Pockets: Impact of Distal Solubilizing Groups on Affinity and Binding Thermodynamics in a Series of Thermolysin Inhibitors</span></div><div class="casAuthors">Cramer, Jonathan; Krimmer, Stefan G.; Heine, Andreas; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5791-5799</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In lead optimization, open, solvent-exposed protein pockets are often disregarded as prospective binding sites.  Because of bulk-solvent proximity, researchers are instead enticed to attach charged polar groups at inhibitor scaffolds to improve soly. and pharmacokinetic properties.  It is rarely considered that solvent effects from water reorganization in the first hydration shell of protein-ligand complexes can have a significant impact on binding.  The authors investigate the thermodn. fingerprint of thermolysin inhibitors featuring terminal charged ammonium groups that are gradually pulled from a distal, solvent-exposed position into the flat, bowl-shaped S2' pocket.  Even for the most remote attachment, costs for partial desolvation of the polar group next to the protein-solvent interface are difficult to compensate by interactions with the protein or surrounding water mols.  Through direct comparison with hydrophobic analogs, a significant 180-fold affinity loss was recorded, which questions popular strategies to attach polar ligand-solubilizing groups at the exposed terminus of substituents accommodated in flat open pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrATxTWUYuldbVg90H21EOLACvtfcHk0liNxQpUIBaNQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsVeqtLs%253D&md5=1e36b68aa48a4133f77097343a48230e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00490%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DJ.%26aulast%3DKrimmer%26aufirst%3DS.%2BG.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DPaying%2520the%2520price%2520of%2520desolvation%2520in%2520solvent-exposed%2520protein%2520pockets%253A%2520impact%2520of%2520distal%2520solubilizing%2520groups%2520on%2520affinity%2520and%2520binding%2520thermodynamics%2520in%2520a%2520series%2520of%2520thermolysin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5791%26epage%3D5799%26doi%3D10.1021%2Facs.jmedchem.7b00490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D. K.</span>; <span class="NLM_string-name">Kuduk, S.</span></span> <span> </span><span class="NLM_article-title">Derivatives and methods of treating Hepatitis B infections</span>. U.S. Patent <span class="NLM_patent">2,016,185,777 A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+D.+K.+Hartman&author=S.+Kuduk&title=Derivatives+and+methods+of+treating+Hepatitis+B+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartman%26aufirst%3DG.%2BD.%2BK.%26atitle%3DDerivatives%2520and%2520methods%2520of%2520treating%2520Hepatitis%2520B%2520infections%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mioskowski, C.</span></span> <span> </span><span class="NLM_article-title">A convenient aminolysis of esters catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3863</span>– <span class="NLM_lpage">3866</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.03.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.tetlet.2007.03.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFyqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3863-3866&author=C.+Sabotauthor=K.+A.+Kumarauthor=S.+Meunierauthor=C.+Mioskowski&title=A+convenient+aminolysis+of+esters+catalyzed+by+1%2C5%2C7-triazabicyclo%5B4.4.0%5Ddec-5-ene+%28TBD%29+under+solvent-free+conditions&doi=10.1016%2Fj.tetlet.2007.03.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient aminolysis of esters catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) under solvent-free conditions</span></div><div class="casAuthors">Sabot, Cyrille; Kumar, Kanduluru Ananda; Meunier, Stephane; Mioskowski, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3863-3866</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aminolysis of esters by using the organocatalyst 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) is reported.  Secondary and tertiary amides were synthesized from alkyl or aryl esters with a variety of primary and secondary amines in good to excellent yields (60-94%) under solvent-free conditions (SFC).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpWg2wOwFmFLVg90H21EOLACvtfcHk0ljG20DZ60_oTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFyqs70%253D&md5=3d668f04b0b3a294db6822d467a04876</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.03.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.03.146%26sid%3Dliteratum%253Aachs%26aulast%3DSabot%26aufirst%3DC.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DMeunier%26aufirst%3DS.%26aulast%3DMioskowski%26aufirst%3DC.%26atitle%3DA%2520convenient%2520aminolysis%2520of%2520esters%2520catalyzed%2520by%25201%252C5%252C7-triazabicyclo%255B4.4.0%255Ddec-5-ene%2520%2528TBD%2529%2520under%2520solvent-free%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D3863%26epage%3D3866%26doi%3D10.1016%2Fj.tetlet.2007.03.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T. S.</span></span> <span> </span><span class="NLM_article-title">Efficient and practical synthesis of mannich bases related to gramine mediated by zinc chloride</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1829</span>– <span class="NLM_lpage">1835</span>, <span class="refDoi"> DOI: 10.1080/00397910600602503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1080%2F00397910600602503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=1829-1835&author=H.+G.+Daiauthor=J.+T.+Liauthor=T.+S.+Li&title=Efficient+and+practical+synthesis+of+mannich+bases+related+to+gramine+mediated+by+zinc+chloride&doi=10.1080%2F00397910600602503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and practical synthesis of Mannich bases related to gramine mediated by zinc chloride</span></div><div class="casAuthors">Dai, Hong-Guang; Li, Ji-Tai; Li, Tong-Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1829-1835</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">An efficient and practical procedure for the Mannich reaction of secondary amines, formaldehyde, and indole or N-methylindole employing zinc chloride is presented.  A series of gramine derivs. were obtained in 58-98% yields at room temp. in EtOH by using this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqboWlHV_I1MbVg90H21EOLACvtfcHk0ljG20DZ60_oTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWitLs%253D&md5=b53d259da574a46b96dfec0050ffbcfe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F00397910600602503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910600602503%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DH.%2BG.%26aulast%3DLi%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DT.%2BS.%26atitle%3DEfficient%2520and%2520practical%2520synthesis%2520of%2520mannich%2520bases%2520related%2520to%2520gramine%2520mediated%2520by%2520zinc%2520chloride%26jtitle%3DSynth.%2520Commun.%26date%3D2006%26volume%3D36%26spage%3D1829%26epage%3D1835%26doi%3D10.1080%2F00397910600602503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span> <span> </span><span class="NLM_article-title">Beyond the rule of 5: lessons learned from AbbVie’s drugs and compound collection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2651</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2636-2651&author=D.+A.+DeGoeyauthor=H.-J.+Chenauthor=P.+B.+Coxauthor=M.+D.+Wendt&title=Beyond+the+rule+of+5%3A+lessons+learned+from+AbbVie%E2%80%99s+drugs+and+compound+collection&doi=10.1021%2Facs.jmedchem.7b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection</span></div><div class="casAuthors">DeGoey, David A.; Chen, Hui-Ju; Cox, Philip B.; Wendt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2636-2651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, there has been an increasing focus on the pursuit of targets considered to be less druggable that offer potential for development of promising new therapeutic agents for the treatment of diseases with large unmet medical need, particularly in the areas of oncol. and virol.  However, conducting drug discovery campaigns in "beyond rule of 5" (bRo5) chem. space presents a significant drug design and development challenge to medicinal chemists to achieve acceptable oral pharmacokinetics.  Retrospective anal. of past successes and failures in drug discovery bRo5 may shed light on the key principles that contribute to the oral bioavailability of successful bRo5 compds. and improve the efficiency of drug design for future projects.  We present here highlights and case studies of lessons learned from discovery of bRo5 compds.  A simple multiparametric scoring function (AB-MPS) was devised that correlated preclin. PK results with cLogD, no. of rotatable bonds, and no. of arom. rings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHuaXbtjlALVg90H21EOLACvtfcHk0licBrW23aBnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbjJ&md5=48984dc65410d83d4ac8ddaca030b024</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00717%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DChen%26aufirst%3DH.-J.%26aulast%3DCox%26aufirst%3DP.%2BB.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26atitle%3DBeyond%2520the%2520rule%2520of%25205%253A%2520lessons%2520learned%2520from%2520AbbVie%25E2%2580%2599s%2520drugs%2520and%2520compound%2520collection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2636%26epage%3D2651%26doi%3D10.1021%2Facs.jmedchem.7b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Studier, F. W.</span></span> <span> </span><span class="NLM_article-title">Protein production by auto-induction in high density shaking cultures</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2Fj.pep.2005.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=15915565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=207-234&author=F.+W.+Studier&title=Protein+production+by+auto-induction+in+high+density+shaking+cultures&doi=10.1016%2Fj.pep.2005.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Protein production by auto-induction in high-density shaking cultures</span></div><div class="casAuthors">Studier, F. William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-234</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inducible expression systems in which T7 RNA polymerase transcribes coding sequences cloned under control of a T7lac promoter efficiently produce a wide variety of proteins in Escherichia coli.  Investigation of factors that affect stability, growth, and induction of T7 expression strains in shaking vessels led to the recognition that sporadic, unintended induction of expression in complex media, previously reported by others, is almost certainly caused by small amts. of lactose.  Glucose prevents induction by lactose by well-studied mechanisms.  Amino acids also inhibit induction by lactose during log-phase growth, and high rates of aeration inhibit induction at low lactose concns.  These observations, and metabolic balancing of pH, allowed development of reliable non-inducing and auto-inducing media in which batch cultures grow to high densities.  Expression strains grown to satn. in non-inducing media retain plasmid and remain fully viable for weeks in the refrigerator, making it easy to prep. many freezer stocks in parallel and use working stocks for an extended period.  Auto-induction allows efficient screening of many clones in parallel for expression and soly., as cultures have only to be inoculated and grown to satn., and yields of target protein are typically several-fold higher than obtained by conventional IPTG induction.  Auto-inducing media have been developed for labeling proteins with selenomethionine, 15N or 13C, and for prodn. of target proteins by arabinose induction of T7 RNA polymerase from the pBAD promoter in BL21-AI.  Selenomethionine labeling was equally efficient in the commonly used methionine auxotroph B834(DE3)(found to be metE) or the prototroph BL21(DE3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYNqgn15xP_bVg90H21EOLACvtfcHk0licBrW23aBnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFCktLw%253D&md5=d31b76747c808ce6fbb27c7a1192b6b8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DStudier%26aufirst%3DF.%2BW.%26atitle%3DProtein%2520production%2520by%2520auto-induction%2520in%2520high%2520density%2520shaking%2520cultures%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D41%26spage%3D207%26epage%3D234%26doi%3D10.1016%2Fj.pep.2005.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span> <i>OriginPro, 9.0</i>; <span class="NLM_publisher-name">OriginLab
Corporation</span>: <span class="NLM_publisher-loc">Northampton, MA, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OriginPro%2C+9.0%3B+OriginLab%0ACorporation%3A+Northampton%2C+MA%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOriginPro%252C%25209.0%26pub%3DOriginLab%250ACorporation" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/s0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2Fs0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liHzzYb7gZiQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2Fs0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kantardjieff, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, B.</span></span> <span> </span><span class="NLM_article-title">Matthews coefficient probabilities: improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1865</span>– <span class="NLM_lpage">1871</span>, <span class="refDoi"> DOI: 10.1110/ps.0350503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1110%2Fps.0350503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=12930986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1865-1871&author=K.+A.+Kantardjieffauthor=B.+Rupp&title=Matthews+coefficient+probabilities%3A+improved+estimates+for+unit+cell+contents+of+proteins%2C+DNA%2C+and+protein-nucleic+acid+complex+crystals&doi=10.1110%2Fps.0350503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals</span></div><div class="casAuthors">Kantardjieff, Katherine A.; Rupp, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1865-1871</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Estg. the no. of mols. in the crystallog. asym. unit is one of the first steps in a macromol. structure detn.  Based on a survey of 15,641 crystallog. Protein Data Bank (PDB) entries the distribution of VM, the crystal vol. per unit of protein mol. wt., known as Matthews coeff., has been reanalyzed.  The range of values and frequencies has changed in the 30 yr since Matthews first anal. of protein crystal solvent content.  In the statistical anal., complexes of proteins and nucleic acids have been treated as a sep. group.  In addn., the VM distribution for nucleic acid crystals has been examd. for the first time.  Observing that resoln. is a significant discriminator of VM, an improved estimator for the probabilities of the no. of mols. in the crystallog. asym. unit has been implemented, using resoln. as addnl. information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZvSs0__vK7rVg90H21EOLACvtfcHk0liHzzYb7gZiQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsrw%253D&md5=63589787961a8f694f0d5f39850610d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1110%2Fps.0350503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.0350503%26sid%3Dliteratum%253Aachs%26aulast%3DKantardjieff%26aufirst%3DK.%2BA.%26aulast%3DRupp%26aufirst%3DB.%26atitle%3DMatthews%2520coefficient%2520probabilities%253A%2520improved%2520estimates%2520for%2520unit%2520cell%2520contents%2520of%2520proteins%252C%2520DNA%252C%2520and%2520protein-nucleic%2520acid%2520complex%2520crystals%26jtitle%3DProtein%2520Sci.%26date%3D2003%26volume%3D12%26spage%3D1865%26epage%3D1871%26doi%3D10.1110%2Fps.0350503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/s0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2Fs0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh-3ANhhmjZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2Fs0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imanaka, T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>590</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1002/1873-3468.12044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1002%2F1873-3468.12044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=26762183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Cru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2016&pages=242-250&author=Y.+Watanabeauthor=K.+Kawaguchiauthor=N.+Okuyamaauthor=Y.+Sugawaraauthor=T.+Obitaauthor=M.+Mizuguchiauthor=M.+Moritaauthor=T.+Imanaka&title=Characterization+of+the+interaction+between+Trypanosoma+brucei+Pex5p+and+its+receptor+Pex14p&doi=10.1002%2F1873-3468.12044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the interaction between Trypanosoma brucei Pex5p and its receptor Pex14p</span></div><div class="casAuthors">Watanabe, Yuichi; Kawaguchi, Kosuke; Okuyama, Naoki; Sugawara, Yuri; Obita, Takayuki; Mizuguchi, Mineyuki; Morita, Masashi; Imanaka, Tsuneo</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">242-250</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The interaction of Trypanosoma brucei (Tb) Pex5p and its receptor TbPex14p is essential for the translocation of newly synthesized matrix proteins into the glycosome.  Here, we reveal that only the 3rd WXXXF/Y motif of TbPex5p is involved in the interaction and that neg. charge of the 4th amino acid is important.  We suggest that Phe35 and Phe52 of TbPex14p interact with Trp318 and Phe322 in the 3rd motif and that the Lys56 adjacent to Phe35/Phe52 assocs. with the 4th Glu in the motif to make the complex.  This information is expected to be useful for developing anti-trypanosomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo56GcTq5FHB7Vg90H21EOLACvtfcHk0lh-3ANhhmjZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Cru7bK&md5=74107d32639407a39062d9e557ae6e92</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2F1873-3468.12044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1873-3468.12044%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DKawaguchi%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DN.%26aulast%3DSugawara%26aufirst%3DY.%26aulast%3DObita%26aufirst%3DT.%26aulast%3DMizuguchi%26aufirst%3DM.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DImanaka%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520the%2520interaction%2520between%2520Trypanosoma%2520brucei%2520Pex5p%2520and%2520its%2520receptor%2520Pex14p%26jtitle%3DFEBS%2520Lett.%26date%3D2016%26volume%3D590%26spage%3D242%26epage%3D250%26doi%3D10.1002%2F1873-3468.12044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/s0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2Fs0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljoFiOqfSfa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2Fs0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/s0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2Fs0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljoFiOqfSfa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2Fs0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brünger, A. T.</span></span> <span> </span><span class="NLM_article-title">Free R value: a novel statistical quantity for assessing the accuracy of crystal structures</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1038/355472a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1038%2F355472a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=18481394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK38XktFOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=472-475&author=A.+T.+Br%C3%BCnger&title=Free+R+value%3A+a+novel+statistical+quantity+for+assessing+the+accuracy+of+crystal+structures&doi=10.1038%2F355472a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Free R value:  a novel statistical quantity for assessing the accuracy of crystal structures</span></div><div class="casAuthors">Bruenger, Axel T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6359</span>),
    <span class="NLM_cas:pages">472-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A reliable and unbiased indicator of the accuracy is proposed for fitting at. models for macromol. structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCvKGOC-AKrVg90H21EOLACvtfcHk0ljoFiOqfSfa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktFOrsrc%253D&md5=a382d593937b2394d9354ccba49cdbc3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2F355472a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F355472a0%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCnger%26aufirst%3DA.%2BT.%26atitle%3DFree%2520R%2520value%253A%2520a%2520novel%2520statistical%2520quantity%2520for%2520assessing%2520the%2520accuracy%2520of%2520crystal%2520structures%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D472%26epage%3D475%26doi%3D10.1038%2F355472a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamzin, V. S.</span></span> <span> </span><span class="NLM_article-title">ARP/wARP and automatic interpretation of protein electron density maps</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1016/s0076-6879(03)74011-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0076-6879%2803%2974011-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=14696376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=229-244&author=R.+J.+Morrisauthor=A.+Perrakisauthor=V.+S.+Lamzin&title=ARP%2FwARP+and+automatic+interpretation+of+protein+electron+density+maps&doi=10.1016%2Fs0076-6879%2803%2974011-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">ARP/wARP and automatic interpretation of protein electron density maps</span></div><div class="casAuthors">Morris, Richard J.; Perrakis, Anastassis; Lamzin, Victor S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part D</span>),
    <span class="NLM_cas:pages">229-244</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The unified process of phase improvement, coupled with automated map interpretation and model building, is described within the framework of the Automated Refinement Procedure, ARP/wARP software, suite.  ARP/wARP is a software suite based on the paradigm of viewing model building and refinement as one unified procedure for optimizing phase ests.  The current version, ARP/wARP 6.0, works with d. recognition-driven procedures for placing and removing atoms and is therefore limited to diffraction data extending to about 2.5 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphsTDGGoRLy7Vg90H21EOLACvtfcHk0ljUotWRisMA6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlygtQ%253D%253D&md5=bc260a20be6b71e053ada934ac851cea</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2803%2974011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252803%252974011-7%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BJ.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26atitle%3DARP%252FwARP%2520and%2520automatic%2520interpretation%2520of%2520protein%2520electron%2520density%2520maps%26jtitle%3DMethods%2520Enzymol.%26date%3D2003%26volume%3D374%26spage%3D229%26epage%3D244%26doi%3D10.1016%2Fs0076-6879%2803%2974011-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span> <i>Schrödinger
Release 2018.3</i>; <span class="NLM_publisher-name">Maestro Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,
2019, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0ARelease+2018.3%3B+Maestro+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C%0A2019%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250ARelease%25202018.3%26pub%3DMaestro%2520Schr%25C3%25B6dinger%252C%250ALLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span> <span> </span><span class="NLM_article-title">YASARA View—molecular graphics for all devices—from smartphones to workstations</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2981</span>– <span class="NLM_lpage">2982</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btu426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1093%2Fbioinformatics%2Fbtu426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=24996895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gjs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2014&pages=2981-2982&author=E.+Kriegerauthor=G.+Vriend&title=YASARA+View%E2%80%94molecular+graphics+for+all+devices%E2%80%94from+smartphones+to+workstations&doi=10.1093%2Fbioinformatics%2Fbtu426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">YASARA view-molecular graphics for all devices-from smartphones to workstations</span></div><div class="casAuthors">Krieger, Elmar; Vriend, Gert</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2981-2982</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Today's graphics processing units (GPUs) compose the scene from individual triangles.  As about 320 triangles are needed to approx. a single sphere-an atom-in a convincing way, visualizing larger proteins with at. details requires tens of millions of triangles, far too many for smooth interactive frame rates.We describe a new approach to solve this -∼mol. graphics problem', which shares the work between GPU and multiple CPU cores, generates high-quality results with perfectly round spheres, shadows and ambient lighting and requires only OpenGL 1.0 functionality, without any pixel shader Z-buffer access (a feature which ismissing inmost mobile devices).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHYmHSnUAZrVg90H21EOLACvtfcHk0ljUotWRisMA6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gjs77O&md5=43fdaf50b31738820d4bce5ade23b27c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtu426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtu426%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DE.%26aulast%3DVriend%26aufirst%3DG.%26atitle%3DYASARA%2520View%25E2%2580%2594molecular%2520graphics%2520for%2520all%2520devices%25E2%2580%2594from%2520smartphones%2520to%2520workstations%26jtitle%3DBioinformatics%26date%3D2014%26volume%3D30%26spage%3D2981%26epage%3D2982%26doi%3D10.1093%2Fbioinformatics%2Fbtu426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0ljKF9VPKFPD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+S%C3%B8ndergaardauthor=M.+H.+M.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0ljKF9VPKFPD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0ljAE7P9ilm9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirado-Rives, J.</span></span> <span> </span><span class="NLM_article-title">The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1021/ja00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL1cXht1yjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=1988&pages=1657-1666&author=W.+L.+Jorgensenauthor=J.+Tirado-Rives&title=The+OPLS+%5Boptimized+potentials+for+liquid+simulations%5D+potential+functions+for+proteins%2C+energy+minimizations+for+crystals+of+cyclic+peptides+and+crambin&doi=10.1021%2Fja00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin</span></div><div class="casAuthors">Jorgensen, William L.; Tirado-Rives, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1657-66</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A complete set of intermol. potential functions was developed for use in computer simulations of proteins in their native environment.  Parameters are reported for 25 peptide residues as well as the common neutral and charged terminal groups.  The potential functions have the simple Coulomb plus Lennard-Jones form and are compatible with the widely used models for water, TIP4P, TIP3P, and SPC.  The parameters were obtained and tested primarily in conjunction with Monte Carlo statistical mechanics simulations of 36 pure org. liqs. and numerous aq. solns. of org. ions representative of subunits in the side chains and backbones of proteins.  Bond stretch, angle bend, and torsional terms were adopted from the AMBER united-atom force field.  As reported here, further testing involved studies of conformational energy surfaces and optimizations of the crystal structures for 4 cyclic hexapeptides and a cyclic pentapeptide.  The av. root mean square deviation from the x-ray structures of the crystals is only 0.17 Å for the at. positions and 3% for the unit cell vols.  A more crit. test was then provided by performing energy minimizations for the complete crystal of the protein crambin, including 182 water mols. that were initially placed via a Monte Carlo simulation.  The resultant root mean square deviation for the non-H atoms is still only 0.17 Å and the variation in the errors for charged, polar, and nonpolar residues is small.  Significant improvement is apparent over the AMBER united-atom force field which was previously demonstrated to be superior to many alternatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ6an38QWApbVg90H21EOLACvtfcHk0ljAE7P9ilm9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXht1yjt7Y%253D&md5=b6c901d8c295b3b37329a7faef527e12</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DTirado-Rives%26aufirst%3DJ.%26atitle%3DThe%2520OPLS%2520%255Boptimized%2520potentials%2520for%2520liquid%2520simulations%255D%2520potential%2520functions%2520for%2520proteins%252C%2520energy%2520minimizations%2520for%2520crystals%2520of%2520cyclic%2520peptides%2520and%2520crambin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1988%26volume%3D110%26spage%3D1657%26epage%3D1666%26doi%3D10.1021%2Fja00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. L.</span></span> <span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1063/1.445869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water&doi=10.1063%2F1.445869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0ljl0zbQmyZuOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935%26doi%3D10.1063%2F1.445869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span> <span> </span><span class="NLM_article-title">Temperature and size dependence for Monte Carlo simulations of TIP4P water</span>. <i>Mol. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1381</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1080/00268978500103111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1080%2F00268978500103111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL28XhtlKgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1985&pages=1381-1392&author=W.+L.+Jorgensenauthor=J.+D.+Madura&title=Temperature+and+size+dependence+for+Monte+Carlo+simulations+of+TIP4P+water&doi=10.1080%2F00268978500103111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Temperature and size dependence for Monte Carlo simulations of TIP4P water</span></div><div class="casAuthors">Jorgensen, William L.; Madura, Jeffry D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Physics</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1381-92</span>CODEN:
                <span class="NLM_cas:coden">MOPHAM</span>;
        ISSN:<span class="NLM_cas:issn">0026-8976</span>.
    </div><div class="casAbstract">The TIP4P model potential (J., et al., 1983) was used in Monte-Carlo simulations on liq. water, which were done to study the effects of temp. (-25 to +100°) and system size (64 to 512 mols.) on calcd. thermodn. and structural properties (including intermol. potential energy, heats of vaporization and H-bonding, d., isothermal compressibility, and radial distribution functions).  The results were compared with the existing exptl. data and other published simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW0gx3dh2BVLVg90H21EOLACvtfcHk0ljl0zbQmyZuOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtlKgurw%253D&md5=9173de8795087ef8c2bf007c92133cc2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1080%2F00268978500103111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00268978500103111%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26atitle%3DTemperature%2520and%2520size%2520dependence%2520for%2520Monte%2520Carlo%2520simulations%2520of%2520TIP4P%2520water%26jtitle%3DMol.%2520Phys.%26date%3D1985%26volume%3D56%26spage%3D1381%26epage%3D1392%26doi%3D10.1080%2F00268978500103111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, K. J.</span>; <span class="NLM_string-name">Chow, E.</span>; <span class="NLM_string-name">Xu, H.</span>; <span class="NLM_string-name">Dror, R. O.</span>; <span class="NLM_string-name">Eastwood, M. P.</span>; <span class="NLM_string-name">Gregersen, B. A.</span>; <span class="NLM_string-name">Klepeis, J. L.</span>; <span class="NLM_string-name">Kolossvary, I.</span>; <span class="NLM_string-name">Moraes, M. A.</span>; <span class="NLM_string-name">Sacerdoti, F. D.</span>; <span class="NLM_string-name">Salmon, J. K.</span>; <span class="NLM_string-name">Shan, Y.</span>; <span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters</span>. In  <i>Proceedings of the 2006 ACM/IEEE Conference on Supercomputing</i>; <span class="NLM_publisher-name">ACM</span>: <span class="NLM_publisher-loc">Tampa, Florida</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=K.+J.+Bowers&author=E.+Chow&author=H.+Xu&author=R.+O.+Dror&author=M.+P.+Eastwood&author=B.+A.+Gregersen&author=J.+L.+Klepeis&author=I.+Kolossvary&author=M.+A.+Moraes&author=F.+D.+Sacerdoti&author=J.+K.+Salmon&author=Y.+Shan&author=D.+E.+Shaw&title=Scalable+Algorithms+for+Molecular+Dynamics+Simulations+on+Commodity+Clusters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DK.%2BJ.%26atitle%3DScalable%2520Algorithms%2520for%2520Molecular%2520Dynamics%2520Simulations%2520on%2520Commodity%2520Clusters%26jtitle%3DProceedings%2520of%2520the%25202006%2520ACM%252FIEEE%2520Conference%2520on%2520Supercomputing%26pub%3DACM%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirumi, K.</span></span> <span> </span><span class="NLM_article-title">Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers</span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.2307/3282883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.2307%2F3282883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=2614608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADyaK3c7jtlaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1989&pages=985-989&author=H.+Hirumiauthor=K.+Hirumi&title=Continuous+cultivation+of+Trypanosoma+brucei+blood+stream+forms+in+a+medium+containing+a+low+concentration+of+serum+protein+without+feeder+cell+layers&doi=10.2307%2F3282883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers</span></div><div class="casAuthors">Hirumi H; Hirumi K</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Blood stream forms (BSF) of Trypanosoma brucei brucei GUT at 3.1 were propagated in vitro in the absence of feeder layer cells at 37 C, using a modified Iscove's medium (HMI-18).  The medium was supplemented with 0.05 mM bathocuproine sulfonate, 1.5 mM L-cysteine, 1 mM hypoxanthine, 0.2 mM 2-mercaptoethanol, 1 mM sodium pyruvate. 0.16 mM thymidine, and 20% (v/v) Serum Plus (SP) (Hazleton Biologics, Lenexa, Kansas).  The latter contained a low level of serum proteins (13 micrograms/ml).  Each primary culture was initiated by placing 3.5-4 x 10(6) BSFs isolated from infected mice in a flask containing 5 ml of the medium (HMI-9) supplemented with 10% fetal bovine serum (FBS) and 10% SP.  The cultures were maintained by replacing the medium every 24 hr for 5-7 days.  During this period, many BSFs died.  However, from day 4 onward, long slender BSFs increased in number.  On days 5-7, trypanosome suspensions were pooled and cell debris was removed by means of diethylaminoethyl cellulose (DE52) column chromatography.  Blood stream forms then were collected by centrifugation, resuspended in fresh medium at 7-9 x 10(5)/ml, and transferred to new flasks.  Subcultures were maintained by readjusting the BSF density to 7-9 x 10(5)/ml every 24 hr.  Concentrations of FBS were reduced gradually at 5-7-day intervals by alternating the amounts of FBS and SP in HMI-9 with 5% FBS and 15% SP, with 2% FBS and 18% SP, and finally with 20% SP (HMI-18).  By this method, 2-3 x 10(6) VSFs/ml were obtained consistently every 24 hr. for more than 80 days.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-hsI_lV2EcpPlX7E30qdzfW6udTcc2eY0cY_DNG3BFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7jtlaksw%253D%253D&md5=a5ec1c8efb4c6572ef8ff09ad88edeb0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2307%2F3282883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3282883%26sid%3Dliteratum%253Aachs%26aulast%3DHirumi%26aufirst%3DH.%26aulast%3DHirumi%26aufirst%3DK.%26atitle%3DContinuous%2520cultivation%2520of%2520Trypanosoma%2520brucei%2520blood%2520stream%2520forms%2520in%2520a%2520medium%2520containing%2520a%2520low%2520concentration%2520of%2520serum%2520protein%2520without%2520feeder%2520cell%2520layers%26jtitle%3DJ.%2520Parasitol.%26date%3D1989%26volume%3D75%26spage%3D985%26epage%3D989%26doi%3D10.2307%2F3282883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span> <i>GraphPad Prism, 6.04</i>; <span class="NLM_publisher-name">GraphPad Software,
Inc</span>: <span class="NLM_publisher-loc">San Diego, CA, USA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GraphPad+Prism%2C+6.04%3B+GraphPad+Software%2C%0AInc%3A+San+Diego%2C+CA%2C+USA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGraphPad%2520Prism%252C%25206.04%26pub%3DGraphPad%2520Software%252C%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baltz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giroud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crockett, J.</span></span> <span> </span><span class="NLM_article-title">Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1985.tb03772.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1002%2Fj.1460-2075.1985.tb03772.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=4006919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaL2MXlslGhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1985&pages=1273-1277&author=T.+Baltzauthor=D.+Baltzauthor=C.+Giroudauthor=J.+Crockett&title=Cultivation+in+a+semi-defined+medium+of+animal+infective+forms+of+Trypanosoma+brucei%2C+T.+equiperdum%2C+T.+evansi%2C+T.+rhodesiense+and+T.+gambiense&doi=10.1002%2Fj.1460-2075.1985.tb03772.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense</span></div><div class="casAuthors">Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-7</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    </div><div class="casAbstract">A semi-defined medium for the cultivation of bloodstream forms of the African trypanosome brucei subgroup was developed.  Out of 14 different strains tested, 10 could be cultured including T. brucei, T. equiperdum, T. evansi, T. rhodesiense, and T. gambiense.  The presence of a reducing agent (2-mercaptoethanol or thioglycerol) was essential for growth.  The std. medium consisted of Hepes buffered min. essential medium with Earle's salts supplemented with 0.2 mM 2-mercaptoethanol, 2 mM pyruvate and 10% inactivated serum either from rabbit (T. brucei, T. equiperdum, T. evansi, and T. rhodesiense) or human (T. grambiense).  Although a general medium could be defined for the long-term maintenance of trypanosome cultures, the initiation to culture nevertheless required particular conditions for the different strains.  The cultured trypanosomes had all the characteristics of the in vivo bloodstream forms including: morphol., infectivity, antigenic variation and glucose metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9zVzQmi2a5LVg90H21EOLACvtfcHk0lh4NP9Ua1F9Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXlslGhtb8%253D&md5=f5eac106bf83676bcec41105092c4f7c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1985.tb03772.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1985.tb03772.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaltz%26aufirst%3DT.%26aulast%3DBaltz%26aufirst%3DD.%26aulast%3DGiroud%26aufirst%3DC.%26aulast%3DCrockett%26aufirst%3DJ.%26atitle%3DCultivation%2520in%2520a%2520semi-defined%2520medium%2520of%2520animal%2520infective%2520forms%2520of%2520Trypanosoma%2520brucei%252C%2520T.%2520equiperdum%252C%2520T.%2520evansi%252C%2520T.%2520rhodesiense%2520and%2520T.%2520gambiense%26jtitle%3DEMBO%2520J.%26date%3D1985%26volume%3D4%26spage%3D1273%26epage%3D1277%26doi%3D10.1002%2Fj.1460-2075.1985.tb03772.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Räz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grether-Bühler, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span> <span> </span><span class="NLM_article-title">The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1016/s0001-706x(97)00079-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2FS0001-706X%2897%2900079-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=9386789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1997&pages=139-147&author=B.+R%C3%A4zauthor=M.+Itenauthor=Y.+Grether-B%C3%BChlerauthor=R.+Kaminskyauthor=R.+Brun&title=The+Alamar+Blue+assay+to+determine+drug+sensitivity+of+African+trypanosomes+%28T.b.+rhodesiense+and+T.b.+gambiense%29+in+vitro&doi=10.1016%2Fs0001-706x%2897%2900079-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro</span></div><div class="casAuthors">Raz, B.; Iten, M.; Grether-Buhler, Y.; Kaminsky, R.; Brun, R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Alamar Blue, an indicator for metabolic cell function, was evaluated as a fluorescent and as a colorimetric dye in drug sensitivity assays for human pathogenic African trypanosomes, Trypanosoma brucei rhodesiense and T.b. gambiense.  The exptl. conditions were adjusted to find those where the relationship between trypanosome no. and Alamar Blue signal was linear over the widest possible range.  Fluorescent signals correlated to trypanosome nos. from 104 trypanosomes/mL (T.b. rhodesiense) and 105 trypanosomes/mL (T.b. gambiense) up to 2-3×106 trypanosomes/mL when trypanosomes were incubated for 2 h with 10 Alamar Blue.  Trypanocidal activity of common drugs (melarsoprol, DFMO, suramin, pentamidine and diminazene aceturate) was detd. employing this assay.  The IC50 values obtained were comparable to those obtained with another fluorochrome, BCECF-AM.  The Alamar Blue assay can be applied for drug screening, since it is simple, reproducible and economical.  The assay can also be used in field sites with less equipped labs., because in addn. to fluorometric endpoint detn., a colorimetric reading is possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi-5OGHtif-rVg90H21EOLACvtfcHk0lh4NP9Ua1F9Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXns1Wms7Y%253D&md5=ffbfe3f890d45919b685d051375769ec</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2FS0001-706X%2897%2900079-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0001-706X%252897%252900079-X%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25A4z%26aufirst%3DB.%26aulast%3DIten%26aufirst%3DM.%26aulast%3DGrether-B%25C3%25BChler%26aufirst%3DY.%26aulast%3DKaminsky%26aufirst%3DR.%26aulast%3DBrun%26aufirst%3DR.%26atitle%3DThe%2520Alamar%2520Blue%2520assay%2520to%2520determine%2520drug%2520sensitivity%2520of%2520African%2520trypanosomes%2520%2528T.b.%2520rhodesiense%2520and%2520T.b.%2520gambiense%2529%2520in%2520vitro%26jtitle%3DActa%2520Trop.%26date%3D1997%26volume%3D68%26spage%3D139%26epage%3D147%26doi%3D10.1016%2Fs0001-706x%2897%2900079-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706x(93)90083-n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1016%2F0001-706x%2893%2990083-n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+EC50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706x%2893%2990083-n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2ebmu0fqCsPwyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0001-706x%2893%2990083-n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706x%252893%252990083-n%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520EC50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706x%2893%2990083-n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verlinde, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Flamme, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span> <span> </span><span class="NLM_article-title">Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2592</span>– <span class="NLM_lpage">2597</span>, <span class="refDoi"> DOI: 10.1128/aac.40.11.2592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=10.1128%2FAAC.40.11.2592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=8913471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;key=1%3ACAS%3A528%3ADyaK28Xms1Smsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=2592-2597&author=F.+S.+Bucknerauthor=C.+L.+Verlindeauthor=A.+C.+La+Flammeauthor=W.+C.+Van+Voorhis&title=Efficient+technique+for+screening+drugs+for+activity+against+Trypanosoma+cruzi+using+parasites+expressing+beta-galactosidase&doi=10.1128%2Faac.40.11.2592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase</span></div><div class="casAuthors">Buckner, Frederick S.; Verlinde, Christophe L. M. J.; la Flamme, Anne C.; van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2592-2597</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A new drug screening method was devised utilizing Trypanosoma cruzi cells that express the Escherichia coli β-galactosidase gene.  Transfected parasites catalyze a colorimetric reaction with chlorophenol red β-D-galactopyranoside as substrate.  Parasite growth in the presence of drugs in microtiter plates was quantitated with an ELISA reader.  The assay was performed with the mammalian form of T. cruzi that requires intracellular growth on a monolayer of fibroblast cells.  To det. if selective toxicity to the parasites was occurring, the viability of the host cells in the drug was assayed with AlamarBlue.  The drugs benznidazole, fluconazole, and amphotericin B were shown to inhibit the parasites at concns. similar to those previously reported.  Several compds. were tested that are inhibitors of glyceraldehyde-3-phosphate dehydrogenase of the related organisms Leishmania mexicana and Trypanosoma brucei.  One of these compds., 2-guanidinobenzimidazole, had a 50% inhibitory concn. of 10 μM in our assay.  Two derivs. of this compd. were identified with in vitro activity at even lower concns.  In addn., the assay was modified for testing compds. for lytic activity against the bloodstream form of the parasite under conditions used for storing blood products.  Thus, an assay with β-galactosidase-expressing T. cruzi greatly simplifies screening drugs for selective anti-T. cruzi activity, and three promising new compds. have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcRR1mgX3GyLVg90H21EOLACvtfcHk0liTTyEmTlt6xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xms1Smsbk%253D&md5=0ec1b723ed87c29e5f38f2d46d732c7e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.11.2592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.11.2592%26sid%3Dliteratum%253Aachs%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DVerlinde%26aufirst%3DC.%2BL.%26aulast%3DLa%2BFlamme%26aufirst%3DA.%2BC.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DEfficient%2520technique%2520for%2520screening%2520drugs%2520for%2520activity%2520against%2520Trypanosoma%2520cruzi%2520using%2520parasites%2520expressing%2520beta-galactosidase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D2592%26epage%3D2597%26doi%3D10.1128%2Faac.40.11.2592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W84','PDB','2W84'); return false;">PDB: 2W84</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5MMC','PDB','5MMC'); return false;">PDB: 5MMC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L87" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L87','PDB','5L87'); return false;">PDB: 5L87</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L8A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L8A','PDB','5L8A'); return false;">PDB: 5L8A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N8V','PDB','5N8V'); return false;">PDB: 5N8V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT','PDB','6SPT'); return false;">PDB: 6SPT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AON" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AON','PDB','5AON'); return false;">PDB: 5AON</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i119"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01876">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64682"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01876?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01876</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystal structure data collection and refinement statistics for TbPEX14-<b>61</b> complex structure; details on MDs simulations performed for TbPEX14-<b>50</b>, TbPEX14-<b>61</b>, and TbPEX14-<b>20</b> complexes; and <sup>1</sup>H and <sup>13</sup>C NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_002.csv">CSV</a>)</p></li><li><p class="inline">PDB File of the TbPEX14 model used for docking (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_001.pdf">jm9b01876_si_001.pdf (17.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_002.csv">jm9b01876_si_002.csv (8.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01876/suppl_file/jm9b01876_si_003.pdb">jm9b01876_si_003.pdb (65.57 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates of the crystal structures have been deposited to the RCSB Protein Data Bank under the following accession codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SPT">6SPT</a> (TbPEX14-<b>61</b>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01876&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-2%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01876%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01876" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d20429e43d48","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
